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The Stoltz group, and moreover the synthetic community at large, has long 
been interested in the development of methods for the synthesis of enantioenriched 
all-carbon quaternary stereocenters. Historically, our group’s interest has centered on 
palladium-catalyzed allylic alkylation, though recently effort has moved to include the 
study of iridium catalysts. This thesis presents four related projects, all unified by the 
use of enantioselective iridium-catalyzed allylic alkylation to construct highly-
congested C–C bonds.  
First, the development of the first diastereo-, enantio-, and regioselective 
iridium-catalyzed allylic alkylation reaction of prochiral enolates to form vicinal 
tertiary and all-carbon quaternary stereodyads with alkyl-substituted allylic 
electrophiles is described. Next, the first enantioselective iridium-catalyzed allylic 
alkylation reaction of a masked acyl cyanide (MAC) nucleophile is presented, 
representing a rare example of umpolung strategy in iridium-catalyzed allylic 
alkylation. Additionally, the application of a MAC reagent in the first highly 
enantioselective iridium-catalyzed allylic alkylation to provide access to products 
bearing an allylic all-carbon quaternary stereocenter is detailed. The use of the MAC 
nucleophile enables the one-pot preparation of α-quaternary carboxylic acids, esters, 
and amides with a high degree of enantioselectivity. Finally, the first enantioselective 
transition metal-catalyzed allylic alkylation providing access to acyclic products 
bearing vicinal all-carbon quaternary centers is presented.  
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1.1   INTRODUCTION 
The synthesis of singular all-carbon quaternary stereocenters has been a 
longstanding challenge in the synthetic community.1 Significant progress in this area over 
the past few decades has recently shifted the forefront of investigation toward the more 
difficult task of constructing vicinal stereodyads bearing at least one quaternary 
stereocenter. This nascent field is beset with difficulties not only arising from the 
increased sterics in the bond-forming event, but also the additional requirement of 
diastereocontrol. Among the available methodologies tailored for this challenge, 2 , 3 
iridium-catalyzed allylic alkylations represent some of the most selective strategies, yet 
remain underdeveloped.4 	†	 This work was performed in collaboration with Dr. J. Caleb Hethcox. Portions of this chapter have been 
reproduced with permission from Hethcox, J. C.;‡ Shockley, S. E.;‡ Stoltz, B. M. Angew. Chem. Int. Ed. 
2016, 55, 16092–16095 © 2016 Wiley-VCH and Hethcox, J. C.;‡ Shockley, S. E.;‡ Stoltz, B. M. ACS 
Catal. 2016, 6, 6207–6213 © 2016 American Chemical Society.  
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The first diastereo-, enantio-, and regioselective iridium-catalyzed allylic 
alkylation was disclosed by Takemoto in 2003 and remained the sole report of such a 
transformation for a decade. 5  Of the eleven published accounts of enantio- and 
diastereoselective iridium-catalyzed allylic alkylation since, 6,7,8  only five reports provide 
access to vicinal tertiary and all-carbon quaternary stereocenters.6 However, none of 
these protocols tolerate the use of alkyl-substituted electrophiles (Figure 1.1a). 
Conversely, the four singular examples employing alkyl-substituted electrophiles in two 
published papers fail to enable construction of all-carbon quaternary stereocenters (Figure 
1.1b).7 While these protocols provide access to valuable chiral synthons, a wide variety of 
synthetic targets require the installation of alkyl-substituted stereodyads between 
neighboring tertiary and quaternary carbon atoms (Figure 1.2). To the best of our 





a) Prior Art: Vicinal Tertiary and Quaternary Stereocenters
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• Four examples 
• No all-carbon quaternary stereocenters
• Vicinal tertiary and quaternary stereocenters
• Alkyl-substituted electrophile 
• Commercially available electrophile
• Five reports 
• No alkyl-substituted electrophiles
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desired motif. Herein, we describe the first method for the iridium-catalyzed synthesis of 
alkyl-substituted vicinal tertiary and all-carbon quaternary stereocenters via allylic 
alkylation of prochiral enolates (Figure 1.1c). 
 





1.2   BACKGROUND TO DIASTEREO-, ENANTIO-, AND 
REGIOSELECTIVE IRIDIUM-CATALYZED ALLYLIC ALKYLATION WITH 
PROCHIRAL ENOLATES 
 A more detailed description of the twelve diastereo-, enantio-, and regioselective 
iridium-catalyzed allylic alkylation methods5–8 previously disclosed at the time we began 
this investigation is discussed vide infra. 
 
1.2.1 IRIDIUM CATALYST-CONTROLLED PROCESSES 
1.2.1.1 Acyclic Nucleophiles 
Takemoto reported the first diastereo-, enantio-, and regioselective iridium-
catalyzed allylic alkylation reaction, wherein an iridium complex of bidentate chiral 
phosphite L1 and [Ir(cod)Cl]2 catalyzes the reaction of glycinate nucleophile 4 and aryl-
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and 9 bearing vicinal tertiary and trisubstituted stereocenters are afforded in moderate to 
excellent yields with good to excellent enantioselectivities, albeit with moderate 
diastereoselectivities. Takemoto also found that simply by employing either KOH or 
LiHMDS, the diastereomeric ratio can be inverted in order to preferentially access either 
diastereomer (7 versus 9); this synthetically useful phenomenon has yet to be reported 
again.  
 
Scheme 1.1 First report of diastereo- and enantioselective iridium-catalyzed allylic alkylation 
 
 
The different behavior of the bases is believed to be the result of contrasting 
enolate geometry; the hypothesis being that KOH predominately gives the E-enolate 5 
and LiHMDS instead forms the Z-enolate 8. This observation illuminates the additional 
challenge that acyclic, prochiral nucleophiles present in contrast to cyclic nucleophiles in 
diastereo- and enantioselective allylic alkylation chemistry. In acyclic cases, the enolate 
geometry must be selectively controlled in addition to the facial approach of the 
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nucleophile. This combination of challenges has resulted in significantly fewer reports of 
acyclic, prochiral enolate nucleophiles as compared to cyclic, prochiral nucleophiles.  
A decade after Takemoto’s report, our group disclosed the second report of an 
iridium-catalyzed allylic alkylation of acyclic enolates in 2013 (Scheme 1.2).6a Like 
Takemoto, we found chelation of the enolate with a metal cation, specifically lithium, to 
be crucial to the diastereoselectivity as bases lacking a chelating metal cation (i.e., 
DABCO) provide significantly lower selectivity. By deprotonating ketoesters 10 with 
LiOt-Bu prior to introduction of the electrophile, products 12 bearing vicinal tertiary and 
all-carbon quaternary stereocenters can be obtained in moderate to excellent selectivities 
with the use of a catalyst derived from [Ir(cod)Cl]2 and Me-THQphos (L2). While a 
majority of the cinnamyl carbonates 11 proceed with a high degree of regioselectivity 
(>90:10), we found that the use of electron-deficient aryl-substituted electrophiles 11 
(e.g., R = C6H5NO2 or C6H5CF3) lead to a decrease in selectivity (50:50–86:14). 
 









R1 = alkyl, benzyl,
 propargyl, F, Cl
+ R2 OCO2Me
[Ir(cod)Cl]2 (2 mol %)
(R,Ra)-L2 (4 mol %)
LiOt-Bu (200 mol %)
TBD (10 mol %)
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In 2016, Hartwig found that acyclic α-alkoxy ketones 13 undergo selective allylic 
alkylation reactions with allyl carbonates 14 in the presence of preformed metallacyclic 
iridium complex 15, LiHMDS, and CuBr (Scheme 1.3).7a In these reactions, the geometry 
of the acyclic enolate, formed by deprotonation with the lithium base, is controlled by 
chelation to a copper(I) salt. Interestingly, the identity of the cation associated with the 
base is also found to play an integral role in achieving high diastereoselectivities, with 
KHMDS providing much lower selectivities than LiHMDS. The exact nature of this 
cation dependence is unknown. It is also worth noting that the scope of this reaction 
permits the use of crotyl carbonates, albeit in lower diastereoselectivities (ca. 7:1 dr). 
This is one of only two reports of alkyl-substituted electrophiles in a diastereoselective 
iridium-catalyzed allylic alkylation.  
 
Scheme 1.3 Allylic alkylation with acyclic α-alkoxy ketones by Hartwig 
 
 
1.2.1.2 Cyclic Nucleophiles 
 In 2013, Hartwig published the first example of a diastereoselective iridium-
catalyzed allylic alkylation of cyclic, prochiral nucleophiles (Scheme 1.4).8a In this 
report, vicinal tertiary and tetra-substituted stereodyads are created via the allylic 






15  (2 mol %) 
LiHMDS (200 mol %)














R1 = aryl, heteroaryl
R2 = Me, MOM, MEM, PMB
14
















Chapter 1 – Stereoselective Iridium-Catalyzed Allylic Alkylation Reactions with Crotyl Chloride 
  
presence of catalytic amounts of achiral silver phosphate 17, 3 Å molecular sieves, and an 
iridium catalyst generated in situ from [Ir(cod)Cl]2 and ligand L3. Through a series of 
control experiments, the authors were able to determine that both the phosphate and 
methyl carbonate anions, but not the silver cation, are key to the high reaction 
diastereoselectivity (up to >20:1 dr). The counteranions are presumed to deprotonate and 
control the facial attack of the nucleophile while the silver cation is believed to sequester 
chloride and promote the formation of the active metallacyclic iridium catalyst. 
 
Scheme 1.4 Counterion-assisted iridium-catalyzed allylic alkylation of azlactones by Hartwig 
 
 
 This counterion strategy did not prove fruitful in the iridium-catalyzed allylic 
alkylation of substituted 5H-oxazol-4-ones 20 or 5H-thiazol-4-ones 24 (Scheme 1.5).8b 
Application of the previously developed conditions to the reaction of 5H-oxazol-4-ones 
20 with cinnamyl carbonates failed to yield desired allylic alkylation products 23 
(Scheme 1.5a). The yields were improved by examining a number of organic and 
inorganic bases in combination with silver phosphate 17. However, it was not until a 
substoichiometric amount of diethyl zinc, allylic acetate 21, and preformed catalyst 22 
18
R1 = 1° or 2° alkyl, Bn
[Ir(cod)Cl]2 (2 mol %)
(R,R,Ra)-L3 (4 mol %) 
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were used in place of the silver phosphate that good diastereoselectivities were achieved 
(up to 18:1 dr). The authors propose that the addition of diethyl zinc leads to the 
formation of zinc enolate aggregates ranging from dimers to tetramers, which in turn 
impart facial selectivity to the prochiral nucleophile.  
 
Scheme 1.5 Cation control of diastereoselectivity in iridium-catalyzed allylic alkylation of a) 5H-
oxazol-4-ones 20 and b) 5H-thiazol-4-ones 24 by Hartwig 
 
 
 Application of the optimal conditions developed for 5H-oxazol-4-ones 20 using 
diethyl zinc does not afford a diastereoselective reaction (1.3:1 dr) with substituted 5H-
thiazol-4-ones 24 (Scheme 1.5b). Instead, the authors achieved diastereoselectivity using 
a magnesium enolate formed from magnesium bis(diisopropyl)amide. The aggregation 
states of magnesium enolates, which are generally thought to be higher order aggregates 
than that of the corresponding zinc enolates, are believed to be responsible for the 
difference in diastereoselectivity. The authors also found that tert-butyl carbonate 
electrophiles 25 further improve the diastereoselectivities (up to 13:1 dr) for this 
nucleophile class.  
20
R1 = 1° or 2° alkyl
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In 2013, our group pioneered the discovery of diastereo- and enantioselective 
iridium-catalyzed allylic alkylation chemistry of cyclic enolates for the formation of 
vicinal tertiary and all-carbon quaternary stereocenters (Scheme 1.6).6b Initial 
investigations involving tetralone 27 revealed that a wide variety of aryl- and heteroaryl-
substituted allylic carbonates 28 react to provide products 29 with high yields and 
stereoselectivities (Scheme 1.6a). The use of Me-THQphos (L2) as the chiral ligand and 
LiBr as a stoichiometric additive were found to be critical in attaining high selectivity. 
We postulate that LiBr results in lithium enolate aggregates, similar to those proposed by 
Hartwig.8b In further investigations, we found that reactions involving various 
monocyclic substrates 30 afford the corresponding products 31 with similarly high yields 
and selectivities to those of the tetralone-based nucleophiles (Scheme 1.6b). Of note, the 
use of electron-deficient aryl-substituted electrophiles leads to an erosion in 
regioselectivity (50:50 to 71:29 branched/linear) in reactions of bicyclic nucleophiles. 
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 Studies toward substrate scope expansion of this reaction led to the successful 
allylic alkylation of extended enolates derived from unsaturated β-ketoester 33 (Scheme 
1.7).6e Though the yields and selectivities were generally found to be lower than the 
corresponding saturated analogs (vide supra), allylic alkylation at the α-carbon atom of 
the extended enolate was achieved to provide products 35 bearing an additional olefin for 
further functionalization of the molecule. 
 
Scheme 1.7 Allylic alkylation of extended enolates by Stoltz 
 
 
 In 2013, Hartwig found that non-stabilized enolates 36 undergo selective iridium-
catalyzed allylic alkylation reactions to form vicinal tertiary and all-carbon quaternary 
stereocenters using preformed iridium complex 22 and BaOt-Bu (Scheme 1.8).6d In all 
cases, products 37 are afforded with excellent enantioenrichment (>98% ee), and even 
simple cyclohexanone derivatives provide good selectivity for allylic alkylation of the 
corresponding thermodynamic enolate. This protocol is currently the only reported set of 
conditions for cyclic nucleophiles that is not limited to softer enolate equivalents (e.g., 
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Scheme 1.8 Allylic alkylation of non-stabilized enolates by Hartwig 
 
 
1.2.2 DUAL CATALYST-CONTROLLED PROCESSES 
 Methodology that allows for the selective synthesis of all four branched 
stereoisomers from one set of starting materials is highly sought after in the field of 
allylic alkylation. However, controlling the facial selectivity of both the nucleophile and 
the electrophile is a daunting task for a single catalyst.9 Thus, the use of two catalysts has 
been required to achieve stereodivergence.  
 
Scheme 1.9 Dual catalyst-promoted allylic alkylation of aldehydes by Carreira 
 	
 In 2013, Carreira disclosed the first dual catalytic allylic alkylation to construct 
vicinal tertiary and all-carbon quaternary stereocenters via the use of cinchona alkaloid-




R1 = alkyl, aryl, benzyl, OMe
+ R2 OCO2Me
22 (2 mol %)


















[Ir(cod)Cl]2 (3 mol %)
L4 (10 mol %)
(Ra)-L5 (12 mol %)
Cl3CCO2H (50 mol %)
















R1 = aryl or alkyl
39
R2 = aryl or heteroaryl
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appropriate combination of enantiomers of ligand L5 and pseudo-enantiomers of L4, 
functionalized aldehyde 40, or any of the three other corresponding stereoisomers, can be 
obtained with little erosion of selectivity due to mismatched catalysts from aldehyde 38 
and branched alcohol 39. The authors propose that the lack of an apparent mismatched 
pair of catalysts likely arises from a high degree of planarity between the two chiral 
intermediates in the carbon–carbon bond-forming event. During the course of reaction 
optimization, the authors discovered that an acid co-catalyst is extremely important for 
high stereoselectivity, with trichloroacetic acid being optimal. This pioneering study set 
the foundation for future work using the powerful combination of enamine and iridium 
catalysis. 
 




 In a second-generation protocol, Carreira utilized proline-derived amine L6 for 
the formation of vicinal tertiary stereocenters (Scheme 1.10).8c While seemingly simpler 
from a steric perspective, this transformation in fact produces a number of additional 
challenges; specifically, both the starting material and allylic alkylation products are 











[Ir(cod)Cl]2 (3 mol %)
(Sa)-L5 (12 mol %)
(R)-L6 (10 mol %)
(MeO)2PO2H (75 mol %)























[Ir(cod)Cl]2 (3 mol %)
(Sa)-L5 (12 mol %)
(S)-L6 (10 mol %)
(MeO)2PO2H (75 mol %)
or Cl3CCO2H (50 mol %)
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epimerization. Nevertheless, the authors found that the appropriate selection of the 
enantiomers of L5 and L6 allows for the full complement of stereoisomers to be accessed 
with good to excellent selectivity. Unlike with the cinchona alkaloid-derived catalyst L4 
(Scheme 1.9), a significant mismatched pair of catalysts is observed (7:1 dr mismatched 
versus 20:1 dr matched). In this work, the authors found dimethyl hydrogen phosphate to 
be the optimal acid co-catalyst (42, R = alkyl). In a follow-up study, the authors reported 
that this method tolerates α-heteroatoms (42, R = NPhth or OBn) in similarly high yields 
and selectivities, though trichloroacetic acid is required as the co-catalyst.8d  
 
Scheme 1.11 Diastereoablative allylic alkylation of 46 by Stoltz 
 
 
Our group has developed a two-step procedure for the divergent synthesis of 
various stereoisomers of cyclohexanone derivatives (Scheme 1.11).6b Trimethylsilyl ethyl 
ester 46 is readily accessible via the aforementioned iridium-catalyzed allylic alkylation 
(Scheme 1.6). The use of the two pseudo-enantiomeric phosphinooxazoline (PHOX) 
ligands L7 and L8 allows for a fluoride-triggered diastereoablative palladium-catalyzed 
allylic alkylation, delivering either 45 or 47 selectively. While there is a significant 
















Ar = 4-CF3-PhAr = 4-CF3-Ph
O OPh Ph
4745
(S)-L7 (12.5 mol %)
Pd2dba3 (5 mol %)
TBAT (120 mol %)
allyl methyl carbonate (120 mol %)
THF, 25 °C
91% yield, 8:1 dr
(R)-L8 (12.5 mol %)
Pd2dba3 (5 mol %)
TBAT (120 mol %)
allyl methyl carbonate (120 mol %)
THF, 25 °C
85% yield, 18:1 dr46
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matched), both palladium-catalyzed allylic alkylation products are obtained in good 
yields with no loss in enantioselectivity.  
Finally, in 2016, Zhang developed a bimetallic dual catalysis strategy for the 
stereodivergent allylic alkylation of α-hydroxyketones 49 using a chiral iridium complex 
derived from phosphoramidite L9 and a chiral zinc–ProPhenol (L10) species.7b This 
method does not require the use of an exogenous base and a range of α-hydroxyl-γ,δ-
unsaturated ketones 48/51 containing vicinal stereocenters can be accessed in good yields 
and stereoselectivities utilizing this protocol. Moreover, with the appropriate combination 
of L9 and L10 enantiomers, any stereoisomer of product can be constructed with the dual 
catalytic strategy; however, a significant mismatched pair of catalysts is observed (15:1 
dr matched versus 6:1 dr mismatched).  
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1.3  REACTION OPTIMIZATION 
Based on the precedent from the aforementioned reports of diastereo-, enantio-, 
and regioselective iridium-catalyzed allylic alkylation, our studies commenced with an 
exploration of the efficacy of additives, leaving groups, bases, and ligands on the 
selectivity of the reaction between α-carboxymethyl tetralone (52) and crotyl electrophile 
53. Using our previously reported conditions for iridium-catalyzed allylic alkylations 
with cinnamyl-derived electrophiles as a starting point,6a,b the reactivity of tetralone 52 
was first investigated with crotyl carbonate in the presence of catalytic phosphoramidite 
L2·½[Ir(cod)Cl]2  and either LiBr (Table 1.1, entry 1),6a LiOt-Bu (entry 2),6b or a 
combination of LiBr and LiOt-Bu (entry 3). Unfortunately, while these conditions result 
in excellent conversion and good diastereoselectivity, low levels of regioselectivity were 
observed. As our earlier work on cinnamyl-derived electrophiles revealed that the 
regioselectivity improved as carbocation stability increased (i.e., increasingly electron-
rich aromatic cinnamyl derivatives),6b we reasoned that the poor regioselectivity in this 
case was likely due to the minimal stabilization of the carbocation afforded by the methyl 
substituent of 53. Specifically, we hypothesized that the attenuated carbocation stability 
could be effecting slow equilibration between diastereomers of the iridium π-allyl 
complex, translating into diminished regioselectivity. Previous reports have proposed that 
LiCl may facilitate the equilibration leading to increased regio- and enantioselectivity,10 
but we noted little improvement in selectivity with the use of LiCl as compared to LiBr 
(entry 4). 
We subsequently turned our attention to the nature of the leaving group on the 
electrophile. We envisioned that switching from crotyl methyl carbonate to crotyl 
15
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chloride would render the anions in solution congruent and perhaps make the effect of the 
chloride anions more pronounced. To our delight, regioselectivity is dramatically 
improved with the use of crotyl chloride, albeit with diminished diastereoselectivity 
(entry 5). 
 
Table 1.1 Optimization of reaction parametersa 
 
 
[a] Reactions performed on 0.1 mmol scale. [b] 1H NMR yield based on internal standard of the mixture of diastereomers. [c] 
Determined by 1H NMR analysis of the crude reaction mixture. [d] Determined by chiral SFC analysis. [e] TBD = 1,3,5-
triazabicyclo[4.4.0]dec-5-ene, proton sponge = 1,8-bis(dimethylamino)naphthalene. 
 
 
Previous work demonstrating the marked effect of bases on regio- and 
diastereoselectivity in iridium-catalyzed allylic alkylations prompted an extensive 
Entry L Base(200 mol %)
Additive
(mol %) 52:53 Yield 54+55(%)b 54:55
c dr of 54c ee of 54(%)d
1 L2 – LiBr (100) 2:1
2 L2 – 2:1
3 L2 LiBr (100) 2:1
4 L2 LiCl (100) 2:1
5 L2 LiCl (100) 2:1
6 L2 proton sponge 2:1LiCl (100)
11 L11 proton sponge 2:1LiCl (400)
12 L11 proton sponge 1:1LiCl (400)
13 L11 proton sponge 1:2LiCl (400)


















100 55:45 6.4:1 –
10 L11 proton sponge 2:1– Cl –
9 L11 proton sponge 2:1LiCl (100)
7 L9 proton sponge 2:1LiCl (100)




79 69:31 2.4:1 –















(S,S,Sa)-L9R = H: (S,Sa)-L2
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exploration of bases (see Section 1.7.2.2, Table 1.4).5–8 We found that the use of proton 
sponge in place of LiOt-Bu afforded the desired branched product 54 with high 
regioselectivity (93:7, 54:55) and diastereoselectivity (7.9:1 dr), though in a modest 66% 
enantiomeric excess (entry 6). A brief study of ligand frameworks (entries 7–9) 11 
revealed 3,3’-diphenyl-phosphoramidite L11 to be optimal. Using L11, allylic alkylation 
product 54 is obtained in excellent enantioselectivity (96% ee) with comparable regio- 
and diastereoselectivities to L2, though in considerably lower yield (46%, entry 9). 
Efforts to increase the yield revealed super-stoichiometric levels of LiCl to be both 
essential and correlative to the conversion (entries 10 and 11). Ultimately, we found that 
the combination of catalytic phosphoramidite L11·½ [Ir(cod)Cl]2, 200 mol % proton 
sponge, and 400 mol % LiCl deliver product 54 in 78% yield (entry 11) with an 
exceptional branched to linear ratio (94:6, 54:55), diastereoselectivity (6.7:1 dr), and 
enantioselectivity (97% ee). Finally, it should be noted that we observed optimal 
conversion and selectivity using a 2:1 nucleophile to electrophile ratio; however, the 
nucleophile and electrophile stoichiometry can be varied (1:1 or 1:2) without 
dramatically affecting reaction conversion or selectivity, rendering the reaction 
synthetically practical (entries 12 and 13). Moreover, the excess equivalent of 
nucleophile can be re-isolated during purification.  
 
1.4   SUBSTRATE SCOPE EXPLORATION 
With the optimized conditions identified, we explored the substrate scope of this 
diastereo-, enantio-, and regioselective allylic alkylation reaction (Table 1.2). Generally, 
the process is tolerant of a wide range of substituents and functionality on both the arene 
17
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and ester groups. We found that increasing the size of the ester moiety (–CO2Me, –CO2Et, 
–CO2i-Pr) results in formation of the corresponding products 54, 58a, and 58b in 
increasingly improved regio- and diastereoselectivity but moderately diminished yields. 
As a balance between yield and selectivity, we moved forward in our investigation using 
α-carboxyethyl tetralone derivatives. Moreover, we were pleased to find that a (2-
trimethylsilyl)ethyl substrate undergoes allylic alkylation to provide 58c with good 
selectivity, albeit in modest yield. Alkylation product 58c may undergo subsequent 
fluoride-triggered allylic alkylation mediated by palladium to provide either diastereomer 
of the bis-alkylation product with catalyst control.12  
We sought to further examine the scope of the reaction by exploring the diversity 
of substitution permitted on the tetralone aromatic ring. Gratifyingly, a wide variety of 
both electron-donating and withdrawing groups are tolerated at varying positions, though 
an electronic effect was noted on enantioselectivity. We observed that substrates bearing 
electron-donating groups (MeO–, Me2N–) at the 6-position give products 58d and 58e 
with slightly diminished enantioselectivity (84–86% ee). Conversely, substrates with 
electron-withdrawing groups (7-MeO–, 7-NO2–, 6-Br–) afford the corresponding 
products 58f, 58g, and 58h in excellent enantioselectivity (94–98% ee). Additionally, 5,7-
dimethyl-substituted tetralone 58i is furnished in comparable selectivity to unsubstituted 
α-carboxyethyl tetralone 58a. In all examples, good regio- and diastereoselectivity is 
observed. Furthermore, during the course of our investigations we found that the β-
ketoester moiety is crucial to the reaction. Substrates with this functionality replaced with 
either a nitrile or ketone provide the corresponding products 58j and 58k in decreased 
selectivities.  
18
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Table 1.2 Substrate scope explorationa 
 
[a] Reactions performed on 0.2 mmol scale with 2:1 nucleophile/electrophile. [b] 1H NMR yield based on internal standard 
of the mixture of diastereomers; combined isolated yield of branched and linear products given in parentheses. [c] 
Determined by 1H NMR analysis of the crude reaction mixture. [d] Determined by chiral SFC or HPLC analysis. [e] Absolute 
stereochemistry determined via single-crystal X-ray analysis. 
 
 
A broader investigation of the substrate scope reveals additional limitations of the 
catalytic system (Table 1.3). Foremost, no allylic alkylation is observed with alkyl-
substituted allylic chloride derivatives other than crotyl chloride (57). With respect to 
limitations on the nucleophile substrate scope, altering the saturated ring size (e.g., a 
benzosuberone-derived nucleophile) or employing a 2-tetralone-derived nucleophile 
O
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leads to products 60a and 60b in significantly diminished diastereo- and regioselectivities. 
Additionally, bicyclic nucleophiles containing fused heterocycles give products 60c and 
60d in decreased yields. Use of a chromanone-based nucleophile affords allylic 
alkylation product 60e with no diastereocontrol. Furthermore, we observed that 
monocyclic nucleophiles, including lactones, lactams, and piperidones, afford the 
corresponding products 60f, 60g, 60h, 60i, and 60j in only modest yields. Morever, with 
respect to linear nucleophiles, we noted minimal or no conversion to product when a 
quaternary stereocenter is formed in the allylic alkylation reaction (e.g., 60k, 60l, and 
60m), and in the case of propargyl 60m, we hypothesize that the alkyne functionality 
leads to catalyst poisoning. However, we did observe excellent reactivity for α-
halogenated linear nucleophiles, which reacted to give products 60n and 60o in high yield 
and regioselectivity, though inconsistent diastereo- and enantioselectivities. Finally, we 
were interested to find that in contrast to the case with a tetralone-derived nucleophile, 
exchanging the β-ketoester moiety for a nitrile on a linear nucleophile gave product 60p 
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Table 1.3 Substrate scope limitationsa 
 
 
[a] Reactions performed on 0.2 mmol scale with 2:1 nucleophile/electrophile. [b] Reaction performed with (S,Sa)-L2. [c] 1H 
NMR yield based on internal standard of the mixture of diastereomers; combined isolated yield of branched and linear 
products given in parentheses. [d] Determined by 1H NMR analysis of the crude reaction mixture. [e] Reaction performed 
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1.5   PRODUCT TRANSFORMATIONS 
To demonstrate the synthetic utility of this method, we carried out a number of 
transformations on allylic alkylation products 54 and 58a (Figure 1.3). We found that the 
addition of allylmagnesium chloride proceeds smoothly to furnish alcohol 61 in 71% 
yield as a single diastereomer. In a two-step protocol, addition of allyl Grignard with 
subsequent ring-closing metathesis allows rapid access to tricycle 62 bearing three 
contiguous stereocenters in 58% yield over two steps. The resultant cyclohexene moiety 
undergoes diastereoselective dihydroxylation to provide triol 63 bearing five contiguous 
stereocenters in 59% yield. Both the ester and the ketone functionalities of 58a can be 
reduced to provide 1,3-diol 64 in 43% yield. Dihydroxylation of the pendant olefin of 58a 
proceeds with concomitant lactonization to provide highly functionalized γ-butyrolactone 
65 in 65% yield. Functionalized γ-butyrolactone moieties are highly prevalent and 
estimated to be present in about 10% of all natural products.13 Additionally, Corey–
Chaykovsky epoxidation proceeds smoothly, furnishing 66 in 82% yield. Notably, all six 
of these derivatizations proceed with excellent diastereoselectivity to facilitate the 
synthesis of at least three contiguous stereocenters, demonstrating the ease with which 
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Figure 1.3 Product transformations of allylic alkylation products 54 and 58aa 
 
[a] allylmagnesium chloride, THF, –78 °C, 71% yield. [b] HG-II, CH2Cl2, 81% yield. [c] K2OsO4, NMO, THF/H2O, 59% yield. 
[d] DIBAL, THF, –78 °C, 43% yield. [e] K2OsO4, NMO, THF/H2O, 65% yield. f) Me3S(O)I, NaH, DMSO, 82% yield. 
 
 
1.6  CONCLUSIONS 
In summary, we have developed the first enantioselective transition-metal-
catalyzed allylic alkylation reaction forming vicinal tertiary and all-carbon quaternary 
stereocenters between prochiral enolates and an alkyl-substituted electrophile. Critical to 
the success of this new reaction is the identity and ubiquity of the chloride counterion in 
addition to the use of proton sponge, the combination of which affords excellent regio- 
and enantioselectivities along with good yields and diastereoselectivities. Additionally, a 
number of transformations were carried out on the alkylation products to demonstrate the 
value of this method in rapidly accessing highly functionalized, stereochemically rich 
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1.7  EXPERIMENTAL SECTION 
1.7.1  MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried 
by passage through an activated alumina column under argon. Commercially obtained 
reagents were used as received. Chemicals were purchased from Sigma 
Aldrich/Strem/Alfa Aesar/Oakwood Chemicals and used as received. Reaction 
temperatures were controlled by an IKAmag temperature modulator. Glove box 
manipulations were performed under a nitrogen atmosphere. Thin-layer chromatography 
(TLC) and preparatory TLC was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized by UV fluorescence quenching, KMnO4, or p-
anisaldehyde staining. SiliaFlash P60 Academic Silica gel (particle size 0.040–0.063 
mm) was used for flash chromatography. Preparatory HPLC was performed with an 
Agilent 1200 Series HPLC equipped with two Agilent Zorbax RX-sil silica columns (9.4 
x 250 mm) in series. Analytical chiral HPLC was performed with an Agilent 1100 Series 
HPLC utilizing a Chiralpak AD-H column (4.6 mm x 25 cm) in series with a Chiralpak 
AD column (4.6 mm x 25 cm) or a Chiralpak IC column (4.6 mm x 25 cm), all obtained 
from Daicel Chemical Industries, Ltd. with visualization at 254 nm. Analytical SFC was 
performed with a Mettler SFC supercritical CO2 analytical chromatography system 
utilizing a Chiralpak IC column (4.6 mm x 25 cm) obtained from Daicel Chemical 
Industries, Ltd. with visualization at 254 nm. 1H NMR spectra were recorded on a Bruker 
Avance HD 400 MHz spectrometer and are reported relative to residual CHCl3 (δ 7.26 
ppm). 13C NMR spectra were recorded on a Bruker Avance HD 400 MHz spectrometer 
24
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and are reported relative to residual CDCl3 (δ 77.16 ppm). Data for 1H NMR are reported 
as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m 
= multiplet, br s = broad singlet. Data for 13C NMR are reported in terms of chemical 
shifts (δ ppm). Some reported spectra include minor solvent impurities of benzene (δ 7.36 
ppm), water (δ 1.56 ppm), ethyl acetate (δ 4.12, 2.05, 1.26 ppm), methylene chloride (δ 
5.30 ppm), grease (δ 1.26, 0.86 ppm), and/or silicon grease (δ 0.07 ppm), which do not 
impact product assignments. IR spectra were obtained using a Perkin Elmer Paragon 
1000 spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm-1). High resolution mass spectra (HRMS) were obtained from the Caltech 
Mass Spectral Facility using a JEOL JMS-600H High Resolution Mass Spectrometer in 
fast atom bombardment (FAB+) or electron ionization (EI+) mode, or an Agilent 6200 
Series TOF with an Agilent G1978A Multimode source in electrospray ionization (ESI+), 
atmospheric pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-
APCI+). Optical rotations were measured with a Jasco P-2000 polarimeter operating on 
the sodium D-line (589 nm), using a 100 mm pathlength cell, and are reported as: [α]DT 
(concentration in g/100 mL, solvent).  
 
1.7.1.1 Preparation of Known Compounds 
Previously reported methods were used to prepare ligands (S,Sa)-L2,11a,14 (S,Sa)-
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1.7.2  EXPERIMENTAL PROCEDURES AND SPECTROSCOPIC DATA 
1.7.2.1 Experimental Procedures and Spectroscopic Data for the Synthesis 
of Tetralone Substrates 
 
	
Isopropyl 1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (56b). A solution of 
methyl ester 5216 (0.75 g, 3.7 mmol, 1 equiv), Bu2SnO (0.091 g, 0.37 mmol, 0.1 equiv), 
and IPA (15 mL) was heated under reflux for 72 h then concentrated onto silica and 
purified by silica gel flash column chromatography (3% Et2O/hexanes) to give isopropyl 
ester 56b (1:1 mixture of enol/keto isomers) as a colorless oil (0.62 g, 72% yield): 1H 
NMR (400 MHz, CDCl3) δ 12.56 (s, 0.5H), 8.05 (ddd, J = 7.8, 1.5, 0.6 Hz, 0.5H), 7.81 – 
7.77 (m, 0.5H), 7.49 (td, J = 7.8, 1.5 Hz, 0.5H), 7.35 – 7.23 (m, 2H), 7.20 – 7.14 (m, 
0.5H), 5.14 (dp, J = 17.1, 6.2 Hz, 1H), 3.56 (dd, J = 10.5, 4.7 Hz, 0.5H), 3.13 – 2.93 (m, 
1H), 2.81 (dd, J = 8.6, 6.9 Hz, 1H), 2.60 – 2.52 (m, 1H), 2.53 – 2.43 (m, 0.5H), 2.35 (ddt, 
J = 13.5, 5.7, 4.7 Hz, 0.5H), 1.32 (d, J = 6.3 Hz, 3H), 1.28 (dd, J = 6.3, 2.8 Hz, 3H); 13C 
NMR (101 MHz, CDCl3) δ 193.6, 172.5, 170.0, 165.0, 143.8, 139.5, 133.9, 132.0, 130.5, 
130.3, 128.9, 127.8, 127.5, 127.0, 126.7, 124.4, 97.5, 69.0, 68.2, 54.9, 27.9, 27.8, 26.5, 
22.2 (2C), 21.9, 21.9, 20.7; IR (Neat Film, NaCl) 3070, 3027, 2980, 2937, 2847, 1736, 
1687, 1644, 1618, 1571, 1454, 1384, 1322, 121, 1214, 1106, 1084, 949, 831, 770, 744 
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2-(Trimethylsilyl)ethyl 1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (56c). A 
solution of LiHMDS (1.83 g, 10.9 mmol, 2 equiv) in THF (20 mL) was added dropwise 
to a solution of 1-tetralone (0.804 g, 5.50 mmol, 1 equiv) in THF (20 mL) via cannula at 
–78 °C. After 1.5 h at –78 °C, a solution of 2-(trimethylsilyl)ethyl 1H-imidazole-1-
carboxylate (1.39 g, 6.55 mmol, 1.2 equiv) in THF (5 mL) was then added. The resulting 
reaction mixture was allowed to warm to ambient temperature and stirred for 18 h. The 
reaction was quenched with the addition of saturated NH4Cl aqueous solution (40 mL) 
and the aqueous layer was then extracted with Et2O (3 x 50 mL). The combined organic 
layers were washed with brine (20 mL), dried over Na2SO4, and concentrated under 
reduced pressure. The crude residue was purified by CombiFlash EZ Prep (12 g silica, 
1à5% Et2O/hexanes, 30 min) to provide ester 56c (3:1 mixture of enol/keto isomers) as 
a colorless oil (0.40 g, 25%): 1H NMR (400 MHz, CDCl3) δ 12.57 (s, 0.75H), 8.08 (dd, J 
= 7.8, 1.4 Hz, 0.25H), 7.83 (dd, J = 7.8, 1.4 Hz, 0.75H), 7.52 (td, J = 7.8, 1.4 Hz, 0.25H), 
7.39 – 7.24 (m, 2H), 7.23 – 7.16 (m, 0.75H), 4.41 – 4.14 (m, 2H), 3.61 (dd, J = 10.3, 4.7 
Hz, 0.25H), 3.14 – 2.97 (m, 0.5H), 2.83 (dd, J = 8.9, 6.6 Hz, 1.5H), 2.64 – 2.57 (m, 
1.5H), 2.56 – 2.47 (m, 0.25H), 2.38 (m, 0.25H), 1.24 – 0.99 (m, 2H), 0.10 (s, 9H); 13C 
NMR (101 MHz, CDCl3) δ 193.4, 173.1, 170.5, 165.1, 155.5, 143.8, 139.5, 134.0, 131.9, 
131.0, 130.2, 128.9, 127.9, 127.5, 127.0, 126.7, 124.4, 97.2, 66.2, 63.8, 62.9, 54.8, 27.9, 
27.8, 26.5, 20.7, 17.7, 17.5, 17.5, –1.3, –1.39, –1.41; IR (Neat Film, NaCl) 3071, 3028, 
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1175, 1133, 1084, 859, 837, 769 cm-1; HRMS (FAB+) m/z calc’d for C16H23O3Si 
[M+H]+: 291.1417, found 291.1421. 
 
 
Ethyl 6-(dimethylamino)-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (56e). 
To a suspension of NaH (0.98 g, 29 mmol, 3.7 equiv, 60 wt %) in THF (10 mL) was 
added diethyl carbonate (1.9 mL, 16 mmol, 2 equiv). The reaction mixture was brought to 
reflux at which point a solution of 6-(dimethylamino)-3,4-dihydronaphthalene-1(2H)-one 
(1.5 g, 7.9 mmol, 1 equiv) in THF (10 mL) was added dropwise via addition funnel over 
15 min. The reaction mixture was heated to reflux for an additional 18 h then allowed to 
cool to ambient temperature, whereupon it was quenched with conc. AcOH (10 mL) and 
diluted with Et2O (30 mL). The organic layer was washed with brine (5 x 10 mL), dried 
over Na2SO4, and concentrated under reduced pressure. The crude residue was purified by 
CombiFlash EZ Prep (12 g silica, 10à20% EtOAc/hexanes, 30 min) to provide 
dimethylamine 56e (keto isomer) as a tan solid (1.36 g, 66%): 1H NMR (400 MHz, 
CDCl3) δ 7.95 (d, J = 9.0 Hz, 1H), 6.60 (dd, J = 9.0, 2.6 Hz, 1H), 6.36 (d, J = 2.6 Hz, 
1H), 4.32 – 4.12 (m, 2H), 3.52 (dd, J = 10.2, 4.7 Hz, 1H), 3.06 (s, 6H), 2.99 – 2.83 (m, 
2H), 2.44 (m, 1H), 2.29 (m, 1H), 1.29 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
191.4, 171.2, 153.8, 145.9, 130.1, 128.5, 120.8, 110.6, 109.3, 61.2, 54.5, 40.2, 28.6, 26.8, 
14.4; IR (Neat Film, NaCl) 2935, 1735, 1660, 1593, 1521, 1449, 1372, 1308, 1197, 1121, 
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Ethyl 7-nitro-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (56g). A solution of 
LiHMDS (1.8 g, 11 mmol, 2.1 equiv) in THF (20 mL) was added dropwise to a solution 
of 7-nitro-3,4-dihydronaphthalene-1(2H)-one (1.0 g, 5.2 mmol, 1 equiv) in THF (20 mL) 
via cannula at –78 °C. The reaction was stirred for 1.5 h at –78 °C, whereupon ethyl 
cyanoformate (0.61 g, 6.2 mmol, 1.2 equiv) was added. The resulting reaction mixture 
was allowed to warm to ambient temperature and was stirred for 18 h. The reaction was 
quenched with the addition of saturated NH4Cl aqueous solution (40 mL) and the 
aqueous layer was then extracted with Et2O (3 x 50 mL). The combined organic layers 
were washed with brine (20 mL), dried over Na2SO4, and concentrated under reduced 
pressure. The crude residue was purified by silica gel flash column chromatography (8% 
EtOAc/hexanes) to provide nitroarene 56g (enol isomer) as a colorless solid (114 mg, 
8%): 1H NMR (400 MHz, CDCl3) δ 12.45 (s, 1H), 8.65 (d, J = 2.4 Hz, 1H), 8.20 (dd, J = 
8.3, 2.4 Hz, 1H), 7.37 (dt, J = 8.3, 1.0 Hz, 1H), 4.34 (q, J = 7.1 Hz, 2H), 2.95 (t, J = 7.8 
Hz, 2H), 2.66 (dd, J = 8.8, 6.9 Hz, 2H), 1.39 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 172.4, 162.5, 147.3, 146.3, 131.6, 128.5, 125.0, 119.6, 98.9, 61.2, 28.0, 20.2, 
14.4; IR (Neat Film, NaCl) 2996, 2962, 2907, 2858, 1755, 1648, 1514, 1401, 1344, 1270, 
1252, 1216, 1068, 1027, 907, 806, 745 cm-1; HRMS (FAB+) m/z calc’d for C13H14NO5 
[M+H]+: 264.0872, found 264.0871. Please note that a minor amount of keto isomer is 
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Ethyl 6-bromo-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (56h). A solution 
of LiHMDS (1.8 g, 11 mmol, 2.1 equiv) in THF (20 mL) was added dropwise to a 
solution of 6-bromo-3,4-dihydronaphthalene-1(2H)-one16 (1.2 g, 5.2 mmol, 1 equiv) in 
THF (20 mL) via cannula at –78 °C. The reaction was stirred for 1.5 h at –78 °C, 
whereupon ethyl cyanoformate (0.61 g, 6.2 mmol, 1.2 equiv) was added. The resulting 
reaction mixture was allowed to warm to ambient temperature and was stirred for 18 h. 
The reaction was quenched with the addition of saturated NH4Cl aqueous solution (40 
mL) and the aqueous layer was then extracted with Et2O (3 x 50 mL). The combined 
organic layers were washed with brine (20 mL), dried over Na2SO4, and concentrated 
under reduced pressure. The crude residue was purified by CombiFlash EZ Prep (12 g 
silica, 5à20% EtOAc/hexanes, 30 min) to provide bromide 56h (4:1 mixture of 
enol/keto isomers) as a tan solid (0.63 g, 41%): 1H NMR (400 MHz, CDCl3) δ 12.44 (s, 
0.8H), 7.90 (d, J = 8.3 Hz, 0.2H), 7.64 (d, J = 8.3 Hz, 0.8H), 7.46 – 7.38 (m, 1.2H), 7.33 
(dd, J = 2.0, 1.0 Hz, 0.8H), 4.27 (p, J = 7.0 Hz, 2H), 3.58 (dd, J = 10.0, 4.7 Hz, 0.2H), 
3.09 – 2.90 (m, 0.4H), 2.78 (dd, J = 8.9, 6.7 Hz, 1.6H), 2.62 – 2.52 (m, 1.6H), 2.53 – 2.27 
(m, 0.4H), 1.34 (t, J = 7.1 Hz, 2.4H), 1.29 (t, J = 7.1 Hz, 0.6H); 13C NMR (101 MHz, 
CDCl3) δ 192.5, 172.7, 170.0, 164.2, 145.4, 141.4, 131.8, 130.7, 130.6, 130.0 129.9, 
129.6, 129.3, 129.1, 126.0, 124.9, 97.4, 61.6, 60.8, 54.4, 27.7, 27.5, 26.3, 20.5, 14.4, 
14.3; IR (Neat Film, NaCl) 2979, 2958, 2902, 2848, 1740, 1689, 1645, 1616, 1588, 1558, 
1479, 1406, 1377, 1267, 1214, 1195, 1096, 1025, 845, 829, 758 cm-1; HRMS (FAB+) m/z 
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2-Acetyl-3,4-dihydronaphthalen-1(2H)-one (56k). To a suspension of NaH (0.49 g, 21 
mmol, 2 equiv, 60 wt %) in EtOAc (2 mL) cooled to 0 °C, a solution of 1-tetralone (1.5 
g, 10 mmol, 1 equiv) in toluene (0.5 mL) was added dropwise. After H2 evolution ceased, 
the resulting solution was heated to 40 °C for 3 h. The reaction mixture was then allowed 
to cool to ambient temperature, whereupon it was quenched with MeOH (5 mL), poured 
onto H2O (20 mL), neutralized with conc. HCl, and extracted with CH2Cl2 (3 x 30 mL). 
The combined organic extracts were washed with brine (30 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude residue was purified by silica gel flash 
column chromatography (10% EtOAc/hexanes) to give ketone 56k (enol isomer) as a 
pale yellow solid (0.51 g, 26%): 1H NMR (400 MHz, CDCl3) δ 7.94 (dd, J = 7.7, 1.4 Hz, 
1H), 7.40 (td, J = 7.7, 1.4 Hz, 1H), 7.36 – 7.29 (m, 1H), 7.20 (dq, J = 7.7, 0.7 Hz, 1H), 
2.87 (dd, J = 8.5, 6.3 Hz, 2H), 2.68 – 2.59 (m, 2H), 2.24 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 194.0, 177.0, 140.9, 132.0, 131.2, 127.7, 127.0, 126.0, 106.1, 28.4, 24.1, 22.9; 
IR (Neat Film, NaCl) 3061, 2940, 2893, 2838, 1598, 1567, 1414, 1354, 1294, 1213, 
1156, 1079, 1033, 974, 902, 788, 737, 548 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d 
for C12H13O2 [M+H]+: 189.0910, found 189.0908. Please note that the exchangeable enol 
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1.7.2.2 Additional Optimization of Reaction Parameters	
Table 1.4 Additional optimization of reaction parametersa	
 
[a] Reactions performed with 0.1 mmol of 53, 0.2 mmol of 52, 0.2 mmol of base, and 0.4 mmol of additive. [b] Determined 








CO2Me+[Ir(cod)Cl]2 (2 mol %) L (4 mol %), TBD (10 mol %)

































































11 94:6 6.7:1proton spongeL11 LiCl THF
10 proton sponge 92:8 8.3:1L2 LiCl THF
12 nr nrproton spongeL11 CsCl THF
13 nr nrproton spongeL11 TBAC THF
14 88:12 6.8:1proton spongeL11 CuCl THF
15 80:20 7.7:1proton spongeL11 LiCl TBME
16c 95:5 6.7:1proton spongeL11 LiCl toluene
17 83:17 4.5:1proton spongeL11 LiCl dioxane
18 nr nrproton spongeL11 LiCl cyclohexane
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1.7.2.3 General Procedure for Optimization Reactions (Table 1.1 & 1.4) 
In a nitrogen-filled glove box, to a 1 dram vial (vial A) equipped with a stir bar 
was added [Ir(cod)Cl]2 (1.3 mg, 0.0020 mmol, 2 mol %), ligand L (0.0040 mmol, 4 mol 
%), TBD (1.4 mg, 0.010 mmol, 10 mol%), and THF (0.5 mL). Vial A was stirred at 25 
°C (ca. 10 min) while another 1 dram vial (vial B) was charged with base, additive, 
tetralone 52 (0.20 mmol), and THF (0.25 mL). The pre-formed catalyst solution (vial A) 
was then transferred to vial B followed by 0.25 mL of a solution of crotyl electrophile 53 
(0.2 M in THF). The vial was sealed and stirred at 25 °C. After 18 h, the vial was 
removed from the glove box and filtered through a pad of silica, rinsing with EtOAc. The 
crude mixture was concentrated and dimethyl maleate (0.050 mmol in 0.5 mL CDCl3) 
was added. The NMR yield (measured in reference to dimethyl maleate δ 6.28 ppm (s, 
2H)), regioselectivity (branched product to linear product: 54:55), and 
diastereoselectivity were determined by 1H NMR analysis of the crude mixture. The 
residue was purified by preparatory TLC (10% Et2O/hexanes) to afford the combined 
branched (54/epi-54) and linear (55) products as an inseparable mixture. The major 
diastereomer (54) was isolated by preparatory HPLC (2% EtOAc/hexanes, two Agilent 
Zorbax RX-sil silica columns in series; flow rate = 15 mL/min; λ = 254 nm) and analyzed 
by chiral SFC (3% MeOH, 3.5 mL/min, Chiralpak AD-H column, λ = 254 nm). 
	
1.7.2.4 General Procedure for the Iridium-Catalyzed Allylic Alkylation 
Please note that the absolute configuration was determined only for compound 
58f via x-ray crystallographic analysis. The absolute configuration for all other products 
33
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(54). In a nitrogen-filled glove box, to a 1 dram vial (vial A) equipped with a stir bar was 
added [Ir(cod)Cl]2 (2.7 mg, 0.0040 mmol, 2 mol %), ligand (S,Sa)-L11 (4.9 mg, 0.0080 
mmol, 4 mol %), TBD (2.8 mg, 0.020 mmol, 10 mol %), and THF (1 mL). Vial A was 
stirred at 25 °C (ca. 10 min) while another 1 dram vial (vial B) was charged with proton 
sponge (86 mg, 0.40 mmol, 200 mol %), tetralone 52 (82 mg, 0.40 mmol, 200 mol %), 
LiCl (34 mg, 0.80 mmol, 400 mol %), and THF (0.5 mL). The pre-formed catalyst 
solution (vial A) was then transferred to vial B followed by a solution of crotyl chloride 
57 (18 mg, 0.20 mmol, 100 mol %) in THF (0.5 mL). The vial was sealed and stirred at 
25 °C. After 18 h, the vial was removed from the glove box and filtered through a pad of 
silica, rinsing with EtOAc. The crude mixture was concentrated and dimethyl maleate 
(0.10 mmol in 0.5 mL CDCl3) was added. The NMR yield (74%, measured in reference 
to dimethyl maleate δ 6.28 ppm (s, 2H)), regioselectivity (branched product to linear 
product, b:l = 93:7), and diastereoselectivity (dr = 6:1) were determined by 1H NMR 
analysis of the crude mixture. The residue was purified by preparatory TLC (10% 
Et2O/hexanes) to give the isolated yield of the branched and linear products (38.0 mg, 
74% combined yield). The diastereomers were separated by preparatory HPLC (2% 
EtOAc/hexanes, two Agilent Zorbax RX-sil silica columns in series; flow rate = 15 
mL/min; λ = 254 nm).  
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Major diastereomer 54 was isolated as a colorless oil: 96% ee; [α]D25 –48.5 (c 0.8, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.05 (ddd, J = 7.9, 1.5, 0.5 Hz, 1H), 7.45 (td, J = 
7.4, 1.5 Hz, 1H), 7.30 (ddt, J = 7.3, 6.9, 1.1 Hz, 1H), 7.20 (dtt, J = 7.6, 1.3, 0.7 Hz, 1H), 
5.82 (ddd, J = 17.0, 10.2, 8.9 Hz, 1H), 5.12 – 4.97 (m, 2H), 3.64 (s, 3H), 3.28 – 3.09 (m, 
2H), 2.90 (ddd, J = 17.4, 4.9, 3.0 Hz, 1H), 2.43 (ddd, J = 13.7, 4.7, 3.0 Hz, 1H), 2.22 
(ddd, J = 13.7, 12.3, 4.9 Hz, 1H), 1.15 (d, J = 6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) 
δ 194.3, 171.2, 143.4, 139.1, 133.6, 132.7, 128.9, 128.2, 126.8, 116.6, 61.2, 52.5, 43.5, 
27.8, 26.3, 16.6; IR (Neat Film, NaCl) 3073, 2951, 2850, 1732, 1688, 1600, 1454, 1434, 
1290, 1241, 1220, 993, 917, 746 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C16H19O3 [M+H]+: 259.1329, found 259.1329; SFC conditions: 3% MeOH, 3.5 mL/min, 
Chiralpak AD-H column, λ = 254 nm, tR (min): major = 5.170, minor = 5.968. 
 
 
Minor diastereomer epi-54 (which was inseparable from major diastereomer 54) was 
isolated as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 8.05 (dd, J = 7.9, 1.4 Hz, 1H), 
7.46 (td, J = 7.5, 1.5 Hz, 1H), 7.34 – 7.27 (m, 1H), 7.23 – 7.16 (m, 1H), 5.98 (ddd, J = 
17.2, 10.3, 7.8 Hz, 1H), 5.12 – 5.00 (m, 2H), 3.65 (s, 3H), 3.27 – 3.05 (m, 2H), 2.97 – 
2.85 (m, 1H), 2.45 (dddd, J = 19.3, 13.7, 4.7, 3.2 Hz, 1H), 2.17 – 2.10 (m, 1H), 1.10 (d, J 
= 7.0 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 194.5, 171.3, 143.3, 139.9, 133.6, 132.7, 
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2951, 1734, 1686, 1601, 1453, 1438, 1289, 1240, 1219, 1000, 917, 808, 746 cm-1. HRMS 
(MM: ESI-APCI+) m/z calc’d for C16H19O3 [M+H]+: 259.1329, found 259.1332. Please 
note that the provided spectra for epi-54 reflect the inseparable mixture of epi-54 and 54, 
while the tabulated NMR data is for only epi-54.  
 
 
Linear isomer 55 was isolated as a colorless oil: 23% ee; [α]D25 –5.2 (c 0.7, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 8.14 – 8.06 (m, 1H), 7.60 – 7.47 (m, 1H), 7.36 (tdd, J = 7.8, 
1.3, 0.6 Hz, 1H), 7.29 – 7.23 (m, 1H), 5.68 – 5.56 (m, 1H), 5.56 – 5.40 (m, 1H), 3.73 (s, 
3H), 3.19 – 3.08 (m, 1H), 2.97 (dt, J = 17.3, 4.9 Hz, 1H), 2.71 (ddt, J = 7.2, 2.5, 1.2 Hz, 
2H), 2.57 (dt, J = 13.8, 4.9 Hz, 1H), 2.26 – 2.13 (m, 1H), 1.71 (dq, J = 6.4, 1.2 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 195.3, 172.3, 143.5, 133.6, 132.1, 129.8, 128.9, 128.2, 
126.9, 125.7, 57.8, 52.6, 37.7, 30.5, 26.0, 18.2; IR (Neat Film, NaCl) 2918, 2850, 1732, 
1689, 1601, 1434, 1263, 1236, 1086, 973, 944, 802, 743 cm-1. HRMS (MM: ESI-APCI+) 
m/z calc’d for C16H19O3 [M+H]+: 259.1329, found 259.1324; HPLC conditions: 1% IPA, 
1 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major = 19.785, minor = 24.041. 
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preparatory TLC (10% Et2O/hexanes) to give the isolated yield of the branched and linear 
products (30.3 mg, 56% combined yield). The major diastereomer was isolated as a 
colorless oil by preparatory HPLC (2% EtOAc/hexanes, two Agilent Zorbax RX-sil silica 
columns in series; flow rate = 15 mL/min; λ = 254 nm): 96% ee; [α]D25 –44.3 (c 0.1, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.04 (dd, J = 7.5, 1.5 Hz, 1H), 7.44 (td, J = 7.5, 
1.5 Hz, 1H), 7.31 – 7.26 (m, 1H), 7.19 (d, J = 7.5 Hz, 1H), 5.84 (ddd, J = 17.0, 10.2, 8.8 
Hz, 1H), 5.20 – 4.96 (m, 2H), 4.24 – 3.95 (m, 2H), 3.26 – 3.08 (m, 2H), 2.89 (ddd, J = 
17.4, 4.7, 3.0 Hz, 1H), 2.41 (ddd, J = 13.7, 4.7, 3.0 Hz, 1H), 2.21 (ddd, J = 13.7, 12.3, 4.7 
Hz, 1H), 1.19 – 1.09 (m, 6H); 13C NMR (101 MHz, CDCl3) δ 194.4, 170.7, 143.2, 139.1, 
133.5, 132.9, 128.8, 128.1, 126.7, 116.5, 61.4, 60.8, 43.4, 28.1, 26.3, 16.6, 14.2; IR (Neat 
Film, NaCl) 3073, 2978, 2938, 1729, 1693, 1639, 1600, 1454, 1290, 1237, 1220, 1019, 
909, 746, 652 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C17H21O3 [M+H]+: 
273.1485, found 273.1493; SFC conditions: 3% MeOH, 3.5 mL/min, Chiralpak AD-H 




carboxylate (58b). Product 58b was prepared according to the general procedure and 
isolated by preparatory TLC (8% EtOAc/hexanes) to give the isolated yield of the 
branched and linear products (31.3 mg, 55% combined yield). The major diastereomer 
was isolated as a colorless oil by preparatory HPLC (2% EtOAc/hexanes, two Agilent 
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[α]D25 –61.5 (c 0.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.02 (dd, J = 7.9, 1.4 Hz, 1H), 
7.43 (td, J = 7.5, 1.5 Hz, 1H), 7.37 – 7.22 (m, 1H), 7.18 (d, J = 7.7 Hz, 1H), 5.86 (ddd, J 
= 17.1, 10.2, 8.8 Hz, 1H), 5.12 – 4.92 (m, 3H), 3.23 – 3.11 (m, 1H), 3.11 – 2.98 (m, 1H), 
2.89 (ddd, J = 17.5, 5.1, 2.9 Hz, 1H), 2.39 (ddd, J = 13.7, 4.8, 2.9 Hz, 1H), 2.20 (ddd, J = 
13.7, 12.2, 5.0 Hz, 1H), 1.18 (dd, J = 6.6, 5.3 Hz, 6H), 1.02 (d, J = 6.2 Hz, 3H); 13C NMR 
(101 MHz, CDCl3) δ 194.6, 170.4, 143.0, 139.2, 133.3, 133.2, 128.7, 128.0, 126.7, 116.5, 
69.0, 60.6, 43.4, 28.5, 26.3, 21.8, 21.6, 16.7; IR (Neat Film, NaCl) 3073, 2979, 2936, 
1724, 1694, 16001, 1456, 1374, 1288, 1244, 1220, 1179, 1144, 1105, 915, 744 cm-1; 
HRMS (MM: ESI-APCI+) m/z calc’d for C18H23O3 [M+H]+: 287.1642, found 287.1650; 
HPLC conditions: 1% EtOH/hexanes, 1 mL/min, Chiralpak AD then AD-H column, λ = 




tetrahydronaphthalene-2-carboxylate (58c). Product 58c was prepared according to the 
general procedure and isolated by preparatory TLC (5% Et2O/hexanes) to give the 
isolated yield of the branched and linear products (18.3 mg, 27% combined yield). The 
major diastereomer was isolated as a colorless oil by preparatory HPLC (1% 
EtOAc/hexanes, two Agilent Zorbax RX-sil silica columns in series; flow rate = 15 
mL/min; λ = 254 nm): 89% ee; [α]D25 –46.0 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 8.04 (dd, J = 8.0, 1.5 Hz, 1H), 7.44 (td, J = 8.0, 1.5 Hz, 1H), 7.29 (t, J = 8.0, 1H), 7.19 
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(m, 2H), 3.26 – 3.02 (m, 2H), 2.88 (ddd, J = 17.4, 4.9, 2.9 Hz, 1H), 2.40 (ddd, J = 13.7, 
4.7, 2.9 Hz, 1H), 2.21 (ddd, J = 13.6, 12.3, 4.9 Hz, 1H), 1.16 (d, J = 6.8 Hz, 3H), 0.89 
(dd, J = 9.3, 8.1 Hz, 2H), –0.03 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 194.4, 171.0, 
143.3, 139.2, 133.5, 133.0, 128.8, 128.2, 126.7, 116.5, 63.9, 60.8, 43.5, 28.2, 26.3, 17.4, 
16.6, –1.5 (3C); IR (Neat Film, NaCl) 3074, 2955, 2899, 1727, 1693, 1601, 1454, 1289, 
1251, 1220, 1141, 1041, 918, 860, 837, 746, 695 cm-1; HRMS (FAB+) m/z calc’d for 
C20H28O3SiNa [M+Na]+: 367.1706, found 367.1720; HPLC conditions: 1% 
EtOH/hexanes, 1 mL/min, Chiralpak AD then AD-H column, λ = 254 nm, tR (min): 




carboxylate (58d). Product 58d was prepared according to the general procedure and 
isolated by preparatory TLC (8% Et2O/hexanes) to give the isolated yield of the branched 
and linear products (33.0 mg, 55% combined yield). The major diastereomer was isolated 
as a colorless oil by preparatory HPLC (7% EtOAc/hexanes, two Agilent Zorbax RX-sil 
silica columns in series; flow rate = 15 mL/min; λ = 254 nm): 84% ee; [α]D25 –12.3 (c 0.5, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 8.8 Hz, 1H), 6.81 (ddd, J = 8.8, 2.6, 
0.7 Hz, 1H), 6.63 (d, J = 2.6 Hz, 1H), 5.82 (ddd, J = 17.1, 10.2, 8.8 Hz, 1H), 5.12 – 4.97 
(m, 2H), 4.20 – 3.99 (m, 2H), 3.84 (s, 3H), 3.26 – 3.08 (m, 2H), 2.84 (ddd, J = 17.4, 4.9, 
3.0 Hz, 1H), 2.39 (ddd, J = 13.6, 4.7, 2.9 Hz, 1H), 2.17 (ddd, J = 13.7, 12.4, 4.9 Hz, 1H), 
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170.8, 163.7, 145.9, 139.2, 130.7, 126.5, 116.4, 113.5, 112.3, 61.4, 60.6, 55.6, 43.3, 27.7, 
26.7, 16.5, 14.3; IR (Neat Film, NaCl) 3075, 2964, 2935, 2849, 1727, 1681, 1600, 1494, 
1446, 1354, 1253, 1217, 1094, 1022, 917, 854, 824 cm-1; HRMS (MM: ESI-APCI+) m/z 
calc’d for C18H23O4 [M+H]+: 303.1591, found 303.1583; HPLC conditions: 1% 
EtOH/hexanes, 1 mL/min, Chiralpak AD then AD-H column, λ = 254 nm, tR (min): 




tetrahydronaphthalene-2-carboxylate (58e). Product 58e was prepared according to the 
general procedure and isolated by preparatory TLC (10% EtOAc/hexanes) to give the 
isolated yield of the branched and linear products (29.0 mg, 46% combined yield). The 
major diastereomer was isolated as a colorless solid by preparatory HPLC (10% 
EtOAc/hexanes, two Agilent Zorbax RX-sil silica columns in series; flow rate = 15 
mL/min; λ = 254 nm): 86% ee; [α]D25 +8.5 (c 0.9, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
7.96 (d, J = 8.9 Hz, 1H), 6.59 (dd, J = 9.0, 2.6 Hz, 1H), 6.31 (d, J = 2.5 Hz, 1H), 5.82 
(ddd, J = 17.1, 10.2, 8.7 Hz, 1H), 5.15 – 4.96 (m, 2H), 4.10 (ddq, J = 41.7, 10.8, 7.1 Hz, 
2H), 3.31 – 3.12 (m, 2H), 3.04 (s, 6H), 2.78 (ddd, J = 17.1, 4.8, 3.0 Hz, 1H), 2.36 (ddd, J 
= 13.4, 4.6, 3.0 Hz, 1H), 2.13 (ddd, J = 13.4, 12.5, 4.8 Hz, 1H), 1.18 (t, J = 7.1 Hz, 3H), 
1.09 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 192.1, 171.2, 153.6, 145.5, 
139.5, 130.5, 121.9, 116.1, 110.5, 109.2, 61.2, 60.5, 43.2, 40.2 (2C), 27.4, 26.9, 16.4, 
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1196, 1125, 1025, 912, 813 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C19H26NO3 
[M+H]+: 316.1907, found 316.1912; HPLC conditions: 3% EtOH/hexanes, 1 mL/min, 





carboxylate (58f). Product 58f was prepared according to the general procedure and 
isolated by preparatory TLC (8% Et2O/hexanes) to give the isolated yield of the branched 
and linear products (41.0 mg, 68% combined yield). The major diastereomer was isolated 
as a colorless oil by preparatory HPLC (2% EtOAc/hexanes, two Agilent Zorbax RX-sil 
silica columns in series; flow rate = 15 mL/min; λ = 254 nm): 94% ee; [α]D25 –76.8 (c 0.8, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 2.8 Hz, 1H), 7.10 (d, J = 8.4 Hz, 1H), 
7.03 (dd, J = 8.4, 2.8 Hz, 1H), 5.84 (ddd, J = 17.0, 10.2, 8.9 Hz, 1H), 5.12 – 4.95 (m, 
2H), 4.20 – 4.02 (m, 2H), 3.83 (s, 3H), 3.17 – 3.04 (m, 2H), 2.83 (ddd, J = 17.2, 5.0, 2.9 
Hz, 1H), 2.39 (ddd, J = 13.6, 4.6, 2.9 Hz, 1H), 2.19 (ddd, J = 13.7, 12.2, 5.0 Hz, 1H), 
1.22 – 1.09 (m, 6H); 13C NMR (101 MHz, CDCl3) δ 194.4, 170.7, 158.3, 139.0, 135.7, 
133.6, 129.9, 122.0, 116.4, 109.6, 61.3, 60.5, 55.5, 43.4, 28.4, 25.4, 16.6, 14.1; IR (Neat 
Film, NaCl) 3075, 2963, 2936, 2838, 1728, 1688, 1609, 1497, 1463, 1419, 1329, 1279, 
1232, 1175, 1143, 1034, 920, 881, 819 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
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carboxylate (58g). Product 58g was prepared according to the general procedure and 
isolated by preparatory TLC (20% EtOAc/hexanes) to give the isolated yield of 
inseparable branched and linear products (52.0 mg, 82% combined yield): 93% ee; [α]D25 
–53.5 (c 1.4, CHCl3); 1H NMR (400 MHz, CDCl3, major diastereomer) δ 8.86 (d, J = 2.5 
Hz, 1H), 8.27 (dd, J = 8.4, 2.5 Hz, 1H), 7.39 (dt, J = 8.7, 0.9 Hz, 1H), 5.81 (ddd, J = 17.1, 
10.2, 8.9 Hz, 1H), 5.23 – 4.99 (m, 2H), 4.25 – 3.97 (m, 2H), 3.24 (dddd, J = 18.1, 12.3, 
4.8, 1.1 Hz, 1H), 3.13 – 2.96 (m, 2H), 2.46 (ddd, J = 13.9, 4.8, 2.7 Hz, 1H), 2.24 (ddd, J 
= 13.9, 12.4, 4.9 Hz, 1H), 1.21 – 1.12 (m, 6H); 13C NMR (101 MHz, CDCl3, major 
diastereomer) δ 192.4, 170.2, 149.7, 147.2, 138.5, 133.8, 130.3, 127.2, 123.4, 117.2, 61.8, 
60.8, 43.6, 27.9, 26.7, 16.6, 14.2; IR (Neat Film, NaCl) 3079, 2979, 2938, 1727, 1698, 
1612, 1526, 1421, 1347, 1218, 1181, 1018, 931, 740 cm-1; HRMS (FAB+) m/z calc’d for 
C17H20NO5 [M+H]+: 318.1341, found 318.1333; HPLC conditions: 5% EtOH/hexanes, 1 












carboxylate (58h). Product 58h was prepared according to the general procedure and 
isolated by silica gel flash column chromatography (5% Et2O/hexanes) to give the 
isolated yield of the branched and linear products (44.0 mg, 63% combined yield). The 
major diastereomer was isolated as a colorless oil by preparatory HPLC (0.8% 
EtOAc/hexanes, two Agilent Zorbax RX-sil silica columns in series; flow rate = 15 
mL/min; λ = 254 nm): 98% ee; [α]D25 –32.7 (c 2.3, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 7.89 (d, J = 8.4 Hz, 1H), 7.42 (ddd, J = 8.4, 2.0, 0.8 Hz, 1H), 7.40 – 7.35 (m, 1H), 5.81 
(ddd, J = 17.1, 10.2, 8.9 Hz, 1H), 5.11 – 4.98 (m, 2H), 4.20 – 3.99 (m, 2H), 3.25 – 3.02 
(m, 2H), 2.85 (ddd, J = 17.6, 4.9, 2.8 Hz, 1H), 2.40 (ddd, J = 13.7, 4.8, 2.9 Hz, 1H), 2.19 
(ddd, J = 13.8, 12.3, 4.9 Hz, 1H), 1.20 – 1.12 (m, 6H); 13C NMR (101 MHz, CDCl3) δ 
193.6, 170.5, 144.9, 138.9, 131.8, 131.7, 130.2, 129.8, 128.7, 116.8, 61.6, 60.7, 43.5, 
28.0, 26.1, 16.6, 14.3; IR (Neat Film, NaCl) 3074, 2977, 2936, 1728, 1690, 1587, 1444, 
1353, 1279, 1235, 1218, 1182, 1144, 1018, 910, 838, 670 cm-1; HRMS (EI+) m/z calc’d 
for C17H19O3Br [M]+: 350.0518, found 350.0491; SFC conditions: 3% MeOH/hexanes, 













carboxylate (58i). Product 58i was prepared according to the general procedure and 
isolated by preparatory TLC (9% EtOAc/hexanes) to give the isolated yield of the 
branched and linear products (31.0 mg, 52% combined yield). The major diastereomer 
was isolated as a colorless oil by preparatory HPLC (1.5% EtOAc/hexanes, two Agilent 
Zorbax RX-sil silica columns in series; flow rate = 15 mL/min; λ = 254 nm): 96% ee; 
[α]D25 –35.1 (c 0.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 2.0 Hz, 1H), 7.22 
– 7.08 (m, 1H), 5.85 (ddd, J = 17.0, 10.2, 8.9 Hz, 1H), 5.18 – 4.94 (m, 2H), 4.20 – 3.86 
(m, 2H), 3.18 – 3.08 (m, 1H), 2.92 (ddd, J = 16.9, 11.6, 5.0 Hz, 1H), 2.81 (ddd, J = 17.7, 
5.6, 3.0 Hz, 1H), 2.45 (ddd, J = 13.8, 4.9, 3.0 Hz, 1H), 2.32 (s, 3H), 2.23 (s, 3H), 2.15 
(ddd, J = 13.8, 11.5, 5.5 Hz, 1H), 1.17 – 1.10 (m, 6H); 13C NMR (101 MHz, CDCl3) δ 
194.9, 170.7, 139.2, 138.7, 136.4, 136.0, 135.8, 132.9, 126.0, 116.4, 61.3, 60.2, 42.9, 
27.1, 23.3, 21.0, 19.3, 16.5, 14.2; IR (Neat Film, NaCl) 3075, 2976, 2935, 1730, 1688, 
1611, 1477, 1445, 1375, 1286, 1236, 1222, 1163, 1139, 1020, 919, 884 cm-1; HRMS 
(MM: ESI-APCI+) m/z calc’d for C19H25O3 [M+H]+: 301.1798, found 301.1801; HPLC 
conditions: 1% IPA/hexanes, 1 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): 











Product 58j was prepared according to the general procedure and isolated by preparatory 
TLC (17% EtOAc/hexanes) to give the isolated yield of the branched and linear products 
(43.0 mg, 95% combined yield). The major diastereomer was isolated as a colorless oil 
by preparatory HPLC (4% EtOAc/hexanes, two Agilent Zorbax RX-sil silica columns in 
series; flow rate = 15 mL/min; λ = 254 nm): 52% ee; [α]D25 +11.4 (c 0.4, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 8.03 (dd, J = 8.0, 1.4 Hz, 1H), 7.54 (td, J = 7.5, 1.5 Hz, 1H), 
7.45 – 7.32 (m, 1H), 7.29 – 7.25 (m, 1H), 5.91 (ddd, J = 17.0, 10.3, 8.0 Hz, 1H), 5.17 (dt, 
J = 10.3, 1.1 Hz, 1H), 5.05 (dt, J = 17.1, 1.2 Hz, 1H), 3.27 – 2.89 (m, 3H), 2.43 (ddd, J = 
7.1, 5.3, 3.4 Hz, 2H), 1.22 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 190.3, 
142.4, 137.1, 134.6, 130.7, 129.0, 128.9, 127.6, 118.5, 118.1, 53.0, 39.8, 28.5, 25.2, 15.3; 
IR (Neat Film, NaCl) 2975, 2930, 1693, 1600, 1454, 1292, 1223, 1158, 1096, 992, 927, 
904, 788, 741 cm-1; HRMS (FAB+) m/z calc’d for C15H16ON [M+H]+: 226.1232, found 
226.1240; HPLC conditions: 2% EtOH/hexanes, 1 mL/min, Chiralpak AD then AD-H 
column, λ = 254 nm, tR (min): major = 24.027, minor = 26.658. 
 
 
(R)-2-acetyl-2-((S)-but-3-en-2-yl)-3,4-dihydronaphthalen-1(2H)-one (58k). Product 
10k was prepared according to the general procedure and isolated by preparatory TLC 
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mg, 23% combined yield). The major diastereomer was isolated as a colorless oil by 
preparatory HPLC (4% EtOAc/hexanes, two Agilent Zorbax RX-sil silica columns in 
series; flow rate = 15 mL/min; λ = 254 nm): 65% ee; [α]D25 –43.3 (c 0.2, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 8.05 (dt, J = 8.0, 0.9 Hz, 1H), 7.47 (td, J = 7.5, 1.5 Hz, 1H), 
7.33 – 7.27 (m, 1H), 7.19 (dtt, J = 7.7, 1.2, 0.6 Hz, 1H), 5.64 (ddd, J = 17.0, 10.2, 8.8 Hz, 
1H), 5.27 – 4.94 (m, 2H), 3.46 – 3.32 (m, 1H), 3.16 (dddt, J = 17.4, 12.6, 4.7, 1.1 Hz, 
1H), 2.84 (ddd, J = 17.4, 5.0, 2.7 Hz, 1H), 2.47 (ddd, J = 13.5, 4.7, 2.7 Hz, 1H), 2.12 – 
2.06 (m, 1H), 2.09 (s, 3H), 1.06 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
204.7, 196.8, 144.2, 138.3, 134.1, 132.8, 129.0, 128.0, 126.7, 116.5, 68.4, 42.6, 26.9, 
25.9, 24.7, 16.3; IR (Neat Film, NaCl) 3076, 2971, 2937, 1708, 1674, 1599, 1446, 1359, 
1295, 1231, 1208, 1120, 995, 912, 781, 754, 737 cm-1; HRMS (FAB+) m/z calc’d for 
C16H19O2 [M+H]+: 243.1385, found 243.1381; HPLC conditions: 1% EtOH/hexanes, 1 
mL/min, Chiralpak AD then AD-H column, λ = 254 nm, tR (min): major = 11.271, minor 
= 11.944. 
 
1.7.2.6 Experimental Procedures and Spectroscopic Data for the 
Transformations of Allylic Alkylation Products	
 
Ethyl (1R,2S)-1-allyl-2-((S)-but-3-en-2-yl)-1-hydroxy-1,2,3,4- 
tetrahydronaphthalene-2-carboxylate (61). Allylmagnesium chloride (0.065 mL, 0.11 
mmol, 1.1 equiv, 1.7 M in THF) was added dropwise to a solution of ethyl ester 58a (27 
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4 h, whereupon the reaction was quenched with a saturated NH4Cl aqueous solution (1 
mL). The aqueous layer was then extracted with EtOAc (3 x 5 mL) and the combined 
organic layers were washed with brine (5 mL), dried over Na2SO4, and concentrated 
under reduced pressure. The crude residue was purified by preparatory TLC (9% 
Et2O/hexanes) to give alcohol 61 as a colorless oil (31 mg, 71% yield): [α]D25 +27.3 (c 
0.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.56 – 7.50 (m, 1H), 7.20 – 7.14 (m, 2H), 
7.10 – 7.02 (m, 1H), 5.99 (ddd, J = 17.1, 10.2, 8.5 Hz, 1H), 5.65 (ddt, J = 17.2, 10.2, 7.1 
Hz, 1H), 4.98 – 4.85 (m, 2H), 4.85 – 4.76 (m, 1H), 4.68 (ddd, J = 17.1, 1.9, 1.0 Hz, 1H), 
4.33 – 4.19 (m, 2H), 4.01 (s, 1H), 2.94 – 2.86 (m, 2H), 2.72 (ddt, J = 8.6, 7.0, 0.8 Hz, 
1H), 2.52 – 2.30 (m, 3H), 2.21 – 2.12 (m, 1H), 1.35 (t, J = 7.1 Hz, 3H), 0.80 (d, J = 7.0 
Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 175.9, 142.0, 140.7, 134.1, 133.7, 127.9, 126.7, 
126.3, 125.5, 117.5, 114.7, 76.6, 61.1, 56.4, 47.2, 41.2, 25.2, 23.3, 16.7, 14.4; IR (Neat 
Film, NaCl) 3492, 3075, 2978, 2930, 2853, 1732, 1694, 1640, 1455, 1376, 1267, 1213, 
1026, 914, 766, 732, 665 cm-1; HRMS (FAB+) m/z calc’d for C20H27O3 [M+H]+: 




8a(4bH)-carboxylate (62). A solution of bis-olefin 61 (4.0 mg, 0.013 mmol, 1 equiv), 
Hoveyda-Grubbs Catalyst-II (1.4 mg, 2.6 µmol, 0.2 equiv), and CH2Cl2 (0.5 mL) was 
stirred at ambient temperature for 18 h, whereupon the reaction mixture was concentrated 
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EtOAc/hexanes) to give tricycle 62 as a colorless oil (3.0 mg, 81% yield): [α]D25 +7.9 (c 
0.2, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.55 – 7.46 (m, 1H), 7.22 – 7.16 (m, 2H), 
7.13 – 7.06 (m, 1H), 5.82 (ddt, J = 10.1, 5.1, 2.6 Hz, 1H), 5.56 (ddt, J = 10.1, 2.6, 1.8 Hz, 
1H), 3.96 (qd, J = 7.1, 1.0 Hz, 2H), 3.36 (ddt, J = 18.0, 3.8, 2.6 Hz, 1H), 3.09 – 2.96 (m, 
1H), 2.96 – 2.78 (m, 2H), 2.70 – 2.57 (m, 1H), 2.49 – 2.38 (m, 1H), 2.28 – 2.11 (m, 1H), 
1.12 (d, J = 7.6 Hz, 3H), 1.07 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 172.2, 
140.0, 136.0, 130.6, 129.6, 127.9, 126.3, 125.1, 124.1, 70.5, 60.0, 52.2, 36.8, 36.4, 26.4, 
25.5, 16.2, 14.2; IR (Neat Film, NaCl) 3488, 3019, 2972, 2934, 1727, 1715, 1451, 1368, 
1293, 1251, 1177, 1027, 887, 761, 694 cm-1; HRMS (FAB+) m/z calc’d for C18H23O3 
[M+H]+: 287.1647, found 287.1637. Please note that the exchangeable hydroxy proton 




hexahydrophenanthrene-8a(4bH)-carboxylate (63). A solution of olefin 62 (18 mg, 
0.058 mmol, 1 equiv), K2OsO4 (1.0 mg, 2.8 µmol, 0.05 equiv), N-methylmorpholine N-
oxide (11 mg, 0.093 mmol, 1.6 equiv), and THF/H2O (3:1, 0.2 mL) was stirred at ambient 
temperature for 18 h, whereupon the reaction was quenched with saturated Na2S2O3 
aqueous solution (1 mL). The aqueous layer was then extracted with EtOAc (5 x 5 mL) 
and the combined organic layers were washed with brine (5 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude residue was purified by preparatory TLC 
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0.2, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.34 (dd, J = 7.8, 1.5 Hz, 1H), 7.19 (td, J = 
7.4, 1.5 Hz, 1H), 7.16 – 7.05 (m, 2H), 4.26 (q, J = 3.3 Hz, 1H), 3.82 (q, J = 7.1 Hz, 2H), 
3.74 (dd, J = 11.0, 3.5 Hz, 1H), 3.70 – 3.56 (m, 1H), 3.06 – 2.92 (m, 3H), 2.78 (dd, J = 
14.6, 3.0 Hz, 1H), 2.61 – 2.44 (m, 1H), 2.24 – 2.05 (m, 2H), 1.10 (d, J = 6.8 Hz, 3H), 
0.90 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 172.9, 139.4, 136.9, 129.6, 
128.4, 125.8, 123.8, 73.0, 72.7, 70.5, 60.4, 56.1, 37.3, 35.3, 25.9, 25.1, 13.9, 12.3; IR 
(Neat Film, NaCl) 3284, 2970, 2928, 1723, 1452, 1382, 1259, 1234, 1189, 1103, 1054, 
1020, 867, 834, 763, 722 cm-1; HRMS (MM: ESI-APCI–) m/z calc’d for C18H24O5Cl 
[M+Cl]–: 355.1318, found 355.1326. Please note that two of the exchangeable hydroxy 




(64). DIBAL (0.071 mL, 0.40 mmol, 4 equiv) was added dropwise to a solution of ethyl 
ester 58a (27 mg, 1.0 mmol, 1 equiv) in THF (0.6 mL) at –78 °C. The mixture was stirred 
at –78 °C for 6 h, whereupon the reaction was quenched with a saturated Rochelle’s salt 
aqueous solution (1 mL) and stirred for 18 h at ambient temperature. The aqueous layer 
was then extracted with EtOAc (3 x 5 mL) and the combined organic layers were washed 
with brine (5 mL), dried over Na2SO4, and concentrated under reduced pressure. The 
crude residue was purified by preparatory TLC (20% EtOAc/hexanes) to give diol 64 as a 
colorless oil (10 mg, 43% yield): [α]D25 +105.7 (c 0.7, CHCl3); 1H NMR (400 MHz, 
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6.30 (ddd, J = 17.2, 10.1, 9.1 Hz, 1H), 4.99 (ddd, J = 10.1, 2.1, 0.6 Hz, 1H), 4.90 (ddd, J 
= 17.3, 2.1, 0.9 Hz, 1H), 4.80 (d, J = 7.3 Hz, 1H), 3.81 (dd, J = 11.3, 5.5 Hz, 1H), 3.59 
(dd, J = 11.4, 3.7 Hz, 1H), 2.91 – 2.66 (m, 2H), 2.65 – 2.57 (m, 2H), 2.19 (bs, 1H), 1.75 
(ddd, J = 13.8, 7.2, 6.5 Hz, 1H), 1.64 – 1.50 (m, 1H), 1.04 (d, J = 7.0 Hz, 3H); 13C NMR 
(101 MHz, CDCl3) δ 144.5, 138.9, 135.9, 128.4, 127.3, 127.0, 126.5, 115.1, 75.3, 67.3, 
43.7, 39.8, 25.8, 25.7, 15.5; IR (Neat Film, NaCl) 3404, 3069, 3020, 2932, 1634, 1602, 
1455, 1417, 1374, 1268, 1217, 1191, 1045, 991, 913, 774, 741, 641 cm-1; HRMS (FAB+) 
m/z calc’d for C15H19O2 [(M+H)–H2]+: 231.1385, found 231.1385. Please note that a 




naphthalene]-1',2-dione (65). A solution of methyl ester 54 (20.0 mg, 0.077 mmol, 1 
equiv), K2OsO4 (3.0 mg, 0.0081 mmol, 0.11 equiv), N-methylmorpholine N-oxide (15 
mg, 0.12 mmol, 1.6 equiv), and THF/H2O (3:1, 0.4 mL) was stirred at ambient 
temperature for 12 h, whereupon a second addition of K2OsO4 and N-methylmorpholine 
N-oxide was added and the reaction was stirred for an additional 24 h. The reaction was 
quenched with saturated Na2S2O3 aqueous solution (1 mL). The aqueous layer was then 
extracted with EtOAc (5 x 5 mL) and the combined organic layers were washed with 
brine (5 mL), dried over Na2SO4, and concentrated under reduced pressure. The crude 
residue was purified by preparatory TLC (33% EtOAc/hexanes) to give lactone 65 as a 
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δ 8.07 (dd, J = 7.9, 1.4 Hz, 1H), 7.52 (td, J = 7.5, 1.5 Hz, 1H), 7.38 – 7.31 (m, 1H), 4.26 
(ddd, J = 10.5, 5.6, 2.4 Hz, 1H), 4.01 (ddd, J = 12.8, 7.0, 2.5 Hz, 1H), 3.82 (dt, J = 12.4, 
6.0 Hz, 1H), 3.59 (dq, J = 10.5, 7.0 Hz, 1H), 3.47 – 3.34 (m, 1H), 2.98 (dt, J = 17.0, 3.8 
Hz, 1H), 2.32 – 2.25 (m, 2H), 1.94 (t, J = 6.7 Hz, 1H), 1.03 (d, J = 7.0 Hz, 3H); 13C NMR 
(101 MHz, CDCl3) δ 192.6, 173.5, 144.0, 134.4, 131.8, 129.0, 128.8, 127.2, 84.3, 62.9, 
57.7, 36.1, 25.6, 25.3, 10.8; IR (Neat Film, NaCl) 3444, 2928, 2851, 1760, 1682, 1599, 
1455, 1308, 1239, 1217, 1166, 1094, 1056, 1021, 914, 759, 733, 656 cm-1; HRMS 
(FAB+) m/z calc’d for C15H17O4 [M+H]+: 261.1127, found 261.1129. 





2-carboxylate (66). (CH3)3SOI (35 mg, 0.17 mmol, 1.7 equiv) and NaH (5.0 mg, 0.15 
mmol, 1.5 equiv, 60 wt %) were dissolved in DMSO (1.5 mL). The mixture was stirred 
for 20 min at ambient temperature, whereupon a solution of ketone 58a (27 mg, 0.10 
mmol, 1 equiv) in DMSO (1.0 mL) was added. The resulting solution was stirred for an 
additional 18 h. H2O (2.0 mL) was then added to the reaction mixture and the aqueous 
layer was extractd with EtOAc (3 x 5 mL). The organic layer was washed with H2O (5.0 
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The crude residue was purified by preparatory TLC (3% Et2O/hexanes) to give epoxide 
66 as a colorless oil (23 mg, 82% yield): [α]D25 +10.4 (c 0.1, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.23 – 7.15 (m, 3H), 7.15 – 7.07 (m, 1H), 6.07 (ddd, J = 17.1, 10.3, 8.1 
Hz, 1H), 4.93 (ddd, J = 10.2, 1.9, 0.8 Hz, 1H), 4.74 (ddd, J = 17.1, 2.0, 1.1 Hz, 1H), 4.29 
– 4.06 (m, 2H), 3.01 – 2.94 (m, 1H), 2.98 (d, J = 5.1 Hz, 1H), 2.93 – 2.82 (m, 1H), 2.82 – 
2.71 (m, 1H), 2.62 (d, J = 5.1 Hz, 1H), 2.35 (ddd, J = 14.0, 8.2, 5.7 Hz, 1H), 2.09 (ddd, J 
= 14.2, 6.9, 5.5 Hz, 1H), 1.29 (t, J = 7.1 Hz, 3H), 0.99 (d, J = 6.9 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ; 173.4, 140.9, 138.2, 136.4, 127.8, 127.4, 126.8, 123.4, 115.1, 61.0, 59.1, 
56.5, 51.9, 40.2, 28.0, 26.2, 15.8, 14.4; IR (Neat Film, NaCl) 3073, 2977, 2938, 1723, 
1489, 1456, 1368, 1296, 1255, 1233, 1213, 1134, 1096, 1025, 915, 760 cm-1; HRMS 
(FAB+) m/z calc’d for C18H21O3 [(M+H)–H2]+: 285.1491, found 285.1487. Please note 
that the relative stereochemistry of 16 has been assigned via analogy to 11 and 14. 
 
1.7.2.7 Determination of Enantiomeric Excess 
 
Please note racemic products (rac-54, rac-58) were synthesized as follows: in a 
nitrogen-filled glove box, to a 1 dram vial (vial A) equipped with a stir bar was added 
[Rh(CO)2Cl]2 (10 mol %) and but-3-en-2-yl methyl carbonate (140 mol %) in THF. Vial 
A was stirred at 25 °C (ca. 10 min) while another 1 dram vial (vial B) was charged with 
tetralone 52, 56a–k (100 mol %), NaH (110 mol %), and THF. The pre-formed catalyst 
solution (vial A) was then transferred to vial B and the vial was sealed and stirred at 25 
°C. After 18 h, the vial was removed from the glove box and filtered through celite, 
O
EWG
[Rh(CO)2Cl]2 (10 mol %)
NaH (110 mol %)
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rinsing with EtOAc to give the crude racemic product. The residue was purified as in the 
general procedure for the Ir-catalyzed allylic alkylation. 
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 Figure A1.3 13C NMR (101 MHz, CDCl3) of compound 54 
 
Figure A1.2 Infrared spectrum (Thin Film, NaCl) of compound 54 
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 Figure A1.6 13C NMR (101 MHz, CDCl3) of compound epi-54 
 
Figure A1.5 Infrared spectrum (Thin Film, NaCl) of compound epi-54 
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 Figure A1.9 13C NMR (101 MHz, CDCl3) of compound 55 
 
Figure A1.8 Infrared spectrum (Thin Film, NaCl) of compound 55 
 
64




































































































 Figure A1.12 13C NMR (101 MHz, CDCl3) of compound 56b 
 
Figure A1.11 Infrared spectrum (Thin Film, NaCl) of compound 56b 
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 Figure A1.15 13C NMR (101 MHz, CDCl3) of compound 56c 
 
Figure A1.14 Infrared spectrum (Thin Film, NaCl) of compound 56c 
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 Figure A1.18 13C NMR (101 MHz, CDCl3) of compound 56e 
 
Figure A1.17 Infrared spectrum (Thin Film, NaCl) of compound 56e 
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 Figure A1.21 13C NMR (101 MHz, CDCl3) of compound 56g 
 
Figure A1.20 Infrared spectrum (Thin Film, NaCl) of compound 56g 
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 Figure A1.24 13C NMR (101 MHz, CDCl3) of compound 56h 
 
Figure A1.23 Infrared spectrum (Thin Film, NaCl) of compound 56h 
 
74




































































































 Figure A1.27 13C NMR (101 MHz, CDCl3) of compound 56k 
 
Figure A1.26 Infrared spectrum (Thin Film, NaCl) of compound 56k 
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 Figure A1.30 13C NMR (101 MHz, CDCl3) of compound 58a 
 
Figure A1.29 Infrared spectrum (Thin Film, NaCl) of compound 58a 
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 Figure A1.33 13C NMR (101 MHz, CDCl3) of compound 58b 
 
Figure A1.32 Infrared spectrum (Thin Film, NaCl) of compound 58b 
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 Figure A1.36 13C NMR (101 MHz, CDCl3) of compound 58c 
 
Figure A1.35 Infrared spectrum (Thin Film, NaCl) of compound 58c 
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 Figure A1.39 13C NMR (101 MHz, CDCl3) of compound 58d 
 
Figure A1.38 Infrared spectrum (Thin Film, NaCl) of compound 58d 
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 Figure A1.42 13C NMR (101 MHz, CDCl3) of compound 58e 
 
Figure A1.41 Infrared spectrum (Thin Film, NaCl) of compound 58e 
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 Figure A1.45 13C NMR (101 MHz, CDCl3) of compound 58f 
 
Figure A1.44 Infrared spectrum (Thin Film, NaCl) of compound 58f 
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 Figure A1.48 13C NMR (101 MHz, CDCl3) of compound 58g 
 
Figure A1.47 Infrared spectrum (Thin Film, NaCl) of compound 58g 
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 Figure A1.51 13C NMR (101 MHz, CDCl3) of compound 58h 
 
Figure A1.50 Infrared spectrum (Thin Film, NaCl) of compound 58h 
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 Figure A1.54 13C NMR (101 MHz, CDCl3) of compound 58i 
 
Figure A1.53 Infrared spectrum (Thin Film, NaCl) of compound 58i 
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 Figure A1.57 13C NMR (101 MHz, CDCl3) of compound 58j 
 
Figure A1.56 Infrared spectrum (Thin Film, NaCl) of compound 58j 
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 Figure A1.60 13C NMR (101 MHz, CDCl3) of compound 58k 
 
Figure A1.59 Infrared spectrum (Thin Film, NaCl) of compound 58k 
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 Figure A1.63 13C NMR (101 MHz, CDCl3) of compound 61 
 
Figure A1.62 Infrared spectrum (Thin Film, NaCl) of compound 61 
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 Figure A1.66 13C NMR (101 MHz, CDCl3) of compound 62 
 
Figure A1.65 Infrared spectrum (Thin Film, NaCl) of compound 62 
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 Figure A1.69 13C NMR (101 MHz, CDCl3) of compound 63 
 
Figure A1.68 Infrared spectrum (Thin Film, NaCl) of compound 63 
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 Figure A1.72 13C NMR (101 MHz, CDCl3) of compound 64 
 
Figure A1.71 Infrared spectrum (Thin Film, NaCl) of compound 64 
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 Figure A1.75 13C NMR (101 MHz, CDCl3) of compound 65 
 
Figure A1.74 Infrared spectrum (Thin Film, NaCl) of compound 65 
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 Figure A1.79 13C NMR (101 MHz, CDCl3) of compound 66 
 
Figure A1.78 Infrared spectrum (Thin Film, NaCl) of compound 66 
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Appendix 2 – X-Ray Crystallography Reports Relevant to Chapter 1 
 
A2.1   GENERAL EXPERIMENTAL 
X-ray crystallographic analysis was obtained from the Caltech X-Ray 
Crystallography Facility using a Bruker D8 Venture Kappa Duo Photon 100 CMOS 
diffractometer. 
 
A2.1.1  X-RAY CRYSTAL STRUCTURE ANALYSIS OF ALLYLIC 




The alkylation product 58e (86% ee) was recrystallized by slow evaporation of 
hexanes to provide crystals suitable for X-ray analysis, m.p. = 67 – 69 °C. 
 





Table A2.1 Crystal data and structure refinement for allylic alkylation product 58e 
 
Empirical formula  C19 H25 N O3 
Formula weight  315.40 
Temperature  100(2) K 
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Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 7.5983(10) Å      a = 90°. 
 b = 6.1333(8) Å        b = 99.411(4)°. 
 c = 18.493(3) Å        g = 90°. 
Volume 850.2(2) Å3 
Z 2 
Density (calculated) 1.232 Mg/m3 
Absorption coefficient 0.661 mm-1 
F(000) 340 
Crystal size 0.240 x 0.230 x 0.080 mm3 
Theta range for data collection 2.422 to 79.330°. 
Index ranges -9<=h<=8, -7<=k<=7, -23<=l<=23 
Reflections collected 26025 
Independent reflections 3636 [R(int) = 0.0411] 
Completeness to theta = 67.679° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3636 / 1 / 212 
Goodness-of-fit on F2 1.094 
Final R indices [I>2sigma(I)] R1 = 0.0271, wR2 = 0.0727 
R indices (all data) R1 = 0.0274, wR2 = 0.0730 
Absolute structure parameter 0.07(3) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.132 and -0.164 e.Å-3 
 
 
Table A2.2 Atomic coordinates (x 10
4





) for 58e. U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
_____________________________________________________________________  
O(1) 7683(1) 7250(2) 2322(1) 22(1) 
O(2) 3598(1) 7112(2) 1929(1) 22(1) 
O(3) 2465(1) 3836(2) 2155(1) 26(1) 
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N(1) 7877(2) 5287(2) 5723(1) 22(1) 
C(1) 6891(2) 5855(2) 2615(1) 18(1) 
C(2) 5657(2) 4176(2) 2162(1) 19(1) 
C(3) 5859(2) 1974(2) 2564(1) 21(1) 
C(4) 5385(2) 2122(2) 3330(1) 21(1) 
C(5) 6371(2) 3931(2) 3774(1) 19(1) 
C(6) 6627(2) 3825(2) 4533(1) 20(1) 
C(7) 7579(2) 5444(2) 4976(1) 19(1) 
C(8) 8254(2) 7234(2) 4615(1) 21(1) 
C(9) 8014(2) 7309(2) 3861(1) 20(1) 
C(10) 7074(2) 5687(2) 3423(1) 19(1) 
C(11) 7366(2) 3305(2) 6073(1) 25(1) 
C(12) 8987(2) 6890(2) 6164(1) 23(1) 
C(13) 3720(2) 4979(2) 2090(1) 19(1) 
C(14) 1805(2) 8046(3) 1784(1) 26(1) 
C(15) 1022(2) 7841(3) 986(1) 34(1) 
C(16) 6100(2) 3994(3) 1368(1) 23(1) 
C(17) 4726(2) 2647(3) 886(1) 27(1) 
C(18) 3647(2) 3362(3) 300(1) 34(1) 




Table A2.3 Bond lengths [Å] and angles [°] for 58e 
_____________________________________________________  
O(1)-C(1)  1.2222(17) 
O(2)-C(13)  1.3416(18) 
O(2)-C(14)  1.4618(16) 
O(3)-C(13)  1.2044(18) 
N(1)-C(7)  1.3659(18) 
N(1)-C(12)  1.4557(18) 
N(1)-C(11)  1.4589(18) 
C(1)-C(10)  1.480(2) 
C(1)-C(2)  1.5442(18) 
C(2)-C(3)  1.537(2) 
C(2)-C(13)  1.5374(18) 
C(2)-C(16)  1.5650(19) 
C(3)-C(4)  1.521(2) 
C(3)-H(3A)  0.9900 
115
Appendix 2 – X-Ray Crystallography Reports Relevant to Chapter 1 
 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.5042(19) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(6)  1.388(2) 
C(5)-C(10)  1.4074(19) 
C(6)-C(7)  1.4096(19) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.4236(19) 
C(8)-C(9)  1.376(2) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.4032(19) 
C(9)-H(9)  0.9500 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(14)-C(15)  1.505(2) 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
C(15)-H(15A)  0.9800 
C(15)-H(15B)  0.9800 
C(15)-H(15C)  0.9800 
C(16)-C(17)  1.505(2) 
C(16)-C(19)  1.535(2) 
C(16)-H(16)  1.0000 
C(17)-C(18)  1.322(2) 
C(17)-H(17)  0.9500 
C(18)-H(18A)  0.9500 
C(18)-H(18B)  0.9500 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 










































































































) for 58e. The anisotropic 
displacement factor exponent takes the form:  -2π2 [ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_____________________________________________________________________  
O(1) 19(1)  17(1) 32(1)  2(1) 6(1)  -3(1) 
O(2) 14(1)  16(1) 35(1)  1(1) 1(1)  1(1) 
O(3) 16(1)  21(1) 41(1)  4(1) 3(1)  -3(1) 
N(1) 22(1)  16(1) 28(1)  1(1) 6(1)  -1(1) 
C(1) 11(1)  13(1) 30(1)  2(1) 4(1)  1(1) 
C(2) 14(1)  15(1) 28(1)  0(1) 2(1)  -1(1) 
C(3) 17(1)  13(1) 32(1)  -1(1) 2(1)  -1(1) 
C(4) 18(1)  14(1) 32(1)  2(1) 3(1)  -4(1) 
C(5) 12(1)  14(1) 31(1)  1(1) 4(1)  1(1) 
C(6) 15(1)  14(1) 31(1)  2(1) 6(1)  -1(1) 
C(7) 14(1)  15(1) 28(1)  0(1) 5(1)  3(1) 
C(8) 17(1)  14(1) 32(1)  1(1) 3(1)  -2(1) 
C(9) 14(1)  14(1) 32(1)  3(1) 3(1)  -1(1) 
C(10) 12(1)  15(1) 29(1)  2(1) 3(1)  0(1) 
C(11) 28(1)  17(1) 31(1)  3(1) 9(1)  2(1) 
C(12) 21(1)  19(1) 29(1)  -2(1) 3(1)  0(1) 
C(13) 16(1)  16(1) 24(1)  -1(1) 2(1)  -1(1) 
C(14) 16(1)  20(1) 39(1)  -1(1) 0(1)  3(1) 
C(15) 27(1)  33(1) 40(1)  1(1) -7(1)  5(1) 
C(16) 19(1)  21(1) 28(1)  -1(1) 6(1)  -2(1) 
C(17) 25(1)  27(1) 30(1)  -4(1) 6(1)  -3(1) 
C(18) 30(1)  41(1) 31(1)  -3(1) 3(1)  -3(1) 
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Table A2.5 Hydrogen coordinates (x 10
4







 x  y  z  U(eq) 
_____________________________________________________________________  
H(3A) 5075 886 2276 25 
H(3B) 7106 1463 2599 25 
H(4A) 4085 2369 3292 26 
H(4B) 5673 719 3588 26 
H(6) 6146 2627 4762 24 
H(8) 8872 8379 4895 26 
H(9) 8500 8499 3631 24 
H(11A) 6078 3077 5938 37 
H(11B) 7674 3450 6606 37 
H(11C) 8003 2057 5909 37 
H(12A) 10166 6934 6015 35 
H(12B) 9116 6485 6683 35 
H(12C) 8427 8330 6092 35 
H(14A) 1857 9604 1927 31 
H(14B) 1030 7281 2084 31 
H(15A) 1819 8539 688 52 
H(15B) -147 8555 894 52 
H(15C) 886 6296 854 52 
H(16) 6079 5497 1156 27 
H(17) 4624 1157 1013 33 
H(18A) 3705 4841 153 41 
H(18B) 2815 2397 25 41 
H(19A) 7954 1474 1490 45 
H(19B) 8840 3797 1712 45 
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Triol 63 was recrystallized by slow evaporation of benzene to provide crystals 
suitable for X-ray analysis, m.p. = 111 – 115 °C. 
 




Table A2.6 Crystal data and structure refinement for triol 63 
 
Empirical formula  C28.63 H34.63 O5 
Formula weight  458.70 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Hexagonal 
Space group  P6522 
Unit cell dimensions a = 21.3194(5) Å a = 90°. 
 b = 21.3194(5) Å b = 90°. 
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Volume 7323.6(4) Å3 
Z 12 
Density (calculated) 1.305 Mg/m3 
Absorption coefficient 0.695 mm-1 
F(000) 3108 
Crystal size .2 x .1 x .1 mm3 
Theta range for data collection 2.393 to 58.098°. 
Index ranges -22<=h<=20, -22<=k<=22, -20<=l<=20 
Reflections collected 60463 
Independent reflections 3412 [R(int) = 0.0731] 
Completeness to theta = 67.679° 78.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7514 and 0.6563 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3412 / 1 / 283 
Goodness-of-fit on F2 1.110 
Final R indices [I>2sigma(I)] R1 = 0.0803, wR2 = 0.1889 
R indices (all data) R1 = 0.1100, wR2 = 0.2084 
Absolute structure parameter 0.03(8) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.290 and -0.263 e.Å-3 
 
 
Table A2.7 Atomic coordinates (x 10
4





) for 63. U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________  
 x y z U(eq) 
_____________________________________________________________________  
O(1A) 7920(2) 7040(3) 6808(2) 56(1) 
O(2A) 9307(3) 7800(3) 6495(3) 58(1) 
O(3A) 9815(2) 6894(2) 5959(2) 43(1) 
O(4A) 7565(3) 6012(4) 4758(3) 83(2) 
O(5A) 7359(4) 5007(4) 5298(3) 109(3) 
C(1A) 7758(4) 6774(4) 6067(3) 55(2) 
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C(2A) 7774(4) 6048(4) 6049(3) 52(2) 
C(3A) 7206(4) 5535(4) 6597(4) 63(2) 
C(4A) 6454(4) 5377(7) 6424(5) 91(4) 
C(5A) 6399(5) 6008(7) 6139(4) 83(3) 
C(6A) 5726(6) 5959(9) 6069(5) 125(6) 
C(7A) 5634(7) 6481(12) 5755(7) 136(7) 
C(8A) 6225(7) 7100(9) 5525(5) 109(5) 
C(9A) 6913(5) 7191(6) 5601(4) 81(3) 
C(10A) 7009(4) 6657(6) 5911(4) 70(3) 
C(11A) 8356(4) 7356(4) 5609(4) 57(2) 
C(12A) 9097(4) 7469(4) 5797(3) 48(2) 
C(13A) 9114(3) 6767(4) 5770(3) 42(2) 
C(14A) 8537(3) 6184(4) 6252(3) 44(2) 
C(15A) 8628(4) 5516(4) 6272(4) 63(2) 
C(16A) 7550(4) 5710(5) 5293(4) 63(2) 
C(17A) 7152(6) 4621(7) 4606(5) 137(6) 
C(18A) 6414(7) 4137(6) 4612(5) 113(4) 
C(1) 5200(6) 5125(5) 3686(4) 76(3) 
C(2) 5804(6) 5643(6) 4044(4) 80(3) 
C(3) 6326(6) 6241(6) 3681(5) 91(3) 
C(4) 4612(8) 6693(6) 3992(5) 95(3) 
C(5) 3968(7) 6673(5) 4078(5) 88(3) 
C(6) 5251(7) 7315(7) 4077(5) 100(4) 
C(1DA) 7650(90) 9370(50) 5020(80) 520(40) 
C(2DA) 8300(80) 9420(50) 5190(40) 520(40) 
C(3DA) 8570(40) 9070(70) 4760(80) 520(40) 
C(4DA) 8180(80) 8680(50) 4160(70) 520(40) 
C(5DA) 7520(80) 8630(60) 4000(60) 520(40) 
C(6DA) 7260(40) 8980(70) 4420(100) 520(40) 
C(1DB) 9660(90) 9170(100) 4740(60) 410(30) 
C(2DB) 10280(80) 9850(100) 4720(70) 410(30) 
C(3DB) 10570(30) 10170(40) 4060(110) 410(30) 
C(4DB) 10240(80) 9820(80) 3430(60) 410(30) 
C(5DB) 9620(80) 9140(70) 3450(60) 410(30) 
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Table A2.8 Bond lengths [Å] and angles [°] for 63 
_____________________________________________________  
O(1A)-C(1A)  1.466(7) 
O(2A)-C(12A)  1.438(8) 
O(3A)-C(13A)  1.425(7) 
O(4A)-C(16A)  1.176(10) 
O(5A)-C(16A)  1.344(11) 
O(5A)-C(17A)  1.472(10) 
C(1A)-C(10A)  1.514(10) 
C(1A)-C(11A)  1.519(10) 
C(1A)-C(2A)  1.566(11) 
C(2A)-C(3A)  1.541(10) 
C(2A)-C(16A)  1.543(10) 
C(2A)-C(14A)  1.549(9) 
C(3A)-C(4A)  1.499(12) 
C(4A)-C(5A)  1.504(14) 
C(5A)-C(6A)  1.392(14) 
C(5A)-C(10A)  1.410(14) 
C(6A)-C(7A)  1.35(2) 
C(7A)-C(8A)  1.36(2) 
C(8A)-C(9A)  1.386(13) 
C(9A)-C(10A)  1.382(12) 
C(11A)-C(12A)  1.516(9) 
C(12A)-C(13A)  1.514(9) 
C(13A)-C(14A)  1.527(9) 
C(14A)-C(15A)  1.531(10) 
C(17A)-C(18A)  1.384(14) 
C(1)-C(1)#1  1.341(15) 
C(1)-C(2)  1.378(13) 
C(2)-C(3)  1.379(13) 
C(3)-C(3)#1  1.331(18) 
C(4)-C(6)  1.353(15) 
C(4)-C(5)  1.363(15) 
C(5)-C(5)#2  1.365(19) 
C(6)-C(6)#2  1.36(2) 
C(1DA)-C(2DA)  1.3900 
C(1DA)-C(6DA)  1.3900 
C(2DA)-C(3DA)  1.3900 
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C(3DA)-C(4DA)  1.3900 
C(4DA)-C(5DA)  1.3900 
C(5DA)-C(6DA)  1.3900 
C(1DB)-C(2DB)  1.390(3) 
C(1DB)-C(6DB)  1.3900 
C(2DB)-C(3DB)  1.3900 
C(3DB)-C(4DB)  1.3900 
C(4DB)-C(5DB)  1.3900(12) 






























































Symmetry transformations used to generate equivalent atoms:  
#1 y,x,-z+2/3    #2 x,x-y+1,-z+5/6       
 
 




) for 63. The anisotropic displacement 
factor exponent takes the form: -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
_____________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_____________________________________________________________________  
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O(1A) 51(3)  88(4) 40(2)  -17(3) -8(2)  43(3) 
O(2A) 60(3)  59(3) 61(3)  -10(3) -5(2)  32(3) 
O(3A) 35(3)  45(3) 45(2)  2(2) 1(2)  17(2) 
O(4A) 97(5)  137(5) 36(3)  -23(3) -14(3)  74(4) 
O(5A) 115(5)  73(4) 49(3)  -30(3) 24(3)  -21(4) 
C(1A) 40(4)  94(6) 34(3)  -17(4) -9(3)  36(4) 
C(2A) 40(4)  73(5) 31(3)  -14(3) 3(3)  19(4) 
C(3A) 46(5)  77(5) 37(4)  -16(4) 5(3)  9(4) 
C(4A) 34(5)  139(10) 54(5)  -20(6) 8(4)  8(5) 
C(5A) 41(6)  157(10) 46(5)  -45(6) -13(4)  46(6) 
C(6A) 56(7)  253(17) 59(6)  -80(9) -29(5)  71(9) 
C(7A) 72(8)  300(20) 75(8)  -109(11) -54(7)  127(12) 
C(8A) 86(8)  231(15) 64(6)  -71(8) -44(6)  119(10) 
C(9A) 85(7)  147(9) 48(5)  -40(5) -28(4)  86(7) 
C(10A) 51(5)  128(8) 38(4)  -34(5) -11(4)  51(6) 
C(11A) 54(5)  79(5) 46(4)  2(4) -1(4)  39(4) 
C(12A) 49(4)  58(5) 40(4)  2(3) -1(3)  29(4) 
C(13A) 33(4)  56(4) 31(3)  -4(3) 0(3)  16(3) 
C(14A) 37(4)  46(4) 36(3)  -6(3) 0(3)  12(3) 
C(15A) 51(5)  47(5) 77(5)  -3(4) 12(4)  13(4) 
C(16A) 33(4)  93(7) 40(5)  -22(5) 4(3)  15(4) 
C(17A) 105(9)  133(10) 59(6)  -52(6) 13(6)  -26(8) 
C(18A) 129(10)  92(8) 64(6)  -17(5) -16(6)  16(8) 
C(1) 121(8)  92(7) 49(4)  11(5) 0(5)  79(7) 
C(2) 136(9)  110(8) 38(4)  -5(5) -8(5)  95(7) 
C(3) 115(8)  106(8) 58(5)  -16(5) -17(5)  59(7) 
C(4) 177(12)  91(8) 57(6)  -8(5) -21(7)  99(9) 
C(5) 132(9)  81(6) 60(5)  -9(5) -8(6)  60(6) 




Table A2.10 Hydrogen coordinates (x 10
4







 x  y  z  U(eq) 
_____________________________________________________________________  
H(1A) 7550 6986 7001 84 
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H(2A) 8992 7554 6789 88 
H(3A) 9776 6578 6237 65 
H(3AA) 7212 5083 6610 76 
H(3AB) 7338 5752 7071 76 
H(4AA) 6162 5201 6856 109 
H(4AB) 6247 4990 6072 109 
H(6A) 5320 5549 6245 150 
H(7A) 5172 6417 5698 163 
H(8A) 6168 7465 5316 131 
H(9A) 7313 7616 5440 97 
H(11A) 8255 7221 5107 69 
H(11B) 8358 7808 5675 69 
H(12A) 9445 7802 5444 57 
H(13A) 9015 6589 5274 51 
H(14A) 8634 6383 6740 52 
H(15A) 8599 5337 5793 94 
H(15B) 8251 5147 6561 94 
H(15C) 9091 5645 6476 94 
H(17A) 7272 4964 4216 164 
H(17B) 7414 4363 4534 164 
H(18A) 6293 3825 5022 169 
H(18B) 6279 3852 4180 169 
H(18C) 6157 4400 4636 169 
H(1) 4846 4724 3933 91 
H(2) 5860 5589 4532 96 
H(3) 6738 6584 3921 110 
H(4) 4613 6270 3873 113 
H(5) 3533 6242 4016 106 
H(6) 5686 7320 4014 120 
H(1DA) 7468 9607 5309 622 
H(2DA) 8562 9679 5591 622 
H(3DA) 9005 9096 4874 622 
H(4DA) 8353 8442 3877 622 
H(5DA) 7259 8370 3595 622 
H(6DA) 6817 8953 4311 622 
H(1DB) 9471 8948 5182 495 
H(2DB) 10503 10084 5145 495 
H(3DB) 10983 10630 4047 495 
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H(4DB) 10431 10040 2986 495 
H(5DB) 9399 8904 3023 495 








Diol 64 was recrystallized in boiling heptane to provide crystals suitable for 
X-ray analysis, m.p. = 97 – 99 °C. 
 




Table A2.11 Crystal data and structure refinement for diol 64 
 
Empirical formula  C15 H20 O2 
Formula weight  232.31 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 




Appendix 2 – X-Ray Crystallography Reports Relevant to Chapter 1 
 
 b = 6.3583(2) Å        b = 105.4260(10)°. 
 c = 12.5999(4) Å      g = 90°. 
Volume 625.33(4) Å3 
Z 2 
Density (calculated) 1.234 Mg/m3 
Absorption coefficient 0.630 mm-1 
F(000) 252 
Crystal size .1 x .1 x .1 mm3 
Theta range for data collection 3.639 to 79.259°. 
Index ranges -10<=h<=10, -8<=k<=8, -15<=l<=16 
Reflections collected 20029 
Independent reflections 2647 [R(int) = 0.0449] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2647 / 3 / 163 
Goodness-of-fit on F2 1.085 
Final R indices [I>2sigma(I)] R1 = 0.0296, wR2 = 0.0677 
R indices (all data) R1 = 0.0312, wR2 = 0.0687 
Absolute structure parameter 0.04(8) 
Extinction coefficient n/a 
Largest diff. peak and hole                            0.144 and -0.158 e.Å-3
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Table A2.12 Atomic coordinates (x 10
4
) and equivalent isotropic displacement parameters (≈Å x 
10
3
) for 64. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________  
 x y z U(eq) 
_____________________________________________________________________  
C(1) 8395(2) 5246(3) 8290(1) 13(1) 
C(2) 6809(2) 3826(3) 8166(1) 14(1) 
C(3) 6586(2) 2540(3) 7101(1) 15(1) 
C(4) 6321(2) 3872(3) 6062(1) 18(1) 
C(5) 7576(2) 5670(3) 6196(1) 15(1) 
C(6) 7795(2) 6715(3) 5269(1) 18(1) 
C(7) 8956(2) 8347(3) 5356(2) 20(1) 
C(8) 9945(2) 8942(3) 6391(2) 21(1) 
C(9) 9737(2) 7927(3) 7319(2) 18(1) 
C(10) 8540(2) 6317(3) 7239(1) 14(1) 
O(1) 8491(2) 6779(2) 9145(1) 15(1) 
O(2) 8701(2) 1051(2) 9217(1) 18(1) 
C(11) 7204(2) 2296(3) 9154(2) 16(1) 
C(12) 5173(2) 5063(3) 8245(2) 16(1) 
C(13) 4829(2) 7173(3) 7629(2) 21(1) 
C(14) 3580(2) 3725(3) 7913(2) 19(1) 




Table A2.13 Bond lengths [Å] and angles [°] for 64 
_____________________________________________________  
C(1)-O(1)  1.440(2) 
C(1)-C(10)  1.521(2) 
C(1)-C(2)  1.543(2) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.541(2) 
C(2)-C(11)  1.545(2) 
C(2)-C(12)  1.566(2) 
C(3)-C(4)  1.525(2) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.509(3) 
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C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(6)  1.396(2) 
C(5)-C(10)  1.400(2) 
C(6)-C(7)  1.385(3) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.389(3) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.384(3) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.395(2) 
C(9)-H(9)  0.9500 
O(1)-H(1O)  0.93(2) 
O(2)-C(11)  1.432(2) 
O(2)-H(2O)  0.91(2) 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-C(14)  1.508(2) 
C(12)-C(13)  1.537(3) 
C(12)-H(12)  1.0000 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-C(15)  1.322(3) 
C(14)-H(14)  0.9500 
C(15)-H(15A)  0.9500 


















































































) for 14. The anisotropic 
displacement factor exponent takes the form: -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
_____________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_____________________________________________________________________  
C(1) 15(1)  11(1) 13(1)  -1(1) 2(1)  1(1) 
C(2) 14(1)  11(1) 14(1)  1(1) 2(1)  -1(1) 
C(3) 16(1)  12(1) 16(1)  -1(1) 1(1)  0(1) 
C(4) 19(1)  18(1) 16(1)  -1(1) 2(1)  -3(1) 
C(5) 15(1)  13(1) 16(1)  0(1) 3(1)  3(1) 
C(6) 18(1)  20(1) 16(1)  1(1) 4(1)  2(1) 
C(7) 23(1)  21(1) 18(1)  4(1) 9(1)  1(1) 
C(8) 20(1)  20(1) 24(1)  1(1) 8(1)  -3(1) 
C(9) 17(1)  18(1) 18(1)  -1(1) 5(1)  -1(1) 
C(10) 14(1)  14(1) 15(1)  1(1) 4(1)  2(1) 
O(1) 17(1)  13(1) 14(1)  -3(1) 2(1)  0(1) 
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O(2) 18(1)  11(1) 21(1)  1(1) 0(1)  2(1) 
C(11) 18(1)  12(1) 16(1)  2(1) 3(1)  1(1) 
C(12) 17(1)  14(1) 16(1)  0(1) 4(1)  -1(1) 
C(13) 18(1)  16(1) 29(1)  4(1) 6(1)  3(1) 
C(14) 17(1)  17(1) 21(1)  -2(1) 3(1)  -1(1) 




Table A2.15 Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) 
for 64 
_____________________________________________________________________  
 x  y  z  U(eq) 
_____________________________________________________________________  
H(1) 9423 4319 8540 16 
H(3A) 7615 1651 7174 18 
H(3B) 5590 1591 7016 18 
H(4A) 6441 2964 5448 22 
H(4B) 5141 4443 5864 22 
H(6) 7130 6296 4560 21 
H(7) 9075 9051 4715 24 
H(8) 10761 10042 6462 25 
H(9) 10423 8336 8024 21 
H(1O) 9470(30) 6480(50) 9710(20) 52(8) 
H(2O) 8500(30) -340(30) 9040(20) 42(8) 
H(11A) 7369 3113 9843 19 
H(11B) 6210 1351 9090 19 
H(12) 5343 5400 9042 19 
H(13A) 4478 6913 6834 32 
H(13B) 5875 8025 7814 32 
H(13C) 3914 7925 7847 32 
H(14) 3117 3469 7149 22 
H(15A) 3189 3093 9363 28 
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Enantioselective Iridium-Catalyzed Allylic Alkylation Reactions of 
Masked Acyl Cyanide Equivalents† 
 
 
2.1   INTRODUCTION AND BACKGROUND 
Since the first report of an asymmetric iridium-catalyzed allylic alkylation in 
1997,1 the technology has been widely developed for normal reactivity patterns between 
electrophilic π-allyl species and nucleophilic enolate equivalents, organometallic reagents, 
or heteroatoms (Figure 2.1a, left).2 However, the application of an umpolung strategy to 
stitch together a formally electrophilic group and a π-allyl cation via enantioselective 
iridium-catalyzed allylic alkylation remains underexplored (Figure 2.1a, right).3 To date, 
only two examples of reverse-polarity nucleophiles in iridium-catalyzed allylic alkylation 
have been reported (Figure 2.1b). In 2008, Helmchen showed that the extensively 
explored malononitrile nucleophile can operate as a methoxy carbonyl synthon with the 	†	 This work was performed in collaboration with Dr. J. Caleb Hethcox. Portions of this chapter have been 
reproduced with permission from Hethcox, J. C.;‡ Shockley, S. E.;‡ Stoltz, B. M. Org. Lett. 2017, 19, 1527–
1529 © 2017 American Chemical Society.  
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subsequent application of an oxidative degradation process (Figure 2.1b, left).4 More 
recently, Carreira disclosed the use of formaldehyde N,N-dialkylhydrazone as a formyl 
anion equivalent in iridium-catalyzed allylic alkylation reactions (Figure 2.1b, right).5 
Herein, we describe the first use of an acyl cyanide equivalent in asymmetric iridium-
catalyzed allylic alkylation, which formally serves as the addition of carbon monoxide 
(Figure 2.1c, left).  
 
Figure 2.1 Iridium-catalyzed allylic alkylation strategies 
 
 
As part of our ongoing research program to develop iridium-catalyzed allylic 
alkylation methods,6 we became interested in exploring the reactivity of masked acyl 
cyanide (MAC) reagents as reverse-polarity nucleophiles with π-allyl electrophiles. 
Following reaction with an electrophile, these umpoled synthons, developed by 
a) Iridium-Catalyzed Allylic Alkylation Strategies
































X = OH, NR2, ORMACreagent
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Yamamoto and Nemoto,7 can be unmasked to reveal a transient acyl cyanide intermediate, 
which can be further transformed into a carboxylic acid, amide, or ester.7,8 We envisioned 
that the novel application of MAC reagents to iridium-catalyzed allylic alkylation 
chemistry could provide access to highly desirable, enantioenriched vinylated α-aryl 
carbonyl derivatives, which are otherwise difficult to prepare (Figure 1c, right).9 
 
2.2  REACTION OPTIMIZATION 
Preliminary studies focused on the identification of a suitable protecting group for 
MAC nucleophile 67 in order to achieve the allylic alkylation reaction. Using our 
previously reported conditions for iridium-catalyzed allylic alkylations with cinnamyl-
derived electrophiles as a starting point,6a we found that the reaction of either silyl ether 
67a or acetate 67b with cinnamyl carbonate (68) furnishes desired products 69a and 69b, 
respectively, albeit in low yields (Table 2.1, entries 1 and 2). However, the use of 
methoxymethyl ether 67c provides allylic alkylation product 69c in 64% yield (entry 3). 
Moreover, we were pleased to find that product 69c can be obtained with excellent 
enantioselectivity (95% ee), obviating the need for further optimization beyond that of 
conversion. Of note, as in our prior investigations on iridium-catalyzed allylic 
alkylation,6a LiBr was found to improve the regioselectivity of the allylic alkylation 
reaction – the use of 200 mol % (in comparison to 100 mol % as utilized in our previous 
report6a) provides consistently higher yields of desired branched product 69.  
Efforts to increase the reaction conversion revealed that altering the nucleophile 
to electrophile ratio from 1:2 to 2:1 improves the yield to 77% with no erosion of 
enantioselectivity (entries 4 and 5). We observed that extending the reaction time from 18 
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to 48 hours provides product 69c in a now synthetically useful 85% yield and 97% ee 
(entry 6). Ultimately, we found that treatment of a mixture (2:1) of nucleophile 67c to 
electrophile 68 with a combination of catalytic Ir(cod)Cl·L2 (4 mol %) and LiBr (200 
mol %) at 60 °C delivers allylic alkylation product 69c in a high 86% yield with an 
exceptional 96% enantioselectivity in only 18 hours (entry 7).  
 
Table 2.1 Optimization of reaction parametersa 
 
[a] Reactions performed on 0.1 mmol scale. [b] 1H NMR yield based on internal standard. [c] Determined by chiral HPLC 




2.3   SUBSTRATE SCOPE EXPLORATION 
With the optimized conditions identified, the substrate scope of the 
enantioselective umpolung reaction was explored (Table 2.2). Our investigation began by 
probing the effects of electronics on reaction yield and selectivity. Gratifyingly, we 
observed that para-substituted aryl electrophiles bearing both electron-withdrawing (–Br, 
–CF3, –F) and electron-donating (–OMe) groups furnish products 71a–d with 
consistently excellent enantioselectivities (>95% ee). While products 71a (–Br) and 71d 
(–OMe) are obtained in high yield (>94% yield), diminished yields (58% and 69% yield, 
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respectively) are observed for the more electron-poor products 71b (–CF3) and 71c (–F). 
Further examination of electrophile electronics revealed that meta-Cl-substituted 71e, as 
well as poly-alkoxylated 71f and 71g, are each furnished in good yields (>81%) and high 
enantioselectivities (92–98% ee), despite varying electronics. Studies involving sterically 
demanding substrates showed that products 71h (–2-Np) and 71i (–ortho-Me) can be 
provided with good selectivities (92% and 89% ee, respectively), albeit in moderate 
yields (41% and 65%, respectively). Additionally, we were pleased to discover that 
pyridine 71j, furan 71k, and thiophene 71l are each afforded with excellent 
enantioselectivities (90–96% ee) and in moderate to high yields (73–94%).  
 
Table 2.2 Electrophile substrate scopea 
 
[a] Reactions performed on 0.2 mmol scale. [b] Isolated yield. [c] Determined by chiral HPLC or SFC analysis. [d] Reaction 
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A broader investigation of the substrate scope revealed limitations of the 
developed catalytic system (Table 2.3). Foremost, alkenyl substitution is not tolerated on 
allylic electrophile 70 and leads to significantly diminished yields and enantioselectivities, 
as is observed in the formation of iso-propenyl 71m, cyclohexyl 71n, and propenyl 71o. 
Additionally, a propargyl-substituted electrophile does not give desired product 71q in 
the allylic alkylation reaction, likely due to catalyst poisioning by binding of the alkyne 
to the metal source. Finally, the optimized reaction conditions fail to provide 
synthetically useful yields or high regioselectivities when alkyl-substituted allylic 
electrophiles are employed (e.g., 71q–u). 
 
Table 2.3 Electrophile substrate scope limitationsa 
 
 
[a] Reactions performed on 0.2 mmol scale. [b] Isolated yield. [c] Determined by chiral HPLC or SFC analysis. [d] 1H NMR 










LiBr (200 mol %)
[Ir(cod)Cl]2 (2 mol %)
 (S,Sa)-L2 (4 mol %), TBD (10 mol %)























































Chapter 2 – Enantioselective Iridium-Catalyzed Allylic Alkylation Reactions of  
Masked Acyl Cyanide Equivalents 
  
To demonstrate the synthetic utility of this method, a preparatory scale (4 mmol) 
reaction was performed (Scheme 2.1). Using cinnamyl carbonate (68), both the yield and 
enantioselectivity of the reaction are unchanged from those obtained at 0.1 mmol scale. 
 
Scheme 2.1 Preparatory scale reaction 
 
 
2.4  CONCLUSIONS 
In summary, we have developed the first enantioselective iridium-catalyzed 
allylic alkylation reaction of masked acyl cyanide (MAC) reagents. The umpolung 
strategy showcased in this reaction diverges from the normal reactivity patterns employed 
in all but two of the previously reported iridium-catalyzed allylic alkylations and is the 
first report of a carbon monoxide synthon in iridium-catalyzed allylic alkylation. Critical 
to the success of this new reaction is the identity of the methoxymethyl protecting group 
on the MAC reagent. The developed methodology proceeds with moderate to excellent 
yields (up to 95%) and high levels of enantioselectivity (up to 98% ee) on up to gram 
scale for a wide range of aryl- and heteroaryl-substituted allylic electrophiles. 
Furthermore, MAC adducts bearing resemblance to compound 4c have been transformed 
into acids, amides, and esters by unmasking the alkoxy malononitrile moiety.7,8 Thus, this 









[Ir(cod)Cl]2 (2 mol %)
(S,Sa)-L2 (4 mol %)
TBD (10 mol %)
LiBr (200 mol %)
THF (0.1 M), 60 °C, 18 h
gram scale
86% yield, 95% ee
69c6867c
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2.5  EXPERIMENTAL SECTION 
2.5.1  MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried 
by passage through an activated alumina column under argon. Commercially obtained 
reagents were used as received. Chemicals were purchased from Sigma 
Aldrich/Strem/Alfa Aesar/Oakwood Chemicals and used as received.  Reaction 
temperatures were controlled by an IKAmag temperature modulator. Glove box 
manipulations were performed under a nitrogen atmosphere. Thin-layer chromatography 
(TLC) and preparatory TLC was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized by UV fluorescence quenching, KMnO4 or p-
anisaldehyde staining. SiliaFlash P60 Academic Silica gel (particle size 0.040–0.063 
mm) was used for flash chromatography. Analytical chiral HPLC was performed with an 
Agilent 1100 Series HPLC utilizing a Chiralpak IC column (4.6 mm x 25 cm) or a 
Chiralpak AD column (4.6 mm x 25 cm), both obtained from Daicel Chemical Industries, 
Ltd. with visualization at 210 nm. Analytical SFC was performed with a Mettler SFC 
supercritical CO2 analytical chromatography system utilizing a Chiralpak IC-3 column 
(4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd. with visualization at 
210 nm. 1H NMR spectra were recorded on a Bruker Avance HD 400 MHz spectrometer 
and are reported relative to residual CHCl3 (δ 7.26 ppm). 13C NMR spectra were recorded 
on a Bruker Avance HD 400 MHz spectrometer and are reported relative to residual 
CDCl3 (δ 77.16 ppm). Data for 1H NMR are reported as follows: s = singlet, d = doublet, 
t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet. 
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Data for 13C NMR are reported in terms of chemical shifts (δ ppm). Some reported 
spectra include minor solvent impurities of benzene (δ 7.36 ppm), water (δ 1.56 ppm), 
ethyl acetate (δ 4.12, 2.05, 1.26 ppm), methylene chloride (δ 5.30 ppm), grease (δ 1.26, 
0.86 ppm), and/or silicon grease (δ 0.07 ppm), which do not impact product assignments. 
IR spectra were obtained using a Perkin Elmer Paragon 1000 spectrometer using thin 
films deposited on NaCl plates and reported in frequency of absorption (cm-1). High 
resolution mass spectra (HRMS) were obtained from the Caltech Mass Spectral Facility 
using a JEOL JMS-600H High Resolution Mass Spectrometer in fast atom bombardment 
(FAB+) or electron ionization (EI+) mode, or an Agilent 6200 Series TOF with an 
Agilent G1978A Multimode source in electrospray ionization (ESI+), atmospheric 
pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+). 
Optical rotations were measured with a Jasco P-2000 polarimeter operating on the 
sodium D-line (589 nm), using a 100 mm pathlength cell, and are reported as: [α]DT 
(concentration in g/100 mL, solvent).  
 
2.5.1.1 Preparation of Known Compounds 
Previously reported methods were used to prepare ligand (S,Sa)-L210 as well as 
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2.5.2  EXPERIMENTAL PROCEDURES AND SPECTROSCOPIC DATA 
2.5.2.1 General Procedure for the Synthesis of Electrophiles 
	
(E)-3-(3-Chlorophenyl)allyl methyl carbonate (70e). To a solution of methyl (E)-3-(3-
chlorophenl)prop-2-enoate17 (1.4 g, 7.0 mmol, 1 equiv) in Et2O (28 mL) at –78 °C was 
added DIBAL (3.0 g, 21 mmol, 3 equiv) dropwise. The resulting reaction mixture was 
stirred at –78 °C for 2.5 h, whereupon the reaction was quenched with a saturated 
aqueous Rochelle’s salt solution (10 mL). The cooling bath was then removed and the 
reaction was stirred for 18 h at ambient temperature. The aqueous layer was extracted 
with CH2Cl2 (3 x 50 mL) and the combined organic layers were washed with brine (50 
mL), dried over Na2SO4, and concentrated under reduced pressure.   
The crude material was then dissolved in CH2Cl2 (10 mL) and cooled to 0 °C. 
Pyridine (1.7 mL, 21 mmol, 3 equiv) was added followed by methyl chloroformate (0.81 
mL, 11 mmol, 1.5 equiv) dropwise. The resulting solution was allowed to warm to 
ambient temperature and stirred for 18 h. The reaction was quenched with the addition of 
1 M HCl (10 mL) and the aqueous layer was extracted with CH2Cl2 (3 x 50 mL). The 
combined organic layers were washed with brine (50 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
column chromatography (5% EtOAc/hexanes) to give carbonate 70e as a colorless oil 
(1.0 g, 63% yield): 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.37 (m, 1H), 7.30 – 7.23 (m, 
3H), 6.69 – 6.60 (m, 1H), 6.32 (dt, J = 15.9, 6.3 Hz, 1H), 4.81 (dd, J = 6.3, 1.4 Hz, 2H), 
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126.7, 125.0, 124.2, 68.1, 55.1; IR (Neat Film, NaCl) 3010, 2956, 2856, 1748, 1594, 
1567, 1442, 1377, 1261, 1091, 1078, 962, 791, 777, 682 cm-1; HRMS (MM: FAB+) m/z 
calc’d for C11H11ClO3 [M]+: 226.0397, found 226.0398. 
 
2.5.2.2 Spectroscopic Data for the Synthesis of Electrophiles 
	
(E)-3-(Benzo[d][1,3]dioxol-5-yl)allyl methyl carbonate (70f). Carbonate 70f was 
prepared from methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate18 according to the general 
procedure and isolated by silica gel flash column chromatography (5% EtOAc/hexanes) 
as a colorless solid (0.79 g, 48% yield): 1H NMR (400 MHz, CDCl3) δ 6.93 (d, J = 1.6 
Hz, 1H), 6.83 (ddd, J = 7.9, 1.6, 0.5 Hz, 1H), 6.79 – 6.73 (m, 1H), 6.60 (dt, J = 15.7, 1.3 
Hz, 1H), 6.12 (dt, J = 15.7, 6.6 Hz, 1H), 5.96 (s, 2H), 4.76 (dd, J = 6.6, 1.3 Hz, 2H), 3.80 
(s, 3H); 13C NMR (101 MHz, CDCl3) δ 155.8, 148.2, 147.9, 134.9, 130.6, 121.8, 120.7, 
108.4, 106.0, 101.3, 68.7, 55.0; IR (Neat Film, NaCl) 3003, 2956, 2895, 2781, 1747, 
1504, 1491, 1446, 1384, 1355, 1252, 1194, 1126, 1103, 1039, 933, 863, 791 cm-1; HRMS 
(FAB+) m/z calc’d for C12H12O5 [M]+: 236.0685, found 236.0674. 
 
	
(E)-Methyl (3-(3,4,5-trimethoxyphenyl)allyl) carbonate (70g). Carbonate 70g was 
prepared from methyl 3,4,5-trimethoxycinnamate19 according to the general procedure 
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colorless oil (1.2 g, 65% yield): 1H NMR (400 MHz, CDCl3) δ 6.65 – 6.56 (m, 3H), 6.21 
(dt, J = 15.8, 6.5 Hz, 1H), 4.78 (dd, J = 6.5, 1.3 Hz, 2H), 3.87 (s, 6H), 3.84 (s, 3H), 3.81 
(s, 3H); 13C NMR (101 MHz, CDCl3) δ 155.8, 153.4, 138.4, 135.0, 131.8, 122.0, 103.9, 
68.5, 61.1, 56.2, 55.0; IR (Neat Film, NaCl) 2999, 2956, 2840, 1748, 1583, 1508, 1452, 
1420, 1339, 1265, 1128, 1010, 941, 850, 792 cm-1; HRMS (FAB+) m/z calc’d for 
C14H18O6 [M]+: 282.1103, found 282.1114. 
 
2.5.2.3 General Procedure for Optimization Reactions (Table 2.1) 
In a nitrogen-filled glove box, to a 1 dram vial (vial A) equipped with a stir bar 
was added [Ir(cod)Cl]2 (1.3 mg, 0.0020 mmol, 2 mol %), ligand (S,Sa)-L2 (1.8 mg, 
0.0040 mmol, 4 mol %), TBD (1.4 mg, 0.010 mmol, 10 mol%), and THF (0.5 mL). Vial 
A was stirred at 25 °C (ca. 10 min) while another 1 dram vial (vial B) was charged with 
LiBr (17 mg, 0.20 mmol, 200 mol %), MAC nucleophile 67 (0.20 mmol), and THF (0.25 
mL). The pre-formed catalyst solution (vial A) was then transferred to vial B followed by 
0.25 mL of a solution of cinnamyl carbonate 68 (0.4 M in THF). The vial was sealed and 
stirred at the specified temperature. After 18 or 48 h, the vial was removed from the glove 
box and filtered through a pad of silica, rinsing with EtOAc. The crude mixture was 
concentrated and 1,2,4,5-tetrachloro-3-nitrobenzene (0.10 mmol in 0.5 mL CDCl3) was 
added. The NMR yield (measured in reference to 1,2,4,5-tetrachloro-3-nitrobenzene δ 
7.74 ppm (s, 1H)) was determined by 1H NMR analysis of the crude mixture. The residue 
was purified by preparatory TLC (15% EtOAc/hexanes) to afford product 69, which was 
analyzed by chiral HPLC (1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm). 
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2.5.2.4 General Procedure for the Iridium-Catalyzed Allylic Alkylation 
Please note that the absolute configuration of product 69c was assigned by 
conversion to (R)-2-phenylbutanoic acid.20 All other products (71a–l) were assigned by 
analogy. For respective HPLC and SFC conditions, please refer to Table 2.4. 
 
 
(R)-2-(Methoxymethoxy)-2-(1-phenylallyl)malononitrile (69c). In a nitrogen-filled 
glove box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 
mg, 0.0040 mmol, 2 mol %), ligand (S,Sa)-L2 (3.7 mg, 0.0080 mmol, 4 mol %), TBD 
(2.8 mg, 0.020 mmol, 10 mol %), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 
min) while another 1 dram vial (vial B) was charged with LiBr (35 mg, 0.40 mmol, 200 
mol %), MAC nucleophile 67c (50 mg, 0.40 mmol, 200 mol %), and THF (0.5 mL). The 
pre-formed catalyst solution (vial A) was then transferred to vial B followed by a solution 
of cinnamyl carbonate 68 (38 mg, 0.20 mmol, 100 mol %) in THF (0.5 mL). The vial was 
sealed and stirred at 60 °C. After 18 h, the vial was removed from the glove box and 
filtered through a pad of silica, rinsing with EtOAc. The crude mixture was concentrated 
and the resulting residue was purified by silica gel flash column chromatography (10% 
EtOAc/hexanes) to give the product 69c as a colorless oil (41 mg, 85% yield): 95% ee; 
[α]D25 –41.3 (c 2.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.32 (m, 5H), 6.29 
(ddd, J = 16.9, 10.3, 8.6 Hz, 1H), 5.53 – 5.38 (m, 2H), 5.06 – 4.94 (m, 2H), 3.97 – 3.91 
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122.7, 112.7, 112.7, 96.5, 69.9, 58.4, 57.4; IR (Neat Film, NaCl) 3065, 3033, 2961, 2904, 
2851, 2244, 1750, 1496, 1455, 1420, 1267, 1217, 1164, 1109, 1053, 1033, 967, 940, 791, 
732, 700 cm-1; HRMS (FAB+) m/z calc’d for C14H15N2O2 [M+H]+: 243.1131, found 
243.1134; HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm, tR 
(min): major = 12.831, minor = 17.466. 
 
2.5.2.5 Procedure for the Preparatory Scale Reaction 
 
(R)-2-(Methoxymethoxy)-2-(1-phenylallyl)malononitrile (69c). In a nitrogen-filled 
glove box, a solution of [Ir(cod)Cl]2 (106 mg, 0.16 mmol, 2 mol %), ligand (S,Sa)-L2 
(145 mg, 0.32 mmol, 4 mol %), TBD (110 mg, 0.79 mmol, 10 mol %) in THF (20 mL) 
was stirred at 25 °C. After 10 minutes, the catalyst mixture was added to a mixture of 
LiBr (0.69 g, 7.9 mmol, 200 mol %), MAC nucleophile 67c (1 g, 7.9 mmol, 200 mol %), 
and THF (20 mL) followed by cinnamyl carbonate 68 (0.76 g, 4.0 mmol, 100 mol %). 
The flask was removed from the glove box and stirred at 60 °C. After 18 h, the crude 
reaction mixture was concentrated and the resulting residue was purified by silica gel 
flash column chromatography (10% EtOAc/hexanes) to give the product 69c as a 
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2.5.2.6 Spectroscopic Data for the Iridium-Catalyzed Allylic Alkylation 
Products 
 
(R)-2-(1-(4-Bromophenyl)allyl)-2-(methoxymethoxy)malononitrile (71a). Product 71a 
was prepared according to the general procedure and isolated by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give a colorless oil (60 mg, 94% yield): 96% 
ee; [α]D25 –44.3 (c 3.2, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.56 – 7.50 (m, 2H), 7.32 
– 7.28 (m, 2H), 6.23 (ddd, J = 16.9, 10.3, 8.6 Hz, 1H), 5.55 – 5.38 (m, 2H), 5.05 – 4.96 
(m, 2H), 3.92 (d, J = 8.6 Hz, 1H), 3.44 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 133.4, 
132.1, 131.3, 130.9, 123.4, 123.2, 112.6, 112.5, 96.6, 69.5, 57.8, 57.5; IR (Neat Film, 
NaCl) 3013, 2934, 2242, 1488, 1404, 1274, 1216, 1163, 1108, 1034, 1010, 967, 939, 826, 
762 cm-1; HRMS (FAB+) m/z calc’d for C14H13BrO2N2 [M]+: 320.0160, found 320.0155; 
HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm, tR (min): 




Product 71b was prepared according to the general procedure and isolated by preparatory 
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yield): 96% ee; [α]D25 –25.2 (c 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 
8.6 Hz, 2H), 7.55 (d, J = 8.2 Hz, 2H), 6.27 (ddd, J = 16.9, 10.3, 8.7 Hz, 1H), 5.57 – 5.41 
(m, 2H), 5.09 – 4.96 (m, 2H), 4.02 (d, J = 8.7 Hz, 1H), 3.44 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 138.4, 131.5, 131.1, 130.6, 130.2, 125.9 (q, J = 3.9 Hz), 125.3, 123.6, 122.6, 
112.5, 112.4, 96.7, 69.4, 58.0, 57.6; IR (Neat Film, NaCl) 2962, 2906, 2835, 2245, 1751, 
1618, 1445, 1417, 1445, 1417, 1327, 1269, 1218, 1166, 1127, 1069, 943, 840, 792 cm-1; 
HRMS (MM: FAB+) m/z calc’d for C15H12F3N2O2 [(M+H)–H2]–: 309.0851, found 
309.0849; HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm, tR 
(min): major = 10.681, minor = 8.223. 
 
 
(R)-2-(1-(4-Fluorophenyl)allyl)-2-(methoxymethoxy)malononitrile (71c). Product 71c 
was prepared according to the general procedure and isolated by preparatory TLC (9% 
EtOAc/hexanes, plate eluted two times) to give a colorless oil (37 mg, 69% yield): 96% 
ee; [α]D25 –35.9 (c 1.9, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.32 (m, 2H), 7.15 
– 7.02 (m, 2H), 6.25 (ddd, J = 16.9, 10.3, 8.5 Hz, 1H), 5.57 – 5.35 (m, 2H), 5.11 – 4.94 
(m, 2H), 3.95 (d, J = 8.5 Hz, 1H), 3.44 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 164.3, 
161.9, 131.5, 131.4, 131.2, 130.2 (d, J = 3.5 Hz), 122.9, 116.1, 115.9, 112.7, 112.6, 96.6, 
69.8 (d, J = 1.6 Hz), 57.5 (d, J = 9.2 Hz); IR (Neat Film, NaCl) 3085, 2964, 2847, 2242, 
1606, 1511, 1415, 1281, 1230, 1164, 1108, 1053, 968, 940, 798, 766 cm-1; HRMS (ESI+) 
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(R)-2-(Methoxymethoxy)-2-(1-(4-methoxyphenyl)allyl)malononitrile (71d). Product 
71d was prepared according to the general procedure and isolated by silica gel flash 
column chromatography (5–10% EtOAc/hexanes) to give a colorless oil (52 mg, 95% 
yield): 95% ee; [α]D25 –51.8 (c 2.7, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.31 
(m, 2H), 6.92 (d, J = 8.8 Hz, 2H), 6.26 (ddd, J = 16.9, 10.3, 8.5 Hz, 1H), 5.61 – 5.34 (m, 
2H), 5.08 – 4.94 (m, 2H), 3.91 (d, J = 8.5 Hz, 1H), 3.82 (s, 3H), 3.45 (s, 3H); 13C NMR 
(101 MHz, CDCl3) δ 160.1, 131.7, 130.8, 126.3, 122.3, 114.3, 112.82, 112.78, 96.5, 70.1, 
57.6, 57.4, 55.4; IR (Neat Film, NaCl) 3005, 2962, 2939, 2905, 2838, 2244, 2052, 1890, 
1610, 1584, 15112, 1459, 1305, 1252, 1216, 1182, 1162, 1107, 1031, 937, 834, 783, 765, 
625 cm-1; HRMS (FAB+) m/z calc’d for C15H17N2O3 [M+H]+: 273.1239, found 
273.1227; SFC conditions: 3% IPA, 3.5 mL/min, Chiralpak IC-3 column, λ = 210 nm, tR 
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(R)-2-(1-(3-Chlorophenyl)allyl)-2-(methoxymethoxy)malononitrile (71e). Product 71e 
was prepared according to the general procedure and isolated by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give a colorless oil (47 mg, 85% yield): 92% 
ee; [α]D25 –38.5 (c 2.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.28 (m, 4H), 6.23 
(ddd, J = 16.9, 10.3, 8.7 Hz, 1H), 5.57 – 5.40 (m, 2H), 5.08 – 4.97 (m, 2H), 3.92 (d, J = 
8.7 Hz, 1H), 3.45 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 136.4, 134.7, 130.8, 130.2, 
129.9, 129.3, 127.8, 123.3, 112.6, 112.4, 96.6, 69.5, 57.9, 57.5; IR (Neat Film, NaCl) 
3069, 2962, 2849, 2832, 2244, 1751, 1596, 1576, 1478, 1436, 1418, 1277, 1217, 1164, 
1109, 111055, 1032, 967, 940, 884, 797, 760, 730, 713, 690 cm-1; HRMS (ESI+) m/z 
calc’d for C14H14N2O2Cl [M+H]+: 277.0744, found 277.0715; SFC conditions: 3% IPA, 




Product 71f was prepared according to the general procedure and isolated by silica gel 
flash column chromatography (5–10% EtOAc/hexanes) to give a colorless oil (51 mg, 
90% yield): 96% ee; [α]D25 –40.6 (c 3.4, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.91 – 
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5.03 (d, J = 1.4 Hz, 2H), 3.86 (d, J = 8.5 Hz, 1H), 3.47 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 148.2, 148.1, 131.5, 127.9, 123.5, 122.5, 112.7, 109.7, 108.7, 101.5, 96.6, 70.0, 
58.1, 57.5; IR (Neat Film, NaCl) 3081, 2972, 2902, 2352, 1505, 1488, 1446, 1368, 1251, 
1238, 1164, 1108, 1039, 967, 934, 864, 817, 800, 763 cm-1; HRMS (ESI+) m/z calc’d for 
C15H15N2O4 [M+H]+: 287.1032, found 287.1039; HPLC conditions: 1% IPA, 1.0 




Product 71g was prepared according to the general procedure and isolated by silica gel 
flash column chromatography (20% EtOAc/hexanes) to give a colorless oil (54 mg, 81% 
yield): 98% ee; [α]D25 –28.2 (c 3.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.63 (s, 2H), 
6.23 (ddd, J = 16.8, 10.3, 8.5 Hz, 1H), 5.55 – 5.35 (m, 2H), 5.11 – 4.94 (m, 2H), 3.87 (m, 
7H), 3.85 (s, 3H), 3.46 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 153.4, 138.5, 131.3, 
129.7, 122.6, 112.8, 112.7, 106.6, 96.5, 69.9, 61.0, 58.5, 57.5, 56.3; IR (Neat Film, NaCl) 
2941, 2840, 244, 1591, 1509, 1463, 1418, 1333, 1245, 1163, 1127, 1034, 1007, 950, 925, 
840, 771, 719 cm-1; HRMS (ESI+) m/z calc’d for C17H21N2O5 [M+H]+: 333.1450, found 
333.1450; HPLC conditions: 7% IPA, 1.0 mL/min, Chiralpak AD column, λ = 210 nm, tR 
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(R)-2-(Methoxymethoxy)-2-(1-(naphthalen-1-yl)allyl)malononitrile (71h). Product 
71h was prepared according to the general procedure and isolated by preparatory TLC 
(9% Et2O/hexanes, plate eluted two times) to give a colorless oil (24 mg, 41% yield): 
92% ee; [α]D25 –30.9 (c 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.11 (dt, J = 8.5, 1.0 
Hz, 1H), 7.95 – 7.86 (m, 2H), 7.81 (dd, J = 7.4, 1.2 Hz, 1H), 7.60 (ddd, J = 8.6, 6.8, 1.5 
Hz, 1H), 7.57 – 7.49 (m, 2H), 6.38 (ddd, J = 16.7, 10.3, 8.2 Hz, 1H), 5.57 – 5.43 (m, 2H), 
5.05 – 4.92 (m, 3H), 3.40 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 134.1, 132.2, 132.1, 
130.8, 129.6, 129.3, 126.9, 126.6, 126.1, 125.3, 122.8, 122.7, 113.10, 112.72, 96.5, 70.1, 
57.5, 51.6; IR (Neat Film, NaCl) 3051, 2960, 2926, 2851, 2244, 1708, 1398, 1215, 1162, 
1106, 1030, 960, 925, 783 cm-1; HRMS (ESI+) m/z calc’d for C18H17N2O2 [M+H]+: 
293.1290, found 293.1263; HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC 
column, λ = 210 nm, tR (min): major = 15.134, minor = 10.197. 
 
 
(R)-2-(Methoxymethoxy)-2-(1-(o-tolyl)allyl)malononitrile (71i). Product 71i was 
prepared according to the general procedure and isolated by silica gel flash column 
chromatography (5% EtOAc/hexanes) to give a colorless oil (33 mg, 65% yield): 89% ee; 
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7.19 (m, 3H), 6.22 (ddd, J = 16.9, 10.2, 8.2 Hz, 1H), 5.50 – 5.35 (m, 2H), 5.06 – 4.98 (m, 
2H), 4.34 (dd, J = 8.2, 1.0 Hz, 1H), 3.45 (s, 3H), 2.43 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 137.4, 133.1, 132.0, 131.2, 128.6, 128.1, 126.6, 122.5, 113.0, 112.8, 96.5, 69.8, 
57.5, 53.0, 20.3; IR (Neat Film, NaCl) 3023, 2958, 2360, 2243, 1748, 1640, 1603, 1489, 
1445, 1382, 1264, 1164, 1109, 1034, 943, 846, 792, 748, 654 cm-1; HRMS (FAB+) m/z 
calc’d for C15H17N2O2 [M+H]+: 257.1290, found 257.1280; HPLC conditions: 1% IPA, 
1.0 mL/min, Chiralpak IC column, λ = 210 nm, tR (min): major = 16.719, minor = 9.761. 
 
 
(R)-2-(Methoxymethoxy)-2-(1-(pyridin-3-yl)allyl)malononitrile (71j). Product 71j was 
prepared according to the general procedure and isolated by silica gel flash column 
chromatography (25% acetone/hexanes) to give a pale yellow oil (36 mg, 74% yield): 
90% ee; [α]D25 –30.8 (c 2.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.63 (dd, J = 4.7, 1.7 
Hz, 2H), 7.78 (dddd, J = 8.0, 2.3, 1.6, 0.5 Hz, 1H), 7.35 (ddd, J = 7.9, 4.8, 0.8 Hz, 1H), 
6.27 (ddd, J = 16.9, 10.3, 8.7 Hz, 1H), 5.63 – 5.39 (m, 2H), 5.06 – 4.97 (m, 2H), 4.00 (d, 
J = 8.7 Hz, 1H), 3.42 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 151.1, 150.4, 136.7, 130.4, 
130.3, 123.8, 123.7, 112.5, 112.3, 96.7, 69.4, 57.5, 56.0; IR (Neat Film, NaCl) 2963, 
2943, 2905, 2833, 2244, 1751, 1718, 1590, 1577, 1480, 1419, 1430, 1271, 1217, 1164, 
1109, 2055, 1028, 970, 941, 848, 817, 756, 714 cm-1; HRMS (FAB+) m/z calc’d for 
C13H14N3O2 [M+H]+: 244.1086, found 244.1083; HPLC conditions: 20% IPA, 1.0 
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(R)-2-(1-(Furan-2-yl)allyl)-2-(methoxymethoxy)malononitrile (71k). Product 71k was 
prepared according to the general procedure and isolated by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give a colorless oil (34 mg, 73% yield): 96% 
ee; [α]D25 –44.9 (c 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 (s, 1H), 6.53 – 6.34 
(m, 2H), 6.14 (dddd, J = 16.9, 10.2, 8.5, 0.8 Hz, 1H), 5.58 – 5.43 (m, 2H), 5.10 – 4.94 
(m, 2H), 4.16 (d, J = 8.5 Hz, 1H), 3.48 (d, J = 0.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) 
δ 147.4, 143.5, 129.1, 123.5, 112.4, 112.3, 111.0, 110.4, 96.6, 68.9, 57.5, 52.4; IR (Neat 
Film, NaCl) 3125, 2091, 2964, 2942, 2905, 2833, 2245, 1499, 1444, 14222, 1270, 1217, 
1164, 1109, 1030, 922, 797, 743 cm-1; HRMS (ESI+) m/z calc’d for C12H13N2O3 [M+H]+: 
233.0926, found 233.0948; HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC 
column, λ = 210 nm, tR (min): major = 13.297, minor = 10.761. 
 
 
(S)-2-(Methoxymethoxy)-2-(1-(thiophen-2-yl)allyl)malononitrile (71l). Product 71l 
was prepared according to the general procedure and isolated by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give a colorless oil (49 mg, 98% yield): 93% 
ee; [α]D25 –40.3 (c 2.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J = 5.1, 1.2 Hz, 
1H), 7.20 (ddd, J = 3.6, 1.2, 0.7 Hz, 1H), 7.08 (dd, J = 5.2, 3.6 Hz, 1H), 6.21 (ddd, J = 
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0.8 Hz, 1H), 3.52 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 135.7, 131.3, 128.3, 127.1, 
126.9, 123.0, 112.5, 112.4, 96.7, 69.8, 57.6, 54.0; IR (Neat Film, NaCl) 3090, 2963, 
2904, 2833, 2245, 2079, 1639, 1433k 1365, 1270, 1238, 1216, 1162, 1108, 1029, 922, 
856, 839, 704 cm-1; HRMS (ESI+) m/z calc’d for C12H13N2O2S [M+H]+: 249.0698, found 
249.0703; SFC conditions: 3% IPA, 3.5 mL/min, Chiralpak IC-3 column, λ = 210 nm, tR 
(min): major = 5.289, minor = 4.010. 
 
2.5.2.7 Determination of Enantiomeric Excess 
Please note racemic products were synthesized using racemic L2. 
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 Figure A3.3 13C NMR (101 MHz, CDCl3) of compound 69c 
 
Figure A3.2 Infrared spectrum (Thin Film, NaCl) of compound 69c 
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 Figure A3.6 13C NMR (101 MHz, CDCl3) of compound 70e 
 
Figure A3.5 Infrared spectrum (Thin Film, NaCl) of compound 70e 
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 Figure A3.9 13C NMR (101 MHz, CDCl3) of compound 70f 
 
Figure A3.8 Infrared spectrum (Thin Film, NaCl) of compound 70f 
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 Figure A3.12 13C NMR (101 MHz, CDCl3) of compound 70g 
 
Figure A3.11 Infrared spectrum (Thin Film, NaCl) of compound 70g 
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 Figure A3.15 13C NMR (101 MHz, CDCl3) of compound 71a 
 
Figure A3.14 Infrared spectrum (Thin Film, NaCl) of compound 71a 
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 Figure A3.18 13C NMR (101 MHz, CDCl3) of compound 71b 
 
Figure A3.17 Infrared spectrum (Thin Film, NaCl) of compound 71b 
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 Figure A3.21 13C NMR (101 MHz, CDCl3) of compound 71c 
 
Figure A3.20 Infrared spectrum (Thin Film, NaCl) of compound 71c 
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 Figure A3.24 13C NMR (101 MHz, CDCl3) of compound 71d 
 
Figure A3.23 Infrared spectrum (Thin Film, NaCl) of compound 71d 
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 Figure A3.27 13C NMR (101 MHz, CDCl3) of compound 71e 
 
Figure A3.26 Infrared spectrum (Thin Film, NaCl) of compound 71e 
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 Figure A3.30 13C NMR (101 MHz, CDCl3) of compound 71f 
 
Figure A3.29 Infrared spectrum (Thin Film, NaCl) of compound 71f 
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 Figure A3.33 13C NMR (101 MHz, CDCl3) of compound 71g 
 
Figure A3.32 Infrared spectrum (Thin Film, NaCl) of compound 71g 
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 Figure A3.36 13C NMR (101 MHz, CDCl3) of compound 71h 
 
Figure A3.35 Infrared spectrum (Thin Film, NaCl) of compound 71h 
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 Figure A3.39 13C NMR (101 MHz, CDCl3) of compound 71i 
 
Figure A3.38 Infrared spectrum (Thin Film, NaCl) of compound 71i 
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 Figure A3.42 13C NMR (101 MHz, CDCl3) of compound 71j 
 
Figure A3.41 Infrared spectrum (Thin Film, NaCl) of compound 71j 
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 Figure A3.45 13C NMR (101 MHz, CDCl3) of compound 71k 
 
Figure A3.44 Infrared spectrum (Thin Film, NaCl) of compound 71k 
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 Figure A3.48 13C NMR (101 MHz, CDCl3) of compound 71l 
 
Figure A3.47 Infrared spectrum (Thin Film, NaCl) of compound 71l 
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Enantioselective Synthesis of Acyclic α-Quaternary Carboxylic Acid 
Derivatives via Iridium-Catalyzed Allylic Alkylation† 
 
 
3.1   INTRODUCTION AND BACKGROUND 
The field of enantioselective iridium-catalyzed allylic alkylation has flourished in 
the twenty years since the seminal report by Helmchen.1 Over these two decades, the 
substrate scope with respect to the nucleophile has expanded significantly to encompass a 
vast array of both carbon2 and heteroatom3 nucleophiles.4 Conversely, the scope of the 
electrophiles has remained largely unchanged, being limited to those that produce 
products bearing a tertiary allylic stereocenter (Figure 3.1a, left).5 Despite the synthetic 
community’s longstanding interest in the synthesis of enantioenriched quaternary 
stereocenters as well as the development of other transition metal-catalyzed processes to 
access all-carbon quaternary allylic stereocenters,6,7,8 iridium-catalyzed allylic alkylation 	†	 This work was performed in collaboration with Dr. J. Caleb Hethcox. Portions of this chapter have been 
reproduced with permission from Shockley, S. E.;‡ Hethcox, J. C.;‡ Stoltz, B. M. Angew. Chem. Int. Ed. 
2017, 56, 11545–11548 © 2017 Wiley-VCH.  
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reactions that furnish products possessing such a stereocenter remain conspicuously 
absent from the literature (Figure 3.1a, right).  
 
Figure 3.1 Synthesis of allylic all-carbon quaternary stereocenters via enantioselective iridium-
catalyzed allylic alkylation 
 
As part of our ongoing program in developing iridium-catalyzed allylic alkylation 
technology and our continued interest in the catalytic, asymmetric synthesis of quaternary 
stereocenters,9 we were attracted to this unmet challenge. Moreover, we imagined that an 
umpolung strategy iridium-catalyzed allylic alkylation reaction of a trisubstituted allylic 
electrophile with a masked acyl cyanide (MAC) nucleophile would not only give rise to 
products containing an enantioenriched allylic all-carbon quaternary stereocenter, but 
also provide access to highly valuable acyclic α-quaternary carboxylic acid derivatives 
(i.e., acids, esters, amides) upon unmasking of the MAC functionality (Figure 3.1b). 9e,10 
However, success of this strategy hinged upon the implementation of a trisubstituted 
allylic electrophile, which was predicted to be unreactive in an enantioselective iridium-
catalyzed allylic alkylation reaction. It is known that the reaction rates of these processes 
decrease with increasing substitution on the olefin of the electrophile.5,11,12 Herein, we 





















X = OH, OR, NR2
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discuss the unlocking of this heretofore unreactive class of electrophiles to achieve the 
first example of an enantioselective iridium-catalyzed allylic alkylation reaction forming 
a quaternary stereocenter at the allylic position. 
 
3.2  REACTION OPTIMIZATION 
Preliminary studies focused on identifying a combination of ligand and additive to 
promote the reaction of MAC 67c and trisubstituted allylic electrophile 72 (Table 3.1). 
Application of our standard conditions for iridium-catalyzed allylic alkylation reactions 
of [Ir(cod)Cl]2, L2, and LiBr return only starting material (Table 3.1, entry 1).9a,e A brief 
ligand screen revealed that while ligand L9 also results in no reaction (entry 2), the 
phosphoramidite L5 developed by Carreira provides desired product 73 in 13% yield 
with a moderate 79% ee (entry 3).3b Attempts to further increase yield and selectivity via 
an extensive evaluation of additives known to promote iridium-catalyzed allylic 
alkylations proved ineffective.2–4,9 As we hypothesized that the oxidative addition process 
is slow for trisubstituted allylic electrophiles, we reasoned that the inclusion of a strong 
Lewis acid would facilitate the ionization of the carbonate during the insertion event, 
leading to improved reactivity of these recalcitrant electrophiles. Toward this end, we 
substituted LiBr for triethylborane and were pleased to find that the yield nearly triples 
and the enantioselectivity rises to 93% ee (entry 4).13 Upon varying the stoichiometry of 
nucleophile 67c to electrophile 72, we observed a dramatic increase in yield to 74% with 
no erosion of enantioselectivity (entry 5). Ultimately, we discovered that exposure of a 
mixture (1:2) of MAC 67c and trisubstituted allylic electrophile 72 affords MAC adduct 
73 in nearly quantitative yield and in 94% ee (entry 6). Of note, excess electrophile 72 is 
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not consumed and can be recovered following the iridium-catalyzed allylic alkylation 
reaction.  
 
Table 3.1 Optimization of reaction parametersa 
 
 
[a] Reactions performed on 0.1 mmol scale. [b] 1H NMR yield based on internal standard. [c] Determined by chiral HPLC 




3.3   MECHANISTIC INSIGHTS  
During the course of our optimization studies, we discovered both the surprising 
necessity of the guanidine base TBD as well as the importance of electrophile 
stereochemistry in our newly developed reaction. Though previously reported conditions 
for the use of L5 in iridium-catalyzed allylic alkylations do not require a base additive,14 
we found the inclusion of TBD during the catalyst prestir to be critical to the success of 
the reaction. TBD is included with ligands L2 and L9 to form an active iridicycle 
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Thus, we hypothesize that TBD may be serving as either a placeholder ligand to prevent 
the formation of an inactive catalyst or as a base to promote the formation of an active, 
novel iridicycle.2a,c Additionally, we noted that use of the E-trisubstituted allylic 
electrophile was required, as Z-olefin isomer 74 led to markedly decreased yield and 
selectivity (Table 3.2). We rationalize this difference in reactivity via the preferred 
conformation of the reactants. Whereas 72 may exist in a planar conformation, the phenyl 
group of 74 likely prefers to rotate out of plane to alleviate A1,3 strain (Table 3.2, bottom). 
In adopting this perpendicular conformation, the phenyl ring has now increased the 
sterics above and below the olefin as well as become σ-withdrawing rather than π-
donating. Finally, neither a kinetic nor a dynamic kinetic resolution occurs under the 
reaction conditions with the use of terminal olefin rac-75 (Table 3.2). 
 
Table 3.2 Electrophile isomersa 
 
 
[a] Reactions performed with 67c (0.1 mmol) and 72, 74, or 75 (0.2 mmol). [b] 1H NMR yield based on internal standard. [c] 















BEt3 (200 mol %)
[Ir(cod)Cl]2 (2 mol %)
 (Sa)-L5 (4.2 mol %), TBD (10 mol %)
THF (0.1 M), 60 °C, 18 h
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3.4   SUBSTRATE SCOPE EXPLORATION  
Before substrate scope exploration commenced, we identified an additional 
opportunity for innovation. We imagined that hydrolysis of the MAC functionality of 
product 73 could be performed in the same reaction vessel as the iridium-catalyzed allylic 
alkylation reaction to provide direct access to the corresponding carboxylic acid in a one-
pot, two-step procedure.10 Moreover, we envisioned that these carboxylic acid products 
would be amenable to purification by a simple acid/base extraction. To this end, we 
subjected the crude allylic alkylation mixture to hydrolysis with 6M HCl at 80 °C and 
were pleased to find that pure carboxylic acid 77a is obtained after an aqueous work-up 
with no need for column chromatography (Table 3.3). 
With the optimized protocol in hand, we first explored the effect of substitution 
on the aryl moiety of electrophile 76 (Table 3.3). We were pleased to find that para-
substitution was well tolerated to provide acids 77b–f in consistently high 
enantioselectivities, though electron-rich substrates provide decreased yields. Meta-
substituted products 77g and 77h are obtained in similarly high enantioselectivites (92% 
and 87% ee, respectively), and bulky naphthyl-substituted acid 77i is furnished in 92% ee, 
albeit in a moderate 66% yield. Further exploration of steric effects using methyl-
substituted derivatives demonstrates that while a single meta-substituent is tolerated to 
access 77j in 68% yield with 93% ee, the bis-meta-substituted derivative 77k is afforded 
in a drastically lower 32% yield but with good enantioselectivity (85% ee). Finally, we 
discovered that ortho-substitution is not tolerated and only starting material is recovered 
from the reaction.  
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Table 3.3 Aryl substituent substrate scopea 
 
[a] Reactions performed on 0.2 mmol scale. [b] Isolated yield. [c] Determined by chiral HPLC or SFC analysis. [d] 
Electrophile 76f used as the bis-carbonate which was deprotected during hydrolysis. [e] Reaction run for 48 h. [f] Absolute 
stereochemistry determined via single crystal X-ray analysis, the absolute stereochemistry of all other compounds has been 
assigned by analogy. [g] Reaction performed with double catalyst loading. 
 
With the general trends in reactivity corresponding to aryl substitution elucidated, 
we next turned our attention to the scope of the reaction with respect to the alkyl moiety 
of the electrophile (Table 3.4). We found that extension of the alkyl chain leads to 
decreased yields with ethyl-substituted 79a and n-butyl-substituted 79b able to be 
isolated in 61% and 14% yield, respectively, though both are obtained in similarly 
excellent enantioselectivities. Furthermore, branched-substituted electrophiles are 
unreactive and only starting material is recovered in attempts to prepare isopropyl-













i. BEt3 (200 mol %)
   [Ir(cod)Cl]2 (2 mol %)
   (Sa)-L5 (4.2 mol %), TBD (10 mol %)
   THF (0.1 M), 60 °C, 18 h





































































Chapter 3 – Enantioselective Synthesis of Acyclic α-Quaternary Carboxylic Acid Derivatives  
via Iridium-Catalyzed Allylic Alkylation 
  




[a] Reactions performed on 0.2 mmol scale. [b] Isolated yield. [c] Determined by chiral HPLC or SFC analysis. 
 
We then moved to explore the necessity of the aryl functionality. We 
hypothesized that cyclohexyl- and cyclohexenyl-substituted electrophiles 78d and 78e 
would mimic the steric bulk of the phenyl moiety of 76a when interacting with the chiral 
catalyst, but we found that only trace products 79d and 79e are observed under our 
reaction conditions (Table 3.4). Use of bis-n-alkyl-substituted electrophile 78f provides 
the corresponding acid 79f in moderate yield, though no enantioselectivity is observed. 
Finally, we were pleased to find that prenyl methyl carbonate (78g) is a competent 
electrophile furnishing acid 79g in 63% yield.  
A wider exploration into the scope of this novel transformation revealed 
additional limitations of the catalytic system (Table 3.5). Foremost, while furan- and 
thiophene-substituted allylic electrophiles are well tolerated in the iridium-catalyzed 
allylic alkylation reaction, the heteroaromatic functionality on the allylic alkylation 
product is not amenable to the hydrolysis conditions and thus trace 81a and 81b are 












i. BEt3 (200 mol %)
   [Ir(cod)Cl]2 (4 mol %)
   (Sa)-L5 (8.4 mol %), TBD (20 mol %)
   THF (0.1 M), 60 °C, 18 h
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likely due to its ability to bind to the iridium catalyst, and no conversion to propargyl-
derived 81c is observed. Additionally, only trace conversion to hydroxymethyl 81d is 
noted when corresponding TBS-protected allylic electrophile 80d is employed. A 
trifluoromethyl group in place of the methyl substituent on the electrophile shuts down 
the allylic alkylation reaction entirely, as does the use of a bulky branched geranyl-
derived electrophile, resulting in no isolation of 81e and 81f, respectively. Also, use of a 
tethered allylic electrophile (e.g., tetralone 80g) does not afford corresponding bicyclic 
product 81g. Finally, we found that a tetrasubstituted allylic electrophile was able to yield 
allylic alkylation product 81h, albeit in a modest 11% yield. 
 
Table 3.5 Substrate scope limitationsa 
 
 










i. BEt3 (200 mol %)
   [Ir(cod)Cl]2 (4 mol %)
   (Sa)-L5 (8.4 mol %), TBD (20 mol %)
   THF (0.1 M), 60 °C, 18 h
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3.5  PRODUCT TRANSFORMATIONS 
As MAC adducts can be transformed to essentially any carboxylic acid 
derivative,10 we endeavored to develop additional one-pot transformations to access both 
α-quaternary esters and amides. Gratifyingly, we found that alkanolysis of the crude 
MAC alkylation product with either methanol or allyl alcohol provides methyl ester 82 
and allyl ester 83 in 88% and 74% yield, respectively (Figure 3.2). Similarly, aminolysis 
provides access to both tertiary amide 84 in 61% yield and secondary amide 85 in 63% 
yield. 
 
Figure 3.2 One-pot transformations to α-quaternary carboxylic acid derivativesa 
 
[a] i. CSA, AcOH/DME, 60 °C, 6 h, ii. MeOH, Et3N, –40 °C → 23 °C, 18 h, 88% yield; [b] i. CSA, AcOH/DME, 60 °C, 6 h, ii. 
allyl alcohol, Et3N, 0 °C → 23 °C, 18 h, 74% yield; [c] CSA, AcOH/DME, 60 °C, 6 h, ii. pyrrolidine, Et3N, –40 °C → 23 °C, 
18 h, 61% yield; [d] i. CSA, AcOH/DME, 60 °C, 6 h, ii. allyl amine, Et3N, 0 °C → 23 °C, 18 h, 63% yield. 
 
In order to demonstrate the synthetic utility of the enantioenriched α-quaternary 
carboxylic acid derivatives, a series of transformations were performed to access a 
diverse array of chiral building blocks starting from ester derivative 82 (Figure 3.3). 
Hydrogenation of olefin 82 delivers ethyl-substituted 86 in 97% yield. Alcohol 87 is 
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olefin proceeds with concomitant lactonization to furnish γ-butyrolactone 88 in 82% 
yield as a mixture (1:1) of diastereomers. Finally, ozonolysis furnishes aldehyde 89 in 
moderate yield. 
 
Figure 3.3 Product transformations of α-quaternary ester 82a 
 
[a] Pd/C, H2 (balloon), EtOAc, 23 °C, 18 h, 97% yield; [b] DIBAL, Et2O, 0 °C, 2 h, 73% yield; [c] K2OsO4, NMO, THF/H2O 
(4:1), 23 °C, 18 h, 82% yield (1:1 dr); [d] i. O3, NaHCO3, MeOH/CH2Cl2 (1:5), –78 °C, 0.5 h, ii. DMS, –78 °C→ 23 °C, 18 h, 
50% yield. 
 
3.6  CONCLUSIONS 
In conclusion, we have developed the first synthesis of all-carbon quaternary 
allylic stereocenters via enantioselective iridium-catalyzed allylic alkylation. The 
unprecedented combination of triethylborane and a catalyst prepared from [Ir(cod)Cl]2, 
L5, and TBD was used to coerce reactivity from a once poorly reactive class of 
trisubstituted allylic electrophiles. Furthermore, the use of a single masked acyl cyanide 
nucleophile facilitates the one-pot syntheses of enantioenriched α-quaternary acids, esters, 
and amides. The protocol is tolerant of a wide range of substitution on the aryl moiety to 
provide the corresponding products in good yields and excellent enantioselectivities. This 
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technology to access vicinal quaternary centers via iridium-catalyzed allylic alkylation of 
prochiral nucleophiles.  
 
3.7  EXPERIMENTAL SECTION 
3.7.1  MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried 
by passage through an activated alumina column under argon. Commercially obtained 
reagents were used as received. Chemicals were purchased from Sigma 
Aldrich/Strem/Alfa Aesar/Oakwood Chemicals and used as received.  Reaction 
temperatures were controlled by an IKAmag temperature modulator. Glove box 
manipulations were performed under a nitrogen atmosphere. Thin-layer chromatography 
(TLC) and preparatory TLC was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized by UV fluorescence quenching, KMnO4, or p-
anisaldehyde staining. SiliaFlash P60 Academic Silica gel (particle size 0.040–0.063 
mm) was used for flash chromatography. Analytical chiral HPLC was performed with an 
Agilent 1100 Series HPLC utilizing a Chiralpak IC column (4.6 mm x 25 cm) or a 
Chiralpak AD-H column (4.6 mm x 25 cm), both obtained from Daicel Chemical 
Industries, Ltd. with visualization at 210 nm. Analytical SFC was performed with a 
Mettler SFC supercritical CO2 analytical chromatography system utilizing a Chiralpak 
AD-H column (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd. with 
visualization at 210 nm. Preparatory HPLC was performed with an Agilent 1200 Series 
HPLC equipped with a Viridis SFC 2-Ethylpyridine 5 µm column (4.6 x 250 mm). 1H 
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NMR spectra were recorded on a Bruker Avance HD 400 MHz spectrometer and are 
reported relative to residual CHCl3 (δ 7.26 ppm). 13C NMR spectra were recorded on a 
Bruker Avance HD 400 MHz spectrometer and are reported relative to residual CDCl3 (δ 
77.16 ppm). Data for 1H NMR are reported as follows: s = singlet, d = doublet, t = triplet, 
q = quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet. Data for 13C 
NMR are reported in terms of chemical shifts (δ ppm). Some reported spectra include 
minor solvent impurities of benzene (δ 7.36 ppm), water (δ 1.56 ppm), ethyl acetate (δ 
4.12, 2.05, 1.26 ppm), methylene chloride (δ 5.30 ppm), grease (δ 1.26, 0.86 ppm), and/or 
silicon grease (δ 0.07 ppm), which do not impact product assignments. IR spectra were 
obtained using a Perkin Elmer Paragon 1000 spectrometer using thin films deposited on 
NaCl plates and reported in frequency of absorption (cm-1). High resolution mass spectra 
(HRMS) were obtained from the Caltech Mass Spectral Facility using a JEOL JMS-600H 
High Resolution Mass Spectrometer in fast atom bombardment (FAB+) or electron 
ionization (EI+) mode, or an Agilent 6200 Series TOF with an Agilent G1978A 
Multimode source in electrospray ionization (ESI+), atmospheric pressure chemical 
ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+). Optical rotations were 
measured with a Jasco P-2000 polarimeter operating on the sodium D-line (589 nm), 
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3.7.1.1  Preparation of Known Compounds 
Previously reported methods were used to prepare ligands (S,Sa)-L22c,15 and (Sa)-
L516 as well as starting materials 67c,10b,17 72,18 75,18 76a,19 76b,20 76d,18 76e,18 76j,18 
76l,18 78a,18 78d,18 and 78f18. 
 
3.7.2  EXPERIMENTAL PROCEDURES AND SPECTROSCOPIC DATA 
3.7.2.1 Representative Procedures for the Synthesis of Electrophiles 
3.7.2.1.1 Representative Procedure #1: Oxidative Heck Reaction21 
 
Methyl (E)-3-(4-formylphenyl)but-2-enoate (90). To a solution of (4-
formylphenyl)boronic acid (0.75 g, 5.0 mmol, 1 equiv), Pd(OAc)2 (23 mg, 0.10 mmol, 
0.02 equiv), dppp (62 mg, 0.15 mmol, 0.03 equiv) in acetone (8 mL) was added methyl 
crotonate (1.1 mL, 10.0 mmol, 2 equiv) followed by trifluoroacetic acid (0.12 mL, 1.5 
mmol, 0.3 equiv). The resulting slurry was heated under reflux for 48 h, whereupon the 
reaction was cooled to ambient temperature and concentrated under reduced pressure. 
The crude product was purified by silica gel flash column chromatography (5% 
EtOAc/hexanes) to give carbonate 90 as a colorless oil (0.17 g, 17% yield): 1H NMR 
(400 MHz, CDCl3) δ 10.06 (s, 1H), 7.97 – 7.78 (m, 2H), 7.74 – 7.58 (m, 2H), 6.22 (q, J = 
1.3 Hz, 1H), 3.80 (s, 3H), 2.62 (d, J = 1.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 191.8, 
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2839, 1704, 1631, 1605, 1434, 1349, 1273, 1214, 1171, 1036, 828 cm-1; HRMS (FAB+) 
m/z calc’d for C12H13O3 [M+H]+: 205.0865, found 205.0860. 
3.7.2.1.2 Representative Procedure #2: Reduction & Acylation		
	
(E)-3-(4-Fluorophenyl)but-2-en-1-yl methyl carbonate (76c). To a solution of methyl 
(E)-3-(4-fluorophenyl)but-2-enoate22 (0.30 g, 1.6 mmol, 1 equiv) in THF (3.1 mL) at –78 
°C was added DIBAL (0.85 mL, 4.8 mmol, 3 equiv) dropwise. The resulting reaction 
mixture was stirred at –78 °C for 2.5 h, whereupon the reaction was quenched with a 
saturated aqueous Rochelle’s salt solution (5 mL). The cooling bath was then removed 
and the reaction was stirred for 18 h at ambient temperature. The aqueous layer was 
extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers were washed with 
brine (20 mL), dried over Na2SO4, and concentrated under reduced pressure.   
The crude material was then dissolved in CH2Cl2 (6.4 mL) and cooled to 0 °C. 
Pyridine (1.1 mL, 13 mmol, 8.3 equiv) was added followed by methyl chloroformate 
(0.28 mL, 3.7 mmol, 2.3 equiv) dropwise. The resulting solution was allowed to warm to 
ambient temperature and stirred for 18 h. The reaction was quenched with the addition of 
1 M HCl (5 mL) and the aqueous layer was extracted with CH2Cl2 (3 x 20 mL). The 
combined organic layers were washed with brine (20 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
column chromatography (5% EtOAc/hexanes) to give carbonate 76c as a colorless solid 
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2H), 5.87 (tq, J = 7.0, 1.4 Hz, 1H), 4.84 (dd, J = 7.1, 0.8 Hz, 2H), 3.80 (s, 3H), 2.11 (dd, 
J = 1.4, 0.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 163.7, 161.3, 156.0, 140.2, 138.6 (d, 
J = 3.3 Hz), 127.6 (d, J = 8.0 Hz), 120.7 (d, J = 1.3 Hz), 115.4, 115.1, 65.0, 55.0, 16.5; IR 
(Neat Film, NaCl) 2961, 1896, 1742, 1649, 1589, 1468, 1442, 1379, 1334, 1252, 1110, 
994, 960, 945, 825, 794 cm-1; HRMS (FAB+) m/z calc’d for C12H13FO3 [M]+: 224.0849, 
found 224.0850. 
3.7.2.2 Spectroscopic Data for the Synthesis of Electrophiles 
 
(Z)-methyl (3-phenylbut-2-en-1-yl) carbonate (74). Carbonate 74 was prepared from 
ethyl (Z)-3-phenylbut-2-enoate23 according to Representative Procedure #2 and isolated 
by silica gel flash column chromatography (5% EtOAc/hexanes) as a colorless oil (0.18 g, 
49% yield): 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.18 (m, 5H), 5.76 – 5.68 (m, 1H), 4.58 
(dd, J = 7.2, 1.1 Hz, 2H), 3.79 (s, 3H), 2.13 (q, J = 1.2 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 155.8, 143.8, 140.3, 128.4, 127.8, 127.6, 120.5, 65.8, 54.8, 25.6; IR (Neat Film, 
NaCl) 3023, 2956, 1748, 1494, 1441, 1382, 1350, 1263, 1024, 944, 792, 765, 702 cm-1; 
HRMS (FAB+) m/z calc’d for C12H15O3 [M+H]+: 207.1021, found 207.1011. 
 
(E)-3-(4-(((Methoxycarbonyl)oxy)methyl)phenyl)but-2-en-1-yl methyl carbonate 
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isolated by silica gel flash column chromatography (5% EtOAc/hexanes) as a colorless 
solid (0.11 g, 46% yield): 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.31 (m, 4H), 5.98 – 5.88 
(m, 1H), 5.15 (s, 2H), 4.85 (dd, J = 7.0, 0.9 Hz, 2H), 3.802 (s, 3H), 3.795 (s, 3H), 2.13 – 
2.10 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 156.0, 155.9, 142.8, 140.6, 134.7, 128.5, 
126.3, 121.2, 69.4, 65.0, 55.1, 55.0, 16.4; IR (Neat Film, NaCl) 2959, 1754, 1443, 1385, 
1333, 1288, 958, 909, 794, 731 cm-1; HRMS (FAB+) m/z calc’d for C15H18O6 [M]+: 
294.1103, found 294.1098. 
 
 
Methyl (E)-3-(3-bromophenyl)but-2-enoate (91). Ester 91 was prepared from (3-
bromophenyl)boronic acid according to Representative Procedure #1 and isolated by 
silica gel flash column chromatography (3% EtOAc/hexanes) as a colorless oil (0.54 g, 
42% yield): 1H NMR (400 MHz, CDCl3) δ 7.65 – 7.59 (m, 1H), 7.51 (ddd, J = 7.9, 2.0, 
1.0 Hz, 1H), 7.45 – 7.37 (m, 1H), 7.31 – 7.26 (m, 1H), 6.14 (q, J = 1.3 Hz, 1H), 3.78 (d, J 
= 1.2 Hz, 3H), 2.57 (d, J = 1.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 167.1, 154.3, 
144.4, 132.1, 130.2, 129.6, 125.1, 122.8, 117.9, 51.4, 18.1; IR (Neat Film, NaCl) 3062, 
2948, 1719, 1631, 1558, 1435, 1346, 1274, 1191, 1168, 1037, 869, 785, 688 cm-1; HRMS 
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(E)-3-(3-Bromophenyl)but-2-en-1-yl methyl carbonate (76g). Carbonate 76g was 
prepared from 91 according to Representative Procedure #2 and isolated by silica gel 
flash column chromatography (5% EtOAc/hexanes) as a colorless oil (0.47 g, 78% yield): 
1H NMR (400 MHz, CDCl3) δ 7.54 (t, J = 1.8 Hz, 1H), 7.40 (ddd, J = 7.9, 1.9, 1.0 Hz, 
1H), 7.32 (ddd, J = 7.8, 1.8, 1.0 Hz, 1H), 7.22 – 7.14 (m, 1H), 5.96 – 5.88 (m, 1H), 4.88 – 
4.76 (m, 2H), 3.81 (s, 3H), 2.12 – 2.08 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 155.93, 
144.65, 139.74, 130.68, 129.96, 129.18, 124.64, 122.65, 122.08, 64.84, 55.02, 16.38; IR 
(Neat Film, NaCl) 2955, 1748, 1590, 1558, 1442, 1376, 1332, 1263, 946, 789, 690 cm-1; 
HRMS (FAB+) m/z calc’d for C12H13O3Br [M]+: 284.0048, found 284.0073. 
 
 
(E)-Methyl (3-(3-nitrophenyl)but-2-en-1-yl) carbonate (76h). Carbonate 76h was 
prepared from methyl (E)-3-(3-nitrophenyl)but-2-enoate20 according to Representative 
Procedure #2 and isolated by silica gel flash column chromatography (10% 
EtOAc/hexanes) as a colorless oil (0.47 g, 78% yield): 1H NMR (400 MHz, CDCl3) δ 
8.26 (t, J = 2.0 Hz, 1H), 8.14 (ddd, J = 8.2, 2.3, 1.0 Hz, 1H), 7.73 (ddd, J = 7.8, 1.8, 1.1 
Hz, 1H), 7.51 (t, J = 8.0 Hz, 1H), 6.10 – 5.91 (m, 1H), 4.88 (dt, J = 6.9, 0.8 Hz, 2H), 3.82 
(s, 3H), 2.18 (dd, J = 1.4, 0.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 155.9, 148.5, 
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3108, 3026, 2969, 2868, 1750, 1530, 1443, 1384, 1353, 1279, 1096, 994, 949, 930, 876, 




(E)-methyl (3-(Naphthalen-2-yl)but-2-en-1-yl) carbonate (76i). Carbonate 76i was 
prepared from methyl (E)-3-(naphthalen-2-yl)but-2-enoate24 according to Representative 
Procedure #2 and isolated by silica gel flash column chromatography (5% 
EtOAc/hexanes) as a colorless oil (0.26 g, 51% yield): 1H NMR (400 MHz, CDCl3) δ 
7.86 – 7.77 (m, 4H), 7.58 (dd, J = 8.6, 1.9 Hz, 1H), 7.52 – 7.42 (m, 2H), 6.12 – 6.05 (m, 
1H), 4.92 (dq, J = 7.0, 0.7 Hz, 2H), 3.82 (s, 3H), 2.29 – 2.22 (m, 3H); 13C NMR (101 
MHz, CDCl3) δ 156.0, 140.9, 139.7, 133.4, 133.0, 128.3, 128.0, 127.7, 126.4, 126.1, 
124.9, 124.3, 121.3, 65.2, 55.0, 16.5; IR (Neat Film, NaCl) 3057, 2952, 1752, 1740, 
1596, 1467, 1442, 1382, 1248, 997, 941, 818, 794, 740 cm-1; HRMS (FAB+) m/z calc’d 
for C16H16O3 [M]+: 256.1100, found 256.1095. 
 
 
(E)-3-(3,5-Dimethylphenyl)but-2-en-1-yl methyl carbonate (76k). Carbonate 76k was 
prepared from methyl (E)-3-(3,5-dimethylphenyl)but-2-enoate 25  according to 
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EtOAc/hexanes) as a colorless oil (0.32 g, 86% yield): 1H NMR (400 MHz, CDCl3) δ 
7.02 (dt, J = 1.6, 0.8 Hz, 2H), 6.93 (td, J = 1.6, 0.8 Hz, 1H), 5.96 – 5.82 (m, 1H), 4.84 
(dd, J = 7.0, 0.8 Hz, 2H), 3.80 (s, 3H), 2.31 (d, J = 0.7 Hz, 6H), 2.15 – 2.06 (m, 3H); 13C 
NMR (101 MHz, CDCl3) δ 156.0, 142.6, 141.5, 137.9, 129.4, 123.9, 120.4, 65.1, 54.9, 
21.5, 16.5; IR (Neat Film, NaCl) 2956, 2918, 2862, 1748, 1601, 1443, 1376, 1335, 1262, 




(E)-Methyl (3-phenylhept-2-en-1-yl) carbonate (78b). Carbonate 78b was prepared 
from ethyl (E)-3-phenylhept-2-enoate26 according to Representative Procedure #2 and 
isolated by silica gel flash column chromatography (5% EtOAc/hexanes) as a colorless 
oil (0.31 g, 58% yield): 1H NMR (400 MHz, CDCl3) δ 7.48 – 7.27 (m, 5H), 5.89 – 5.71 
(m, 1H), 4.84 (d, J = 7.0 Hz, 2H), 3.80 (s, 3H), 2.73 – 2.46 (m, 2H), 1.41 – 1.24 (m, 4H), 
1.06 – 0.73 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 156.0, 146.6, 142.0, 128.4, 127.6, 
126.6, 121.1, 65.0, 55.0, 31.2, 30.2, 22.7, 14.0; IR (Neat Film, NaCl) 3034, 2957, 2872, 
1748, 1644, 1599, 1493, 1444, 1378, 1344, 1262, 1129, 941, 792, 766, 698 cm-1; HRMS 
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(E)-Methyl (4-methyl-3-phenylpent-2-en-1-yl) carbonate (78c). Carbonate 78c was 
prepared from ethyl (E)-4-methyl-3-phenylpent-2-enoate27 according to Representative 
Procedure #2 and isolated by silica gel flash column chromatography (5% 
EtOAc/hexanes) as a colorless oil (0.17 g, 17% yield): 1H NMR (400 MHz, CDCl3) δ 
7.37 – 7.27 (m, 3H), 7.11 – 7.02 (m, 2H), 5.61 (td, J = 7.0, 1.3 Hz, 1H), 4.46 (dd, J = 7.0, 
0.8 Hz, 2H), 3.75 (s, 3H), 2.66 – 2.54 (m, 1H), 1.03 (d, J = 6.8 Hz, 6H); 13C NMR (101 
MHz, CDCl3) δ 155.8, 154.0, 139.7, 128.5, 128.2, 127.3, 117.8, 66.1, 54.8, 36.0, 21.5; IR 
(Neat Film, NaCl) 2961, 2872, 1749, 1492, 1442, 1263, 942, 792, 771, 703 cm-1; HRMS 
(FAB+) m/z calc’d for C14H19O3 [M+H]+: 235.1334, found 235.1344. 
 
 
(E)-3-(Cyclohex-1-en-1-yl)but-2-en-1-yl methyl carbonate (78e). Carbonate 78e was 
prepared from ethyl (E)-3-(cyclohex-1-en-1-yl)but-2-enoate 28  according to 
Representative Procedure #2 and isolated by silica gel flash column chromatography (5% 
EtOAc/hexanes) as a colorless oil (0.25 g, 73% yield): 1H NMR (400 MHz, CDCl3) δ 
6.00 – 5.92 (m, 1H), 5.68 – 5.55 (m, 1H), 4.79 (d, J = 7.0 Hz, 2H), 3.78 (s, 3H), 2.16 
(ddd, J = 12.0, 5.9, 3.7 Hz, 4H), 1.85 (d, J = 1.1 Hz, 3H), 1.73 – 1.49 (m, 4H); 13C NMR 
(101 MHz, CDCl3) δ 156.0, 141.2, 137.0, 126.0, 116.8, 65.5, 54.9, 26.1, 25.8, 23.0, 22.3, 
14.1; IR (Neat Film, NaCl) 2929, 2859, 1749, 1638, 1443, 1263, 1119, 940, 792 cm-1; 




Chapter 3 – Enantioselective Synthesis of Acyclic α-Quaternary Carboxylic Acid Derivatives  
via Iridium-Catalyzed Allylic Alkylation 
  
3.7.2.3 General Procedure for Optimization Reactions (Table 3.1) 
 
(S)-2-(Methoxymethoxy)-2-(2-phenylbut-3-en-2-yl)malononitrile (73). In a nitrogen-
filled glove box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 
(1.3 mg, 0.0020 mmol, 2 mol %), ligand (Sa)-L5 (2.5 mg, 0.0042 mmol, 4.2 mol %), 
TBD (1.4 mg, 0.010 mmol, 10 mol %), and THF (0.5 mL). Vial A was stirred at 25 °C 
(ca. 10 min) while another 1 dram vial (vial B) was charged with MAC nucleophile 67c 
(0.10 mmol or 0.20 mmol, as specified), THF (0.5 mL), and the Lewis acid additive (200 
mol %). The pre-formed catalyst solution (vial A) was then transferred to vial B followed 
immediately by carbonate 72 (0.20 mmol, 0.10 mmol, or 0.12 mmol, as specified). The 
vial was sealed and stirred at 60 °C. After 18 h, the vial was removed from the glove box 
and filtered through a pad of silica, rinsing with EtOAc. The crude mixture was 
concentrated and 1,2,4,5-tetrachloro-3-nitrobenzene (0.10 mmol in 0.5 mL CDCl3) was 
added. The NMR yield (measured in reference to 1,2,4,5-tetrachloro-3-nitrobenzene δ 
7.74 ppm (s, 1H)) was determined by 1H NMR analysis of the crude mixture. The residue 
was purified by preparatory TLC (15% EtOAc/hexanes) to afford MAC adduct product 
73 as a colorless oil. For the purposes of characterization, product 73 was further purified 
by preparatory HPLC (20% EtOAc/hexanes, Viridis SFC 2-Ethylpyridine 5 µm column, 
flow rate = 1.5 mL/min; λ = 230 nm): 94% ee (entry 9); [α]D25 +11.7 (c 0.07, CHCl3) 
(entry 9); 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.54 (m, 2H), 7.42 – 7.32 (m, 3H), 6.51 
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13C NMR (101 MHz, CDCl3) δ 138.3, 137.6, 129.0, 128.57, 238.55, 128.3, 125.2, 119.2, 
112.8, 112.7, 96.7, 73.9, 57.5, 52.8, 20.9; IR (Neat Film, NaCl) 3062, 2957, 2896, 2242, 
2189, 1750, 1492, 1445, 1358, 1268, 1161, 1108, 1030, 930, 751, 698 cm-1; HRMS 
(ESI+) m/z calc’d for C15H17N2O2 [M+H]+: 257.1290, found 257.1313; HPLC conditions: 
1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm, tR (min): major = 13.303, minor 
= 17.243. 
 
3.7.2.4 General Procedure for the Enantioenriched Carboxylic Acid 
Synthesis 
Please note that the absolute configuration was determined only for compound 
77h via x-ray crystallographic analysis. The absolute configuration for all other products 
has been inferred by analogy. For respective HPLC and SFC conditions, please refer to 
Table 3.6. 
 
(S)-2-Methyl-2-phenylbut-3-enoic acid (77a). In a nitrogen-filled glove box, to a 1 
dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 mg, 0.0040 mmol, 
2 mol %), ligand (Sa)-L5 (4.9 mg, 0.0084 mmol, 4.2 mol %), TBD (2.8 mg, 0.020 mmol, 
10 mol %), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 min) while another 1 
dram vial (vial B) was charged with MAC nucleophile 67c (25 mg, 0.20 mmol, 100 
mol %), THF (1 mL), and BEt3 (400 µL, 1M in hexanes). The pre-formed catalyst 
solution (vial A) was then transferred to vial B followed immediately by carbonate 72 (83 
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the vial was removed from the glove box, transferred to a 20 mL vial with CH2Cl2, and 
concentrated. The crude material was heated at 80 °C in 6M HCl (4 mL) for 18 h. 
Whereupon, the reaction mixture was cooled to 0 °C and basified with 6M NaOH (4.5 
mL). The aqueous layer was extracted with CH2Cl2 (4 x 8 mL). The combined organic 
layers were washed with 2M NaOH (8 mL). The combined aqueous layers were acidified 
with concentrated HCl, extracted with CH2Cl2 (4 x 8 mL), dried over Na2SO4, and 
concentrated under reduced pressure at 0 °C to give the product 77a as a colorless solid 
(27 mg, 77% yield): 95% ee; [α]D25 +13.5 (c 1.3, CHCl3); HPLC conditions: 2% IPA, 1.0 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 12.198, minor = 11.426. 
Characterization data match those reported in the literature.29 Please note Compounds 77i, 
77j, 77k, and 79a–g were prepared at the same concentration with double catalyst 
loadings. 
 
3.7.2.5 Spectroscopic Data for the Enantioenriched Carboxylic Acids 
 
(S)-2-(4-Chlorophenyl)-2-methylbut-3-enoic acid (77b). Product 77b was prepared 
according to the general procedure to give a pale yellow oil (33 mg, 80% yield): 93% ee; 
[α]D25 +8.1 (c 1.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.24 (m, 4H), 6.38 (dd, 
J = 17.5, 10.7 Hz, 1H), 5.44 – 5.16 (m, 2H), 1.66 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
180.4, 141.1, 140.1, 133.3, 128.7, 128.3, 116.1, 53.3, 23.3; IR (Neat Film, NaCl) 3089, 
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(FAB+) m/z calc’d for C11H12O2Cl [M+H]+: 211.0526, found 211.0528; HPLC 
conditions: 2% IPA, 1.0 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 
15.642, minor = 14.104. 
 
(S)-2-(4-Fluorophenyl)-2-methylbut-3-enoic acid (77c). Product 77c was prepared 
according to the general procedure to give a pale yellow oil (35 mg, 90% yield): 90% ee; 
[α]D25 +3.4 (c 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.19 (m, 2H), 7.05 (t, J 
= 8.7 Hz, 2H), 6.39 (dd, J = 17.5, 10.7 Hz, 1H), 5.42 – 5.14 (m, 2H), 1.67 (s, 3H); 13C 
NMR (101 MHz, CDCl3) δ 180.6, 163.2, 160.7, 140.4, 138.3 (d, J = 3.4 Hz), 128.5 (d, J 
= 8.1 Hz), 115.9, 115.5, 115.3, 53.2, 23.5; IR (Neat Film, NaCl) 3088, 2987, 2924, 2642, 
1704, 1603, 1510, 1462, 1412, 1277, 1234, 1165, 928, 833, 816, 735 cm-1; HRMS 
(FAB+) m/z calc’d for C11H12FO2 [M+H]+: 195.0833, found 195.0841; HPLC conditions: 
2% IPA, 1.0 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 15.499, 
minor = 13.811. 
 
 
(S)-2-Methyl-2-(4-(trifluoromethyl)phenyl)but-3-enoic acid (77d). Product 77d was 
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92% ee; [α]D25 –2.2 (c 2.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.60 (dt, J = 8.1, 0.8 
Hz, 2H), 7.45 (dt, J = 8.3, 0.8 Hz, 2H), 6.38 (dd, J = 17.5, 10.7 Hz, 1H), 5.48 – 5.09 (m, 
2H), 1.68 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 179.0, 146.6, 139.7, 129.6, 130.0, 
129.5, 127.2, 125.6 (q, J = 3.7 Hz), 122.8, 116.6, 53.7, 29.9, 23.4; IR (Neat Film, NaCl) 
2926, 2649, 1707, 1618, 1413, 1328, 1277, 1167, 1126, 1081, 1016, 930, 940 cm-1; 
HRMS (FAB+) m/z calc’d for C12H12O2F3 [M+H]+: 245.0789, found 245.0794; SFC 
conditions: 2% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 
13.592, minor = 15.745. 
 
 
(S)-2-Methyl-2-(p-tolyl)but-3-enoic acid (77e). Product 77e was prepared according to 
the general procedure to give a pale yellow oil (24 mg, 63% yield): 94% ee; [α]D25 +4.6 (c 
0.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.01 (m, 4H), 6.40 (dd, J = 17.5, 10.7 
Hz, 1H), 5.59 – 5.08 (m, 2H), 2.34 (s, 3H), 1.64 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
181.0, 140.7, 139.8, 137.0, 129.3, 126.6, 115.4, 53.3, 23.3, 21.1; IR (Neat Film, NaCl) 
2986, 1702, 1636, 1512, 1457, 1412, 1276, 1191, 1132, 1077, 1020, 925, 815, 730 cm-1; 
HRMS (ESI-) m/z calc’d for C12H13O2 [M-H]-: 189.0916, found 189.0903; HPLC 
conditions: 2% IPA, 1.0 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 
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(S)-2-(4-(Hydroxymethyl)phenyl)-2-methylbut-3-enoic acid (77f). Product 77f was 
prepared according to the general procedure and isolated by preparatory TLC (30% 
acetone/hexanes) to give a colorless soild (21 mg, 51% yield): 95% ee; [α]D25 +3.4 (c 0.5, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.33 (q, J = 8.2 Hz, 4H), 6.37 (dd, J = 17.5, 10.7 
Hz, 1H), 5.39 – 5.10 (m, 2H), 4.57 (s, 2H), 1.63 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
180.1, 143.2, 140.4, 136.4, 128.8, 127.2, 115.8, 53.6, 45.9, 23.4; IR (Neat Film, NaCl) 
2985, 2927, 2642, 1703, 1636, 1512, 1460, 1268, 1182, 1076, 926, 836, 731, 683 cm-1; 
HRMS (FAB+) m/z calc’d for C12H15O3 [M+H]+: 207.1021, found 207.1025; HPLC 
conditions: 2% IPA, 1.0 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 
15.258, minor = 14.667. 
 
 
(S)-2-(3-Bromophenyl)-2-methylbut-3-enoic acid (77g). Product 77g was prepared 
according to the general procedure to give a pale yellow oil (35 mg, 69% yield): 92% ee; 
[α]D25 –2.6 (c 1.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 (t, J = 1.9 Hz, 1H), 7.41 
(ddd, J = 7.6, 1.9, 1.2 Hz, 1H), 7.29 – 7.18 (m, 2H), 6.35 (dd, J = 17.5, 10.7 Hz, 1H), 
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130.5, 130.2, 129.9, 125.5, 122.8, 116.4, 53.5, 23.3; IR (Neat Film, NaCl) 2987, 2644, 
1705, 1593, 1566, 1475, 1413, 1280, 1129, 1070, 997, 928, 785, 760, 700 cm-1; HRMS 
(ESI-) m/z calc’d for C11H10O2Br [M-H]-: 252.9864, found 252.9864; HPLC conditions: 
2% IPA, 1.0 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 15.217, 
minor = 14.439. 
 
 
(S)-2-Methyl-2-(3-nitrophenyl)but-3-enoic acid (77h). Product 77h was prepared 
according to the general procedure to give a colorless solid (41 mg, 93% yield): 87% ee; 
[α]D25 +94.5 (c 3.4, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.22 (t, J = 2.0 Hz, 1H), 8.15 
(ddd, J = 8.2, 2.2, 1.0 Hz, 1H), 7.69 (ddd, J = 7.9, 1.9, 1.1 Hz, 1H), 7.53 (t, J = 8.0 Hz, 
1H), 6.38 (dd, J = 17.5, 10.7 Hz, 1H), 5.59 – 5.11 (m, 2H), 1.72 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 179.6, 148.5, 144.7, 139.2, 133.3, 129.6, 122.5, 122.1, 117.2, 53.7, 23.4; 
IR (Neat Film, NaCl) 3089, 2988, 2924, 2641, 1707, 1530, 1351, 1276, 1106, 929, 808, 
738, 688 cm-1; HRMS (FAB+) m/z calc’d for C11H12O4N [M+H]+: 222.0766, found 
222.0769; HPLC conditions: 3% IPA, 1.0 mL/min, Chiralpak AD-H column, λ = 210 nm, 
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(S)-2-Methyl-2-(naphthalen-2-yl)but-3-enoic acid (77i). Product 77i was prepared 
according to the general procedure to give a pale yellow oil (30 mg, 66% yield): 92% ee; 
[α]D25 +7.8 (c 0.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.91 – 7.72 (m, 4H), 7.55 – 
7.39 (m, 3H), 6.52 (dd, J = 17.5, 10.7 Hz, 1H), 5.57 – 5.11 (m, 2H), 1.77 (s, 3H); 13C 
NMR (101 MHz, CDCl3) δ 180.9, 140.5, 140.0, 133.3, 132.5, 128.3, 128.2, 127.6, 126.3, 
126.2, 125.3, 125.2, 116.0, 53.9, 23.4; IR (Neat Film, NaCl) 3057, 2984, 1701, 1506, 
1458, 1411, 1274, 1182, 1128, 1102, 925, 856, 816, 747 cm-1; HRMS (FAB+) m/z calc’d 
for C15H14O2 [M]+: 226.0994, found 226.0992; HPLC conditions: 2% IPA, 1.0 mL/min, 
Chiralpak AD-H column, λ = 210 nm, tR (min): major = 28.272, minor = 24.870. 
 
 
(S)-2-Methyl-2-(m-tolyl)but-3-enoic acid (77j). Product 77j was prepared according to 
the general procedure to give a pale yellow oil (26 mg, 68% yield): 93% ee; [α]D25 +5.2 (c 
1.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.25 – 7.04 (m, 4H), 6.40 (dd, J = 17.5, 10.7 
Hz, 1H), 5.45 – 5.08 (m, 2H), 2.44 – 2.20 (m, 3H), 1.65 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 180.2, 142.7, 140.6, 138.3, 128.5, 128.1, 127.3, 123.7, 115.6, 53.6, 23.3, 21.7; 
IR (Neat Film, NaCl) 2984, 2923, 2648, 1703, 1606, 1459, 1411, 1275, 1178, 1127, 
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found 191.1074; HPLC conditions: 2% IPA, 1.0 mL/min, Chiralpak AD-H column, λ = 
210 nm, tR (min): major = 13.800, minor = 12.388. 
 
 
(S)-2-(3,5-Dimethylphenyl)-2-methylbut-3-enoic acid (77k). Product 77k was prepared 
according to the general procedure and isolated by preparatory TLC (30% 
acetone/hexanes) to give a colorless oil (13 mg, 32% yield): 85% ee; [α]D25 –40.6 (c 0.1, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.94 (d, J = 8.5 Hz, 3H), 6.42 (dd, J = 17.4, 10.6 
Hz, 1H), 5.45 – 5.08 (m, 2H), 2.33 (s, 6H), 1.65 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
180.5, 142.8, 140.8, 138.1, 129.0, 124.4, 115.3, 53.6, 23.3, 21.6; IR (Neat Film, NaCl) 
2983, 2919, 2639, 1700, 1602, 1411, 1279, 1125, 923, 848, 708 cm-1; HRMS (FAB+) m/z 
calc’d for C13H17O2 [M+H]+: 205.1229, found 205.1233; HPLC conditions: 2% IPA, 1.0 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 11.107, minor = 
10.064. Please note an HMBC has been included due to the low intensity of the carbonyl 
13C shift at δ 180.5. 
 
 
(S)-2-Ethyl-2-phenylbut-3-enoic acid (79a). Product 79a was prepared according to the 
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colorless oil (23 mg, 61% yield): 92% ee; [α]D25 +17.4 (c 0.4, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.38 – 7.22 (m, 5H), 6.36 (dd, J = 17.7, 10.9 Hz, 1H), 5.35 (d, J = 10.7 
Hz, 1H), 5.09 (d, J = 17.6 Hz, 1H), 2.36 – 2.00 (m, 2H), 0.87 (t, J = 7.2 Hz, 3H).; 13C 
NMR (101 MHz, CDCl3) δ 180.1, 141.3, 139.1, 128.4, 127.6, 127.2, 116.9, 58.0, 29.4, 
9.4; IR (Neat Film, NaCl) 3060, 2970, 2928, 2636, 1702, 1495, 1448, 1407, 1381, 1261, 
1083, 924, 761, 700 cm-1; HRMS (FAB+) m/z calc’d for C12H15O2 [M+H]+: 191.1072, 
found 191.1071; HPLC conditions: 1.5% IPA, 1.0 mL/min, two Chiralpak AD-H 
columns in series, λ = 210 nm, tR (min): major = 46.253, minor = 47.271. 
 
 
(S)-2-Phenyl-2-vinylhexanoic acid (79b). Product 79b was prepared according to the 
general procedure and isolated by preparatory TLC (30% acetone/hexanes) to give a 
colorless oil (6 mg, 14% yield): 95% ee; [α]D25 –106.0 (c 0.07, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.40 – 7.29 (m, 5H), 6.38 (dd, J = 17.6, 10.9 Hz, 1H), 5.32 (dd, J = 10.9, 
0.9 Hz, 1H), 5.06 (dd, J = 17.6, 0.9 Hz, 1H), 2.28 – 1.98 (m, 2H), 1.44 – 1.14 (m, 4H), 
0.87 (t, J = 7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 178.4, 141.6, 139.7, 128.4, 
127.5, 127.1, 116.6, 57.5, 36.5, 27.0, 23.4, 14.1; IR (Neat Film, NaCl) 2956, 2920, 2851, 
1734, 1706, 1466, 1378, 1260, 1098, 925, 800, 722, 700 cm-1; HRMS (FAB+) m/z calc’d 
for C14H19O2 [M+H]+: 219.1385, found 219.1291; SFC conditions: 5% IPA, 2.5 mL/min, 
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(R)-2-Methyl-2-phenethylbut-3-enoic acid (79f). Product 79f was prepared according 
to the general procedure and isolated by preparatory TLC (33% acetone/hexanes) to give 
a colorless oil (13 mg, 32% yield): 3% ee; [α]D25 –12.1 (c 0.7, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.44 – 7.04 (m, 5H), 6.10 (dd, J = 17.6, 10.7 Hz, 1H), 5.21 (dd, J = 14.0, 
3.3 Hz, 2H), 2.60 (dt, J = 11.0, 4.9 Hz, 2H), 2.33 – 1.79 (m, 2H), 1.40 (s, 3H); 13C NMR 
(101 MHz, CDCl3) δ 182.0, 142.0, 140.9, 128.54, 128.49, 126.1, 114.7, 48.7, 41.1, 31.2, 
20.7; IR (Neat Film, NaCl) 3026, 2927, 1702, 1496, 1454, 1380, 1264, 1097, 925, 748, 
700 cm-1; HRMS (FAB+) m/z calc’d for C13H17O2 [M+H]+: 267.1385, found 267.1376; 
HPLC conditions: 2% IPA, 1.0 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): 
major = 18.485, minor = 14.652. Please note an HMBC has been included due to the low 
intensity of the carbonyl 13C shift at δ 182.0. 
 
 
2,2-Dimethylbut-3-enoic acid (79g). Product 79g was prepared according to the general 
procedure to give a colorless oil (15 mg, 63% yield). Characterization data match those 
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3.7.2.6 Experimental Procedures and Spectroscopic Data for the One-pot 
Syntheses of Carboxylic Acid Derivatives 
	
Methyl (S)-2-(4-chlorophenyl)-2-methylbut-3-enoate (82). In a nitrogen-filled glove 
box, to a scintillation vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (13 
mg, 0.02 mmol, 2 mol %), ligand (Sa)-L5 (25 mg, 0.042 mmol, 4.2 mol %), TBD (14 mg, 
0.10 mmol, 10 mol %), and THF (5 mL). Vial A was stirred at 25 °C (ca. 10 min) while 
another scintillation vial (vial B) was charged with MAC nucleophile 67c (126 mg, 1.0 
mmol, 100 mol %), THF (5 mL), and BEt3 (2.0 mL, 1M in hexanes). The pre-formed 
catalyst solution (vial A) was then transferred to vial B followed immediately by 
carbonate 76b (480 mg, 2.0 mmol, 200 mol %). The vial was sealed and stirred at 60 °C. 
After 18 h, the vial was removed from the glove box and the reaction mixture was 
concentrated under reduced pressure.  
To the vial of crude MAC adduct equipped with a stir bar and septum cap was 
added 1:1 AcOH/DME (2 mL, 0.5 M) and CSA (0.26 g, 1.1 mmol, 1.1 equiv) under a 
nitrogen atmosphere. The reaction was heated to 60 °C for 6 h, whereupon the reaction 
mixture was cooled to ambient temperature, diluted with anhydrous MeOH (2.8 mL), and 
cooled to –40 °C. A solution of 1:1 MeOH/Et3N (5.6 mL, 20.1 equiv of Et3N) was added 
dropwise over 10 min. The reaction mixture was allowed to warm to ambient temperature 
over 18 h, whereupon the reaction was slowly quenched with saturated NH4Cl aqueous 
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combined organic layers were washed with brine (10 mL), dried over Na2SO4, and 
concentrated under reduced pressure at 0 °C. The crude residue was purified by silica gel 
flash column chromatography (10% EtOAc/hexanes) to give methyl ester 82 as a 
colorless oil (0.20 g, 88% yield): [α]D25 +1.5 (c 0.8, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 7.41 – 6.99 (m, 4H), 6.35 (dd, J = 17.5, 10.7 Hz, 1H), 5.48 – 5.00 (m, 2H), 3.70 (s, 3H), 
1.62 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 175.0, 142.0, 140.6, 132.9, 128.7, 128.1, 
115.6, 53.5, 52.7, 23.7; IR (Neat Film, NaCl) 2986, 2952, 1734, 1637, 1493, 1459, 1246, 
1181, 1123, 1098, 1014, 926, 828, 757 cm-1; HRMS (FAB+) m/z calc’d for C12H13ClO2 
[M+]+: 224.0604, found 224.0621. 
 
 
Allyl (S)-2-(4-chlorophenyl)-2-methylbut-3-enoate (83). In a nitrogen-filled glove box, 
to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 mg, 0.0040 
mmol, 2 mol %), ligand (Sa)-L5 (4.9 mg, 0.0084 mmol, 4.2 mol %), TBD (2.8 mg, 0.020 
mmol, 10 mol %), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 min) while 
another 1 dram vial (vial B) was charged with MAC nucleophile 67c (25 mg, 0.20 mmol, 
100 mol %), THF (1 mL), and BEt3 (400 µL, 1M in hexanes). The pre-formed catalyst 
solution (vial A) was then transferred to vial B followed immediately by carbonate 76b 
(96 mg, 0.40 mmol, 200 mol %). The vial was sealed and stirred at 60 °C. After 18 h, the 
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To the vial of crude MAC adduct equipped with a stir bar and septum cap was 
added 1:1 AcOH/DME (0.4 mL, 0.5 M) and CSA (51 mg, 0.22 mmol, 1.1 equiv) under a 
nitrogen atmosphere. The reaction was heated to 60 °C for 6 h, whereupon the reaction 
mixture was cooled to ambient temperature, diluted with allyl alcohol (0.4 mL), and 
cooled to 0 °C. A solution of 1:1 Et3N/allyl alcohol (1.1 mL, 20.4 equiv of Et3N) was 
added dropwise over 10 min. The reaction mixture was allowed to warm to ambient 
temperature over 18 h, whereupon the reaction was slowly quenched with saturated 
NH4Cl aqueous solution (5 mL). The aqueous layer was then extracted with CH2Cl2 (3 x 
10 mL) and the combined organic layers were washed with brine (10 mL), dried over 
Na2SO4, and concentrated under reduced pressure at 0 °C. The crude residue was purified 
by preparatory TLC (8% EtOAc/hexanes) to give allyl ester 83 as a colorless oil (37 mg, 
74% yield): [α]D25 +0.4 (c 2.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.12 (m, 
4H), 6.36 (dd, J = 17.5, 10.7 Hz, 1H), 5.85 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.38 – 5.02 
(m, 4H), 4.61 (dt, J = 5.6, 1.4 Hz, 2H), 1.63 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
174.1, 142.0, 140.6, 132.9, 131.9, 128.6, 128.1, 118.5, 115.6, 65.9, 53.5, 23.6; IR (Neat 
Film, NaCl) 3089, 2985, 2930, 2857, 1900, 1734, 1638, 1493, 1236, 1177, 1122, 1097, 






Chapter 3 – Enantioselective Synthesis of Acyclic α-Quaternary Carboxylic Acid Derivatives  
via Iridium-Catalyzed Allylic Alkylation 
  
 
(S)-2-(4-Chlorophenyl)-2-methyl-1-(pyrrolidin-1-yl)but-3-en-1-one (84). In a 
nitrogen-filled glove box, to a 1 dram vial (vial A) equipped with a stir bar was added 
[Ir(cod)Cl]2 (2.7 mg, 0.0040 mmol, 2 mol %), ligand (Sa)-L5 (4.9 mg, 0.0084 mmol, 4.2 
mol %), TBD (2.8 mg, 0.020 mmol, 10 mol %), and THF (1 mL). Vial A was stirred at 
25 °C (ca. 10 min) while another 1 dram vial (vial B) was charged with MAC nucleophile 
67c (25 mg, 0.20 mmol, 100 mol %), THF (1 mL), and BEt3 (400 µL, 1M in hexanes). 
The pre-formed catalyst solution (vial A) was then transferred to vial B followed 
immediately by carbonate 76b (96 mg, 0.40 mmol, 200 mol %). The vial was sealed and 
stirred at 60 °C. After 18 h, the vial was removed from the glove box, transferred to a 20 
mL vial with CH2Cl2, and concentrated. 
To the vial of crude MAC adduct equipped with a stir bar and septum cap was 
added 1:1 AcOH/DME (0.4 mL, 0.5 M) and CSA (51 mg, 0.22 mmol, 1.1 equiv) under a 
nitrogen atmosphere. The reaction was heated to 60 °C for 6 h, whereupon the reaction 
mixture was cooled to ambient temperature, diluted with CH2Cl2 (0.4 mL), and cooled to 
–40 °C. A solution of 1:1 pyrrolidine/CH2Cl2 (0.67 mL, 20.4 equiv of pyrrolidine) was 
added dropwise over 10 min then Et3N (0.57 mL, 4.1 mmol, 20.4 equiv). The reaction 
mixture was allowed to warm to ambient temperature over 18 h, whereupon the reaction 
was slowly quenched with saturated NH4Cl aqueous solution (5 mL). The aqueous layer 
was then extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers were 
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at 0 °C. The crude residue was purified by preparatory TLC (30% acetone/hexanes) to 
give amide 84 as a colorless oil (32 mg, 61% yield): [α]D25 –49.5 (c 1.7, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.34 – 7.28 (m, 2H), 7.21 – 7.14 (m, 2H), 6.45 (dd, J = 17.4, 10.7 
Hz, 1H), 5.27 (dd, J = 10.7, 0.8 Hz, 1H), 5.10 (dd, J = 17.4, 0.8 Hz, 1H), 3.63 – 3.47 (m, 
2H), 2.98 (dt, J = 10.6, 6.3 Hz, 1H), 2.52 (dt, J = 10.6, 6.7 Hz, 1H), 1.78 – 1.62 (m, 2H), 
1.64 – 1.55 (m, 5H); 13C NMR (101 MHz, CDCl3) δ 172.1, 143.2, 139.7, 132.5, 129.0, 
127.6, 115.5, 54.3, 47.52, 47.44, 28.4, 26.5, 23.5; IR (Neat Film, NaCl) 2928, 2873, 
1742, 1627, 1491, 1396, 1228, 1185, 1096, 1012, 921, 829, 723 cm-1; HRMS (FAB+) m/z 
calc’d for C15H19ClNO [M+H]+: 264.1155, found 264.1154. 
 
 
(S)-N-allyl-2-(4-chlorophenyl)-2-methylbut-3-enamide (85). In a nitrogen-filled glove 
box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 mg, 
0.0040 mmol, 2 mol %), ligand (Sa)-L5 (4.9 mg, 0.0084 mmol, 4.2 mol %), TBD (2.8 
mg, 0.020 mmol, 10 mol %), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 min) 
while another 1 dram vial (vial B) was charged with MAC nucleophile 67c (25 mg, 0.20 
mmol, 100 mol %), THF (1 mL), and BEt3 (400 µL, 1M in hexanes). The pre-formed 
catalyst solution (vial A) was then transferred to vial B followed immediately by 
carbonate 76b (96 mg, 0.40 mmol, 200 mol %). The vial was sealed and stirred at 60 °C. 
After 18 h, the vial was removed from the glove box, transferred to a 20 mL vial with 
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To the vial of crude MAC adduct equipped with a stir bar and septum cap was 
added 1:1 AcOH/DME (0.4 mL, 0.5 M) and CSA (51 mg, 0.22 mmol, 1.1 equiv) under a 
nitrogen atmosphere. The reaction was heated to 60 °C for 6 h, whereupon the reaction 
mixture was cooled to ambient temperature, diluted with allyl amine (0.4 mL), and 
cooled to 0 °C. A solution of 1:1 Et3N/allyl amine (1.1 mL, 20.4 equiv of Et3N) was 
added dropwise over 10 min. The reaction mixture was allowed to warm to ambient 
temperature over 18 h, whereupon the reaction was slowly quenched with saturated 
NH4Cl aqueous solution (5 mL). The aqueous layer was then extracted with CH2Cl2 (3 x 
10 mL) and the combined organic layers were washed with brine (10 mL), dried over 
Na2SO4, and concentrated under reduced pressure at 0 °C. The crude residue was purified 
by preparatory TLC (30% EtOAc/hexanes) to give allyl amide 85 as a colorless oil (31 
mg, 63% yield): [α]D25 +10.2 (c 1.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.17 
(m, 4H), 6.29 (dd, J = 17.4, 10.6 Hz, 1H), 5.90 – 5.75 (m, 1H), 5.64 (s, 1H), 5.33 (dd, J = 
10.6, 0.8 Hz, 1H), 5.20 – 5.03 (m, 3H), 3.96 – 3.82 (m, 2H), 1.67 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 174.1, 142.0, 141.8, 134.1, 133.1, 128.9, 128.8, 116.6, 116.5, 54.3, 42.3, 
24.6; IR (Neat Film, NaCl) 3341, 3085, 2983, 2931, 1739, 1658, 1520, 1493, 1414, 1270, 
1096, 1014, 922, 827, 725, 657 cm-1; HRMS (FAB+) m/z calc’d for C14H17NOCl 
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3.7.2.7 Experimental Procedures and Spectroscopic Data for the Product 
Transformations of α-Quaternary Ester 82 
 
Methyl (S)-2-(4-chlorophenyl)-2-methylbutanoate (86). To a solution of olefin 82 (13 
mg, 0.056 mmol, 1 equiv) in EtOAc (1 mL) was added Pd/C (2.5 mg, 20% w/w). The 
reaction mixture was sparged with a hydrogen gas (balloon) for 5 minutes and then 
stirred under a hydrogen atmosphere for 18 h, whereupon the reaction was filtered 
through celite with EtOAc (5 mL) and concentrated under reduced pressure at 0 °C to 
give alkyl 86 as a colorless oil (12 mg, 97% yield): [α]D25 +3.6 (c 1.2, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.41 – 7.15 (m, 4H), 3.67 (s, 3H), 2.31 – 1.80 (m, 2H), 1.53 (s, 3H), 
0.83 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 176.5, 142.4, 132.6, 128.6, 
127.7, 52.3, 50.4, 32.0, 22.2, 9.2; IR (Neat Film, NaCl) 2970, 2880, 1731, 1493, 1457, 
1383, 1307, 1238, 1147, 1096, 1012, 824, 756, 720 cm-1; HRMS (FAB+) m/z calc’d for 
C12H16O2Cl [M+H]+: 227.0839, found 227.0840. 
 
 
(S)-2-(4-Chlorophenyl)-2-methylbut-3-en-1-ol (87). DIBAL (0.029 mL, 0.16 mmol, 3 
equiv) was added dropwise to a solution of methyl ester 82 (13 mg, 0.056 mmol, 1 equiv) 
in Et2O (1.0 mL) at 0 °C. The mixture was stirred at 0 °C for 2 h, whereupon the reaction 
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h at ambient temperature. The aqueous layer was then extracted with CH2Cl2 (3 x 5 mL) 
and the combined organic layers were washed with brine (5 mL), dried over Na2SO4, and 
concentrated under reduced pressure at 0 °C. The crude residue was purified by 
preparatory TLC (25% acetone/hexanes) to give alcohol 87 as a colorless oil (8 mg, 73% 




(3S)-3-(4-Chlorophenyl)-4-hydroxy-3-methyldihydrofuran-2(3H)-one (88). To a 
solution of olefin 82 (24 mg, 0.10 mmol, 1 equiv) in THF/H2O (4:1, 1 mL) was added 
K2OsO4 (4.0 mg, 0.010 mmol, 0.1 equiv) and N-methylmorpholine N-oxide (19 mg, 0.16 
mmol, 1.6 equiv). The reaction mixture was stirred for 18 h, whereupon the reaction was 
quenched with sodium sulfite (10 mg, 0.079 mmol, 0.79 equiv) and diluted with water 
(0.5 mL). The aqueous layer was then extracted with EtOAc (3 x 5 mL) and the 
combined organic layers were washed with brine (5 mL), dried over Na2SO4, and 
concentrated under reduced pressure at 0 °C. The crude residue was purified by 
preparatory TLC (30% acetone/hexanes) to give lactone 88 as a colorless oil (19 mg, 
82% yield, 1:1 dr): [α]D25 –115.6 (c 0.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.43 – 
7.26 (m, 4H), 4.58 (dd, J = 4.4, 2.8 Hz, 0.5H), 4.54 (dd, J = 10.2, 4.5 Hz, 0.5H), 4.35 – 
4.31 (m, 0.5H), 4.28 – 4.20 (m, 1H), 4.16 (dd, J = 10.1, 2.8 Hz, 0.5H), 1.66 (s, 1.5H), 
1.57 (s, 1.5H); 13C NMR (101 MHz, CDCl3) δ 178.4, 178.1, 138.4, 134.4, 134.0, 133.9, 
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NaCl) 3448, 2976, 2929, 1761, 1496, 1384, 1218, 1178, 1096, 1072, 1014, 982, 927, 737, 
688 cm-1; HRMS (FAB+) m/z calc’d for C11H12O3Cl [M+H]+: 227.0475, found 227.0481. 
 
 
Methyl (R)-2-(4-chlorophenyl)-2-methyl-3-oxopropanoate (89). A solution of olefin 
82 (10 mg, 0.045 mmol, 1 equiv) and NaHCO3 (1.0 mg, 0.011 mmol, 0.25 equiv) in 
MeOH/ CH2Cl2 (1:5, 2.6 mL) was cooled to –78 °C. Ozone was bubbled through the 
reaction mixture for 0.5 h, whereupon the reaction mixture was sparged with N2 and 
dimethyl sulfide (0.10 mL, 0.14 mmol, 3 equiv) was added. The cooling bath was then 
removed and the reaction was stirred for 18 h at ambient temperature. The reaction 
mixture was concentrated under reduced pressure at 0 °C and the crude residue was 
purified by preparatory TLC (17% Et2O/hexanes) to afford aldehyde 89 as a colorless oil 
(5.0 mg, 50% yield): [α]D25 +9.1 (c 0.07, CHCl3); 1H NMR (400 MHz, CDCl3) δ 9.83 (s, 
1H), 7.41 – 7.33 (m, 2H), 7.22 – 7.13 (m, 2H), 3.81 (s, 3H), 1.69 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 196.2, 171.8, 134.8, 134.5, 129.5, 128.5, 61.7, 53.1, 18.0; IR (Neat Film, 
NaCl) 2992, 2954, 2845, 2726, 1721, 1596, 1494, 1455, 1252, 1122, 1096, 1013, 911, 











Chapter 3 – Enantioselective Synthesis of Acyclic α-Quaternary Carboxylic Acid Derivatives  
via Iridium-Catalyzed Allylic Alkylation 
  
3.7.2.8 Determination of Enantiomeric Excess 
Please note racemic products were synthesized using racemic L5. 
 
Table 3.6 Determination of enantiomeric excess 
238
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 Figure A4.3 13C NMR (101 MHz, CDCl3) of compound 73 
 
Figure A4.2 Infrared spectrum (Thin Film, NaCl) of compound 73 
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 Figure A4.6 13C NMR (101 MHz, CDCl3) of compound 74 
 
Figure A4.5 Infrared spectrum (Thin Film, NaCl) of compound 74 
 
249






































































































































 Figure A4.9 13C NMR (101 MHz, CDCl3) of compound 76c 
 
Figure A4.8 Infrared spectrum (Thin Film, NaCl) of compound 76c 
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 Figure A4.12 13C NMR (101 MHz, CDCl3) of compound 76f 
 
Figure A4.11 Infrared spectrum (Thin Film, NaCl) of compound 76f 
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 Figure A4.15 13C NMR (101 MHz, CDCl3) of compound 76g 
 
Figure A4.14 Infrared spectrum (Thin Film, NaCl) of compound 76g 
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 Figure A4.18 13C NMR (101 MHz, CDCl3) of compound 76h 
 
Figure A4.17 Infrared spectrum (Thin Film, NaCl) of compound 76h 
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 Figure A4.21 13C NMR (101 MHz, CDCl3) of compound 76i 
 
Figure A4.20 Infrared spectrum (Thin Film, NaCl) of compound 76i 
 
259




































































































 Figure A4.24 13C NMR (101 MHz, CDCl3) of compound 76k 
 
Figure A4.23 Infrared spectrum (Thin Film, NaCl) of compound 76k 
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 Figure A4.27 13C NMR (101 MHz, CDCl3) of compound 77b 
 
Figure A4.26 Infrared spectrum (Thin Film, NaCl) of compound 77b 
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 Figure A4.30 13C NMR (101 MHz, CDCl3) of compound 77c 
 
Figure A4.29 Infrared spectrum (Thin Film, NaCl) of compound 77c 
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 Figure A4.33 13C NMR (101 MHz, CDCl3) of compound 77d 
 
Figure A4.32 Infrared spectrum (Thin Film, NaCl) of compound 77d 
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 Figure A4.36 13C NMR (101 MHz, CDCl3) of compound 77e 
 
Figure A4.35 Infrared spectrum (Thin Film, NaCl) of compound 77e 
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 Figure A4.39 13C NMR (101 MHz, CDCl3) of compound 77f 
 
Figure A4.38 Infrared spectrum (Thin Film, NaCl) of compound 77f 
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 Figure A4.42 13C NMR (101 MHz, CDCl3) of compound 77g 
 
Figure A4.41 Infrared spectrum (Thin Film, NaCl) of compound 77g 
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 Figure A4.45 13C NMR (101 MHz, CDCl3) of compound 77h 
 
Figure A4.44 Infrared spectrum (Thin Film, NaCl) of compound 77h 
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 Figure A4.48 13C NMR (101 MHz, CDCl3) of compound 77i 
 
Figure A4.47 Infrared spectrum (Thin Film, NaCl) of compound 77i 
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 Figure A4.51 13C NMR (101 MHz, CDCl3) of compound 77j 
 
Figure A4.50 Infrared spectrum (Thin Film, NaCl) of compound 77j 
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 Figure A4.54 13C NMR (101 MHz, CDCl3) of compound 77k 
 
Figure A4.53 Infrared spectrum (Thin Film, NaCl) of compound 77k 
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 Figure A4.58 13C NMR (101 MHz, CDCl3) of compound 78b 
 
Figure A4.57 Infrared spectrum (Thin Film, NaCl) of compound 78b 
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 Figure A4.61 13C NMR (101 MHz, CDCl3) of compound 78c 
 
Figure A4.60 Infrared spectrum (Thin Film, NaCl) of compound 78c 
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 Figure A4.64 13C NMR (101 MHz, CDCl3) of compound 78e 
 
Figure A4.63 Infrared spectrum (Thin Film, NaCl) of compound 78e 
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 Figure A4.67 13C NMR (101 MHz, CDCl3) of compound 79a 
 
Figure A4.66 Infrared spectrum (Thin Film, NaCl) of compound 79a 
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 Figure A4.70 13C NMR (101 MHz, CDCl3) of compound 79b 
 
Figure A4.69 Infrared spectrum (Thin Film, NaCl) of compound 79b 
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 Figure A4.73 13C NMR (101 MHz, CDCl3) of compound 79f 
 
Figure A4.72 Infrared spectrum (Thin Film, NaCl) of compound 79f 
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 Figure A4.77 13C NMR (101 MHz, CDCl3) of compound 82 
 
Figure A4.76 Infrared spectrum (Thin Film, NaCl) of compound 82 
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 Figure A4.80 13C NMR (101 MHz, CDCl3) of compound 83 
 
Figure A4.79 Infrared spectrum (Thin Film, NaCl) of compound 83 
 
299






































































































































 Figure A4.83 13C NMR (101 MHz, CDCl3) of compound 84 
 
Figure A4.82 Infrared spectrum (Thin Film, NaCl) of compound 84 
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 Figure A4.86 13C NMR (101 MHz, CDCl3) of compound 85 
 
Figure A4.85 Infrared spectrum (Thin Film, NaCl) of compound 85 
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 Figure A4.89 13C NMR (101 MHz, CDCl3) of compound 86 
 
Figure A4.88 Infrared spectrum (Thin Film, NaCl) of compound 86 
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 Figure A4.92 13C NMR (101 MHz, CDCl3) of compound 88 
 
Figure A4.91 Infrared spectrum (Thin Film, NaCl) of compound 88 
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 Figure A4.95 13C NMR (101 MHz, CDCl3) of compound 89 
 
Figure A4.94 Infrared spectrum (Thin Film, NaCl) of compound 89 
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 Figure A4.98 13C NMR (101 MHz, CDCl3) of compound 90 
 
Figure A4.97 Infrared spectrum (Thin Film, NaCl) of compound 90 
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 Figure A4.101 13C NMR (101 MHz, CDCl3) of compound 91 
 
Figure A4.100 Infrared spectrum (Thin Film, NaCl) of compound 91 
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A5.1   GENERAL EXPERIMENTAL 
X-ray crystallographic analysis was obtained from the Caltech X-Ray 
Crystallography Facility using a Bruker D8 Venture Kappa Duo Photon 100 CMOS 
diffractometer. 
 





Carboxylic acid 77h (87% ee) was recrystallized by slow evaporation of 
CH2Cl2 to provide crystals suitable for X-ray analysis. 
 




Table A5.1 Crystal data and structure refinement for carboxylic acid 77h 
 
Empirical formula  C11 H11 N O4 
Formula weight  221.21 
Temperature  200(2) K 
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Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 7.3561(3) Å            a= 90° 
 b = 6.7600(3) Å            b= 94.5940(10)° 
 c = 10.9461(5) Å          g = 90° 
Volume 542.57(4) Å3 
Z 2 
Density (calculated) 1.354 Mg/m3 
Absorption coefficient 0.879 mm-1 
F(000) 232 
Theta range for data collection 4.051 to 72.406°. 
Index ranges -9<=h<=9, -8<=k<=8, -13<=l<=13 
Reflections collected 24109 
Independent reflections 2132 [R(int) = 0.0427] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2132 / 1 / 146 
Goodness-of-fit on F2 1.315 
Final R indices [I>2sigma(I)] R1 = 0.0495, wR2 = 0.1336 
R indices (all data) R1 = 0.0497, wR2 = 0.1346 
Absolute structure parameter 0.08(5) 
Extinction coefficient n/a 
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Table A5.2 Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for 77h. U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________  
 x y z U(eq) 
_____________________________________________________________________  
C(1) 6927(3) 5263(3) 4602(2) 32(1) 
C(2) 7734(2) 5232(3) 5795(2) 30(1) 
C(3) 6640(2) 5267(3) 6762(2) 27(1) 
C(4) 4752(2) 5328(3) 6510(2) 33(1) 
C(5) 3969(2) 5364(3) 5309(2) 35(1) 
C(6) 5062(3) 5332(3) 4329(2) 34(1) 
C(7) 7495(2) 5394(3) 8089(2) 33(1) 
C(8) 7573(4) 7595(4) 8448(2) 52(1) 
C(9) 9331(3) 4360(5) 8210(2) 51(1) 
C(10) 10884(3) 5180(9) 8624(2) 86(2) 
C(11) 6291(2) 4290(3) 8935(2) 33(1) 
O(1) 6125(2) 2390(3) 8666(1) 46(1) 
O(2) 5572(2) 5042(3) 9776(1) 49(1) 
N(1) 8117(3) 5216(4) 3590(2) 47(1) 
O(3) 9753(2) 5210(6) 3825(2) 84(1) 




Table A5.3 Bond lengths [Å] and angles [°] for 77h 
_____________________________________________________  
C(1)-C(6)  1.381(3) 
C(1)-C(2)  1.390(2) 
C(1)-N(1)  1.466(3) 
C(2)-C(3)  1.380(2) 
C(3)-C(4)  1.395(2) 
C(3)-C(7)  1.538(2) 
C(4)-C(5)  1.392(3) 
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C(5)-C(6)  1.391(3) 
C(7)-C(9)  1.517(3) 
C(7)-C(11)  1.527(2) 
C(7)-C(8)  1.539(3) 
C(9)-C(10)  1.318(4) 
C(11)-O(2)  1.210(2) 
C(11)-O(1)  1.321(3) 
N(1)-O(3)  1.210(3) 
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Table A5.4 Anisotropic displacement parameters  (Å2x 103) for 77h. The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
_____________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_____________________________________________________________________  
C(1) 38(1)  32(1) 26(1)  -1(1) 2(1)  1(1) 
C(2) 29(1)  34(1) 28(1)  0(1) 1(1)  0(1) 
C(3) 30(1)  25(1) 27(1)  1(1) 1(1)  -1(1) 
C(4) 30(1)  34(1) 35(1)  1(1) 4(1)  1(1) 
C(5) 29(1)  34(1) 41(1)  3(1) -5(1)  -1(1) 
C(6) 40(1)  28(1) 32(1)  -2(1) -8(1)  1(1) 
C(7) 31(1)  42(1) 26(1)  0(1) 3(1)  -4(1) 
C(8) 72(2)  48(1) 36(1)  -7(1) 6(1)  -24(1) 
C(9) 33(1)  91(2) 30(1)  16(1) 4(1)  5(1) 
C(10) 32(1)  176(5) 49(1)  35(2) -6(1)  -14(2) 
C(11) 33(1)  39(1) 26(1)  2(1) 1(1)  2(1) 
O(1) 62(1)  37(1) 42(1)  0(1) 22(1)  -4(1) 
O(2) 60(1)  51(1) 38(1)  -7(1) 22(1)  5(1) 
N(1) 50(1)  67(1) 26(1)  2(1) 4(1)  5(1) 
O(3) 40(1)  176(3) 36(1)  0(1) 9(1)  5(1) 




Table A5.5 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 
77h 
_____________________________________________________________________  
 x  y  z  U(eq) 
_____________________________________________________________________  
H(2) 9023 5188 5942 36 
H(4) 3987 5347 7168 40 
H(5) 2680 5410 5158 42 
H(6) 4546 5355 3505 40 
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H(8A) 8291 8322 7880 78 
H(8B) 8145 7730 9284 78 
H(8C) 6333 8135 8410 78 
H(9) 9363 3012 7967 62 
H(10A) 10911 6525 8877 103 
H(10B) 11978 4427 8671 103 
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Enantioselective Synthesis Vicinal All-Carbon Quaternary Centers  
via Iridium-Catalyzed Allylic Alkylation† 
 
 
4.1   INTRODUCTION AND BACKGROUND 
The enantioselective preparation of singular all-carbon quaternary stereocenters 
has been a persistent challenge in the synthetic community and a topic of great interest to 
our research group. 1  However, due to significant progress in this area over recent 
decades,2 the more formidable challenge of constructing vicinal all-carbon quaternary 
centers has become the forefront of investigation. A limited number of organic3 and 
transition metal-catalyzed4,5 methods for the enantioselective preparation of vicinal all-
carbon quaternary stereocenters have been reported, 6  with enantioselective transition 
metal-catalyzed allylic alkylation strategies remaining underexplored.  
	†	 This work was performed in collaboration with Dr. J. Caleb Hethcox. Portions of this chapter have been 
reproduced with permission from Hethcox, J. C.;‡ Shockley, S. E.;‡ Stoltz, B. M. Angew. Chem. Int. Ed. 
2018, doi: 10.1002/anie.201804820 © 2018 Wiley-VCH.  
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In 2011, Trost reported an enantioselective palladium-catalyzed allylic alkylation 
of oxindoles to provide reverse prenylated products containing a homoallylic quaternary 
stereocenter vicinal to an all-carbon quaternary center (Figure 4.1a).5a,b In 2014, Ooi5c 
and Zhang5d each disclosed examples of enantio- and diastereoselective palladium-
catalyzed allylic alkylation reactions to form cyclic products bearing vicinal all-carbon 
quaternary stereocenters (Figure 4.1b). To date, these three methods represent the only 
enantioselective transition metal-catalyzed allylic alkylation protocols for the synthesis of 
vicinal all-carbon quaternary centers7,8 – none of these reports provide access to acyclic 
products.  
 
Figure 4.1 State-of-the-art in the enantioselective synthesis of vicinal all-carbon quaternary centers 
via transition metal-catalyzed allylic alkylation  
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Recently, our group reported the first iridium-catalyzed allylic alkylation method 
to allow for the synthesis of highly enantioenriched allylic quaternary stereocenters.9 
Given that iridium-catalyzed allylic alkylation is well known to facilitate the synthesis of 
vicinal stereocenters (3°/3° and 3°/4°),10 we hypothesized that we could utilize our newly 
developed technology to prepare vicinal all-carbon quaternary centers, with the use of 
appropriately designed nucleophiles. 11  Herein, we discuss the first enantioselective 
transition metal-catalyzed allylic alkylation to form acyclic products bearing vicinal all-
carbon quaternary centers (Figure 4.1c). 
 
4.2  REACTION OPTIMIZATION 
Preliminary studies focused on identifying a suitable catalyst system to promote 
the reaction of nucleophile 92 and trisubstituted allylic electrophile 72 (Table 4.1). In 
designing our optimal nucleophile for the allylic alkylation reaction, we imagined that 
methylmalononitrile (92) would mimic both the acidity and steric bulk of the previously 
utilized masked acyl cyanide (MAC) nucleophile9  (Figure 1C, R1 = OMOM) as well as 
provide versatile functional handles for derivatizations of product 93. We were pleased to 
find that our hypothesis was valid, and when utilizing our optimized conditions for the 
iridium-catalyzed allylic alkylation of MAC reagents9 with nucleophile 92, product 93 is 
obtained in nearly quantitative yield, though in only a moderate 73% ee (Table 4.1, entry 
1). In an effort to improve the enantioselectivity of the transformation we investigated a 
range of basic additives, as bases have been reported to have a pronounced effect on 
selectivity in allylic alkylation reactions.12 While addition of LiOt-Bu provided only a 
slight enhancement in enantioselectivity to 81% ee (entry 2), we were delighted to find 
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that the amine base DABCO affords product 93 in 92% yield and an excellent 95% ee 
(entry 3). At this time, the specific role of DABCO remains unknown; however, due to 
the additive’s drastic effect on enantioselectivity, we hypothesize that DABCO allows for 
increased equilibration between diastereomers of an iridium π-allyl complex by slowing 
the rate of nucleophilic attack.13,14 Moreover, while we observed the highest yield for the 
allylic alkylation reaction using a 1:2 nucleophile to electrophile ratio, the nucleophile 
and electrophile stoichiometry can be varied (1:1 or 2:1) without affecting reaction 
selectivity, though yields are diminished (entries 4 and 5). Of note, excess electrophile 72 
is unable to be quantitatively recovered as a competing elimination reaction takes place to 
form a diene byproduct. 
 
Table 4.1 Optimization of reaction parametersa 
 
 
[a] Reactions performed on 0.1 mmol scale. [b] 1H NMR yield based on internal standard. [c] Determined by chiral SFC 









Base (200 mol %)
BEt3 (200 mol %)
[Ir(cod)Cl]2 (2 mol %)
(Sa)-L5 (4 mol %), TBD (10 mol %)
THF (0.1 M), 60 °C, 18 hOCO2MePh
+ NC
Ph

























5 2:1 DABCO 41 94
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4.3   SUBSTRATE SCOPE EXPLORATION  
With the optimal conditions identified (Table 4.1, entry 3), we explored the 
substrate scope for this new transformation. With respect to nucleophile 94, the process is 
tolerant of a wide variety of substituted malononitrile derivatives (Table 4.2). Specifically, 
we were pleased to find that increasing the steric bulk on the nucleophile results in 
formation of the corresponding ethyl-substituted 95a and benzyl-substituted 95b products 
in only slightly decreased yields (76% and 69%, respectively) and no significant loss in 
enantioselectivity. Interestingly, phenyl-substituted nucleophile 94c gives full conversion 
to the linear product (105, Section 4.6.2.5) in the allylic alkylation reaction rather than 
branched product 95c. Additionally, olefinic substituents on the nucleophile are tolerated 
under the reaction conditions provided the olefin is at least di-substituted; allyl-
substituted 94d returns only starting material in the allylic alkylation reaction while 
methallyl-substituted product 95e can be prepared in 33% yield with 92% ee and prenyl-
substituted product 95f can be constructed in an excellent 92% yield with 96% ee. We 
reason that increased olefin substitution decreases the affinity of the olefin to bind to the 
catalyst,15 thus leading to increased yields. Furthermore, we were delighted to discover 
that carbonyl-containing product 95g can be obtained in a moderate 52% yield with an 
excellent 96% ee. Finally, fluorinated product 95h can be accessed in a moderate 50% 
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Table 4.2 Nucleophile substrate scopea 
 
 
[a] Reactions performed on 0.2 mmol scale. [b] Isolated yield. [c] Determined by chiral SFC. [d] 99% conversion by 1H NMR 
to linear product 105. 
 
Pleased to find the reaction amenable to a range of nucleophilic substrates, we 
sought to further examine the scope of the transformation by exploring the diversity of 
substitution permitted on trisubstituted allylic electrophile 96 (Table 4.3). Gratifyingly, 
we observed that a series of para-substituted allylic electrophiles bearing both electron-
donating (–p-Me, –p-OMe) and withdrawing groups (–p-Ph, –p-F) on the aromatic ring 
furnish the corresponding products 97a–d in consistently excellent enantioselectivities 
(>94% ee) when subjected to the reaction conditions utilizing methylmalononitrile (92) 
as the nucleophile. In evaluating the effect of meta-substitution, we found that products 
97e–h (–m-Me, –m-Cl, –m-NO2, 2-Np) can be obtained with similarly high 
enantiocontrol (>93% ee). Generally, we noted that electron-rich electrophiles (i.e., 96a, 























































DABCO (200 mol %)
BEt3 (200 mol %)
[Ir(cod)Cl]2 (2 mol %)
(Sa)-L5 (4 mol %), TBD (10 mol %)
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96b, 96e) provide the corresponding allylic alkylation products in slightly diminished 
yields (67–80% versus 84–99%) as compared to electron-poor electrophiles (i.e., 96c, 
96d, 96f, 96g). At this time, ortho-substitution (i.e., –o-Me) is not tolerated under the 
reaction conditions and no conversion to product 97i is observed. However, we were 
pleased to discover that the reaction is amenable to bis-alkyl-substitution on the allylic 
electrophile allowing for access to product 97j in 65% yield and 84% ee as an inseparable 
mixture (1:1.5) of branched and linear isomers. Additionally, reverse prenylation can be 
effected to produce achiral product 97k in 61% yield. Finally, extension of the alkyl 
chain on the allylic electrophile to an ethyl group leads to a decreased yield with 97l 
isolated in 50% yield but with no loss in selectivity (96% ee). 
 




[a] Reactions performed on 0.2 mmol scale. [b] Isolated yield. [c] Determined by chiral HPLC or SFC. [d] Absolute 
stereochemistry determined by single-crystal X-ray analysis; the absolute stereochemistry of all other compounds was 











































DABCO (200 mol %)
BEt3 (200 mol %)
[Ir(cod)Cl]2 (2 mol %)
(Sa)-L5 (4 mol %), TBD (10 mol %)
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A deeper investigation into the scope of this novel transformation revealed the 
limits of the catalytic system (Table 4.4). Foremost, Lewis basic functionalities are not 
tolerated on nucleophile 98 or electrophile 99, thus low yields or no reactivity was 
observed in the formation of thiophene 100a, furan 100b, ketone 100d, alkyne 100f, 
pyridine 100k, and thiophene 100l. Moreover, branched substitution on the nucleophile is 
not permitted in the allylic alkylation reaction as isopropyl-substituted 98 (R1 = i-Pr) 
returns only starting material. Additionally, drastically altering the pKa of nucleophile 98 
shuts down the reaction, as seen with ester-functionalized 100e (R1 = CO2Et). Also, 
adding significant steric bulk to nucleophile 98 leads to low to no conversion to product 
(e.g., 100g, 100h). Furthermore, to date, only functionalized-malononitrile nucleophiles 
have been successful utilized in the reported allylic alkylation reaction, despite studies 
into other bis-electron-withdrawing group-functionalized nucleophiles (e.g., 1,3-diketone 
100j) and unfunctionalized malononitrile (100i). Of note, para-trifluoromethyl-
substituted allylic alkylation product 100m can be isolated in a good 75% yield, however 
the enantiomeric excess could not be determined due to inseparable enantiomers by 
HPLC and SFC; though we hypothesize that the value would be consistently high as with 
other electrophile substrates (Table 4.3). With respect to substitution on the electrophile, 
replacement of the aryl moiety with an alkyl group leads to minimal to no yield of allylic 
alkylation products 100n, and 100o. Use of a cyclic allylic electrophile does not afford 
corresponding bicyclic product 100p. Finally, despite the interest and value in the 
corresponding products (100q and 100r), due to difficulty of substrate preparation, a 
trifluoromethyl-substitute malononitrile nucleophile and halogen-substituted 
malononitriles were not explored in the newly developed allylic alkylation reaction. 
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Table 4.4 Substrate scope limitationsa 
 
 
[a] Reactions performed on 0.2 mmol scale. [b] 1H NMR yield based on internal standard. [c] Determined by chiral HPLC or 
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4.4  PRODUCT TRANSFORMATIONS 
With the general reactivity trends for the allylic alkylation reaction explored, we 
sought to demonstrate the utility of these sterically congested products (Figure 4.2). 
Though hydrogenation of the olefin in allylic alkylation product 93 using palladium 
catalysis proved problematic due to competing reduction of the nitrile groups, we found 
that treatment of 93 with Wilkinson’s catalyst under a hydrogen atmosphere 
chemoselectively reduces the olefin to furnish 101 in 92% yield. Additionally, ozonolysis 
of olefin 93 proceeds smoothly to give enantioenriched aldehyde 102 in 93% yield,16 
wherein the aldehyde moiety can serve as a valuable functional handle for further 
manipulation (e.g., reductive aminations, allylations, and olefinations). Allylic alkylation 
product 95f was subjected to a two-step ozonolysis/aldol condensation process to deliver 
a densely functionalized, enantioenriched cyclopentene (106, Section 4.6.2.6) in 43% 
yield, which can then undergo diastereoselective hydration of the bis-nitrile functionality 
to provide amide 103 in 1:11 dr. Chiral cyclopentenes have been demonstrated to be key 
building blocks in a number of complex molecule total syntheses. 17  Finally, 
enantioenriched lactone 104 bearing vicinal all-carbon quaternary stereocenters can be 
accessed in 65% yield and 1:2.5 dr from allylic alkylation product 93 via ozonolysis 
followed by reductive quenching. The transformations forming products 103 and 104 
showcase that the diastereotopic nitrile functionalities of the allylic alkylation products 
are amenable to diastereoselective differentiation to afford vicinal all-carbon quaternary 
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Figure 4.2 Product transformations of allylic alkylation products 
 
 
[a] RhCl(PPh3)3, H2 (balloon), benzene, 23 °C, 18 h, 92% yield; [b] O3, pyridine, CH2Cl2, –78 °C, 4 min, 93% yield; [c[ i. O3, 
pyridine, CH2Cl2, –78 °C, 4 min, ii. p-TsOH, benzene, reflux, 18 h, 47% yield; [d[ NaOH, EtOH/H2O (1:1), 60 °C, 18 h, 38% 
yield, 1:11 dr; [e] i. O3, MeOH, –78 °C, 0.5 h, ii. NaBH4, 0 °C, 3 h, 65% yield, 1:2.5 dr. 
 
 
4.5  CONCLUSIONS 
In conclusion, we have developed the first enantioselective transition metal-
catalyzed allylic alkylation reaction for the preparation of acyclic products bearing 
vicinal all-carbon quaternary centers. Key to the success of this new reaction is the use of 
DABCO in combination with triethylborane and our unique catalyst prepared from 
[Ir(cod)Cl]2, (Sa)-L5, and TBD. The developed method proceeds with moderate to 
excellent yields and high levels of enantioselectivity for a wide range of substitution on 
both the malononitrile-derived nucleophile and the trisubstituted allylic electrophile. 
Furthermore, the allylic alkylation products can be transformed by chemo- and 
diastereoselective methods to a number of highly valuable, densely functionalized 






























R = Me R = CH2CH2C(O)Me
R = Me
331
Chapter 4 – Enantioselective Synthesis of Vicinal All-Carbon Quaternary Centers via  
Iridium-Catalyzed Allylic Alkylation 
  
4.6  EXPERIMENTAL SECTION 
4.6.1  MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried 
by passage through an activated alumina column under argon. Chemicals were purchased 
from Sigma Aldrich/Strem/Alfa Aesar/Oakwood Chemicals and used as received. 
Reaction temperatures were controlled by an IKAmag temperature modulator. Glove box 
manipulations were performed under a nitrogen atmosphere. Thin-layer chromatography 
(TLC) and preparatory TLC was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized by UV fluorescence quenching, KMnO4, or p-
anisaldehyde staining. SiliaFlash P60 Academic Silica gel (particle size 0.040–0.063 
mm) was used for flash chromatography. Analytical chiral HPLC was performed with an 
Agilent 1100 Series HPLC utilizing a Chiralpak OJ column (4.6 mm x 25 cm) or a 
Chiralpak AD-H column (4.6 mm x 25 cm), both obtained from Daicel Chemical 
Industries, Ltd. with visualization at 210 nm. Analytical SFC was performed with a 
Mettler SFC supercritical CO2 analytical chromatography system utilizing a Chiralpak 
OJ–H column (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd. with 
visualization at 210 nm. 1H NMR spectra were recorded on a Bruker Avance HD 400 
MHz spectrometer and are reported relative to residual CHCl3 (δ 7.26 ppm). 13C NMR 
spectra were recorded on a Bruker Avance HD 400 MHz spectrometer and are reported 
relative to residual CDCl3 (δ 77.16 ppm). Data for 1H NMR are reported as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br 
s = broad singlet. Data for 13C NMR are reported in terms of chemical shifts (δ ppm). 
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Some reported spectra include minor solvent impurities of water (δ 1.56 ppm), ethyl 
acetate (δ 4.12, 2.05, 1.26 ppm), methylene chloride (δ 5.30 ppm), acetone (δ 2.17 ppm), 
grease (δ 1.26, 0.86 ppm), and/or silicon grease (δ 0.07 ppm), which do not impact 
product assignments. IR spectra were obtained using a Perkin Elmer Paragon 1000 
spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm-1). High resolution mass spectra (HRMS) were obtained from the Caltech 
Mass Spectral Facility using a JEOL JMS-600H High Resolution Mass Spectrometer in 
fast atom bombardment (FAB+) or electron ionization (EI+) mode, or an Agilent 6200 
Series TOF with an Agilent G1978A Multimode source in electrospray ionization (ESI+), 
atmospheric pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-
APCI+). Optical rotations were measured with a Jasco P-2000 polarimeter operating on 
the sodium D-line (589 nm), using a 100 mm pathlength cell, and are reported as: [α]DT 
(concentration in g/100 mL, solvent).  
4.6.1.1 Key Considerations 
All synthesized reagents (i.e., (Sa)-L5, 92, 72, 94, and 96) were dried over P2O5 
and drierite in a vacuum desiccator under vacuum overnight before use in the iridium-
catalyzed allylic alkylation reaction. THF was taken directly from an activated alumina 
column under argon and used immediately to eliminate the possibility of peroxides. 
Mesitylene or 1,2,4,5-tetrachloro-3-nitrobenzene were used as the internal standard for 
determining 1H NMR yields. Prolonged storage of electrophiles 72 and 96 at room 
temperature under an air atmosphere results in the formation of an unidentified impurity; 
storage in a –30 °C freezer allows for prolonged storage.   
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4.6.1.2 Preparation of Known Compounds 
Previously reported methods were used to prepare ligand (Sa)-L518 as well as 
starting materials 92,19 72,20 94a,21 94b,19 94c,22 94d,23 94e,24 94f,24 94g, 25 94h,26 96a,27 
96d,9  96e,27 96g,9  96h,9 96i,27 96j,27 96k,28 and 96l.27 
 
4.6.2  EXPERIMENTAL PROCEDURES AND SPECTROSCOPIC DATA 
4.6.2.1 Representative Procedures for the Synthesis of Electrophiles 
 
(E)-3-(4-Methoxyphenyl)but-2-en-1-yl methyl carbonate (96b). To a solution of 
methyl (E)-3-(4-methoxyphenyl)but-2-enoate29 (0.21 g, 1.0 mmol, 1 equiv) in THF (6.0 
mL) at –78 °C was added DIBAL (0.62 mL, 3.0 mmol, 3.5 equiv) dropwise. The 
resulting reaction mixture was stirred at –78 °C for 2.5 h, whereupon the reaction was 
quenched with a saturated aqueous Rochelle’s salt solution (10 mL). The cooling bath 
was then removed and the reaction was stirred for 18 h at ambient temperature. The 
aqueous layer was extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers 
were washed with brine (20 mL), dried over Na2SO4, and concentrated under reduced 
pressure.   
The crude material was dissolved in CH2Cl2 (4.0 mL) and cooled to 0 °C. 
Pyridine (0.64 mL, 8.3 mmol, 8.3 equiv) was added followed by methyl chloroformate 
(0.20 mL, 2.3 mmol, 2.3 equiv) dropwise. The resulting solution was allowed to warm to 
ambient temperature and was stirred for 18 h. The reaction was quenched with the 
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mL). The combined organic layers were washed with brine (20 mL), dried over Na2SO4, 
and concentrated under reduced pressure. The crude product was purified by silica gel 
flash column chromatography (5% EtOAc/hexanes) to give carbonate 96b as a colorless 
solid (0.13 g, 53% yield): 1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 8.8 Hz, 2H), 6.86 (d, 
J = 8.8 Hz, 2H), 5.92 – 5.82 (m, 1H), 4.84 (dd, J = 7.2, 0.8 Hz, 2H), 3.81 (s, 3H), 3.80 (s, 
3H), 2.16 – 2.05 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 159.4, 156.0, 140.7, 134.9, 
127.1, 119.1, 113.8, 65.2, 55.4, 54.9, 16.4; IR (Neat Film, NaCl) 2958, 2832, 1753, 1740, 
1440, 1381, 1336, 1249, 1028, 942, 819, 798 cm-1; HRMS (FAB+) m/z calc’d for 
C13H16O3 [M]+•: 236.1049, found 236.1053. 
 
4.6.2.2 Spectroscopic Data for the Synthesis of Electrophiles 
 
(E)-3-([1,1'-Biphenyl]-4-yl)but-2-en-1-yl methyl carbonate (96c). Carbonate 96c was 
prepared from methyl (E)-3-([1,1'-biphenyl]-4-yl)but-2-enoate 30  according to the 
representative procedure and isolated by silica gel flash column chromatography (5% 
EtOAc/hexanes) as a colorless oil (0.17 g, 52% yield): 1H NMR (400 MHz, CDCl3) δ 
7.58 (d, J = 19.6 Hz, 4H), 7.51 – 7.41 (m, 4H), 7.35 (t, J = 7.3 Hz, 1H), 6.00 (td, J = 7.0, 
1.4 Hz, 1H), 4.88 (dq, J = 7.0, 0.8 Hz, 2H), 3.81 (s, 3H), 2.17 (dt, J = 1.3, 0.7 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 156.0, 141.4, 140.7, 140.7, 140.6, 128.9, 127.5, 127.1, 
126.4, 120.8, 65.1, 55.0, 16.4; IR (Neat Film, NaCl) 3032, 2968, 1750, 1740, 1441, 1408, 
1340, 1245, 992, 943, 827, 794, 759, 689 cm-1; HRMS (FAB+) m/z calc’d for C18H18O3 
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(E)-3-(3-Chlorophenyl)but-2-en-1-yl methyl carbonate (96f). Carbonate 96f was 
prepared from methyl (E)-3-(3-chlorophenyl)but-2-enoate 31  according to the 
representative procedure and isolated by silica gel flash column chromatography (10% 
EtOAc/hexanes) as a colorless oil (0.43 g, 88% yield): 1H NMR (400 MHz, CDCl3) δ 
7.38 (q, J = 1.5 Hz, 1H), 7.30 – 7.22 (m, 3H), 5.92 (ddt, J = 6.9, 5.6, 1.4 Hz, 1H), 4.84 
(dq, J = 7.0, 0.8 Hz, 2H), 3.81 (s, 3H), 2.10 (dt, J = 1.4, 0.7 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 155.9, 144.4, 139.8, 134.4, 129.7, 127.8, 126.3, 124.2, 122.0, 64.9, 55.0, 
16.4; IR (Neat Film, NaCl) 2957, 1748, 1594, 1564, 1443, 1377, 1333, 1268, 1172, 1102, 
997, 948, 906, 884, 782, 691 cm-1; HRMS (FAB+) m/z calc’d for C12H13ClO3 [M]+•: 
240.0553, found 240.0564. 
 
4.6.2.3 General Procedure for Optimization Reactions (Table 4.1) 
 
(S)-2-Methyl-2-(2-phenylbut-3-en-2-yl)malononitrile (93). In a nitrogen-filled glove 
box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (1.3 mg, 
0.0020 mmol, 2 mol %), ligand (Sa)-L5 (2.0 mg, 0.004 mmol, 4 mol %), TBD (1.4 mg, 
0.010 mmol, 10 mol %), and THF (0.5 mL). Vial A was stirred at 25 °C (ca. 10 min) 
while another 1 dram vial (vial B) was charged with nucleophile 92 (0.10 mmol or 0.20 
mmol, as specified), THF (0.5 mL), and the base additive (0 or 200 mol %). The pre-
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carbonate 72 (0.20 mmol, 0.10 mmol, or 0.20 mmol, as specified). The vial was sealed 
and stirred at 60 °C. After 18 h, the vial was removed from the glove box concentrated 
under reduced pressure. To the crude reaction mixture was added 1,2,4,5-tetrachloro-3-
nitrobenzene (0.10 mmol in 0.5 mL CDCl3). The NMR yield (measured in reference to 
1,2,4,5-tetrachloro-3-nitrobenzene δ 7.74 ppm (s, 1H)) was determined by 1H NMR 
analysis of the crude mixture. The residue was purified by preparatory TLC (15% 
Et2O/hexanes, eluted twice) to afford allylic alkylation product 3 as a pale yellow oil. 
 
4.6.2.4 General Procedure for the Iridium-Catalyzed Allylic Alkylation 
Please note that the absolute configuration was determined only for compound 
97c via X-ray crystallographic analysis. The absolute configuration for all other products 
has been inferred by analogy. For respective HPLC and SFC conditions, please refer to 
Table S1. 
 
(S)-2-Methyl-2-(2-phenylbut-3-en-2-yl)malononitrile (93). In a nitrogen-filled glove 
box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 mg, 
0.0040 mmol, 2 mol %), ligand (Sa)-L5 (4.0 mg, 0.008 mmol, 4 mol %), TBD (2.8 mg, 
0.020 mmol, 10 mol %), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 min) while 
another 1 dram vial (vial B) was charged with nucleophile 92 (18 mg, 0.20 mmol, 100 
mol %), THF (1 mL), DABCO (45 mg, 0.40 mmol, 200 mol %), and BEt3 (400 µL, 1M in 
hexanes). The pre-formed catalyst solution (vial A) was then transferred to vial B 
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sealed and stirred at 60 °C. After 18 h, the vial was removed from the glove box, 
transferred to a 20 mL vial with CH2Cl2, and concentrated under reduced pressure. The 
crude residue was purified by preparatory TLC (15% Et2O/hexanes, eluted twice) to 
afford allylic alkylation product 93 as a pale yellow oil (37 mg, 89% yield): 95% ee; 
[α]D25 +32.9 (c 1.9, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.52 (m, 2H), 7.44 – 
7.33 (m, 3H), 6.49 (dd, J = 17.3, 11.0 Hz, 1H), 5.63 – 5.31 (m, 2H), 1.80 (s, 3H), 1.66 (s, 
3H); 13C NMR (101 MHz, CDCl3) δ 139.2, 138.3, 128.7, 128.6, 128.1, 119.0, 116.1, 
116.0, 49.4, 41.9, 21.8, 21.5; IR (Neat Film, NaCl) 3095, 3062, 2992, 2951, 2247, 1749, 
1639, 1600, 1496, 1447, 1417, 1386, 1270, 1217, 1165, 1102, 1074, 1031, 1003, 937, 
802, 751, cm-1; HRMS (ESI+) m/z calc’d for C14H14N2 [M]+•: 210.1157, found 210.1156; 
SFC conditions: 3% IPA, 2.5 mL/min, Chiralpak OJ–H column, λ = 210 nm, tR (min): 
major = 3.832, minor = 4.594.  
 
4.6.2.5 Spectroscopic Data for the Iridium-Catalyzed Allylic Alkylation 
Products 
 
(S)-2-Ethyl-2-(2-phenylbut-3-en-2-yl)malononitrile (95a). Allylic alkylation product 
95a was prepared according to the general procedure and isolated by preparatory TLC 
(100% toluene, eluted twice) to give a pale yellow oil (34 mg, 76% yield): 95% ee; [α]D25 
+19.0 (c 0.87, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.63 – 7.51 (m, 2H), 7.45 – 7.31 
(m, 3H), 6.51 (dd, J = 17.3, 11.0 Hz, 1H), 5.52 (d, J = 11.0 Hz, 1H), 5.40 (d, J = 17.3 Hz, 
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138.7, 128.6, 128.5, 128.2, 118.7, 115.2, 115.1, 49.9, 49.7, 27.7, 22.0, 10.7; IR (Neat 
Film, NaCl) 3094, 3061, 2959, 2931, 2874, 2244, 1730, 1640, 1600, 1496, 1461, 1446, 
1416, 1382, 1271, 1175, 1074, 1031, 1002, 937, 793, 750, 701 cm-1; HRMS (ESI+) m/z 
calc’d for C15H17N2 [M+H]+: 225.1392, found 225.1395; SFC conditions: 3% IPA, 2.5 
mL/min, Chiralpak OJ–H column, λ = 210 nm, tR (min): major = 3.378, minor = 4.088. 
 
(S)-2-Benzyl-2-(2-phenylbut-3-en-2-yl)malononitrile (95b). Allylic alkylation product 
95b was prepared according to the general procedure and isolated by preparatory TLC 
(15% Et2O/hexanes, eluted twice) to give a pale yellow oil (39 mg, 69% yield): 93% ee; 
[α]D25 +11.0 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.68 – 7.62 (m, 2H), 7.51 – 
7.29 (m, 8H), 6.64 (dd, J = 17.3, 11.0 Hz, 1H), 5.60 (d, J = 11.0 Hz, 1H), 5.47 (d, J = 
17.2 Hz, 1H), 3.07 – 2.90 (m, 2H), 1.93 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 139.4, 
138.5, 132.6, 130.5, 128.9, 128.7, 128.7, 128.6, 128.3, 119.1, 114.9, 114.7, 50.6, 50.3, 
39.6, 22.1; IR (Neat Film, NaCl) 3092, 3063, 3034, 2990, 2927, 2245, 1957, 1884, 1810, 
1748, 1602, 1498, 1456, 1446, 1416, 1383, 1270, 1212, 1159, 1110, 1080, 1032, 1004, 
938, 766, 749 cm-1; HRMS (FAB+) m/z calc’d for C20H19N2 [M+H]+: 287.1548, found 
287.1553; SFC conditions: 3% IPA, 2.5 mL/min, Chiralpak OJ–H column, λ = 210 nm, tR 
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(E)-2-Phenyl-2-(3-phenylbut-2-en-1-yl)malononitrile (105). Linear allylic alkylation 
product SI-1 was prepared according to the general procedure in 99% conversion by 1H 
NMR yield but was inseparable from unreacted electrophile 72. 105 was prepared via an 
alternate route for verification and characterization. In a nitrogen-filled glove box, to a 1 
dram vial equipped with a stir bar was added Pd(PPh3)4 (11 mg, 0.01 mmol, 0.1 mol %), 
nucleophile 94c (21 mg, 0.15 mmol, 1.5 equiv), electrophile 72 (21 mg, 0.10 mmol, 1.0 
equiv), and THF (1 mL). The reaction was stirred for 18 h whereupon the vial was 
removed from the glove box, transferred to a 20 mL vial with CH2Cl2, and concentrated 
under reduced pressure. The crude residue was purified by preparatory TLC (20% 
Et2O/hexanes, eluted twice) to afford 105 as a colorless crystalline solid (23 mg, 43% 
yield): 1H NMR (400 MHz, CDCl3) δ 7.67 – 7.28 (m, 10H), 5.75 (td, J = 7.8, 1.5 Hz, 
1H), 3.23 – 3.01 (m, 2H), 1.95 (d, J = 1.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 143.8, 
142.6, 131.7, 130.1, 129.8, 128.5, 128.0, 126.1, 126.1, 117.2, 115.0, 42.5, 42.0, 16.6; IR 
(Neat Film, NaCl) 3062, 3032, 2983, 2930, 2246, 1599, 1494, 1451, 1383, 1277, 1027, 




(S)-2-(2-methylallyl)-2-(2-phenylbut-3-en-2-yl)malononitrile (95d). Allylic alkylation 
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TLC (100% toluene, eluted twice) to give a pale yellow oil (17 mg, 33% yield): 92% ee; 
[α]D25 +26.0 (c 0.94, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.56 (m, 2H), 7.45 – 
7.32 (m, 3H), 6.54 (dd, J = 17.3, 11.0 Hz, 1H), 5.55 (d, J = 11.0 Hz, 1H), 5.41 (d, J = 
17.3 Hz, 1H), 5.11 (t, J = 1.4 Hz, 1H), 5.01 (p, J = 1.0 Hz, 1H), 2.50 – 2.35 (m, 2H), 1.91 
(dd, J = 1.6, 0.8 Hz, 3H), 1.84 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 139.4, 138.5, 
137.9, 128.7, 128.6, 128.3, 119.1, 118.7, 115.4, 115.2, 50.4, 47.6, 41.5, 23.2, 22.0; IR 
(Neat Film, NaCl) 3085, 2988, 2242, 1747, 1650, 1496, 1445, 1416, 1381, 1264, 1072, 
1004, 910, 792, 750, 698 cm-1; HRMS (FAB+) m/z calc’d for C17H19N2 [M+H]+: 
251.1548, found 251.1539; SFC conditions: 3% IPA, 2.5 mL/min, Chiralpak OJ–H 
column, λ = 210 nm, tR (min): major = 3.138, minor = 3.923. 
 
 
(S)-2-(3-Methylbut-2-en-1-yl)-2-(2-phenylbut-3-en-2-yl)malononitrile (95e). Allylic 
alkylation product 95e was prepared according to the general procedure and isolated by 
preparatory TLC (5% Et2O/hexanes, eluted twice) to give a colorless oil (49 mg, 92% 
yield): 96% ee; [α]D25 +7.87 (c 6.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.56 
(m, 2H), 7.47 – 7.31 (m, 3H), 6.54 (dd, J = 17.3, 11.0 Hz, 1H), 5.54 (d, J = 11.0 Hz, 1H), 
5.41 (d, J = 17.3 Hz, 1H), 5.34 – 5.24 (m, 1H), 2.46 (qd, J = 14.1, 7.6 Hz, 2H), 1.84 (s, 
3H), 1.78 (d, J = 1.4 Hz, 3H), 1.60 (d, J = 1.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
140.4, 139.6, 138.7, 128.6, 128.5, 128.1, 118.7, 115.3, 115.3, 115.2, 49.6, 48.9, 32.7, 
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1004, 935, 838, 750, 700 cm-1; HRMS (FAB+) m/z calc’d for C18H21N2 [M+H]+: 
265.1705, found 265.1709; SFC conditions: 3% IPA, 2.5 mL/min, Chiralpak OJ–H 
column, λ = 210 nm, tR (min): major = 3.095, minor = 4.061. 
 
 
(S)-2-(3-oxobutyl)-2-(2-phenylbut-3-en-2-yl)malononitrile (95f). Allylic alkylation 
product 95f was prepared according to the general procedure and isolated by preparatory 
TLC (20% Et2O/hexanes, eluted twice) to give a colorless oil (28 mg, 52% yield): 96% 
ee; [α]D25 +16.8 (c 1.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.62 – 7.53 (m, 2H), 7.46 
– 7.30 (m, 3H), 6.50 (dd, J = 17.2, 10.9 Hz, 1H), 5.54 (d, J = 11.0 Hz, 1H), 5.41 (d, J = 
17.2 Hz, 1H), 2.86 – 2.75 (m, 2H), 2.19 (s, 3H), 2.17 – 1.97 (m, 2H), 1.82 (s, 3H); 13C 
NMR (101 MHz, CDCl3) δ 205.1, 139.2, 138.2, 128.7, 128.6, 128.1, 119.1, 115.0, 114.9, 
49.8, 47.7, 40.0, 30.2, 27.8, 21.8; IR (Neat Film, NaCl) 3094, 3061, 2991, 2957, 2246, 
1721, 1640, 1601, 1582, 1496, 1446, 1418, 1370, 1288, 1215, 1170, 1118, 1080, 1032, 
1002, 938, 754, 702 cm-1; HRMS (FAB+) m/z calc’d for C17H19N2O [M+H]+: 267.1497, 
found 267.1499; SFC conditions: 3% IPA, 2.5 mL/min, Chiralpak OJ–H column, λ = 210 
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(S)-2-(2-Phenylbut-3-en-2-yl)-2-(3,3,3-trifluoropropyl)malononitrile (95g). Allylic 
alkylation product 95g was prepared according to the general procedure and isolated by 
preparatory TLC (100% toluene, eluted twice) to give a colorless oil (29 mg, 50% yield): 
91% ee; [α]D25 +16.6 (c 1.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.32 (m, 5H), 
6.50 (dd, J = 17.2, 10.9 Hz, 1H), 5.59 (d, J = 11.0 Hz, 1H), 5.44 (d, J = 17.2 Hz, 1H), 
2.57 – 2.39 (m, 2H), 2.12 – 1.93 (m, 2H), 1.84 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
138.8, 137.7, 128.87, 128.86, 127.9, 125.7 (q, J = 276.4 Hz), 119.5, 114.3, 114.1, 49.9, 
47.5, 31.7, 31.3 (q, J = 30.3 Hz), 27.1 (q, J = 3.4 Hz); IR (Neat Film, NaCl) 3096, 3063, 
2992, 2928, 2242, 1496, 1447, 1400, 1318, 1257, 1157, 1089, 1046, 940, 845, 752, 701, 
624 cm-1; HRMS (ESI+) m/z calc’d for C16H15F2N2 [M]+•: 292.1187, found 292.1173; 
SFC conditions: 1% IPA, 3.0 mL/min, Chiralpak OJ–H column, λ = 210 nm, tR (min): 
major = 1.651, minor = 1.868. 
 
 
(S)-2-Methyl-2-(2-(p-tolyl)but-3-en-2-yl)malononitrile (97a). Allylic alkylation 
product 97a was prepared according to the general procedure and isolated by preparatory 
TLC (15% Et2O/hexanes, eluted twice) to give a pale yellow oil (36 mg, 80% yield): 96% 
ee; [α]D25 +48.7 (c 1.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.39 (m, 2H), 7.23 
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17.3 Hz, 1H), 2.35 (s, 3H), 1.77 (s, 3H), 1.66 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
138.44, 138.42, 136.2, 129.3, 128.0, 118.8, 116.2, 116.1, 49.2, 42.0, 21.8, 21.5, 21.1; IR 
(Neat Film, NaCl) 3094, 2992, 2953, 2925, 2247, 1748, 1682, 1639, 1614, 1515, 1454, 
1416, 1383, 1268, 1198, 1102, 1074, 1019, 937, 825, 804, 774 cm-1; HRMS (ESI+) m/z 
calc’d for C15H16N2 [M]+•: 224.1314, found 224.1306; SFC conditions: 1% IPA, 3.0 
mL/min, Chiralpak OJ–H column, λ = 210 nm, tR (min): major = 3.658, minor = 4.375. 
 
 
(S)-2-(2-(4-Methoxyphenyl)but-3-en-2-yl)-2-methylmalononitrile (97b). Allylic 
alkylation product 97b was prepared according to the general procedure and isolated by 
preparatory TLC (20% Et2O/hexanes, eluted twice) to give a pale yellow oil (34 mg, 70% 
yield): 96% ee; [α]D25 +25.4 (c 2.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.54 – 7.42 
(m, 2H), 6.95 – 6.88 (m, 2H), 6.47 (dd, J = 17.3, 11.0 Hz, 1H), 5.52 (d, J = 11.0 Hz, 1H), 
5.39 (d, J = 17.3 Hz, 1H), 3.82 (s, 3H), 1.77 (s, 3H), 1.65 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 159.5, 138.5, 131.0, 129.4, 118.7, 116.2, 116.1, 113.9, 55.4, 49.0, 42.1, 21.7, 
21.6; IR (Neat Film, NaCl) 2998, 2934, 2832, 2242, 1609, 1514, 1458, 1298, 1257, 1188, 
1029, 932, 832, 808, 774 cm-1; HRMS (FAB+) m/z calc’d for C15H15ON2 [(M+H)–H2]+: 
239.1184, found 239.1198; SFC conditions: 3% IPA, 2.5 mL/min, Chiralpak OJ–H 
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(S)-2-(2-([1,1'-Biphenyl]-4-yl)but-3-en-2-yl)-2-methylmalononitrile (97c). Allylic 
alkylation product 97c was prepared according to the general procedure and isolated by 
preparatory TLC (20% Et2O/hexanes, eluted twice) to give a colorless crystalline solid 
(58 mg, 99% yield): 95% ee; [α]D25 +42.3 (c 1.9, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
7.67 – 7.32 (m, 9H), 6.53 (dd, J = 17.3, 10.9 Hz, 1H), 5.58 (d, J = 10.9 Hz, 1H), 5.46 (d, 
J = 17.3 Hz, 1H), 1.84 (s, 3H), 1.71 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 141.3, 140.1, 
138.2, 138.1, 129.0, 128.5, 127.8, 127.24, 127.21, 119.1, 116.1, 116.0, 49.3, 41.9, 21.8, 
21.5; IR (Neat Film, NaCl) 3059, 3032, 2992, 2952, 2247, 1749, 1488, 1450, 1416, 1386, 
1267, 1214, 1168, 1102, 1076, 1007, 937, 842, 766, 749, 698 cm-1; HRMS (FAB+) m/z 
calc’d for C20H18N2 [M]+•: 286.1470, found 286,1466; SFC conditions: 1% IPA, 2.5 
mL/min, Chiralpak OJ–H column, λ = 210 nm, tR (min): major = 43.531, minor = 40.798. 
 
 
(S)-2-(2-(4-fluorophenyl)but-3-en-2-yl)-2-methylmalononitrile (97d). Allylic 
alkylation product 97d was prepared according to the general procedure and isolated by 
preparatory TLC (15% Et2O/hexanes, eluted twice) to give a colorless oil (45 mg, 99% 
yield): 94% ee; [α]D25 +23.5 (c 3.4, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 
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J = 11.0 Hz, 1H), 5.41 (d, J = 17.3 Hz, 1H), 1.78 (s, 3H), 1.67 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 162.6 (d, J = 249.0 Hz), 138.1, 135.1 (d, J = 3.3 Hz), 130.1, 130.0, 119.3, 
115.9 (d, J = 10.2 Hz), 115.6 (d, J = 21.4 Hz), 49.1, 42.0, 21.7, 21.7; IR (Neat Film, 
NaCl) 3074, 2993, 2247, 1752, 16001, 1509, 1453, 1416, 1386, 1239, 1170, 1097, 1014, 
936, 838, 820, 782, 643 cm-1; HRMS (ESI+) m/z calc’d for C14H13FN2 [M]+•: 228.1063, 
found 228.1036; HPLC conditions: 3% IPA, 1 mL/min, Chiralpak OJ column, λ = 210 
nm, tR (min): major = 22.493, minor = 29.003. 
 
 
(S)-2-Methyl-2-(2-(m-tolyl)but-3-en-2-yl)malononitrile (97e). Allylic alkylation 
product 97e was prepared according to the general procedure and isolated by preparatory 
TLC (15% Et2O/hexanes, eluted twice) to give a colorless oil (30 mg, 67% yield): 95% 
ee; [α]D25 +29.8 (c 1.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.33 (m, 2H), 7.32 
– 7.22 (m, 1H), 7.17 (ddt, J = 7.4, 1.4, 0.7 Hz, 1H), 6.48 (dd, J = 17.3, 11.0 Hz, 1H), 5.53 
(d, J = 11.0 Hz, 1H), 5.42 (d, J = 17.3 Hz, 1H), 2.38 (d, J = 0.8 Hz, 3H), 1.78 (s, 3H), 
1.66 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 139.1, 138.4, 138.3, 129.2, 128.7, 128.5, 
125.1, 118.8, 116.1, 116.0, 49.2, 41.8, 21.8, 21.8, 21.4; IR (Neat Film, NaCl) 3092, 2992, 
2951, 2924, 2246, 1638, 1606, 1588, 1492, 1454, 1417, 1384, 1250, 1162, 1106, 1042, 
1002, 937, 794, 766, 705 cm-1; HRMS (ESI+) m/z calc’d for C15H17N2 [M+H]+: 
225.1392, found 225.1387; SFC conditions: 3% IPA, 2.5 mL/min, Chiralpak OJ–H 
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(S)-2-(2-(3-Chlorophenyl)but-3-en-2-yl)-2-methylmalononitrile (97f). Allylic 
alkylation product 97f was prepared according to the general procedure and isolated by 
preparatory TLC (15% Et2O/hexanes, eluted twice) to give a pale yellow oil (48 mg, 99% 
yield): 99% ee; [α]D25 +3.2 (c 3.2, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.55 – 7.43 (m, 
2H), 7.40 – 7.30 (m, 2H), 6.43 (dd, J = 17.3, 10.9 Hz, 1H), 5.58 (d, J = 11.0 Hz, 1H), 
5.43 (d, J = 17.3 Hz, 1H), 1.78 (s, 3H), 1.68 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
141.4, 137.6, 134.7, 129.9, 128.8, 128.5, 126.2, 119.6, 115.8, 115.7, 49.3, 41.7, 21.7, 
21.4; IR (Neat Film, NaCl) 3071, 2992, 2957, 2247, 1880, 1752, 1637, 1594, 1571, 1478, 
1458, 1414, 1261, 1217, 1168, 1094, 999, 938, 885, 811, 739, 695 cm-1; HRMS (ESI+) 
m/z calc’d for C14H13ClN2 [M]+•: 244.0767, found 244.0773; SFC conditions: 3% IPA, 




(S)-2-Methyl-2-(2-(3-nitrophenyl)but-3-en-2-yl)malononitrile (97g). Allylic alkylation 
product 97g was prepared according to the general procedure and isolated by preparatory 
TLC (25% Et2O/hexanes) to give a pale yellow solid (43 mg, 84% yield): 93% ee; [α]D25 
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= 8.3, 2.2, 1.0 Hz, 1H), 7.98 (ddd, J = 8.0, 2.1, 1.0 Hz, 1H), 7.63 (t, J = 8.1 Hz, 1H), 6.50 
(dd, J = 17.2, 10.9 Hz, 1H), 5.66 (d, J = 11.0 Hz, 1H), 5.46 (d, J = 17.2 Hz, 1H), 1.85 (s, 
3H), 1.73 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 148.3, 141.8, 136.9, 134.1, 129.8, 
123.7, 123.3, 120.5, 115.4, 115.3, 49.4, 41.7, 21.7, 21.3; IR (Neat Film, NaCl) 3093, 
2994, 2957, 2927, 2248, 1749, 1534, 1455, 1418, 1379, 1351, 1266, 1218, 1107, 1002, 
942, 906, 854, 812, 795, 739, 721, 688 cm-1; HRMS (ESI+) m/z calc’d for C14H13N2O2 
[M]+•: 255.1008, found 255.0983; HPLC conditions: 6% IPA, 1 mL/min, Chiralpak AD–
H column, λ = 210 nm, tR (min): major = 12.542, minor = 11.851. 
 
 
(S)-2-Methyl-2-(2-(naphthalen-2-yl)but-3-en-2-yl)malononitrile (97h). Allylic 
alkylation product 97h was prepared according to the general procedure and isolated by 
preparatory TLC (15% Et2O/hexanes, eluted twice) to give a colorless oil (48 mg, 93% 
yield): 95% ee; [α]D25 +57.9 (c 3.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 
2.2 Hz, 1H), 7.93 – 7.80 (m, 3H), 7.70 (dd, J = 8.8, 2.1 Hz, 1H), 7.57 – 7.49 (m, 2H), 
6.60 (dd, J = 17.3, 10.9 Hz, 1H), 5.60 (d, J = 11.0 Hz, 1H), 5.46 (d, J = 17.3 Hz, 1H), 
1.91 (s, 3H), 1.70 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 138.4, 136.5, 132.9, 132.8, 
128.6, 128.3, 127.8, 127.5, 127.0, 126.7, 125.4, 119.2, 116.1, 116.0, 49.6, 41.8, 21.8 
(2C); IR (Neat Film, NaCl) 3060, 2992, 2950, 2246, 1748, 1637, 1598, 1507, 1453, 1416, 
1386, 1277, 1194, 1164, 1130, 1103, 999, 937, 902, 859, 819, 779, 747, 666 cm-1; HRMS 
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(R)-2-Methyl-2-(3-methyl-5-phenylpent-1-en-3-yl)malononitrile (97j). Allylic 
alkylation product 97j was prepared according to the general procedure and isolated by 
preparatory TLC (20% Et2O/hexanes, eluted twice) to give a pale yellow oil (31 mg, 65% 
yield as a 1:1.5 mixture of linear to branched products): 84% ee; [α]D25 +17.0 (c 1.9, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.28 – 7.06 (m, 13.5H), 5.80 (dd, J = 17.3, 10.8 
Hz, 1.5H), 5.48 (dd, J = 10.8, 0.5 Hz, 1.5H), 5.30 (dd, J = 17.4, 0.6 Hz, 1.5H), 5.19 – 
5.11 (m, 1H), 2.70 (dd, J = 8.9, 6.7 Hz, 2.5H), 2.57 (dq, J = 7.7, 0.7 Hz, 2H), 2.54 – 2.40 
(m, 3H), 2.34 (ddd, J = 8.6, 6.4, 1.1 Hz, 2H), 1.94 (ddd, J = 10.3, 6.8, 5.6 Hz, 3H), 1.71 – 
1.67 (m, 3H), 1.64 (s, 4.5H), 1.55 (s, 3H), 1.30 (s, 4.5H); 13C NMR (101 MHz, CDCl3) δ 
143.7, 141.4, 141.1, 137.0, 128.7, 128.5, 128.4, 126.4, 126.1, 120.5, 116.3, 115.8, 115.7, 
115.3, 46.2, 41.8, 41.5, 38.7, 37.4, 34.2, 31.8, 30.9, 23.8, 20.5, 17.1, 16.9; IR (Neat Film, 
NaCl) 3087, 3064, 3028, 2989, 2930, 2864, 2247, 1949, 1871, 1812, 1638, 1604, 1497, 
1453, 1418, 1385, 1277, 1179, 1104, 1074, 1030, 1002, 936, 751, 714, 699, 624 cm-1; 
HRMS (ESI+) m/z calc’d for C16H19N2 [M+H]+: 239.1548, found 239.1530; SFC 
conditions: 0.1% IPA, 2.5 mL/min, Chiralpak OJ–H column, λ = 210 nm, tR (min): major 
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2-Methyl-2-(2-methylbut-3-en-2-yl)malononitrile (97k). Allylic alkylation product 97k 
was prepared according to the general procedure and isolated by preparatory TLC (20% 
Et2O/hexanes, eluted twice) to give a colorless oil (18 mg, 61% yield): 1H NMR (400 
MHz, CDCl3) δ 5.92 (dd, J = 17.2, 10.8 Hz, 1H), 5.45 – 5.04 (m, 2H), 1.68 (s, 3H), 1.35 
(s, 6H); 13C NMR (101 MHz, CDCl3) δ 138.8, 118.2, 115.8, 42.9, 41.2, 22.9, 20.6; IR 
(Neat Film, NaCl) 3095, 2981, 2941, 2885, 2248, 1643, 1459, 1419, 1383, 1176, 1155, 
1112, 998, 934, 735, 688 cm-1; HRMS (ESI+) m/z calc’d for C9H11N2 [(M+H)–H2]+: 
147.0922, found 147.0945. 
 
 
(S)-2-Methyl-2-(3-phenylpent-1-en-3-yl)malononitrile (97l). Allylic alkylation product 
97l was prepared according to the general procedure and isolated by preparatory TLC 
(15% Et2O/hexanes, eluted twice) to give a colorless oil (23 mg, 50% yield): 96% ee; 
[α]D25 +30.4 (c 1.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.55 – 7.46 (m, 2H), 7.46 – 
7.29 (m, 3H), 6.19 (ddd, J = 17.6, 11.3, 0.7 Hz, 1H), 5.69 (d, J = 11.3 Hz, 1H), 5.42 (d, J 
= 17.6 Hz, 1H), 2.50 (dqd, J = 14.3, 7.2, 0.7 Hz, 1H), 2.15 (dq, J = 14.4, 7.2 Hz, 1H), 
1.60 (s, 3H), 0.87 (t, J = 7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 134.8, 134.7, 129.8, 
128.58, 128.57, 121.2, 116.3, 116.1, 54.4, 42.6, 26.4, 21.9, 9.1; IR (Neat Film, NaCl) 
3094, 3061, 2981, 2944, 2884, 2246, 1638, 1601, 1496, 1448, 1414, 1382, 1180, 1161, 
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225.1392, found 225.1377; SFC conditions: 3% IPA, 2.5 mL/min, Chiralpak OJ–H 
column, λ = 210 nm, tR (min): major = 3.270, minor = 4.727. 
 
4.6.2.6 Experimental Procedures and Spectroscopic Data for the Product 
Transformations of Allylic Alkylation Products 
 
 
(S)-2-Methyl-2-(2-phenylbutan-2-yl)malononitrile (101). In a nitrogen-filled glove 
box, to a 1 dram vial equipped with a stir bar was added olefin 93 (25 mg, 0.12 mmol, 1 
equiv), RhCl(PPh3)3 (11 mg, 0.012 mmol, 10 mol %) and benzene (1.2 mL). The reaction 
mixture was removed from the glove box, sparged with hydrogen (balloon) for 5 minutes, 
and stirred under a hydrogen atmosphere for 18 h, whereupon the reaction was 
concentrated under reduced pressure. The crude residue was purified by preparatory TLC 
(20% EtOAc/hexanes) to give alkyl 101 as a colorless oil (23 mg, 92% yield): [α]D25 
+16.6 (c 1.2, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.31 (m, 5H), 2.58 – 2.46 (m, 
1H), 1.94 (dq, J = 13.6, 7.2 Hz, 1H), 1.65 (d, J = 0.9 Hz, 3H), 1.56 (s, 3H), 0.83 (t, J = 
7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 136.9, 128.7, 128.3 (2C), 116.3, 116.3, 47.3, 
43.3, 29.5, 21.2, 20.5, 8.8; IR (Neat Film, NaCl) 3059, 2979, 2943, 2885, 2245, 1602, 
15001, 1451, 1391, 1192, 1164, 1098, 1030, 806, 774, 741, 702, 662 cm-1; HRMS (ESI+) 
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(S)-2-Methyl-2-(1-oxo-2-phenylpropan-2-yl)malononitrile (102). A solution of olefin 
93 (40.0 mg, 0.19 mmol, 1 equiv) and pyridine (0.038 mL, 0.48 mmol, 2.5 equiv) in 
CH2Cl2 (2.0 mL) was cooled to –78 °C. Ozone was bubbled through the resulting 
solution for 4 min, whereupon the reaction mixture was sparged with O2, warmed to 
ambient temperature, and diluted with CH2Cl2 (5.0 mL). The reaction mixture was 
washed with saturated aqueous NaHCO3 (5 mL) and the aqueous layer was further 
extracted with CH2Cl2 (2 x 5 mL). The combined organic layers were washed with 1 M 
HCl (5 mL), brine (5 mL), dried over Na2SO4, and concentrated under reduced pressure 
to give aldehyde 102 as a colorless solid (37 mg, 93% yield): [α]D25 –46.9 (c 2.1, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 9.45 (s, 1H), 7.55 – 7.45 (m, 3H), 7.41 – 7.30 (m, 2H), 
1.88 (s, 3H), 1.70 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 194.9, 131.1, 130.2, 129.6, 
128.9, 115.3, 115.2, 58.3, 37.4, 21.4, 16.3; IR (Neat Film, NaCl) 3033, 3063, 2985, 2954, 
2832, 2720, 2249, 1726, 1498, 1448, 1395, 1376, 1262, 1190, 1172, 1080, 923, 869, 764, 
703 cm-1; HRMS (ESI+) m/z calc’d for C13H12N2O [M]+•: 212.0950, found 212.0948. 
 
 
(S)-4-Acetyl-2-methyl-2-phenylcyclopent-3-ene-1,1-dicarbonitrile (106). A solution of 
olefin 95f (42 mg, 0.16 mmol, 1 equiv) and pyridine (0.031 mL, 0.39 mmol, 2.5 equiv) in 
CH2Cl2 (2.0 mL) was cooled to –78 °C. Ozone was bubbled through the resulting 
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ambient temperature, and diluted with CH2Cl2 (5.0 mL). The reaction mixture was 
washed with saturated aqueous NaHCO3 (5 mL) and the aqueous layer was further 
extracted with CH2Cl2 (2 x 5 mL). The combined organic layers were washed with 1 M 
HCl (5 mL), brine (5 mL), dried over Na2SO4, and concentrated under reduced pressure.  
The crude material was dissolved in benzene (10 mL) and p-toluenesulfonic acid 
(30.0 mg, 0.16 mmol, 1 equiv) was added. The resulting solution was stirred at ambient 
temperature for 0.5 h and then heated under reflux for 18 h, whereupon the reaction 
mixture was cooled to ambient temperature and diluted with Et2O (10 mL). Saturated 
aqueous NaHCO3 (10 mL) was added to the resulting solution and allowed to stir for 5 
min. The organic layer was then separated and washed further with saturated aqueous 
NaHCO3 (10 mL), brine (10 mL), dried over Na2SO4, and concentrated under reduced 
pressure. The crude residue was purified by preparatory TLC (33% acetone/hexanes) to 
give enone 106 as a colorless oil (19 mg, 47% yield over two steps): [α]D25 –27.3 (c 1.2, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.52 – 7.36 (m, 5H), 6.91 (dd, J = 2.2, 1.2 Hz, 
1H), 3.56 (dd, J = 16.7, 1.2 Hz, 1H), 3.39 (dd, J = 16.7, 2.1 Hz, 1H), 2.48 (s, 3H), 1.82 (s, 
3H); 13C NMR (101 MHz, CDCl3) δ 194.6, 145.4, 140.5, 138.8, 129.5 (d, J = 2.6 Hz), 
126.3, 114.7, 114.4, 61.4, 45.7, 42.2, 26.8, 23.6; IR (Neat Film, NaCl) 3063, 2978, 2934, 
2249, 1676, 1629, 1499, 1446, 1371, 1335, 1267, 1098, 1026, 953, 896, 764, 699 cm-1; 
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(1S,2S)-4-acetyl-1-cyano-2-methyl-2-phenylcyclopent-3-ene-1-carboxamide (103). A 
solution of bis-nitrile 106 (19 mg, 0.074 mmol, 1 equiv), NaOH (10 mg, 0.25 mmol, 3.4 
equiv) in EtOH/H2O (1:1, 1.0 mL) was heated to 60 °C for 18 h, whereupon the resulting 
mixture was cooled to ambient temperature and diluted with EtOAc (5 mL). The solution 
was washed with brine (5 mL), dried over Na2SO4, and concentrated under reduced 
pressure. The crude product was purified by preparatory TLC (50% acetone/hexanes) to 
give amide 103 as a colorless oil (7.5 mg, 38% yield, 1:11 dr): [α]D25 +4.4 (c 1.2, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.47 – 7.38 (m, 5H), 6.65 (dd, J = 2.3, 1.1 Hz, 1H), 5.76 
(s, 2H), 3.71 (dd, J = 17.0, 2.3 Hz, 1H), 3.22 (dd, J = 17.0, 1.1 Hz, 1H), 2.44 (s, 3H), 1.58 
(s, 3H); 13C NMR (101 MHz, CDCl3) δ 195.4, 165.9, 146.5, 141.9, 129.8, 129.0, 127.4, 
124.9, 120.6, 60.5, 59.0, 39.2, 26.9, 21.4; IR (Neat Film, NaCl) 3338, 3201, 3062, 2980, 
2929, 2854, 2242, 1732, 1694, 1673, 1604, 1498, 1446, 1371, 1338, 1259, 1102, 1046, 
913, 767. 734, 702 cm-1; HRMS (FAB+) m/z calc’d for C16H17O2N2 [M+H]+: 269.1290, 
found 269.1282. Please note that the NMR data listed is for the major diastereomer, 
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(3R,4S)-3,4-dimethyl-2-oxo-4-phenyltetrahydrofuran-3-carbonitrile (104). A solution 
of olefin 93 (100.0 mg, 0.48 mmol, 1 equiv) in MeOH (5.0 mL) was cooled to –78 °C. 
Ozone was bubbled through the reaction mixture for 0.5 h, whereupon the resulting 
solution was sparged with O2 and NaBH4 (0.80 mg, 2.1 mmol, 4.4 equiv) was added. The 
reaction was then warmed to 0 °C and stirred for 3 h. The reaction mixture was quenched 
with the addition of 1 M HCl (5 mL) and the aqueous layer was extracted with EtOAc (3 
x 20 mL). The combined organic layers were washed with brine (20 mL), dried over 
Na2SO4, and concentrated under reduced pressure. The crude product was purified by 
silica gel flash column chromatography (20% acetone/hexanes) to give lactone 104 as a 
colorless solid (66 mg, 65% yield, 1:2.5 dr): [α]D25 +21.3 (c 3.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.47 – 7.33 (m, 3H), 7.26 – 7.23 (m, 2H), 4.78 (dt, J = 9.1, 0.8 Hz, 1H), 








There is an NOE between the bottom allylic proton 
(blue) and the methyl group, but not the phenyl 
group and the top allylic proton (red), leading us 




O NH2 There is a HMBC between the bottom proton (blue) and 
the amide; thus we believe that the amide is on the top 
face which provides a great angle for coupling as 
opposed to if the amide were in the equatorial position, 
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CDCl3) δ 171.7, 138.7, 129.6, 128.5, 125.6, 117.7, 74.6, 49.6, 49.0, 27.1, 18.9; IR (Neat 
Film, NaCl) 2979, 2930, 2355, 2242, 1783, 1498, 1445, 1381, 1279, 1172, 1092, 1012, 
764, 699 cm-1; HRMS (ESI+) m/z calc’d for C13H13NO2 [M]+•: 215.0946, found 
215.0966. Please note that the NMR data listed is for the major diastereomer. 
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4.6.2.7 Determination of Enantiomeric Excess 
Please note racemic products were synthesized using racemic L5. 
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 Figure A6.3 13C NMR (101 MHz, CDCl3) of compound 93 
 
Figure A6.2 Infrared spectrum (Thin Film, NaCl) of compound 93 
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 Figure A6.6 13C NMR (101 MHz, CDCl3) of compound 95a 
 
Figure A6.5 Infrared spectrum (Thin Film, NaCl) of compound 95a 
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 Figure A6.9 13C NMR (101 MHz, CDCl3) of compound 95b 
 
Figure A6.8 Infrared spectrum (Thin Film, NaCl) of compound 95b 
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 Figure A6.12 13C NMR (101 MHz, CDCl3) of compound 95d 
 
Figure A6.11 Infrared spectrum (Thin Film, NaCl) of compound 95d 
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 Figure A6.15 13C NMR (101 MHz, CDCl3) of compound 95e 
 
Figure A6.14 Infrared spectrum (Thin Film, NaCl) of compound 95e 
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 Figure A6.18 13C NMR (101 MHz, CDCl3) of compound 95f 
 
Figure A6.17 Infrared spectrum (Thin Film, NaCl) of compound 95f 
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 Figure A6.21 13C NMR (101 MHz, CDCl3) of compound 95g 
 
Figure A6.20 Infrared spectrum (Thin Film, NaCl) of compound 95g 
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 Figure A6.24 13C NMR (101 MHz, CDCl3) of compound 96b 
 
Figure A6.23 Infrared spectrum (Thin Film, NaCl) of compound 96b 
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 Figure A6.27 13C NMR (101 MHz, CDCl3) of compound 96c 
 
Figure A6.26 Infrared spectrum (Thin Film, NaCl) of compound 96c 
 
383







































































































































 Figure A6.30 13C NMR (101 MHz, CDCl3) of compound 96f 
 
Figure A6.29 Infrared spectrum (Thin Film, NaCl) of compound 96f 
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 Figure A6.33 13C NMR (101 MHz, CDCl3) of compound 97a 
 
Figure A6.32 Infrared spectrum (Thin Film, NaCl) of compound 97a 
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 Figure A6.36 13C NMR (101 MHz, CDCl3) of compound 97b 
 
Figure A6.35 Infrared spectrum (Thin Film, NaCl) of compound 97b 
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 Figure A6.39 13C NMR (101 MHz, CDCl3) of compound 97c 
 
Figure A6.38 Infrared spectrum (Thin Film, NaCl) of compound 97c 
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 Figure A6.42 13C NMR (101 MHz, CDCl3) of compound 97d 
 
Figure A6.41 Infrared spectrum (Thin Film, NaCl) of compound 97d 
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 Figure A6.45 13C NMR (101 MHz, CDCl3) of compound 97e 
 
Figure A6.44 Infrared spectrum (Thin Film, NaCl) of compound 97e 
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 Figure A6.48 13C NMR (101 MHz, CDCl3) of compound 97f 
 
Figure A6.47 Infrared spectrum (Thin Film, NaCl) of compound 97f 
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 Figure A6.51 13C NMR (101 MHz, CDCl3) of compound 97g 
 
Figure A6.50 Infrared spectrum (Thin Film, NaCl) of compound 97g 
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 Figure A6.54 13C NMR (101 MHz, CDCl3) of compound 97h 
 
Figure A6.53 Infrared spectrum (Thin Film, NaCl) of compound 97h 
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 Figure A6.57 13C NMR (101 MHz, CDCl3) of compound 97j 
 
Figure A6.56 Infrared spectrum (Thin Film, NaCl) of compound 97j 
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 Figure A6.60 13C NMR (101 MHz, CDCl3) of compound 97k 
 
Figure A6.59 Infrared spectrum (Thin Film, NaCl) of compound 97k 
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 Figure A6.63 13C NMR (101 MHz, CDCl3) of compound 97l 
 
Figure A6.62 Infrared spectrum (Thin Film, NaCl) of compound 97l 
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 Figure A6.66 13C NMR (101 MHz, CDCl3) of compound 101 
 
Figure A6.65 Infrared spectrum (Thin Film, NaCl) of compound 101 
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 Figure A6.69 13C NMR (101 MHz, CDCl3) of compound 102 
 
Figure A6.68 Infrared spectrum (Thin Film, NaCl) of compound 102 
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 Figure A6.72 13C NMR (101 MHz, CDCl3) of compound 103 
 
Figure A6.71 Infrared spectrum (Thin Film, NaCl) of compound 103 
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 Figure A6.78 13C NMR (101 MHz, CDCl3) of compound 104 
 
Figure A6.77 Infrared spectrum (Thin Film, NaCl) of compound 104 
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 Figure A6.82 13C NMR (101 MHz, CDCl3) of compound 105 
 
Figure A6.81 Infrared spectrum (Thin Film, NaCl) of compound 105 
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 Figure A6.86 13C NMR (101 MHz, CDCl3) of compound 106 
 
Figure A6.85 Infrared spectrum (Thin Film, NaCl) of compound 106 
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A7.1   GENERAL EXPERIMENTAL 
Low-temperature diffraction data (φ-and ω-scans) were collected on a Bruker 
AXS D8 VENTURE KAPPA diffractometer coupled to a PHOTON II CPAD 
detector with Cu Kα radiation (λ = 1.54178 Å) from an IµS micro-source for the 
structure of compound 97c. The structure was solved by direct methods using 
SHELXS 1  and refined against F2 on all data by full-matrix least squares with 
SHELXL-20162 using established refinement techniques.3 All non-hydrogen atoms 
were refined anisotropically. All hydrogen atoms were included into the model at 
geometrically calculated positions and refined using a riding model. The isotropic 
displacement parameters of all hydrogen atoms were fixed to 1.2 times the U value of 
the atoms they are linked to (1.5 times for methyl groups). All disordered atoms were 
refined with the help of similarity restraints on the 1,2- and 1,3-distances and 
displacement parameters as well as enhanced rigid bond restraints for anisotropic 
displacement parameters.  
Compound 97c crystallizes in the tetragonal space group I41 with half a 
molecule in the asymmetric unit. The molecule is located near a crystallographic 2-
fold rotation axis and is disordered by the rotation. The phenyl moiety was disordered 
over four positions, two of which are pairwise related to the other two by the 2-fold 
rotation. This requires a number of SADI restraints during refinement. We note that a 
Bayesian analysis of the Friedel pairs (performed using the "Bijvoet-Pair Analysis" 
routine of PLATON) confirms the absolute stereochemical assignment based on the 
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Bayesian Statistics 
Student_T Nu 99 
Select Pairs 752 






G .......... 2.0938 
G (su) ..... 0.4726 
Hooft y .... -0.5(2) 
 




Bis-nitrile 97c (95% ee) was recrystallized from boiling hexane to provide 
crystals suitable for X-ray analysis. 
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Table A7.1 Crystal data and structure refinement for bis-nitrile 97c 
 
Empirical formula  C20 H18 N2 
Formula weight  286.36 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Tetragonal 
Space group  I41 
Unit cell dimensions a = 10.0971(4) Å a= 90°. 
 b = 10.0971(4) Å b= 90°. 
 c = 15.5215(7) Å g = 90°. 
Volume 1582.44(14) Å3 
Z 4 
Density (calculated) 1.202 Mg/m3 
Absorption coefficient 0.545 mm-1 
F(000) 608 
Crystal size 0.600 x 0.150 x 0.150 mm3 
Theta range for data collection 5.226 to 74.482°. 
Index ranges -12<=h<=12, -12<=k<=12, -17<=l<=19 
Reflections collected 10160 
Independent reflections 1590 [R(int) = 0.0381] 
Completeness to theta = 67.679° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7538 and 0.5549 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1590 / 823 / 256 
Goodness-of-fit on F2 1.044 
Final R indices [I>2sigma(I)] R1 = 0.0422, wR2 = 0.1227 
R indices (all data) R1 = 0.0433, wR2 = 0.1248 
Absolute structure parameter -0.6(3) 
Extinction coefficient n/a 
Largest diff. peak and hole             0.211 and -0.114 e.Å-3 	
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Table A7.2 Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 
103) for 97c. U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________  
 x y z U(eq) 
_____________________________________________________________________  
C(11) 4978(4) 4611(3) 4288(2) 41(1) 
C(12) 3831(6) 4487(6) 4770(4) 50(1) 
C(13) 3815(16) 4637(13) 5665(6) 44(2) 
C(14) 4960(20) 4930(50) 6109(3) 47(3) 
C(15) 6113(19) 5045(15) 5612(9) 58(3) 
C(16) 6135(6) 4925(6) 4736(4) 50(1) 
C(21) 5150(20) 4990(50) 7046(10) 44(3) 
C(22) 4028(19) 5180(30) 7561(12) 58(4) 
C(23) 4064(18) 5150(30) 8460(12) 68(4) 
C(24) 5262(18) 4980(40) 8853(12) 63(5) 
C(25) 6388(16) 4750(30) 8376(10) 69(4) 
C(26) 6337(17) 4800(30) 7479(10) 54(3) 
C(21A) 4840(30) 4910(40) 7104(13) 43(5) 
C(22A) 3718(19) 4470(30) 7512(12) 47(4) 
C(23A) 3681(18) 4450(20) 8410(11) 57(4) 
C(24A) 4750(30) 4830(40) 8896(17) 56(6) 
C(25A) 5830(20) 5330(30) 8484(15) 57(4) 
C(26A) 5890(20) 5390(30) 7587(15) 52(4) 
C(1) 5012(4) 4373(4) 3312(3) 45(1) 
C(2) 6410(11) 3889(10) 3042(7) 52(2) 
C(3) 6731(6) 2674(6) 2858(5) 78(2) 
C(4) 3908(17) 3438(17) 3046(13) 70(5) 
C(5) 4782(5) 5744(4) 2825(3) 51(1) 
C(6) 3509(14) 6450(11) 3020(8) 65(3) 
C(7) 5866(16) 6713(17) 3030(10) 50(2) 
N(1) 6596(5) 7446(5) 3232(4) 78(1) 
C(8) 4876(5) 5491(6) 1886(3) 64(1) 
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Table A7.3 Bond lengths [Å] and angles [°] for 97c 
_____________________________________________________  
C(11)-C(12)  1.385(7) 
C(11)-C(16)  1.396(7) 
C(11)-C(1)  1.534(6) 
C(12)-C(13)  1.398(11) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.380(16) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.400(16) 
C(14)-C(21)  1.467(18) 
C(15)-C(16)  1.366(14) 
C(15)-H(15)  0.9500 
C(16)-H(16)  0.9500 
C(21)-C(26)  1.390(17) 
C(21)-C(22)  1.397(17) 
C(22)-C(23)  1.396(17) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.366(18) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.376(16) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.394(15) 
C(25)-H(25)  0.9500 
C(26)-H(26)  0.9500 
C(21A)-C(22A)  1.374(19) 
C(21A)-C(26A)  1.384(19) 
C(22A)-C(23A)  1.395(17) 
C(22A)-H(22A)  0.9500 
C(23A)-C(24A)  1.37(2) 
C(23A)-H(23A)  0.9500 
C(24A)-C(25A)  1.36(2) 
C(24A)-H(24A)  0.9500 
C(25A)-C(26A)  1.395(18) 
C(25A)-H(25A)  0.9500 
C(26A)-H(26A)  0.9500 
C(1)-C(4)  1.518(16) 
C(1)-C(2)  1.551(11) 
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C(1)-C(5)  1.594(6) 
C(2)-C(3)  1.301(10) 
C(2)-H(2)  0.9500 
C(3)-H(3A)  0.9500 
C(3)-H(3B)  0.9500 
C(4)-H(4A)  0.9800 
C(4)-H(4B)  0.9800 
C(4)-H(4C)  0.9800 
C(5)-C(8)  1.482(7) 
C(5)-C(6)  1.501(13) 
C(5)-C(7)  1.503(15) 
C(6)-H(6A)  0.9800 
C(6)-H(6B)  0.9800 
C(6)-H(6C)  0.9800 
C(7)-N(1)  1.091(15) 



























































































_____________________________________________________________   
 
 
Table A7.4 Anisotropic displacement parameters (Å2x 103) for 97c. The anisotropic 
displacement factor exponent takes the form: -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
_____________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_____________________________________________________________________  
C(11) 47(2)  43(2) 34(2)  1(1) 1(1)  4(2) 
C(12) 42(2)  67(3) 43(2)  2(3) 5(2)  2(3) 
C(13) 53(3)  48(5) 32(3)  2(3) 8(2)  3(3) 
C(14) 65(3)  39(7) 37(2)  1(4) 6(5)  7(3) 
C(15) 55(3)  62(8) 58(4)  -15(4) -8(3)  -3(4) 
C(16) 49(2)  56(3) 46(3)  -3(3) 4(2)  -5(3) 
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C(21) 56(8)  31(5) 44(5)  -5(6) 10(5)  1(8) 
C(22) 63(9)  67(8) 45(6)  1(6) 4(5)  -1(8) 
C(23) 80(9)  83(9) 40(6)  -1(6) 9(6)  -2(10) 
C(24) 85(10)  69(10) 36(6)  -5(6) 11(6)  -3(10) 
C(25) 82(9)  89(9) 36(5)  -11(4) 5(5)  -14(8) 
C(26) 64(8)  72(8) 26(4)  -3(4) 3(4)  -7(7) 
C(21A) 64(10)  47(10) 18(6)  -10(7) 4(7)  2(9) 
C(22A) 51(8)  55(9) 36(6)  0(5) 5(5)  7(7) 
C(23A) 64(9)  69(10) 37(6)  -11(6) 5(6)  5(7) 
C(24A) 75(11)  58(11) 35(8)  -3(6) 2(7)  -2(8) 
C(25A) 71(10)  63(10) 38(7)  1(7) -4(7)  -4(9) 
C(26A) 64(10)  46(8) 46(7)  1(7) 4(6)  -3(9) 
C(1) 48(2)  47(2) 39(2)  -5(2) 4(2)  -2(1) 
C(2) 66(3)  41(4) 49(3)  -11(3) 19(2)  -3(3) 
C(3) 82(3)  66(3) 86(4)  -8(3) 32(3)  0(3) 
C(4) 79(7)  73(8) 57(6)  -24(5) 15(5)  -25(6) 
C(5) 57(2)  59(2) 37(3)  2(2) -3(2)  -2(2) 
C(6) 91(5)  51(6) 53(3)  21(3) 18(3)  17(3) 
C(7) 67(4)  48(3) 36(4)  -1(3) -2(3)  2(3) 
N(1) 86(3)  62(2) 84(3)  -4(2) 7(2)  -12(2) 
C(8) 64(3)  84(3) 45(3)  4(2) 0(2)  -21(3) 




Table A7.5 Hydrogen coordinates (x 104) and isotropic  displacement parameters (Å2x 103) for 
97c 
_____________________________________________________________________  
 x  y  z  U(eq) 
_____________________________________________________________________  
H(12) 3024 4292 4482 61 
H(13) 3007 4534 5971 53 
H(15) 6925 5212 5901 70 
H(16) 6940 5055 4430 60 
H(22) 3202 5331 7286 70 
H(23) 3277 5256 8789 81 
H(24) 5318 5012 9463 76 
H(25) 7201 4562 8658 83 
H(26) 7131 4701 7157 65 
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H(22A) 2977 4171 7187 57 
H(23A) 2893 4179 8693 68 
H(24A) 4744 4738 9506 67 
H(25A) 6561 5645 8813 69 
H(26A) 6643 5751 7309 62 
H(2) 7091 4536 3009 62 
H(3A) 6082 1995 2883 93 
H(3B) 7615 2467 2698 93 
H(4A) 3973 3256 2428 104 
H(4B) 3049 3848 3172 104 
H(4C) 3988 2607 3368 104 
H(6A) 3559 7361 2805 98 
H(6B) 3364 6462 3644 98 
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Stereoselective Iridium-Catalyzed Allylic Alkylation 
 in the Stoltz Laboratory: A Summary† 
 
 
5.1   INTRODUCTION 
To enable our ongoing research program focused on the synthesis of complex 
natural products, we became intested in developing robust methods for the synthesis of 
stereochemically rich building blocks containing quaternary stereocenters. As a result, 
our group has developed a range of technologies for the enantioselective preparation of 
all-carbon quaternary stereocenters. 1  Perhaps most notably, we reported a general 
asymmetric palladium-catalyzed allylic alkylation method to provide access to a wide 
variety of products 109 bearing a homoallylic quaternary stereocenter (Figure 5.1, top).2 
Over the past decade, we have expanded this methodology to a broad array of substrates 
1073 and applied this chemistry to facilitate expedient total syntheses of a variety of 
	†	 Portions of this chapter have been reproduced from Shockley, S. E.;‡ Hethcox, J. C.;‡ Stoltz, B. M. 
Manuscript submitted.  
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natural products, including (–)-cyanthiwigin F (110),4 (+)-dichroanone (111),5 and (+)-
sibirinine (112, Figure 5.1, bottom).6 
 
Figure 5.1 Stoltz group contributions to palladium-catalyzed allylic alkylation methodology and 




Despite its extensive substrate tolerance, our palladium-catalyzed allylic 
alkylation technology is limited to the synthesis of isolated stereocenters. Thus, to date, 
this methodology is not amenable to the direct preparation of vicinal stereocenters, which 
are found in a variety of synthetic targets such as ligularone (1), crinipellin B (2), and 
elisabethin A (3, Figure 5.2, top). Inspired by these diverse and numerous stereodyad-
containing natural products, we sought to expand our stereoselective allylic alkylation 
research program to include iridium-catalyzed processes that do enable the construction 
of such vicinal stereocenters 114 (Figure 5.2, bottom).  
prochiral
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Figure 5.2 Stereodyad-containing natural products as inspiration for the development of novel 




While the aforementioned palladium-catalyzed allylic alkylation has been under 
exploration since the 1960s,7 iridium-catalyzed allylic alkylation is a relatively new area 
of research. Takeuchi reported the first example of iridium-catalyzed allylic alkylation in 
1997 using malonate nucleophiles 115, demonstrating that iridium catalysts can provide 
high branched selectivity (branched to linear ratio, b:l) in contrast to palladium catalysts 
that favor the synthesis of linear products (Figure 5.3a).8,9 Shortly thereafter, Helmchen 
reported that the reaction could be rendered enantioselective with the inclusion of chiral 
phosphinooxazoline ligand L12 (Figure 5.3b).10 In 2003, Takemoto disclosed the first 
report of a diastereoselective iridium-catalyzed allylic alkylation reaction, wherein 
prochiral nucleophiles 120 were utilized to form vicinal trisubstituted and tertiary 
stereocenters  122 (Figure 5.3c, top).11 It was then a decade later before the next report of 
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enabled the preparation of vicinal tertiary and tetra-substituted stereocenters 125 (Figure 
5.3c, bottom).12 
 
Figure 5.3 Timeline for the development of iridium-catalyzed allylic alkylation prior to the Stoltz 




Despite these seminal reports, when our group entered the field in 2013, there 
were no examples of an iridium-catalyzed allylic alkylation reaction to form a single all-
a) First Report of Iridium-Catalyzed Allylic Alkylation  Takeuchi (1997)
NaCH(CO2Me)2 + R OAc
[Ir(cod)Cl]2 (2 mol %)
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carbon quaternary stereocenter, let alone a stereodyad containing an all-carbon 
quaternary stereocenter. 13  Therefore, we were highly intrigued by the possibility of 
developing new iridium-catalyzed allylic alkylation technology that would allow for the 
preparation of sterically congested enantioenriched quaternary stereocenters, and thus 
potentially open the door to the synthesis of a range of new natural product targets 
(Figure 5.2, top). 
 
5.2  SYNTHESIS OF VICINAL TERTIARY AND ALL-CARBON 
QUATERNARY STEREOCENTERS VIA ENANTIO- AND DIASTEREOSELECTIVE 
IRIDIUM-CATALYZED ALLYLIC ALKYLATION 
 
5.2.1 CYCLIC NUCLEOPHILES14,15 
In our quest to develop the first iridium-catalyzed allylic alkylation reaction to 
form vicinal tertiary and all-carbon quaternary stereocenters, we initially selected cyclic 
prochiral enolates as our nucleophiles in order to obviate the need to control enolate 
geometry during the allylic alkylation reaction.1,16 Thus, our preliminary exploration into 
this research area commenced with tetralone 27. We rapidly found that the standard 
phosphoramidite ligands L13 and L9, which were at the time typically utilized in 
iridium-catalyzed allylic alkylation with enolate equivalents, were not amenable to the 
synthesis of a quaternary stereocenter, as neither provided high levels of 
diastereoselectivity (Table 5.1, entries 1 and 2). Inspired by the work of the You group on 
the allylic alkylation of heterocycles,17 we evaluated the effect of MeTHQPhos (L2) as 
the ligand and found that it provided product 127 with a high degree of regio-, diastereo-, 
and enantioselectivity (entry 3).  
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Table 5.1 Development of conditions for the iridium-catalyzed allylic alkylation reaction of cyclic 
nucleophiles forming vicinal tertiary and all-carbon quaternary stereocentersa 
 
 
[a] Reactions performed with 0.1 mmol of 126, 0.2 mmol of 27 in THF (0.1M) and allowed to proceed to complete 
consumption of 126. [b] Determined by 1H NMR and UHPLC-MS analysis of the crude mixture. [c] Determined by chiral 
HPLC analysis of the major diastereomer. [d] TBD = 1,3,5-triazabicyclo[4.4.0]dec-5-ene. 
 
At this point in our optimization efforts, we realized that the reaction conditions 
could be simplified if the exogenous base was removed and the carbonate leaving group 
was instead relied on as the stoichiometric base required for enolate formation. Toward 
this end, sodium hydride was excluded from the reaction, but we observed diminished 
selectivity (Table 5.1, entry 4). Previous literature reports documented the beneficial 
effects of halide salts on selectivity in iridium-catalyzed allylic alkylation reactions.18 
When this strategy was explored in our reaction conditions, LiCl provided only minor 



























Entry L Additive (X mol %) b:lb drb ee (%)c
1 L13 NaH (200) >95:5 1:1 99
2 L9 NaH (200) >95:5 1:2 32
3 L2 NaH (200) 95:5 >20:1 98
4 L2 – 80:20 11:1 96
5 L2 LiCl (100) 88:12 14:1 98
6 L2 LiBr (100) 95:5 >20:1 >99
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both conversion and selectivity, providing us with our optimized reaction conditions 
(entry 6).  
Upon investigating the substrate scope of the developed transformation, we found 
the reaction amenable to a wide variety of substitution on both the allylic electrophile and 
the nucleophile (Scheme 5.1).14 Though, as a general trend, branched regioselectivity 
increases with greater carbocation stability on the allylic electrophile, thus electron-rich 
aromatics 129 (R2 = EDG–Ar) provide higher branched to linear ratios. Additionally, the 
reaction is not limited to aryl substitution on the allylic electrophile, as both heteroaryl 
and alkenyl substitution provide the corresponding products in good yields and 
selectivities (e.g., 131a). A key limitation to this initial report is that alkyl-substituted 
allylic electrophiles are not tolerated and instead proceed with poor conversions and 
selectivities. With respect to nucleophile 128, we found that the aryl ring of tetralone 27, 
used as the optimization substrate, could be removed without diminishing reactivity or 
stereoselectivity of the reaction (e.g., as seen in products 131b and 131c). Finally, we 
observed that unsaturated nucleophiles 128 are tolerated, allowing for access to products 
bearing a 1,5-diene (e.g., 131d) for subsequent functionalization, though the addition of 
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Scheme 5.1 Enantio- and diastereoselective iridium-catalyzed allylic alkylation of cyclic nucleophiles 
128 
 
[a] Reaction performed with (S,Sa)-L2 without LiBr. 
 
Upon further optimization, we found that the reactions of unsaturated 
nucleophiles (e.g., 132) progressed with a higher degree of selectivity when LiOt-Bu was 
utilized as a base additive in place of LiBr.15 These allylic alkylation conditions followed 
by a subsequent thermal Cope rearrangement, allow unsaturated compounds 132 to 
formally undergo allylic alkylation at the γ-position to produce comounds such as 35 with 
a high degree of enantioselectivity (Scheme 5.2).  
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5.2.2 ACYCLIC NUCLEOPHILES19 
In looking to expand our iridium-catalyzed allylic alkylation reaction from cyclic 
enolate nucleophiles to acyclic variants, we fortuitously discovered that our conditions 
for cyclic nucleophiles provide satisfactory reactivity and selectivity for acyclic 
nucleophile 134 (Scheme 5.3). With further optimization though, we ultimately found 
LiOt-Bu to be the optimal additive as it led to shorter reaction times. With respect to the 
substrate scope of this transformation, we again observed that reaction regioselectivity is 
directly affected by the electronics of the aryl functionality on allylic electrophile 135, 
however, enantio- and diastereoselectivities remain consistently excellent. Moreover, 
heteroaryl-substituted allylic electrophiles are tolerated, as are various substituents at the 
α-position of acyclic β-ketoester nucleophile 134. However, in contrast to the cyclic 
variants, we noted pronounced decreases in the diastereomeric ratio of product 136 when 
ketone 134 was not an aryl ketone (e.g., 136a versus 136d). 
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5.2.3 ALKYL-SUBSTITUTED ELECTROPHILES20 
After disclosing methods for the synthesis of vicinal tertiary and all-carbon 
quaternary stereocenters using cyclic,14 acyclic,19 and extended enolate15 nucleophiles in 
iridium-catalyzed allylic alkylation, we noted that none of these protocols tolerated the 
use of alkyl-substituted electrophiles. In fact, at the time, no transition metal-catalyzed 
process enabled the construction of an alkyl-substituted stereodyad between neighboring 
tertiary and quaternary carbon atoms. Realizing that many synthetic targets require the 
installation of this specific stereodyad, we became intrigued with the possibility of further 
developing our enantio- and diastereoselective iridium-catalyzed allylic alkylation 
chemistry to allow for the use of allylic electrophiles bearing an sp3-hybridized 
substituent.  
Based on our prior efforts in optimizing iridium-catalyzed allylic alkylation 
reactions, we anticipated that we would need to explore new combinations of additives 
and ligands in order to effect selectivity in the reaction between tetralone nucleophile 52, 
utilized in our seminal report14 (Table 5.1), and alkyl-substituted electrophile 53 (Table 
5.2). Indeed, when we employed our previously reported conditions for cyclic or acyclic 
nucleophiles,14,19 we observed excellent yields and good diastereoselectivities but poor 
branched to linear ratios (Table 5.2, entries 1 and 2). Given the trends established in our 
earlier work where regioselectivity increases with increasing carbocation stability of the 
iridium π-allyl cation, these findings were not surprising as the methyl group is less 
stabilizing than an aryl substituent. We hypothesized that decreasing carbocation stability 
results in slow equilibration between iridium π-allyl diastereomers. Thus, we sought to 
employ LiCl as an additive, which has been proposed to facilitate iridium π-allyl 
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equilibration and therefore improve regio- and enantioselectivity in iridium-catalyzed 
allylic alkylation reactions.18 While we did not see a marked effect by adding LiCl alone 
(entry 3), we postulated that by rendering all anions in solution congruent, the effect of 
the chloride additive would be more pronounced. This hypothesis led us to replace the 
methyl carbonate leaving group of crotyl electrophile 53 with chloride, and in doing so 
we noted a significant increase in reaction regioselectivity, though the diastereoselectivity 
was now only moderate (entry 4).  
 
Table 5.2 Optimization of iridium-catalyzed allylic alkylation reaction of alkyl-substituted 
electrophile 53a 
 
[a] Reactions performed on 0.1 mmol of 53, 0.2 mmol of 52 in THF (0.1 M) for 18 h. [b] 1H NMR yield of the mixture of 
diastereomers based on internal standard. [c] Determined by 1H NMR analysis of the crude reaction mixture. [d] 
Determined by chiral SFC analysis. [e] Proton sponge = 1,8-bis(dimethylamino)naphthalene.  
 
We next sought to improve the diastereoselectivity of the reaction by 
investigating additional bases other than LiOt-Bu, as we had found in our prior work that 
bases had a significant effect on selectivity.14,15,19 After an extensive screen of bases, we 






1 L2 – LiBr (100)
2 L2 –
3 L2 LiCl (100)
4 L2 LiCl (100)
5 L2 proton sponge LiCl (100)
7 L11 proton sponge LiCl (400)
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identified that the bulky amine base, proton sponge, allowed our transformation to 
proceed in good yield, regio- and diastereoselectivity, but poor enantioselectivity (entry 
5). In order to increase the enantioselectivity of our desired reaction, we moved to 
employ bulkier phosphoramidite ligand L11, which led to excellent enantioselectivity, 
though at the expense of yield (entry 6). Ultimately, we discovered that we could improve 
the reaction yield, with no effect on selectivity, by increasing the amount of the 
inexpensive LiCl additive to 400 mol % (entry 7). This extensive fine-tuning of reaction 
parameters is included here as an illustrative example of how altering one reaction 
partner (e.g., the substituent on the electrophile) in an iridium-catalyzed allylic alkylation 
reaction necessitates complete reoptimization of the system.  
The optimized conditions allow for a wide range of substituted tetralone 
nucleophiles 56 to undergo a highly selective iridium-catalyzed allylic alkylation reaction 
with crotyl chloride (57, Scheme 5.4). However, at this time, the nucleophile scope is 
limited to β-ketoester-based tetralones. We postulate that this limitation is due to both 
pKa restrictions of the nucleophile that prevent the use of tetralones bearing other α-
electron withdrawing groups (e.g., nitrile, ketone; 58j versus 54) as well as the necessity 
of sp2-hybridized bulk at the carbonyl α’ position to induce selectivity. With respect to 
the electrophile, longer chain alkyl-substituted electrophiles result in diminished yields 
and selectivities, likely due to increased sterics. Limitations aside, this transformation 
represents the first transition metal-catalyzed allylic alkylation reaction forming vicinal 
tertiary and all-carbon quaternary stereocenters between prochiral enolates and an alkyl-
substituted electrophile.20 We envision that with further exploration of new catalytic 
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systems that the substrate scope of this transformation can be expanded to additional 
alkyl-substituted electrophiles in the future. 
 




In order to demonstrate the synthetic utility of our enantio- and diastereoselective 
iridium-catalyzed allylic alkylation methodology, we carried out series of product 
transformations on allylic alkylation products 137 (Figure 5.4). Notably, all of these 
derivatizations proceed with excellent diastereoselectivity to facilitate the synthesis of 
complex building blocks, demonstrating the ease with which complexity can be added to 
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Figure 5.4 Select examples of diverse product transformations of enantio- and diastereoselective 




[a] pyrrolidine, AcOH, t-BuOMe, reflux, 95% yield; [b] Co2(CO)8, CH2Cl2, then Me3NO⋅2H2O, >20:1 dr, 99% yield; [c] HG-
II (10 mol %), CH2Cl2, 40 °C, 96% yield; [d] i) allylmagnesium chloride, THF, –78 °C, 71% yield, ii) HG-II, CH2Cl2, 81% 




5.3   UMPOLED IRIDIUM-CATALYZED ALLYLIC ALKYLATION 
REACTIONS 
After four years of expanding the limits of enantio- and diastereoselective 
iridium-catalyzed allylic alkylation, we became aware of another limitation in the field. 
Specifically, we noted that over the past two decades of iridium-catalyzed allylic 
alkylation research since the seminal report,8 the technology had been widely developed 
for standard reactivity patterns between electrophilic π-allyl species and nucleophilic 
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5.5a).13,21 However, the application of an umpolung strategy in iridium-catalyzed allylic 
alkylation to stitch together two formally electrophilic species remained underexplored 
(144, Figure 5.5b, left). At the time, only two examples of reverse-polarity nucleophiles 
had been reported for this chemistry, 22  though neither were in the carboxylic acid 
oxidation state which would allow for direct access to either enantioenriched amides, 
esters, or carboxylic acids. 
 




5.3.1 TERTIARY ALLYLIC STEREOCENTERS23 
With this gap in the literature noted we set forth to develop an iridium-catalyzed 
allylic alkylation method for accessing carboxylic acid derivatives and we identified 
masked acyl cyanide (MAC) reagents 67 as potential nucleophiles (Figure 5.5b, left). 
These MAC reagents which were developed by Nemoto and Yamamoto, and popularized 
by Rawal, can expel an equivalent of cyanide when exposed to acid therefore allowing 
them to function as acyl cyanide nucleophiles (145, Figure 5.5b, right). 24  As acyl 
cyanides are highly electrophilic, the MAC reagent truly functions as a carbon monoxide 
a) Standard Iridium-Catalyzed Allylic Alkylation
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synthon (146). Thus, we envisioned that if the MAC reagent could react with an iridium-
π allyl species to generate an alkylation product, we could use extensive literature 
precedent to unmask the MAC adduct and further transform the transient acyl cyanide to 
carboxylic acid derivatives 144 upon treatment with heteroatom nucleophiles (e.g., H2O, 
RNH2, ROH).24,25 As a result, the MAC reagent would function as each an amide, ester, 
and carboxylic acid synthon. 
Employing our previously disclosed conditions for the iridium-catalyzed allylic 
alkylation of cyclic nucleophiles to form vicinal tertiary and all-carbon quaternary 
stereocenters,14 we were able to rapidly establish that the MAC reagent was a competent 
nucleophile in the iridium-catalyzed reaction given the judicious choice of protecting 
group on the hydroxyl moiety. Specifically, we found that a methyoxymethyl (MOM) 
group (67c) was required in order to access products 71 in high yields (Scheme 5.5). We 
hypothesize that this protecting group is optimal due to its small steric profile as well as 
its potential to coordinate and be activated by the LiBr additive. Using these optimized 
conditions, we discovered that a range of cinnamyl-derived electrophiles, including 
heteroaryl-substituted allylic electrophiles, react in high yields and excellent 
enantioselectivities in up to gram scale to provide allylic alkylation products 71, which 
are amenable to the synthesis of highly desirable, enantioenriched vinylated α-aryl 
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Scheme 5.5 First report of MAC reagent 67c in an asymmetric transition-metal catalyzed reaction 
 
 
5.3.2 QUATERNARY ALLYLIC STEREOCENTERS26 
After having developed the iridium-catalyzed allylic alkylation chemistry for 
MAC nucleophile 67c, 23 we sought to further leverage the utility of the MAC reagents to 
access an even more challenging class of compounds – acyclic α-quaternary carbonyl 
derivatives. However, our proposed allylic alkylation strategy had one major caveat, 
namely, enantioenriched quaternary allylic stereocenters had never been synthesized via 
iridium-catalyzed allylic alkylation reactions (Figure 5.6).27 
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Over the past twenty years, enantioselective iridium-catalyzed allylic alkylation 
reactions have been exclusively limited to those synthesizing tertiary allylic stereocenters 
149 (Figure 5.6, left).13,21 In contrast, use of a 1,1-disubstituted π-allyl to forge quaternary 
allylic stereocenters 150 was unreported (Figure 5.6, right). In order to access such a 
geminal-disubstituted π-allyl species, a trisubstituted allylic electrophile would need to be 
utilized; however, this class of electrophile was predicted to be unreactive in iridium-
catalyzed allylic alkylation chemistry. Literature reports have demonstrated that the 
reaction rates of these processes decrease with increasing substitution on the olefin of the 
electrophile. 28  Therefore, we anticipated that our preliminary experiments into this 
research area would focus on identifying a method in which to unlock reactivity from a 
heretofore unreactive trisubstituted allylic electrophile 72 (Table 5.3).  
As we anticipated, application of our standard conditions for the iridium-
catalyzed allylic alkylation of cyclic nucleophiles failed to invoke reactivity from 
trisubstituted allylic electrophile 72, instead returning starting material (Table 5.3, entry 
1). We rationalized that we would need to explore other phosphoramidite ligand 
frameworks in order to identify a more reactive catalyst (entries 2 and 3). Ultimately, we 
identified that phosphoramidite L5, developed by Carreira, was uniquely effective in 
providing desired product 73, though in only modest yield (entry 3).29 In an effort to 
increase the yield and selectivity of the transformation, we performed an extensive 
investigation into alternative additives that have proven successful in promoting iridium-
catalyzed allylic alkylation reactions. However, it was not until we identified the 
necessity of a strong Lewis acid co-catalyst to promote oxidative addition via facilitating 
the ionization of the carbonate leaving group from allylic electrophile 72 that we saw 
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improved reactivity. Specifically, we discovered that the addition of Lewis acidic 
triethylborane to the reaction provided access to desired product 73 in nearly triple the 
conversion and excellent enantioselectivity (entry 4). Finally, we found that we could 
further improve reaction yield by altering the nucleophile to electrophile stoichiometry 
such that an excess of electrophile is present (entry 5). Of note, the E-olefin isomer of 
allylic electrophile 72 is required, as the Z-trisubstituted allylic electrophile gave 
significantly decreased yields and selectivities. 
 
Table 5.3 Optimization of the enantioselective synthesis of products 73 bearing allylic quaternary 
stereocenters 
 
[a] Reactions performed on 0.1 mmol scale. [b] 1 H NMR yield based on internal standard. [c] Determined by chiral HPLC 
analysis.  
 
While optimizing the reaction parameters for this novel transformation, we noted 
the importance of the guanidine base, 1,3,5-triazabicyclo[4.4.0]dec-5-ene (TBD), on 
























[Ir(cod)Cl]2 (2 mol %)
 L  (4.2 mol %), TBD (10 mol %)
THF, 60 °C
67c 72 73
Entry L 67c:72 Additive(200 mol %) Yieldb ee (%)c
1 L2 2:1 LiBr 0 –
2 L9 2:1 LiBr 0 –
3 L5 2:1 LiBr 12 79
4 L5 2:1 BEt3 34 93
5 L5 1:2 BEt3 99 94
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formation of an active iridicycle catalyst. 30  However, Carreira has reported that 
phosphoramidite L5 does not form an iridicycle and thus a base additive is not required 
when employing this ligand in iridium-catalyzed allylic alkylation reactions. 31  We 
postulate that in the case of our developed reaction, TBD may be serving as a labile 
placeholder ligand to prevent the formation of an inactive catalyst or as a base to promote 
the formation of a novel active iridicycle.  
In looking to how this new reaction could be even further improved, we 
envisioned that hydrolysis of the MAC functionality of allylic alkylation product 152 
could be carried out in the same reaction vessel as the iridium-catalyzed reaction to 
provide direct access to the corresponding carboxylic acid in a one-pot, two-step 
procedure (Scheme 5.6).25e Moreover, we hypothesized that carboxylic acid products 153 
could be isolated in high purify after a simple acid/base work up alone, with no need for 
column chromatography. We were pleased to find that our hypothesis was valid and with 
our optimized conditions a range of acyclic α-quaternary carboxylic acids 153 were 
prepared with varying substitution at the α-position. Specifically, both electron 
withdrawing and donating groups are well tolerated at the para and meta positions of the 
aryl substituent on electrophile 151, though diminished yields are observed for bis-meta-
substituted arenes and no reactivity is observed with ortho-substituted aryl groups. With 
respect to the alkyl substituent (R), lengthening the n-alkyl group beyond an ethyl moiety 
results in poor yields, as does the use of branched alkyl substituents. Also of note, bis-
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Scheme 5.6 Enantioselective synthesis of acyclic α-quaternary carboxylic acids 153 
 
 
As MAC adducts can be transformed into essentially any carboxylic acid 
derivative, we sought to develop additional one-pot methods to access α-quaternary 
esters and amides.25e Toward this end, we were pleased to find that MAC adduct 154 
could be advanced in a one-pot fashion to a variety of esters (e.g., 82), as well as amides 
(e.g., 84) in moderate to high yields following cleavage of the MOM group and 
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5.4  SYNTHESIS OF VICINAL ALL-CARBON QUATERNARY CENTERS 
VIA ENANTIOSELECTIVE IRIDIUM-CATALYZED ALLYLIC ALKYLATION32 
Noting that our preparation of enantioenriched α-quaternary carboxylic acid 
derivatives progresses through intermediate 152, bearing vicinal tetra-substituted and 
quaternary centers, led us to imagine that we could utilize this iridium-catalyzed allylic 
alkylation methodology to synthesize highly congested vicinal all-carbon quaternary 
centers. In designing a nucleophile for this desired reaction, we postulated that the most 
facile reaction development would be achieved if the malononitrile functionality of the 
previously utilized MAC nucleophile 67c was kept intact and the α-substitution were not 
more sterically demanding than the MOM group. Indeed, our previously reported 
conditions for the synthesis of α-quaternary carboxylic acid derivatives using MAC 
reagent 67c translated directly to the reaction of methylmalononitrile (155, R1 = Me) with 
trisubstituted allylic electrophile 156, though the enantioselectivity was low (Scheme 














      (88% yield)
i. CSA, AcOH/DME
ii. pyrrolidine, Et3N
       (61% yield)
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selectivity, we explored the effect of base on our current reaction. Ultimately, DABCO 
was revealed to be uniquely effective for this transformation, providing products 157 
bearing vicinal all-carbon quaternary centers in moderate to good yields and excellent 
enantioselectivities for a variety of substituted malononitrile nucleophiles 155 and 
trisubstituted allylic electrophiles 156. At this time, we believe that the DABCO increases 
the enantioselectivity of the transformation by allowing for increased equilibration 
between diastereomers of an iridium π-allyl complex by slowing the rate of nucleophilic 
attack.18,33 
 
Scheme 5.7 Synthesis of vicinal all-carbon quaternary centers 157 via enantioselective iridium-
catalyzed allylic alkylation 
 
 
As we are inspired and driven by the application of our methods in complex 
molecule synthesis, we sought to demonstrate the feasibility of chemoselective 
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157 can either be chemoselectively reduced or oxidized via ozonolysis. Furthermore, 
multistep procedures can be utilized to prepare densely-functionalized compounds 
bearing two contiguous all-carbon quaternary stereocenters, such as 103 and 104. 
 
Figure 5.8 Product derivatizations of iridium-catalyzed allylic alkylation products 157 bearing vicinal 




[a] RhCl(PPh3)3, H2 (balloon), benzene, 23 °C, 18 h, 92% yield; [b] O3, pyridine, CH2Cl2, –78 °C, 4 min, 93% yield; [c] i. O3, 
pyridine, CH2Cl2, –78 °C, 4 min, ii. p-TsOH, benzene, reflux, 18 h, 47% yield; [d] NaOH, EtOH/H2O (1:1), 60 °C, 18 h, 38% 
yield, 1:11 dr; [e] i. O3, MeOH, –78 °C, 0.5 h, ii. NaBH4, 0 °C, 3 h, 65% yield, 1:2.5 dr. 
 
5.5   CONCLUSIONS AND FUTURE OUTLOOK 
Building on our group’s longstanding interest in the synthesis of enantioenriched 
quaternary stereocenters, we have sought to expand the limits of iridium-catalyzed allylic 
alkylation chemistry to encompass the synthesis of sterically congested all-carbon 
quaternary stereocenters. Initially, we focused on the development of enantio- and 
diastereoselective iridium-catalyzed allylic alkylation technology for the construction of 
vicinal tertiary and all-carbon quaternary stereocenters. Our work has enabled the use of 
both cyclic and acyclic nucleophiles, as well as alkyl-substituted allylic electrophiles in 
this methodology. We then shifted our attention to umpolung strategy iridium-catalyzed 



























R1 = Me R1 = Me
R1 = CH2CH2C(O)MeR1 = Me
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study of the umpolung chemistry led to the synthesis of allylic quaternary stereocenters 
via the use of trisubstituted allylic electrophiles in conjunction with a Lewis acid co-
catalyst. Most recently, we have discovered iridium-catalyzed allylic alkylation 
technology that provides access to vicinal all-carbon quaternary centers. 
Despite these advances by our group, as well as beautiful work from other groups 
in the area,13,21 this emerging field is not without limitations. While there have been 
extensive advances to widen the substrate scope with respect to the nucleophile partner, 
the allylic electrophile remains largely limited to aryl- and alkenyl-substitution, aside 
from our reported method for the use of crotyl chloride as an electrophile.20 Most 
importantly though, no general method for iridium-catalyzed allylic alkylation exists. As 
demonstrated vide supra, even minor changes to either the nucleophile or electrophile 
partner necessitate complete reoptimization of the reaction parameters. Ideally, a single 
catalyst system will be developed in the future which enables highly selective iridium-
catalyzed allylic alkylation reactions for any combination of nucleophile and electrophile.  
In looking forward, we envision that the field will shift its attention to the 
development of enantio- and diastereoselective iridium-catalyzed allylic alkylation for 
the synthesis of vicinal all-carbon quaternary stereocenters; a highly challenging motif to 
access that has also become a holy grail for many other areas of synthetic methodology. 
We hope that our recent work on the synthesis of vicinal quaternary centers will inspire 
and enable these studies. Ultimately, we look forward to a time when the broader 
synthetic community embraces iridium-catalyzed allylic alkylation as an enabling and 
reliable technology for the synthesis of complex targets.  
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A Catalytic, Enantioselective Formal Synthesis of (+)-Dichroanone  
and (+)-Taiwaniaquinone H† 
 
 
A8.1   INTRODUCTION 
First isolated in 1995, the taiwaniaquinoid natural products are a family of 
tricyclic diterpenoids with a unique [6,5,6]-abeo-abietane skeleton (158–164, Figure 
A8.1).1 Since their isolation, the taiwaniaquinoids have attracted significant attention 
from the synthetic community, resulting in a multitude of total and formal syntheses.2 
Interest in these compounds stems from their reported biological activity,3 in addition to 
their unique architecture containing a benzylic quaternary stereocenter. Due to the limited 
number of methodologies capable of installing benzylic quaternary stereocenters, only 
four catalytic, enantioselective syntheses of taiwaniaquinoids have been published to 
date.2e,m,q,t  	†	This work was performed in collaboration with Dr. Jeffrey C. Holder. Portions of this chapter have been 
reproduced with permission from Shockley, S. E.;‡ Holder, J. C.;‡ Stoltz, B. M. Org. Lett. 2014, 16, 6362–
6365 © 2014 American Chemical Society and Shockley, S. E.; Holder, J. C.; Stoltz, B. M. Org. Process 
Res. Dev. 2015, 19, 974–981 © 2015 American Chemical Society. 
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Figure A8.1 Taiwaniaquinoid natural products 
 
Our laboratory has a longstanding interest in the development of methods for the 
enantioselective synthesis of quaternary stereocenters and the application of these 
technologies to the synthesis of natural product targets. In 2006, our group reported the 
first catalytic, enantioselective total synthesis of (+)-dichroanone (159) via 
enantioselective palladium-catalyzed allylic alkylation (Scheme A8.1).2e This work 
featured a linear synthetic sequence, elaborating palladium-catalyzed allylic alkylation 
product 166 to bicyclic enone 165 by Wacker oxidation and subsequent aldol 
condensation. The final ring was appended by another aldol condensation, and a novel 
series of oxidations provided the natural product in only 11 steps.  
 















(+)-taiwaniaquinone A (R = H) (162)
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In 2011, the Stoltz group disclosed the first enantioselective palladium-catalyzed 
conjugate addition methodology to form quaternary stereocenters in high yields and 
enantioselectivities (Figure A8.2, top).4 Following this report, we recognized that the β-
aryl ketone motif found in these conjugate addition products 169 mapped onto the 
scaffold of the taiwaniaquinoid terpene natural products, and we envisioned that a more 
convergent synthesis of these natural products could be achieved by employing β-aryl 
ketone 170 as the key intermediate (Figure A8.2, bottom). This modified retrosynthetic 
analysis facilitates a highly convergent, catalytic, enantioselective key step that brings 
together 13 of the 19 carbon atoms of the taiwaniaquinoid tricyclic core, including the 
quaternary stereocenter, in a single chemical transformation. Herein, we discuss the 
rational design of high-yielding and highly enantioselective conjugate addition reactions 
of arylboronic acids that facilitate the catalytic, enantioselective formal synthesis of (+)-
taiwaniaquinone H (158) and (+)-dichroanone (159) in >99% ee. 
 
Figure A8.2 Stoltz group conjugate addition chemistry as inspiration for revised retrosynthetic 
analysis of (+)-taiwaniaquinone H (158) and (+)-dichroanone (159) 
 
 
R = H, (+)-dichroanone (159)
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A8.2  BACKGROUND TO THE STOLTZ GROUP’S ENANTIOSELECTIVE 
PALLADIUM-CATALYZED CONJUGATE ADDITION CHEMISTRY 
A8.2.1  INTRODUCTION TO ENANTIOSELECTIVE TRANSITION METAL-
CATALYZED CONJUGATE ADDITION CHEMISTRY 
Enantioselective conjugate addition has become a powerful synthetic tool for the 
assembly of structurally complex molecules. 5  Recently, new developments in this 
transformation have served as solutions to the persistent challenge of the catalytic, 
enantioselective synthesis of all-carbon quaternary stereocenters (Scheme A8.2). 6  To 
date, copper catalysis has dominated the field of enantioselective conjugate addition, 
however, these copper-catalyzed methods require the use of highly reactive 
organometallic reagents (e.g., diorganozinc, 7  triorganoaluminum, 8  and 
organomagnesium 9  reagents). Thus, these reactions typically necessitate rigorously 
anhydrous reaction conditions and often operate at cryogenic temperatures. Alternatively, 
chiral rhodium catalysts in combination with air-stable, easily handled organoboron 
reagents have been shown to produce a wide array of conjugate addition adducts in very 
high yield and enantiomeric excess.10,11,12 Although extremely effective, these rhodium 
catalysts are expensive, air-sensitive, and many of the most widely used precatalysts are 
not commercially available. Additionally, rhodium-catalyzed conjugate additions to form 
quaternary stereocenters require boroxine or tetraarylborate reagents rather than widely 
available arylboronic acids. Furthermore, large excesses of the boron reagents are 
necessary to drive the reactions to completion. These factors diminish the appeal of such 
rhodium-catalyzed methods in complex molecule synthesis where custom aromatic units 
are often desired and thus the arene material is of high value.8,13 
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Scheme A8.2 Enantioselective transition metal-catalyzed conjugate addition 
 
 
Palladium-catalyzed conjugate addition reactions are less developed than those 
using copper and rhodium but offer significant advantages. For example, palladium-
catalyzed conjugate addition reactions utilize commercially available, air-stable, and 
functional group-tolerant boron nucleophiles. Furthermore, the reactions are typically not 
sensitive to water or oxygen. Together, these features comprise an operationally simple 
and robust transformation.14 At the time the Stoltz group began our work in this area, 
there were only examples of the enantioselective synthesis of tertiary stereocenters in the 
palladium literature and a single report of the synthesis of quaternary stereocenters, albeit 
as a racemate.15 It was not until our report in 2011 that a palladium-derived catalyst was 
employed to construct an enantioenriched quaternary stereocenter via conjugate addition 
methodology.4a Subsequent to our studies, similar palladium-catalyzed conjugate 
additions to forge quaternary stereocenters were reported by Minnaard and de Vries16 as 
well as Stanley.17 
 
A8.2.2  INITIAL DISCOVERIES 
Our initial studies involved the enantioselective conjugate addition of arylboronic 
acids to β-substituted carbocyclic enones to generate benzylic all-carbon quaternary 
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methylcyclohexen-2-one (167) with phenylboronic acid (174, Scheme A8.3). Building on 
the precedent for bidentate, dinitrogen ligands in conjugate addition chemistry,15,18 we 
found that a catalyst formed in situ from the combination of Pd(OCOCF3)2 and the chiral 
pyridinooxazoline ligand, (S)-t-BuPyOx (L14), 19  proved effective in forming β-
quaternary ketone product 175 in high yield and enantioselectivity. Many other ligands 
were examined in the course of our studies but none provided the high selectivities 
observed with t-BuPyOx (L14). Further optimization revealed that polar, coordinating 
solvents hindered the reaction while non-polar solvents provided higher conversions and 
superior enantioinduction. Ultimately, we found that 1,2-dichloroethane allowed for the 
fastest reaction times (12–24 h) with minimization of side product formation. 
Furthermore, we were pleased to find that the amount of phenylboronic acid could be 
reduced to 1.1 equivalents with no detrimental effect on the reactivity other than 
increased reaction times.  
 




Based on control studies, we found the reaction to be insensitive to adventitious 
moisture and air atmosphere as neither the high yield nor enantioselectivity were 
impacted upon addition of water (up to 10 equivalents) and no improvements were noted 
under inert gas atmospheres. Therefore, the reactions may be conducted under ambient 
O
L3  (6 mol %)
Pd(OCOCF3)2 (5 mol %)
ClCH2CH2Cl
60 °C, 12 h
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air in screw-top vials without the need for purification or distillation of any commercially 
obtained materials. Moreover, the optimal chiral ligand, (S)-t-BuPyOx (L14), can be 
expediently prepared on relatively large scale in two steps from readily available starting 
materials.20  
Gratifyingly, a wide range of arylboronic acids and enones undergo highly 
enantioselective reactions under the developed conditions (Table A8.1). With respect to 
the nucleophile scope, para-substituted arylboronic acids are well tolerated. Alkyl-
substituted arylboronic acids react with good yields and enantioselectivities to give 
products such as 4-methyl- and 4-ethyl-substituted ketones 177a and 177b. However, we 
noted a distinct electronic trend on selectivity, wherein electron-rich nucleophiles tend to 
furnish more modest yields and enantioselectivities (177c, 177d, and 177h). Conversely, 
arylboronic acids bearing electron-withdrawing substituents produce ketone products in 
excellent enantioselectivities. Specifically, the electron-poor substitution can include 
carbonyl (177e), trifluoromethyl (177f) or halide (177g) functional groups. Additionally, 
reactions involving meta-substituted nucleophiles fare well with alkyl (177i), ester (177j), 
halide (177k), or even nitro groups (177l) on the arylboronic acid. Notably, substituents 
at the 2-position of the arylboronic acid result in slower reactions and furnish diminished 
yields of the ketone products in low enantioselectivity (e.g., 2-methylphenylboronic acid 
results in 13% of its corresponding product in 22% ee). These ortho-arylboronic acid 
substrates react with higher yields and enantioselectivities in the palladium-catalyzed 





Appendix 8 – A Catalytic, Enantioselective Formal Synthesis of (+)-Dichroanone  
and (+)-Taiwaniaquinone H             
  
Table A8.1 Scope of arylboronic acid and enone conjugate acceptorsa 
 
[a] Reactions performed with arylboronic acid (0.50 mmol), cycloalkenone (0.25 mmol), Pd(OCOCF3)2 (5 mol %), and L14 (6 
mol %) in ClCH2CH2Cl (1 mL) at 60 °C for 12 h. [b] Isolated yield. [c] Determined by chiral HPLC. 	
Cyclic enones of different ring sizes, and with a range of β-substitution, react to 
afford enantioenriched β-quaternary ketone products (Table A8.1). Cyclohexanone 
products bearing both linear (177o–q) and branched β-substituents (177r and 177s) as 
L14 (6 mol %)
Pd(OCOCF3)2 (5 mol %)
ClCH2CH2Cl
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well as functionalized side chains (177t) are formed in good to excellent yields and 
selectivity from their corresponding substituted Michael acceptors. Moreover, altering the 
ring size has no deleterious effect on reactivity and furnishes products with five- (177m) 
or seven-membered (177n) cycloalkanones in high yields and enantioselectivity. To the 
best of our knowledge, this represents the first example of a single catalyst system that 
successfully constructs quaternary stereocenters via enantioselective conjugate addition 
to 5-, 6-, and 7-membered enones.  
 
A8.2.3  FURTHER REACTION DEVELOPMENT 
Following our initial communication of the construction of quaternary 
stereocenters by enantioselective palladium-catalyzed conjugate addition,4a we sought to 
further generalize the substrate scope, reduce the catalyst loading, and lower the reaction 
temperature.4b While we noted that the addition of water had no deleterious effect in our 
initial report, we did not consider adventitious water to be a crucial component. Thus, it 
came as a surprise when attempts to perform the reaction on large scale failed to fully 
convert enone 167 to product ketone 175. We rationalized that, on small scale, the 
moisture in the air and on the glassware provided sufficient water to drive the reaction to 
completion, however, on larger scale this trace moisture was insufficient. Analysis of the 
balanced equation for the overall transformation indicated that the addition of water is 
necessary to achieve catalyst turnover (Scheme A8.4). Thus, we found that the addition of 
5 equivalents of water to the reaction mixture restored the reactivity when performing 
reactions on multi-gram scale. To date, reactions as large as 35 mmol scale have been 
successfully conducted.  
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Examination of deuterium incorporation in the product ketone supported our 
hypothesis of water’s role in catalyst turnover. In reactions performed with deuterium 
oxide in place of water, we found significant deuterium incorporation at the α-methylene 
position of the carbonyl. This observation was true in reactions run to low conversion as 
well. These experiments, in combination with the scalability problems encountered 
without water as an additive, suggested that water is the reagent assisting turnover, rather 
than the boron nucleophile (Scheme A8.4). 
Based on literature reports detailing palladium-catalyzed conjugate addition 
employing cationic or dicationic precatalysts possessing weakly coordinating anions 
(PF6¯, SbF6¯, BF4¯, etc.),14 we sought to evaluate the effect of salt additives on the 
reaction rate with the hope of achieving milder reaction conditions (Table A8.2). At 40 
°C, with no additives, the addition of phenylboronic acid to 3-methylcyclohexenone 
(167) is very slow and rarely goes to full conversion before the catalyst decomposes. At 
this same temperature, we observed that the addition of strongly coordinating anions 
(e.g., chloride, entry 1) shutdown the reaction while sodium salts with weakly 
coordinating anions greatly enhanced the reaction rate, albeit with diminished 
enantioselectivity (e.g., NaPF6, entry 2). Other additives required extended reaction times 
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coordinating counterions revealed that NH4PF6 gave the optimal combination of short 
reaction time with minimized loss of enantioselectivity (entry 4). We posit that these 
additives alter the catalyst resting state and result in a larger percentage of dissolved 
palladium species in the catalytic cycle.  
 
Table A8.2 Effect of additives on reaction rate, yield, and enantioselectivitya 
 
[a] Reactions performed with phenylboronic acid (0.5 mmol), 167 (0.25 mmol), NH4PF6 (30 mol %), water (5 equiv), 
Pd(OCOCF3)2 (5 mol %), and L14 (6 mol %) in ClCH2CH2Cl (1 mL) at 40 °C. [b] GC yield utilizing tridecane standard. [c] 
Determined by chiral HPLC. 	
Incorporation of the optimized additives (5 equivalents water, 30 mol % NH4PF6) 
into the reaction conditions allowed for reactions to be conducted at decreased 
temperatures (23–40 °C) and significantly broadened the substrate scope. Many of the 
previously studied substrates that contained temperature-sensitive functionalities (e.g., 
silyl ethers) or groups that may react with trace palladium(0) formed by off-cycle 
pathways (e.g., arylbromides) afforded higher desired product yields under the modified 
conditions. For example, ketones 177k, 181a, 177l, and 181b were obtained in nearly 
double the yield under the new conditions (Table A8.3). Furthermore, at 40 °C the 
combination of additives allowed catalyst loadings of only 2.5 mol % of palladium and 3 
mol % of ligand for most reactions. Moreover, the additives facilitated the reactions of 
PhB(OH)2 (2 equiv)L14 (6 mol %)
Pd(OCOCF3)2 (5 mol %)
H2O (5 equiv)
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two new substrate classes: (1) β-acyl cyclic enones and (2) arylboronic acids containing 
nitrogen substituents. We were pleased to note that β-acyl enone substrates provided 
access to enantioenriched 1,4-dicarbonyl compounds, with only the olefin insertion 
process forming the quaternary stereocenter observed (181c–f), as opposed to the 
isomeric insertion products that would afford tertiary stereocenters. We also observed that 
aniline-derived boronic acid substrates protected with a trifluoroacetyl group did not 
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Table A8.3 Expanded substrate scope with improved reaction conditionsa 
 
[a] Blue font: reported yield and ee of the product in the absence of NH4PF6 and water, with reactions performed at 60 °C. 
Red font: yield and ee of the product with additives. Conditions: reactions were performed with arylboronic acid (1.0 mmol), 
cycloalkenone (0.5 mmol), NH4PF6 (30 mol %), water (5 equiv), Pd(OCOCF3)2 (5 mol %), and L14 (6 mol %) in ClCH2CH2Cl 
(2 mL) at 40 °C. [b] Isolated yield. [c] Determined by chiral HPLC. 
 
A8.2.4  MECHANISTIC HYPOTHESIS 
Studies have been conducted to elucidate the catalytic cycle active in our 
enantioselective conjugate addition chemistry.4b A range of Lewis and π-acidic metal salts 
were substituted for palladium with no product observed, signifying that palladium-
catalyzed conjugate addition is not a Lewis acid-catalyzed process. The reaction proceeds 
Pd(OCOCF3)2 (5 mol %)L3 (6 mol %)
NH4PF6 (30 mol %)
H2O (5 equiv)
ClCH2CH2Cl
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177k
55% yield, 97% ee
96% yield, 96% ee
181a
44% yield, 86% ee
84% yield, 84% ee
177l
40% yield, 92% ee
81% yield, 91% ee
181b
32% yield, 77% ee
70% yield, 77% ee
Cl Br NO2 F
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in the presence of mercury drops, which would poison a heterogeneous catalyst, 
indicating that a soluble complex likely catalyzes the reaction. Furthermore, a nonlinear 
effect study supported the action of a single, monomeric ML-type catalyst as the 
kinetically relevant species (Figure A8.3).21 The linear relationship between catalyst ee 
and product ee argues against the kinetic relevance of palladium/ligand dimers in 
solution, as opposed to some catalysts that are known to aggregate in reservoirs.15,22  
 
Figure A8.3 Linear relationship of catalyst ee to product ee  
 
Density functional theory (DFT) calculations, performed in collaboration with the 
Houk laboratory, support the cationic catalytic cycle shown in Figure A8.4.4b, 23  We 
postulate that the active catalyst is a cationic palladium(II) hydroxide species, which are 
known to undergo rapid transmetallation with arylboronic acids without added base.24 We 
envision that arylpalladium 183 forms by transmetallation of the arylboronic acid with 
cationic catalyst 182. Substrate association via the carbonyl yields an equilibrating 
mixture of carbonyl-bound complex 184 and olefin-bound complex 185. C-bound enolate 
188 is the initial product of alkene insertion into the aryl C–Pd bond. Notably, this 
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insertion is calculated to be both the enantiodetermining and turnover-limiting step of the 
catalytic cycle. Subsequent isomerization to O-bound tautomer 187 followed by 
protonation affords the product ketone and regenerates the catalyst (182).25 This proposed 
mechanism was experimentally substantiated by a recent collaboration with the Zare 
laboratory in which arylpalladium cation 183 and enone complex 184/185 were identified 
by DESI-MS monitoring of the reaction mixture.26 No intermediates occurring after the 
predicted turnover-limiting step were observed. The observation of enone-arylpalladium 
complex 184 for a variety of arylboronic acid substrates led us to hypothesize that 
complex 184 may be the resting state. The enantiodetermining alkene insertion step 
involves a four-membered cyclic transition state, with the lowest energy diastereomer 
calculated to be transition state 186a, which leads to the observed (R)-product. 
Diastereomer 186a is the most stable as the bulky t-Bu group on the ligand points away 
from the substrate. Analysis of the effects of substituents on the ligand at the 4-position of 
the oxazoline revealed that replacing the t-Bu functionality with smaller groups, such as 
i-Pr, i-Bu, or Ph, significantly reduced the selectivity. If instead the oxazoline is 
substituted at the 5-position practically no enantioselectivity is afforded. Electronic 
perturbation of the pyridine moiety of the ligand did not erode enantioselectivity, though 
rates were greatly changed. Therefore, enantioselectivity is primarily attributed to the 
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Figure A8.4 Proposed catalytic cycle for the enantioselective conjugate addition of arylboronic acids 
to cyclic enones catalyzed by the combination of Pd(OCOCF3)2 and (S)-t-BuPyOx (L14) 	
 
	
Transition state calculations suggested that stereocontrol predominantly arises 
from the repulsion of the α’-methylene hydrogens on the cyclohexenone substrate with 
the ligand (Figure A8.5). In the disfavored diastereomeric transition state (186b), these 
atoms are only 2.3 Å apart and thus incur a significant energetic penalty. Consequently, 
replacing the CH2 group with an oxygen atom (e.g., lactone 189, Figure A8.5) decreases 
the energy difference between the two diastereomeric transition states and leads to an 
observed decrease in enantioselectivity from 93% ee to 57% ee. Of note, α,β-unsaturated 
lactone substrates afford high enantioselectivity in the enantioselective palladium-
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Figure A8.5 Calculated transition states and effect of α’-substituents on enantioselectivity 
 
 
A8.2.5  HETEROCYCLIC ACCEPTORS 
We wished to extend our conjugate addition methodology to the synthesis of 
stereochemically complex heterocyclic molecules. We found that the palladium-catalyzed 
conjugate addition of arylboronic acids to chromones and 4-quinolones delivered tertiary 
stereocenters in high yield and enantioselectivities across multiple heterocyclic scaffolds 
with a wide range of arylboronic acids (Table A8.4).4c While chromones27 ,28  and 4-
quinolones29 have been successfully employed in rhodium-catalyzed conjugate addition, 
to our knowledge, these are the first examples of enantioselective transition metal-
catalyzed conjugate additions to chromones and 4-quinolones using either palladium 
catalysis or arylboronic acid nucleophiles.30   
Overall, a total of 38 adducts were prepared in moderate to excellent yield and 
high enantioselectivity. Furthermore, the stability of the reaction components to air and 























Appendix 8 – A Catalytic, Enantioselective Formal Synthesis of (+)-Dichroanone  
and (+)-Taiwaniaquinone H             
  
bearing heterocyclic substitution (192c), free phenolic groups (192d), and N-substituted 
arenes (192b and 192f) could be obtained via the conjugate addition methodology. 
 
Table A8.4 Enantioselective conjugate addition of arylboronic acids to heterocyclic conjugate 
acceptorsa 
 
[a] Reactions performed with arylboronic acid (0.50 mmol), heterocyclic acceptor (0.25 mmol), NH4PF6 (30 mol %), water (5 
equiv), Pd(OCOCF3)2 (5 mol %), and L14 (6 mol %) in ClCH2CH2Cl (1 mL) at 60 °C for 12 h. [b] Isolated yield. [c] 
Determined by chiral HPLC.  
 
A8.3  RETROSYNTHETIC ANALYSIS 
The formal synthesis of (+)-taiwaniaquinone H (158) and (+)-dichroanone (159) 
provided an optimal forum for demonstrating the breadth and generality of our 
aforementioned palladium-catalyzed conjugate addition chemistry. Our preliminary 
L14 (6 mol %)
Pd(OCOCF3)2 (5 mol %)
NH4PF6 (30 mol %)
H2O (5 equiv)
ClCH2CH2Cl
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strategic disconnections of (+)-taiwaniaquinone H (158) and (+)-dichroanone (159) 
involved late stage introduction of the gem-dimethyl functionality and oxidation of the C-
ring of enone 193 to the quinone (Figure A8.6).31,2f In turn, the B-ring of tricycle 193 was 
envisioned to be established through ortho-formylation of phenol 194 and subsequent 
aldol condensation. Finally, we anticipated that the all-carbon quaternary stereocenter 
could be constructed by enantioselective palladium-catalyzed conjugate addition of 3-
methyl-2-cyclohexenone (167) with an appropriate arylboronic acid 195.4 
 
Figure A8.6 Planned retrosynthesis of (+)-taiwaniaquinone H (158) and (+)-dichroanone (159) 
 
 
A8.4  FIRST GENERATION ROUTE 
We first selected para-acetylphenylboronic acid 199 (Scheme A8.5) as our 
conjugate addition substrate. In our previous work we noted that electron-withdrawing 
substituents at the para-position of the arylboronic acid often afforded highly 
enantioenriched β-quaternary ketone products.4 A plot of the enantiomeric ratio versus the 
Hammett value (σp) for a variety of para-substituted phenylboronic acids demonstrates a 
strong positive linear correlation, R2 = 0.92 (Figure A8.7).32 The positive value of ρ 
194
193R
3 = Me, (+)-taiwaniaquinone (158)
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(0.81) suggests that the difference in energy between the diastereomeric transition states 
leading to the enantiomeric (S) and (R) products increases as the boronic acid becomes 
increasingly electron deficient. Thus, the best selectivity in the conjugate addition 
reaction is achieved with electron-withdrawing substituents in the para-position. 
Therefore, we chose to mask the isopropyl group as a methyl ketone to achieve a 
selective conjugate addition reaction.  
 
Figure A8.7 Hammett plot of log10(er) vs σp for select boronic acids in the palladium-catalyzed 
conjugate addition reaction 
 
 
Access to para-acetylphenylboronic acid 199 began with acylation of 2,6-
dihydroxyacetophenone (196) with pivaloyl chloride to provide arene 197 (Scheme 
A8.5). Installation of the boryl substituent was accomplished through an iridium-
catalyzed C–H borylation.33 This reaction provided pinacol boronate ester 198 as the 
exclusive product in 89% yield. Empirically, we identified that protecting the meta-
hydroxyl substituents with pivalate groups allowed for the highest yields in this 
borylation chemistry. After exhaustive exploration of deprotection conditions, we found 
























y = 0.8058x + 1.3096 R2=0.92
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that treatment with diethanolamine and subsequent acid-catalyzed hydrolysis of the 
transesterified intermediate afforded arylboronic acid 199 in 92% yield.34 Boronic acid 
199 was treated with 3-methyl-2-cyclohexenone (167) in the presence of Pd(OCOCF3)2, 
(S)-t-BuPyOx (L14), and NH4PF6 at 50° C to afford enantioenriched ketone 169b in 93% 
yield and 94% ee.4b   
 
Scheme A8.5 Synthesis of acetyl conjugate addition product 169b 	
 
	
With ketone 169b in hand, we turned our attention to the installation of the final 
carbon of the tricyclic core and completion of the B-ring. Regrettably, attempts to 
formylate arene 169b were unsuccessful. We rationalized that the sterically congested 
environment surrounding the arene C–H bonds prohibited installation of a functional 
group handle. Moreover, deprotection of the hydroxyl groups of ketone 169b was not 
facile, and required treatment with LiSEt to cleanly remove both pivaloyl groups and 
afford what we predicted to be resorcinol 200 (Scheme A8.6). Though HRMS data 
matched the molecular formula of desired resorcinol 200, the 1H NMR spectra did not 
OH







2. 0.1 M HCl, CH2Cl2, 23 °C
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match that of a typical β-quaternary ketone conjugate addition product. We suspected that 
an unproductive cyclization may have occurred and sought to crystallize derivatives of 
ketone 202 to confirm the new structure by single crystal X-ray diffraction. Bromination 
and methylation of compound 202 provided bromoarene 203 as a white crystalline solid. 
As we suspected, a cyclization had occurred and the structure proved to be [3.2.1]bicycle 
203. Thus, we were able to properly assign the structures of cyclization product 202 and 
arene bromination adduct 203. This X-ray structure also confirms the absolute 
stereochemistry imparted in enantioselective conjugate addition reactions of arylboronic 
acids to cyclic conjugate acceptors facilitated by the catalyst derived from the 
combination of (S)-t-BuPyOx (L14) and Pd(OCOCF3)2.  
 
Scheme A8.6 Unexpected cyclization of phenolic intermediatea 
 
[a] DBDMH = 1,3-dibromo-5,5-dimethylhydantoin 	
Cyclizations of β-aryl ketones to form [3.2.1] bicycles are rare; the few other 
reports of this transformation require treatment with strong Lewis35 or Brønsted acids36 at 
elevated temperatures. These reactions presumably operate via an electrophilic aromatic 
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similar mechanism, we did not observe cyclization with substrates bearing protected 
phenols, which suggests that the hydroxyl group or phenoxide may be involved in the 
cyclization mechanism. This observation led us to propose that this unexpected 
cyclization may instead occur through a carbonyl ene or lithium phenoxide aldol reaction 
pathway. 
 
A8.5  SECOND GENERATION ROUTE 
As we were unable to functionalize ketone 169b without causing the undesired 
cyclization, we decided to redesign the arylboronic acid substrate and began examining 
alternative conjugate addition reactions. Removing the acetyl group would obviate the 
need to differentiate the benzylic carbonyl from the cyclic ketone while installing the 
requisite isopropyl group in the first-generation conjugate addition product 169b. We 
envisioned that a para-halogenated arylboronic acid derivative would allow for facile 
installation of the isopropyl group via cross-coupling chemistry. Additionally, based on 
our Hammett plot analysis, we posited that the para-halide would serve as a necessary 
para-electron-withdrawing group to impart high enantioselectivity in the palladium/L14 
conjugate addition chemistry (Figure A8.7).4 Gratifyingly, we found that use of these 
boronic acids furnished products bearing para-iodo (169c), para-bromo (169d), and 
para-chloro (169e) arenes in high enantioselectivity and moderate to high yields (Table 
A8.5).  
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Table A8.5 Identification of a suitable conjugate addition systema 
 
[a] Reactions performed with boronic acid (1.5 equiv), 167 (1 equiv), NH4PF6 (30 mol %), water (5 equiv), Pd(OCOCF3)2 (5 
mol %), and L14 (6 mol %) in ClCH2CH2Cl at 50 °C for 12 h. [b] Isolated yield. [c] Determined by chiral HPLC or SFC. 	
We consequently pursued a revised approach to the natural products via 
bromoarene 169d, selected both for its superior reactivity in palladium-catalyzed 
conjugate addition chemistry and facile cross-coupling ability. To access this 
intermediate, 2-bromoresorcinol 204 was converted to para-bromophenyl boronic acid 
derivative 207 in 73% yield over four steps (Scheme A8.7). Subsequent catalytic, 







L14  (6 mol %)
Pd(OCOCF3)2 (5 mol %)
NH4PF6 (30 mol %)
H2O (5 equiv)
ClCH2CH2Cl
50 °C, 72 h
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Scheme A8.7 Synthesis of para-bromo conjugate addition product 169d 
 	
Having installed the quaternary stereocenter, we next sought to append the 
isopropyl group. Attempts to directly cross-couple an isopropyl zinc reagent with 
bromide 169d gave an inseparable mixture of iso- and n-propyl products.37 The steric 
hindrance of the nearby pivaloyl groups thwarted our attempts to cross couple 169d with 
isopropenyl organometallic regents, but we ultimately achieved success using Molander’s 
protocol for Suzuki-Miyaura couplings of potassium isopropenyltrifluoroboronate salts.38 
Our optimized conditions (170 °C, 1 h, microwave) gave a crude mixture of both cross 
coupled product and mono-deprotected cross coupled product that could be stirred with 






































CH2Cl2, 0 °C → 23 °C
PivCl, DMAP, NEt3
2. 0.1 M HCl, CH2Cl2, 23 °C
(82% yield, 2 steps)
1. diethanolamine, EtOAc
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Scheme A8.8 Isopropenyl cross-coupling 
 
With a route to mono-deprotected arene 208 established, we turned our efforts 
once more toward the formation of the B-ring. However, despite the successful removal 
of one pivaloyl group, the system proved resistant to a number of metal and non-metal 
mediated ortho-formylations, directed ortho-metalations, and halogenations, regardless of 
protection of the ketone. We speculate that the failure of these efforts may again be 
attributed to the formidable steric environment of the arene C–H bonds.  
Recognizing that significant steric hindrance would prevent the formation of the 
B-ring, we sought to diminish the steric environment of the arene by reductive removal of 
the free phenol. Activation of phenol 208 by exposure to excess perfluorobutanesulfonyl 
fluoride led to the generation of nonaflate 209 in 80% yield (Scheme A8.9). Subsequent 
hydrogenation with Pd/C simultaneously cleaved the nonaflate and reduced the 
isopropenyl functionality to afford isopropyl arene 210 in 72% yield. 39  Finally, the 
pivaloyl group was replaced with a methyl group by one pot deprotection and 
methylation with LiSEt and Me2SO4 to provide ketone 169f in 83% yield. With the less 
substituted arene 169f in hand, we believed that the necessary tricycle could now be 
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Scheme A8.9 Synthesis of key intermediate 169f   
 
 
Concurrent with our synthetic efforts, Qin and coworkers reported a formal total 
synthesis of (+)-taiwaniaquinone H (158) and (+)-dichroanone (159) via enantioselective 
conjugate addition of (4-isopropyl-3-methyloxyphenyl)boronic acid to 3-methyl-2-
cyclohexenone (167) in 85% yield and 85% ee (169f, Table A8.5) using the catalyst 
developed in our laboratory.2t,4a However, Qin was unable to optimize the conjugate 
addition substrates to achieve yields or enantioselectivities over 85%. This result aligns 
well with our Hammett plot analysis; the determined linear relationship predicts an 
enantioselectivity of 88% for the electron-donating isopropyl group (Figure A8.7). 
Moreover, this study demonstrated that our common intermediate 169f could be further 
transformed into the taiwaniaquinoid tricyclic skeleton by ortho-formylation followed by 
aldol condensation. Therefore, our synthesis of ketone 169f in >99% ee constitutes 
a formal synthesis of (+)-taiwaniaquinone H (158) and (+)-dichroanone (159) in the 
highest reported enantioselectivity to date. 
 
H2 (1 atm), Pd/C
Et3N, MeOH, 65 °C
NfF, DMAP
Et3N, CH2Cl2, 23 °C
LiSEt, DMF/THF
0 °C → 45 °C












R = H, (+)-dichroanone (159)
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A8.6  CONCLUSIONS 
In summary, we have completed the formal catalytic, enantioselective total 
syntheses of (+)-taiwaniaquinone H (158) and (+)-dichroanone (159) in 35% overall 
yield, starting from commercially available 2-bromoresorcinol (204). Investigation of 
electronic effects of arylboronic acid substituents on enantioselectivity enabled the 
rational design of a highly enantioselective reaction that furnished established 
intermediate 169f in exceptionally high yield and enantioselectivity. Additionally, an 
unexpected cyclization to form a [3.2.1] bicycle permitted the unambiguous 
determination of the absolute stereochemistry of the quaternary stereocenter installed by 
the palladium/L14-catalyzed conjugate addition reaction by X-ray diffraction analysis.  
 
A8.7  EXPERIMENTAL SECTION 
A8.7.1  MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried 
by passage through an activated alumina column under argon.  Triethylamine was 
distilled over CaH2 prior to use. Purified water was obtained using a Barnstead 
NANOpure Infinity UV/UF system. Chemicals were purchased from Sigma 
Aldrich/Strem/Alfa Aesar and used as received. Reaction temperatures were controlled 
by an IKAmag temperature modulator. Microwave-assisted reactions were performed in 
a Biotage Initiator 2.5 microwave reactor. Glove box manipulations were performed 
under a nitrogen atmosphere. Thin-layer chromatography (TLC) was performed using E. 
Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized by UV fluorescence 
494
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quenching or p-anisaldehyde staining. SiliaFlash P60 Academic Silica gel (particle size 
0.040–0.063 mm) was used for flash chromatography. 1H NMR spectra were recorded on 
a Varian Inova 500 MHz spectrometer or a Bruker Avance HD 400 MHz spectrometer 
and are reported relative to residual CHCl3 (δ 7.26 ppm) or (CH3)2SO (δ 2.50 ppm). 13C 
NMR spectra were recorded on a Varian Inova 500 MHz spectrometer and are reported 
relative to residual CDCl3 (δ 77.16 ppm), (CD3)2SO (δ 39.52 ppm) or (CD3)2CO (δ 29.84 
ppm). Data for 1H NMR are reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet, app = apparent. 
Data for 13C NMR are reported in terms of chemical shifts (δ ppm). IR spectra were 
obtained using a Perkin Elmer Paragon 1000 spectrometer using thin films deposited on 
NaCl plates and reported in frequency of absorption (cm-1). High resolution mass spectra 
(HRMS) were obtained from an Agilent 6200 Series TOF with Agilent G1978A 
Multimode source in mixed ionization mode (MultiMode ESI/APCI) or from a JEOL 
JMS-600H in fast atom bombardment (FAB+). Optical rotations were measured with a 
Jasco P-2000 polarimeter operating on the sodium D-line (589 nm), using a 100 mm 
pathlength cell, and are reported as [α]DT (concentration in g/100 mL, solvent). 
 
A8.7.1.1 Preparation of Known Compounds 
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A8.7.2  EXPERIMENTAL PROCEDURES AND SPECTROSCOPIC DATA 
A8.7.2.1 General Procedure and Spectroscopic Data for the Synthesis of 
Resorcinol Pivaloyl Esters 
 
2-Acetyl-1,3-phenylene bis(2,2-dimethylpropanoate) (197). An oven-dried 1 L round-
bottom flask was charged with a magnetic stir bar, 2,6-dihydroxyacetophenone (10 g, 
65.7 mmol, 1 equiv) and DMAP (800 mg, 6.57 mmol, 10 mol %). The flask was 
evacuated under vacuum and back-filled three times with argon. The solids were 
suspended in CH2Cl2 (450 mL), and NEt3 (23 mL, 165 mmol, 2.5 equiv) was added, at 
which time the solution became homogenous and a transparent, pale yellow color was 
observed. The reaction solution was cooled to 0 °C in an ice/water bath and pivaloyl 
chloride (17 mL, 138 mmol, 2.1 equiv) was added via mechanical syringe pump addition 
over the course of 2 h. Slow addition is essential to maintain an internal temperature of 
less than 5 °C and minimize formation of side products. Upon complete addition, the 
ice/water bath was removed and the reaction mixture was allowed to warm to ambient 
temperature. After 1 h, the starting material was consumed by TLC analysis (30% 
acetone/hexanes, stain p-anisaldehyde), and the reaction mixture was quenched with sat. 
NH4Cl (aq, 300 mL). The mixture was diluted with CH2Cl2 (400 mL) and transferred to a 
separatory funnel. The aqueous layer was extracted with CH2Cl2 (3 x 100 mL) and the 
combined organic extracts were washed with 1M HCl (3 x 100 mL) and brine (1 x 100 
mL), dried over Mg2SO4 and concentrated under reduced pressure. The crude mixture 
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acetone/hexanes) to afford pivaloyl 197 as a white, crystalline solid (19.73 g, 94% yield): 
1H NMR (500 MHz, CDCl3) δ 7.40 (t, J = 8.3 Hz, 1H), 6.99 (d, J = 8.2 Hz, 2H), 2.45 (s, 
3H), 1.32 (s, 18H); 13C NMR (125 MHz, CDCl3)  δ 198.7, 176.4, 147.9, 130.4, 128.6, 
120.1, 39.2, 31.7, 27.1; IR (Neat Film, NaCl): 3487, 3395, 2976, 2936, 2874, 1755, 1705, 
1611, 1576, 1478, 1457, 1397, 1368, 1274, 1251, 1233, 1117, 1101 cm-1; HRMS 
(MultiMode ESI/APCI-) m/z calc’d for C18H23O5 [M-H]-: 319.1551, found 319.1542.  
 
 
2-Bromo-1,3-phenylene bis(2,2-dimethylpropanoate) (205). White, crystalline solid 
(3.77 g, 95% yield): 1H NMR (500 MHz, CDCl3) δ 7.33 (t, J = 8.2 Hz, 1H), 7.00 (d, J = 
8.2 Hz, 2H), 1.40 (s, 18H); 13C NMR (125 MHz, CDCl3) δ 175.8, 149.9, 128.0, 120.9, 
111.4, 39.6, 27.4; IR (Neat Film, NaCl): 2971, 2934, 2972, 1762, 1586, 1479, 1460, 
1396, 1365, 1274, 1254, 1233, 1093, 1031, 884 cm-1; HRMS (MultiMode ESI/APCI+) 
m/z calc’d for C16H25BrNO4 [M+NH4]+: 374.0961, found 374.0960.  
 
 
2-Chloro-1,3-phenylene bis(2,2-dimethylpropanoate) (211). White, crystalline solid 
(7.57 g, 98% yield): 1H NMR (500 MHz, CDCl3) δ 7.28 (t, J = 8.2 Hz, 1H), 7.03 (d, J = 
8.2 Hz, 2H), 1.40 (s, 18H); 13C NMR (125 MHz, CDCl3) δ 175.8, 148.4, 127.0, 121.0, 
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1463, 14552, 1397, 1368, 1273, 1259, 1235, 1112, 1033 cm-1; HRMS (MultiMode 
ESI/APCI+) m/z calc’d for C16H25ClNO4 [M+NH4]+: 330.1467, found 330.1472.  
 
 
2-Iodo-1,3-phenylene bis(2,2-dimethylpropanoate) (212). White, crystalline solid (14.0 
g, 96% yield): 1H NMR (500 MHz, CDCl3) δ 7.35 (t, J = 8.1 Hz, 1H), 6.95 (d, J = 8.1 Hz, 
2H), 1.42 (s, 18H); 13C NMR (125 MHz, CDCl3) δ 175.9, 152.9, 129.5, 120.0, 88.0, 39.5, 
27.5; IR (Neat Film, NaCl): 2972, 2873, 1755, 1583, 1479, 1451, 1396, 1367, 1274, 
1244, 1218, 1095, 1029, 967, 941, 886 cm-1; HRMS (MultiMode ESI/APCI-) m/z calc’d 
for C16H20IO4 [M-H]-: 403.0412, found 403.0413.  
 




dimethylpropanoate) (198). In a nitrogen-filled glove box, a 500 mL round-bottom flask 
with a Kontes valve was charged with a stir bar, arene 197 (16.02 g, 50.0 mmol, 1.0 
equiv), B2Pin2 (9.5 g, 37.5 mmol, 0.75 equiv), [Ir(cod)(OMe)]2 (33 mg, 0.05 mmol, 0.1 
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suspended in THF (50 mL), and the flask was sealed and removed from the glove box. 
The reaction mixture was stirred in an oil bath heated at 60 °C for 45 h, at which time the 
reaction was complete by TLC analysis (20% acetone/hexanes, p-anisaldehyde stain). 
The reaction mixture was cooled to ambient temperature and filtered through a silica gel 
plug (50 g silica gel, eluent: acetone), and concentrated under reduced pressure. The 
crude reaction mixture was further purified by silica gel flash chromatography (200 g 
silica gel, eluent: 20% acetone/hexanes) to afford borylated 198 as an amorphous off-
white solid (19.85 g, 89% yield): 1H NMR (500 MHz, CDCl3) δ 7.38 (s, 2H), 2.43 (s, 
3H), 1.33 (s, 12H), 1.32 (s, 18H); 13C NMR (125 MHz, CDCl3) δ 198.8, 176.5, 147.3, 
131.0, 126.0, 120.1, 84.6, 39.2, 31.5, 27.2, 25.0; IR (Neat Film, NaCl): 3509, 2981, 2935, 
1766, 1707, 1482, 1459, 1405, 1396, 1354, 1331, 1259, 1212, 1147 cm-1; HRMS 





dimethylpropanoate) (206). Amorphous off-white solid (2.04 g, 96% yield): 1H NMR 
(500 MHz, CDCl3) δ 7.38 (s, 2H), 1.39 (s, 18H), 1.32 (s, 12H); 13C NMR (125 MHz, 
CDCl3) δ 175.8, 149.5, 129.8, 126.6, 114.9, 84.6, 39.5, 27.4, 25.0; IR (Neat Film, NaCl): 
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dimethylpropanoate) (213). Amorphous off-white solid (9.01 g, 99% yield): 1H NMR 
(400 MHz, CDCl3) δ 7.41 (s, 2H), 1.38 (s, 18H), 1.33 (s, 12H); 13C NMR (100 MHz, 
CDCl3) δ 175.9, 148.1, 128.6, 126.8, 124.1, 84.6, 39.4, 27.3, 23.0; IR (Neat Film, NaCl): 
2977, 2935, 2873, 1763, 1605, 1480, 1404, 1365, 1326, 1270, 1213, 1145, 1121, 1094, 
1036 cm-1; HRMS (MultiMode ESI/APCI+) m/z calc’d for C22H36BClNO6 [M+NH4]+: 




dimethylpropanoate) (214). Amorphous off-white solid (12.5 g, 95% yield): 1H NMR 
(300 MHz, CDCl3) δ 7.30 (s, 2H), 1.41 (s, 18H), 1.32 (s, 12H); 13C NMR (125 MHz, 
CDCl3) δ 175.9, 152.6, 131.2, 125.7, 92.3, 84.6, 39.5, 27.5, 25.0; IR (Neat Film, NaCl): 
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1094, 1034, 965, 900, 848 cm-1; HRMS (MultiMode ESI/APCI-) m/z calc’d for 
C22H32BFIO6 [M+F]-: 549.1321, found 549.1337. 
 
A8.7.2.3 General Procedure and Spectroscopic Data for the Synthesis of 
Boronic Acid Analogues 
 
(4-Acetyl-3,5-bis(pivaloyloxy)phenyl)boronic acid (199). A 250 mL round-bottom 
flask was charged with a stir bar and pinacol boronate ester 198 (8.65 g, 19.27 mmol, 1.0 
equiv). The solid was dissolved in EtOAc (250 mL), and diethanolamine (2.35 mL, 24.10 
mmol, 1.25 equiv) was added with vigorous stirring. (Note: a glass pipette was cut to 
have a wide bore, and this wide-bored pipet was used to add the viscous diethanolamine.) 
Upon addition of diethanolamine, a white precipitate formed. This suspension was stirred 
vigorously for a further 4 h at ambient temperature, at which time the mixture was 
concentrated under reduced pressure. The crude white semi-solid reaction residue was 
suspended in Et2O (300 mL) and stirred vigorously for 30 min. The suspension was then 
cooled to –20 °C in a freezer overnight. The white solid was collected by vacuum 
filtration, and the compound was washed with additional portions of Et2O (3 x 50 mL). 
The collected white solid (7.38 g) was suspended in 0.5 M HCl (200 mL) and stirred 
vigorously. CH2Cl2 (ca. 50 mL) was added until the solid fully dissolved. The biphasic 
mixture was stirred for 12 h with extreme vigor. The mixture was then subjected to 
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extracts were concentrated in vacuo and dried under high vacuum to afford boronic acid 
199 as an off-white, flaky solid (6.45 g, 92% yield over two steps): 1H NMR (300 MHz, 
CDCl3) δ 7.35 (s, 2H), 2.19 (s, 3H), 1.08 (s, 18H); 13C NMR (125 MHz, acetone-d6) 
δ 198.5, 176.7, 148.1, 138.0, 131.2, 126.2, 39.5, 31.7, 27.2; IR (Neat Film, NaCl): 3446, 
2975, 2359, 1751, 1700, 1653, 1635, 1558, 1540, 1480, 1456, 1407, 1340, 1247, 1100, 
1038 cm-1; HRMS (MultiMode ESI/APCI+) m/z calc’d for C18H29BNO7 [M+NH4]+: 
381.2068, found 381.2061. 
 
 
(4-Bromo-3,5-bis(pivaloyloxy)phenyl)boronic acid (207). Please note 2 M H2SO4 and 
THF were used in place of 0.5 M HCl and CH2Cl2, a continuous extraction was not 
required. Off-white, flaky solid (11.0 g, 82% yield over two steps): 1H NMR (500 MHz, 
DMSO-d6) δ 7.50 (s, 2H), 1.40 (s, 18H); 13C NMR (125 MHz, DMSO-d6) δ 175.3, 148.6, 
135.6, 126.3, 112.8, 38.8, 26.8; IR (Neat Film, NaCl): 3454, 3364, 2976, 2937, 2874, 
1755, 1733, 1736, 1480, 1454, 1426, 1365, 1342, 1271, 1218, 1137, 1108, 1038 cm-1; 
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(4-Chloro-3,5-bis(pivaloyloxy)phenyl)boronic acid (215). Please note 2 M H2SO4 and 
THF were used in place of 0.5 M HCl and CH2Cl2, a continuous extraction was not 
required. Off-white, flaky solid (3.50 g, 86% yield over two steps): 1H NMR (400 MHz, 
DMSO-d6) δ 7.53 (s, 2H), 1.34 (s, 18H); 13C NMR (100 MHz, DMSO-d6) δ 175.3, 147.2, 
134.8, 126.3, 121.5, 38.8, 26.7; IR (Neat Film, NaCl): 3377, 2980, 1753, 1735, 1639, 
1480, 1463, 1428, 1366, 1342, 1280, 1139, 1113, 1089 cm-1; HRMS (MultiMode 
ESI/APCI-) m/z calc’d for C16H22BCl2O6 [M+Cl]-: 390.0928, found 390.0936. 
 
 
(4-Iodo-3,5-bis(pivaloyloxy)phenyl)boronic acid (216). Please note 2 M H2SO4 and 
THF were used in place of 0.5 M HCl and CH2Cl2, a continuous extraction was not 
required. Off-white, flaky solid (4.82 g, 94% yield over two steps): 1H NMR (500 MHz, 
DMSO-d6) δ 7.37 (s, 2H), 1.37 (s, 18H); 13C NMR (125 MHz, DMSO-d6) δ 175.4, 152.0, 
136.5, 125.2, 92.0, 38.8, 27.0; IR (Neat Film, NaCl): 3369, 2975, 1759, 1735, 1395, 
1360, 1277, 1095, 1034, 904 cm-1; HRMS (MultiMode ESI/APCI-) m/z calc’d for 
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A8.7.2.4 General Procedure and Spectroscopic Data for the Enantioselective 
Palladium-Catalyzed Conjugate Addition of Arylboronic Acids 
 
(R)-2-Acetyl-5-(1-methyl-3-oxocyclohexyl)-1,3-phenylene bis(2,2-
dimethylpropanoate) (169b). A 20 mL screw-top vial was charged with a stir bar, 
Pd(OCOCF3)2 (25 mg, 0.075 mmol, 2.5 mol %), (S)-t-BuPyOx (18 mg, 0.099 mmol, 3 
mol %), NH4PF6 (145 mg, 0.99 mmol, 30 mol %), and the solids were dissolved in 1,2-
dichloroethane (2 mL) and stirred at ambient temperature for 5 min. Not all solids 
dissolved at this time. A 100 mL round bottom flask was charged with a stir bar, boronic 
acid 19 (1.20 g, 3.30 mmol, 1.1 equiv), and 1,2-dichloroethane (10 mL), and stirred at 
ambient temperature. The catalyst solution was filtered through a pipet plugged with a 
Kimwipe and added to the suspension of boronic acid in one portion. 3-
methylcyclohexen-2-one (340 µL, 3.00 mmol, 1.0 equiv) and water (270 µL, 15 mmol, 5 
equiv) were added by syringe and the flask was stirred in an oil bath heated to 50 °C for 
72 h. When the starting material was consumed as determined by TLC analysis (10% 
acetone/hexanes, p-anisaldehyde stain), the mixture was cooled to ambient temperature 
and filtered through a plug of silica gel (eluent: CH2Cl2) and concentrated under reduced 
pressure. The crude residue was purified by silica gel flash chromatography (200 g silica 
gel, eluent gradient: 5% acetone/hexanes to 10% acetone/hexanes) to afford conjugate 
addition product 169b as a colorless oil (1.19 g, 93% yield): 94% ee; [α]25D –36.1° (c 
1.85, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.91 (s, 2H), 2.77 (d, J = 14.1 Hz, 1H), 
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1H), 1.32 (s, 21H);13C NMR (125 MHz, CDCl3) δ 210.4, 198.5, 176.4, 151.3, 148.0, 
126.5, 117.5, 52.8, 43.0, 40.8, 39.2, 37.6, 31.5, 28.9, 27.2, 27.1, 27.1, 22.0; IR (Neat 
Film, NaCl): 3404, 2973, 2937, 2874, 1758, 1708, 1620, 1562, 1480, 1408, 1397, 1257, 
1095 cm-1; HRMS (MultiMode ESI/APCI+) m/z calc’d for C25H34NaO6 [M+Na]+: 
453.2248, found 453.2234; HPLC conditions: 5% IPA, 1.0 mL/min, Chiralpak AD-H 




dimethylpropanoate) (169d). Please note 1.5 equiv of boronic acid were employed. 
Colorless solid (4.57 g, 98% yield): >99% ee; [α]25D –34.5° (c 1.41, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 6.93 (s, 2H), 2.76 (d, J = 14.1 Hz, 1H), 2.44 (d, 14.1 Hz, 1H), 2.33 
(t, J = 6.7 Hz, 2H), 2.19 – 2.06 (m, 1H), 1.98 – 1.85 (m, 2H), 1.80 – 1.74 (m, 1H), 1.40 
(s, 18H), 1.30 (s, 3H); 13C NMR (125 MHz, CDCl3) δ   210.2, 175.8, 149.8, 149.0, 
118.4, 108.9, 53.0, 42.8, 40.8, 39.6, 37.7, 28.8, 27.4, 22.1; IR (Neat Film, NaCl): 2973, 
2936, 2874, 1763, 1713, 1601, 1571, 1480, 1463, 1408, 1397, 1365, 1272, 1227, 1096, 
1037, 894 cm-1; HRMS (MultiMode ESI/APCI+) m/z calc’d for C23H35BrNO5 
[M+NH4]+: 484.1693, found 484.1693; HPLC conditions: 20% IPA, 1.0 mL/min, 








Appendix 8 – A Catalytic, Enantioselective Formal Synthesis of (+)-Dichroanone  




dimethylpropanoate) (169e). Please note 1.5 equiv of boronic acid were employed. 
Colorless solid (0.74 g, 94% yield): >99% ee; [α]25D –38.9° (c 2.59, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 6.95 (s, 2H), 2.76 (d, J = 14.1 Hz, 1H), 2.43 (d, J = 14.1 Hz, 1H), 
2.32 (t, J = 6.7 Hz, 2H), 2.15 – 2.06 (m, 1H), 1.98 – 1.84 (m, 2H), 1.82 – 1.71 (m, 1H), 
1.38 (s, 18H), 1.30 (s, 3H); 13C NMR (125 MHz, CDCl3) δ   210.3, 175.7, 148.2, 147.8, 
118.4, 118.3, 52.8, 42.6, 40.6, 39.3, 37.5, 28.7, 27.2, 21.9; IR (Neat Film, NaCl): 2972, 
2936, 2874, 2256, 1763, 1713, 1607, 1574, 1479, 1413, 1397, 1352, 1316, 1272, 1227, 
1050, 1038, 895, 734 cm-1; HRMS (MultiMode ESI/APCI+) m/z calc’d for C23H35ClNO5 
[M+NH4]+: 440.2198, found 440.2197; SFC conditions: 3% IPA, 2.5 mL/min, Chiralpak 




(169c). Please note 1.5 equiv of boronic acid were employed. Colorless solid (0.40 g, 
42% yield): 92% ee; [α]25D –29.2° (c 4.47, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.87 
(s, 2H), 2.75 (d, J = 14.1 Hz, 1H), 2.42 (d, 14.1 Hz, 1H), 2.30 (t, J = 6.8 Hz, 2H), 2.12 – 










Appendix 8 – A Catalytic, Enantioselective Formal Synthesis of (+)-Dichroanone  
and (+)-Taiwaniaquinone H             
  
NMR (125 MHz, CDCl3) δ   210.4, 175.9, 152.7, 150.4, 117.6, 85.0, 52.8, 42.7, 40.7, 
39.4, 37.5, 28.7, 27.4, 22.0; IR (Neat Film, NaCl): 2972, 2936, 2873, 1759, 1711, 1598, 
1560, 1480, 1461, 1396, 1368, 1314, 1271, 1226, 1098, 1036, 938, 914, 894, 754, 733 
cm-1; HRMS (MultiMode ESI/APCI+) m/z calc’d for C23H35INO5 [M+NH4]+: 532.1554, 
found 532.1567; HPLC conditions: 20% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 
nm, tR (min): major = 6.130, minor = 7.008. 
 
A8.7.2.5 Procedures and Spectroscopic Data for Synthetic Intermediates 
 
(R)-1-(1,3,9-Trihydroxy-5-methyl-6,7,8,9-tetrahydro-5H-5,9-
methanobenzo[7]annulen-2-yl)ethanone (202). A 250 mL round-bottom flask was 
charged with a stir bar, flame-dried under vacuum, back-filled with argon, and charged 
with THF (25 mL). The solution was cooled to 0 °C in an ice/water bath and ethanethiol 
(0.890 mL, 12.5 mmol, 2.7 equiv) was added via syringe. n-BuLi (2.5 M solution in 
hexanes, 5.5 mL, 13.75 mmol, 2.97 equiv) was added dropwise, and a white precipitate 
was observed at the completion of the addition. DMF (25 mL) was added until the 
solution became homogenous and clear. The solution was allowed to stir at 0 °C for 30 
min. A flame-dried, 25 mL conical flask was charged with ketone 169b (1.99 g, 4.62 
mmol, 1 equiv) and DMF (10 mL). The ketone solution was transferred via cannula to the 
cooled, freshly-prepared solution of LiSEt dropwise over 10 min. The ice/water bath was 
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min, at which time the starting material was consumed as determined by TLC analysis 
(20% EtOAc/hexanes, p-anisaldehyde stain). The reaction was quenched by addition of 
sat. NH4Cl solution (aq, 50 mL), diluted with CH2Cl2 (200 mL) and water (200 mL) and 
transferred to a separatory funnel. 1M HCl (aq) was added until the aqueous layer was pH 
2–4. The aqueous layer was extracted with CH2Cl2 (5 x 50 mL) and the combined organic 
extracts were washed with water (7 x 50 mL), brine (1 x 50 mL), dried with Na2SO4 and 
concentrated under reduced pressure. The crude residue was purified via silica gel flash 
chromatography (90 g silica gel, eluent gradient: 10% EtOAc/hexanes to 20% 
EtOAc/hexanes) to afford tricycle 202 as a pale yellow oil (1.15 g, 95% yield): [α]25D –
19.0° (c 0.26, CHCl3); 1H NMR (500 MHz, CDCl3) δ 13.30 (s, 1H), 8.30 (s, 1H), 6.23 
(d, J = 1.9 Hz, 1H), 2.71 (s, 3H), 2.58 (bs, 1H), 2.12 (ddd, J = 9.5, 2.9, 2.2 Hz, 1H), 2.01–
1.89 (m, 1H), 1.76 – 1.59 (m, 3H), 1.48 – 1.32 (m, 2H), 1.31 (s, 3H), 1.03 – 0.81 (m, 1H); 
13C NMR (125 MHz, CDCl3) δ 204.9, 165.8, 156.1, 154.4, 118.8, 109.1, 102.4, 82.3, 
59.0, 45.7, 35.4, 34.5, 33.2, 22.9, 21.4; IR (Neat Film, NaCl): 3338, 2934, 2867, 1641, 
1588, 1435, 1375, 1324, 1270, 1243, 1124, 1055, 1027, 973, 839 cm-1; HRMS 




methanobenzo[7]annulen-2-yl)ethanone (217). A 50 mL, flame-dried, round-bottom 
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dibromodimethylhydantoin (151 mg, 0.461 mmol, 1.1 equiv). The flask was evacuated 
under vacuum and back-filled with argon, and the solids were dissolved in CH2Cl2 (5 
mL) and stirred at ambient temperature. After 30 min, an aliquot was partitioned between 
EtOAc (1 mL) and sat. Na2S2O3 (aq, 1 mL), and the organic layer was subjected to 
LCMS analysis, where no starting material was observed. The red-colored reaction was 
quenched by the addition of 20% Na2S2O3 solution (aq, 20 mL) and stirred vigorously for 
3 h, until the orange/red color was no longer observed. The mixture was partitioned 
between CH2Cl2 (20 mL) and water (20 mL) and transferred to a separatory funnel. 1M 
HCl was added until the aqueous layer was pH 3. The aqueous layer was extracted with 
CH2Cl2 (5 x 25 mL) and the combined organic extracts were dried over Na2SO4 and 
concentrated under reduced pressure. The crude residue was purified by silica gel column 
chromatography (12 g silica gel, eluent gradient: 10% EtOAc/hexanes to 25% 
EtOAc/hexanes) to afford bromo arene 217 as a yellow, semi-crystalline solid (92 mg, 
66% yield): [α]25D –20.8° (c 1.26, CHCl3); 1H NMR (500 MHz, CDCl3) δ 13.37 (s, 1H), 
9.10 (s, 1H), 2.74 (s, 3H), 2.55 (s, 1H), 2.22 (ddd, J = 9.7, 3.0, 2.2 Hz, 1H), 1.93 (ddd, J = 
11.2, 6.2, 3.0 Hz, 1H), 1.75 – 1.64 (m, 4H), 1.61 (s, 3H), 1.35 (td, J = 13.0, 5.5 Hz, 1H), 
0.96 – 0.80 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 204.5, 154.3, 151.9, 120.2, 110.2, 
109.9, 97.9, 81.4, 59.1, 48.8, 34.4, 33.1, 33.0, 24.6, 21.6; IR (Neat Film, NaCl): 3381, 
2936, 2852, 1631, 1566, 1415, 1373, 1326, 1274, 1233 cm-1; HRMS (MultiMode 
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methanobenzo[7]annulen-2-yl)ethanone (203). A flame-dried 20 mL vial was charged 
with a stir bar, bromo-diphenol 217 (92 mg, 0.270 mmol, 1 equiv), Cs2CO3 (194 mg, 
0.595 mmol, 2.2 equiv), and acetone (5 mL). The vial was stirred under argon 
atmosphere at ambient temperature, and methyl iodide (0.037 mL, 0.595 mmol, 2.2 
equiv) was added in one portion. The yellow reaction slurry was stirred for 40 h at 
ambient temperature, at which time the color had faded to a white slurry and the starting 
material was consumed as determined by TLC analysis (20% EtOAc/hexanes, p-
anisaldehyde stain). The reaction was quenched with sat. NH4Cl solution (aq, 5 mL) and 
stirred for 12 h at ambient temperature. The reaction was diluted with EtOAc (10 mL) 
and water (10 mL), and the mixture was transferred to a separatory funnel. The aqueous 
layer was extracted with EtOAc (3 x 10 mL) and the combined organic extracts were 
washed with water (2 x 10 mL) and brine (1 x 10 mL), dried over MgSO4 and 
concentrated under reduced pressure. The crude residue was purified by silica gel flash 
chromatography (12 g silica gel, eluent gradient 10% EtOAc/hexanes to 20% 
EtOAC/hexanes) to afford 203 as a clear oil that solidified to an amorphous white solid 
upon standing (62 mg, 63% yield): [α]25D –5.8° (c 0.73, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ 3.81 (s, 3H), 3.80 (s, 3H), 2.56 (s, 3H), 2.24 (dt, J = 10.1, 2.5 Hz, 1H), 1.84 – 
1.71 (m, 2H), 1.71 – 1.61 (m, 4H), 1.60 (s, 3H), 1.35 (td, J = 12.9, 5.8 Hz, 1H), 0.81 – 
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108.9, 79.7, 63.9, 63.1, 58.6, 48.0, 36.7, 33.2, 32.6, 25.1, 21.6; IR (Neat Film, NaCl): 
3429, 2938, 2853, 1704, 1642, 1590, 1450, 1382, 1323, 1237, 1120, 1077 cm-1; HRMS 




(208). Four 20 mL microwave vials were each charged with a stir bar, ketone 169d 
(0.594 g, 1.27 mmol, 1 equiv), potassium isopropenyltrifluoroborate (281 mg, 1.91 
mmol, 1.25 equiv), K2CO3 (263 g, 1.91 mmol, 1.5 equiv), PPh3 (33 mg, 0.127 mmol, 10 
mol %), and Pd(OAc)2 (14 mg, 0.0635 mmol, 5 mol %), and capped with a microwave 
septum top. The vials were evacuated with vacuum and back-filled with argon three 
times. The solids were suspended in degassed dioxane/H2O (9:1 ratio, 20 mL) before the 
reaction was stirred in the microwave reactor for 1 h at 170 °C on very high absorbance 
mode. The mixture was cooled to ambient temperature and filtered through a plug of 
silica gel (eluent: EtOAc) and concentrated under reduced pressure to afford a brown oil.  
A 100 mL round-bottom flask was charged with the combined crude reaction 
residues, a stir bar, Bu4NOH (4.7 mL, 7.15 mmol, 2.4 equiv), and dioxane/H2O (9:1 ratio, 
50 mL). The reaction was stirred at ambient temperature for 10 h, at which point the 
starting material was consumed as determined by TLC analysis (20% EtOAc/hexanes, p-
anisaldehyde stain). The reaction was quenched with sat. NH4Cl (aq, 25 mL) and 
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mL), and the combined organic extracts were washed with brine (1 x 100 mL), dried over 
MgSO4 and concentrated under reduced pressure. The crude residue was purified by 
silica gel flash chromatography (50 g silica gel, eluent gradient: 10% EtOAc/hexanes to 
20% EtOAc/hexanes) to afford isopropenyl 208 as a yellow oil (1.23 g, 70% yield over 2 
steps): [α]25D –37.4° (c 1.26, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.79 (d, J = 1.8 Hz, 
1H), 6.53 (d, J = 1.8 Hz, 1H), 5.52 (s, 1H), 5.43 (s, 1H), 5.04 (s, 1H), 2.79 (d, J = 14.1 
Hz, 1H), 2.41 (d, J = 14.1 Hz, 1H), 2.32 (t, J = 6.7 Hz, 2H), 2.14 – 2.08 (m, 1H), 2.00 (s, 
3H), 1.91 – 1.84 (m, 2H), 1.83 – 1.73 (m, 1H), 1.31 (s, 9H), 1.29 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 211.0, 176.8, 152.9, 149.1, 148.7, 138.1, 121.3, 119.3, 111.9, 110.3, 
53.2, 42.8, 40.9, 39.2, 37.8, 29.0, 27.3, 23.6, 22.2; IR (Neat Film, NaCl): 3418, 3083, 
2970, 2874, 1712, 1620, 1480, 1414, 1368, 1316, 1278, 1230, 1122, 1073, 1035, 1017, 
943, 901, 758 cm-1; HRMS (MultiMode ESI/APCI-) m/z calc’d for C21H27O4 [M-H]-: 




pivalate (209). A 15 mL, flame-dried, round-bottom flask was charged with a stir bar, 
phenol 208 (165 mg, 0.479 mmol, 1 equiv) and DMAP (3 mg, 0.024 mmol, 5 mol%). 
The flask was evacuated under vacuum and back-filled with argon three times. The solids 
were dissolved in CH2Cl2 (5 mL), and NEt3 (1.34 mL, 9.58 mmol, 20 equiv) was added. 
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dropwise and the resulting solution was stirred at ambient temperature for 18 h, at which 
time the starting material was consumed as determined by TLC analysis (30% 
EtOAc/hexanes, p-anisaldehyde stain). The mixture was washed with water (10 mL) and 
brine (10 mL), and the organic extracts were dried over MgSO4 and concentrated under 
reduced pressure. The crude residue was purified by silica gel column chromatography (9 
g silica gel, gradient: 10% EtOAc/hexanes) to afford nonaflate 209 as a colorless oil 
(0.2694 g, 80% yield): [α]25D –22.1° (c 1.31, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.12 
(d, J = 1.8 Hz, 1H), 7.00 (d, J = 1.9 Hz, 1H), 5.39 (t, J = 1.2 Hz, 1H), 5.00 (t, J = 1.2 Hz, 
1H), 2.76 (d, J = 14.0 Hz, 1H), 2.47 (d, J = 14.0 Hz, 1H), 2.35 (t, J = 6.8 Hz, 2H), 2.19 – 
2.05 (m, 1H), 2.00 (s, 3H), 1.99 – 1.87 (m, 2H), 1.86 – 1.74 (m, 1H), 1.32 (s, 9H), 1.31 
(s, 3H). 13C NMR (100 MHz, CDCl3) δ 210.1, 176.7, 149.5, 149.5, 147.3, 135.1, 129.6, 
120.3, 120.3, 117.0, 116.4, 114.3, 109.9, 108.0, 52.9, 42.9, 40.8, 39.2, 37.6, 28.8, 27.2, 
23.1, 22.0; 19F (376 MHz, CDCl3) δ -80.94 (t, J = 9.9 Hz, 3F), -109.86 (t, J = 14.0 Hz, 
2F), -121.04 – -120.86 (m, 2F), -126.04 (dt, J = 13.9, 13.5, 4.9 Hz, 2F). IR (Neat Film, 
NaCl): 2971, 2877, 1759, 1720, 1649, 1623, 1553, 1482, 1427, 1353, 1240, 1200, 1145, 
1107, 1032, 1011, 985, 944, 922 cm-1. HRMS (FAB+) m/z calc’d for C25H28F9O6S 
[M+H]+: 627.1457, found 627.2216. 
 
 
(R)-2-Isopropyl-5-(1-methyl-3-oxocyclohexyl)phenyl pivalate (210). A 25 mL Schlenk 
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Pd/C (62.1 mg, equal weight to that of the nonaflate), Et3N (38 µL, 0.276 mmol, 2.5 
equiv), and MeOH (5 mL). The reaction mixture was degassed then back-filled with H2 
gas (1 atm) using Schlenk technique. The flask was sealed and stirred in an oil bath 
heated to 65 °C for 11 h. The mixture was cooled to ambient temperature, filtered 
through a silica gel plug (10 g silica gel, eluent: EtOAc) and concentrated under reduced 
pressure. The crude residue was purified by silica gel flash chromatography (9 g silica 
gel, eluent: 5% EtOAc/hexanes) to afford pivaloyl 209 as a colorless oil (26.4 mg, 72% 
yield): [α]25D –41.4° (c 1.30, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 2.4 Hz, 
1H), 7.16 (dd, J = 8.2, 2.1 Hz, 1H), 6.90 (d, J = 2.1 Hz, 1H), 3.13 (p, J = 6.9 Hz, 1H), 
2.84 (d, J = 14.1 Hz, 1H), 2.45 (d, J = 14.2 Hz, 1H), 2.33 (t, J = 6.7 Hz, 2H), 2.19 – 2.12 
(m, 1H), 1.99 – 1.84 (m, 2H), 1.84 – 1.70 (m, 1H), 1.41 (s, 9H), 1.32 (s, 3H), 1.21 (d, J = 
6.9 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 211.4, 177.2, 148.6, 146.5, 138.0, 126.5, 
123.3, 119.5, 53.2, 42.6, 40.9, 39.3, 37.9, 29.3, 27.4, 27.1, 23.0, 22.9, 22.2; IR (Neat 
Film, NaCl): 2963, 2872, 1750, 1714, 1619, 1504, 1462, 1410, 1365, 1276, 1229, 1160, 
1120, 1055, 1030, 932, 904 cm-1; HRMS (MultiMode ESI/APCI+) m/z calc’d for 
C21H34NO3 [M+NH4]+: 348.2533, found 348.2518. 
 
 
(R)-3-(4-Isopropyl-3-methoxyphenyl)-3-methylcyclohexane-1-one (169f). A 25 mL 
round bottom flask was charged with a stir bar, flame-dried under vacuum, back-filled 




Appendix 8 – A Catalytic, Enantioselective Formal Synthesis of (+)-Dichroanone  
and (+)-Taiwaniaquinone H             
  
ice/water bath and ethanethiol (57 µL, 0.787 mmol, 10 equiv) was added via syringe. n-
BuLi (2.5 M solution in hexanes, 322 µL, 0.802 mmol, 10.2 equiv) was added dropwise, 
and a white precipitate was observed at the completion of the addition. The solution was 
allowed to stir at 0 °C for 1 h. A flame-dried 15 mL conical flask was charged with 
pivaloyl 210 (26.0 mg, 0.079 mmol, 1 equiv) and DMF (1 mL). The ketone solution was 
transferred via cannula to the cooled, freshly-prepared solution of LiSEt dropwise over 5 
min. The ice/water bath was removed and the reaction was stirred in an oil bath heated to 
45 °C for 6 h, at which time the starting material was consumed as determined by TLC 
analysis (30% EtOAc/hexanes, p-anisaldehyde stain). Me2SO4 (112 µL, 1.185 mmol, 15 
equiv) was added to the reaction mixture and stirred at 45 °C for an additional 15 min, at 
which time the reaction was complete as determined by TLC analysis (30% 
EtOAc/hexanes, p-anisaldehyde stain). The reaction was quenched with NH4OH (aq, 5 
mL) and stirred at 45 °C for another 15 min then diluted with H2O (10 mL). The aqueous 
layer was extracted with EtOAc (3 x 10 mL), dried with MgSO4 and concentrated under 
reduced pressure. The crude residue was purified via silica gel flash chromatography (9 g 
silica gel, eluent: 2.5% EtOAc/hexanes) to afford key intermediate 169f as a colorless oil 
(17.0 mg, 83 % yield): [α]25D –60.4° (c 1.49, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.14 
(d, J = 8.0 Hz, 1H), 6.86 (dd, J = 8.0, 1.9 Hz, 1H), 6.78 (d, J = 1.9 Hz, 1H) 3.82 (s, 3H), 
3.26 (p, J = 6.9 Hz, 1H), 2.87 (d, J = 14.2 Hz, 1H), 2.43 (d, J = 14.1 Hz, 1H), 2.31 (t, J = 
6.8 Hz, 2H), 2.20 – 2.14 (m, 1H), 1.93 – 1.82 (m, 2H), 1.72 – 1.62 (m, 1H), 1.33 (s, 3H), 
1.19 (d, J = 6.9 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 211.8, 156.8, 146.1, 134.9, 
126.1, 117.8, 108.3, 55.5, 53.4, 43.0, 41.0, 38.3, 30.1, 26.6, 22.8, 22.2; IR (Neat Film, 
NaCl): 2958, 2869, 1713, 1611, 1573, 1504, 1462, 1409, 1350, 1305, 1254, 1240, 1164, 
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A8.7.2.6 Determination of Enantiomeric Excess 
	
Please note racemic products were synthesized using racemic i-Pr-PyOx. 
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A8.7.2.7 Hammett Plot Data4a,b 
 
 




σp2 ee3 er log10(er) 
p-Et -0.15 85 12 1.1 
p-Me -0.17 87 14 1.2 
p-H 0 92 24 1.4 
p-F 0.06 92 24 1.4 
p-Cl 0.23 95 39 1.6 
p-Ac 0.50 96 49 1.7 
p-CF3 0.54 96 49 1.7 
p-Br 0.23    
p-iPr -0.15    
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 Figure A9.3 13C NMR (125 MHz, CDCl3) of compound 169b 
 
Figure A9.2 Infrared spectrum (Thin Film, NaCl) of compound 169b 
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 Figure A9.6 13C NMR (125 MHz, CDCl3) of compound 169c 
 
Figure A9.5 Infrared spectrum (Thin Film, NaCl) of compound 169c 
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 Figure A9.9 13C NMR (125 MHz, CDCl3) of compound 169d 
 
Figure A9.8 Infrared spectrum (Thin Film, NaCl) of compound 169d 
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 Figure A9.12 13C NMR (125 MHz, CDCl3) of compound 169e 
 
Figure A9.11 Infrared spectrum (Thin Film, NaCl) of compound 169e 
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 Figure A9.15 13C NMR (125 MHz, CDCl3) of compound 169f 
 
Figure A9.14 Infrared spectrum (Thin Film, NaCl) of compound 169f 
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 Figure A9.18 13C NMR (125 MHz, CDCl3) of compound 197 
 
Figure A9.17 Infrared spectrum (Thin Film, NaCl) of compound 197 
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 Figure A9.21 13C NMR (125 MHz, CDCl3) of compound 198 
 
Figure A9.20 Infrared spectrum (Thin Film, NaCl) of compound 198 
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 Figure A9.24 13C NMR (125 MHz, CDCl3) of compound 199 
 
Figure A9.23 Infrared spectrum (Thin Film, NaCl) of compound 199 
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 Figure A9.27 13C NMR (125 MHz, CDCl3) of compound 202 
 
Figure A9.26 Infrared spectrum (Thin Film, NaCl) of compound 202 
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 Figure A9.30 13C NMR (125 MHz, CDCl3) of compound 203 
 
Figure A9.29 Infrared spectrum (Thin Film, NaCl) of compound 203 
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 Figure A9.33 13C NMR (125 MHz, CDCl3) of compound 205 
 
Figure A9.32 Infrared spectrum (Thin Film, NaCl) of compound 205 
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 Figure A9.36 13C NMR (125 MHz, CDCl3) of compound 206 
 
Figure A9.35 Infrared spectrum (Thin Film, NaCl) of compound 206 
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 Figure A9.39 13C NMR (125 MHz, CDCl3) of compound 207 
 
Figure A9.38 Infrared spectrum (Thin Film, NaCl) of compound 207 
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 Figure A9.42 13C NMR (125 MHz, CDCl3) of compound 208 
 
Figure A9.41 Infrared spectrum (Thin Film, NaCl) of compound 208 
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 Figure A9.45 13C NMR (125 MHz, CDCl3) of compound 209 
 
Figure A9.44 Infrared spectrum (Thin Film, NaCl) of compound 209 
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 Figure A9.49 13C NMR (125 MHz, CDCl3) of compound 210 
 
Figure A9.48 Infrared spectrum (Thin Film, NaCl) of compound 210 
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 Figure A9.52 13C NMR (125 MHz, CDCl3) of compound 211 
 
Figure A9.51 Infrared spectrum (Thin Film, NaCl) of compound 211 
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 Figure A9.55 13C NMR (125 MHz, CDCl3) of compound 212 
 
Figure A9.54 Infrared spectrum (Thin Film, NaCl) of compound 212 
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 Figure A9.58 13C NMR (125 MHz, CDCl3) of compound 213 
 
Figure A9.57 Infrared spectrum (Thin Film, NaCl) of compound 213 
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 Figure A9.61 13C NMR (125 MHz, CDCl3) of compound 214 
 
Figure A9.60 Infrared spectrum (Thin Film, NaCl) of compound 214 
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 Figure A9.64 13C NMR (125 MHz, CDCl3) of compound 215 
 
Figure A9.63 Infrared spectrum (Thin Film, NaCl) of compound 215 
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 Figure A9.67 13C NMR (125 MHz, CDCl3) of compound 216 
 
Figure A9.66 Infrared spectrum (Thin Film, NaCl) of compound 216 
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 Figure A9.70 13C NMR (125 MHz, CDCl3) of compound 217 
 
Figure A9.69 Infrared spectrum (Thin Film, NaCl) of compound 217 
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A10.1   GENERAL EXPERIMENTAL 
X-ray crystallographic analysis was obtained from the Caltech X-Ray 
Crystallography Facility using a Bruker D8 Venture Kappa Duo Photon 100 CMOS 
diffractometer. 
 





Undesired tricycle 203 was recrystallized by slow evaporation of CH2Cl2 and 
hexanes to provide crystals suitable for X-ray analysis. 
 




Table A10.1 Crystal data and structure refinement for undesired tricycle 203 
 
Empirical formula  C17 H23 Br O5 
Formula weight  387.26 
Temperature  100 K 
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Crystal system  Monoclinic 
Space group  C 1 2 1 
Unit cell dimensions a = 18.8295(9) Å a= 90°. 
 b = 7.8451(4) Å b= 95.208(2)°. 
 c = 11.4443(5) Å g = 90°. 
Volume 1683.56(14) Å3 
Z 4 
Density (calculated) 1.528 Mg/m3 
Absorption coefficient 2.464 mm-1 
F(000) 800 
Crystal size 0.43 x 0.42 x 0.29 mm3 
Theta range for data collection 1.787 to 48.826°. 
Index ranges -39<=h<=39, -16<=k<=16, -22<=l<=24 
Reflections collected 78240 
Independent reflections 16574 [R(int) = 0.0370] 
Completeness to theta = 25.000° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5777 and 0.4462 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 16574 / 1 / 299 
Goodness-of-fit on F2 0.966 
Final R indices [I>2sigma(I)] R1 = 0.0256, wR2 = 0.0521 
R indices (all data) R1 = 0.0344, wR2 = 0.0538 
Absolute structure parameter 0.0289(17) 
Extinction coefficient n/a 
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Table A10.2 Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 
103) for 203. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________  
 x y z U(eq) 
_____________________________________________________________________  
Br(1) 2611(1) 10106(1) 9689(1) 15(1) 
O(1) 3623(1) 7401(1) 8867(1) 14(1) 
O(2) 3898(1) 5319(1) 6487(1) 32(1) 
O(3) 2081(1) 4751(1) 5906(1) 15(1) 
O(4) 746(1) 6695(1) 5256(1) 15(1) 
C(1) 1792(1) 8548(1) 7722(1) 10(1) 
C(2) 2444(1) 8611(1) 8398(1) 10(1) 
C(3) 2985(1) 7448(1) 8188(1) 10(1) 
C(4) 2858(1) 6206(1) 7328(1) 10(1) 
C(5) 2190(1) 6066(1) 6697(1) 10(1) 
C(6) 1663(1) 7235(1) 6896(1) 9(1) 
C(7) 883(1) 7289(1) 6423(1) 11(1) 
C(8) 433(1) 6312(1) 7261(1) 15(1) 
C(9) 584(1) 6889(1) 8542(1) 17(1) 
C(10) 655(1) 8831(1) 8680(1) 17(1) 
C(11) 1110(1) 9610(1) 7757(1) 12(1) 
C(12) 734(1) 9187(1) 6539(1) 13(1) 
C(13) 4140(1) 8608(2) 8543(1) 21(1) 
C(14) 3440(1) 4958(1) 7122(1) 14(1) 
C(15) 3422(1) 3280(1) 7728(1) 21(1) 
C(16) 2247(1) 5220(2) 4744(1) 23(1) 
C(17) 1200(1) 11532(1) 7918(1) 21(1) 
O(5) 4353(1) 8297(2) 5398(1) 43(1) 
_____________________________________________________________________
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Table A10.3 Bond lengths [Å] and angles [°] for 203 
_____________________________________________________  
Br(1)-C(2)  1.8906(8) 
O(1)-C(3)  1.3713(9) 
O(1)-C(13)  1.4310(12) 
O(2)-C(14)  1.2111(12) 
O(3)-C(5)  1.3751(10) 
O(3)-C(16)  1.4412(14) 
O(4)-H(4A)  0.70(4) 
O(4)-C(7)  1.4158(11) 
C(1)-C(2)  1.3921(11) 
C(1)-C(6)  1.4044(11) 
C(1)-C(11)  1.5333(11) 
C(2)-C(3)  1.4041(11) 
C(3)-C(4)  1.3893(12) 
C(4)-C(5)  1.3969(11) 
C(4)-C(14)  1.5033(12) 
C(5)-C(6)  1.3859(11) 
C(6)-C(7)  1.5183(10) 
C(7)-C(8)  1.5397(13) 
C(7)-C(12)  1.5231(12) 
C(8)-H(8A)  0.98(2) 
C(8)-H(8B)  0.949(19) 
C(8)-C(9)  1.5366(14) 
C(9)-H(9A)  1.035(18) 
C(9)-H(9B)  1.01(2) 
C(9)-C(10)  1.5357(16) 
C(10)-H(10A)  0.98(2) 
C(10)-H(10B)  0.906(18) 
C(10)-C(11)  1.5458(13) 
C(11)-C(12)  1.5417(13) 
C(11)-C(17)  1.5262(13) 
C(12)-H(12A)  0.993(18) 
C(12)-H(12B)  0.961(15) 
C(13)-H(13A)  0.92(2) 
C(13)-H(13B)  0.98(2) 
C(13)-H(13C)  0.932(18) 
C(14)-C(15)  1.4899(15) 
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C(15)-H(15A)  0.97(3) 
C(15)-H(15B)  0.95(2) 
C(15)-H(15C)  1.00(2) 
C(16)-H(16A)  1.02(2) 
C(16)-H(16B)  0.97(2) 
C(16)-H(16C)  0.84(3) 
C(17)-H(17A)  0.96(2) 
C(17)-H(17B)  0.93(2) 
C(17)-H(17C)  1.19(2) 
O(5)-H(5A)  0.83(4) 































































































Table A10.4 Anisotropic displacement parameters (Å2x 103) for 203. The anisotropic 
displacement factor exponent takes the form: -2π2[ h2 a*2U11 + ... + 2 h k a* b* U12 ] 
_____________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_____________________________________________________________________  
Br(1) 16(1)  16(1) 13(1)  -6(1) 0(1)  -2(1) 
O(1) 9(1)  19(1) 15(1)  2(1) -3(1)  -1(1) 
O(2) 24(1)  30(1) 44(1)  12(1) 22(1)  12(1) 
O(3) 15(1)  14(1) 14(1)  -5(1) 1(1)  1(1) 
O(4) 12(1)  20(1) 11(1)  -3(1) -2(1)  1(1) 
C(1) 9(1)  10(1) 10(1)  0(1) 1(1)  1(1) 
C(2) 10(1)  11(1) 9(1)  -1(1) 1(1)  -1(1) 
C(3) 8(1)  12(1) 10(1)  1(1) 0(1)  0(1) 
C(4) 8(1)  12(1) 12(1)  1(1) 1(1)  1(1) 
C(5) 9(1)  11(1) 10(1)  -1(1) 1(1)  1(1) 
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C(6) 7(1)  12(1) 9(1)  0(1) 0(1)  1(1) 
C(7) 8(1)  16(1) 10(1)  0(1) 0(1)  1(1) 
C(8) 10(1)  20(1) 16(1)  2(1) 1(1)  -2(1) 
C(9) 14(1)  25(1) 14(1)  4(1) 3(1)  -3(1) 
C(10) 12(1)  25(1) 14(1)  -2(1) 4(1)  2(1) 
C(11) 10(1)  13(1) 13(1)  0(1) 2(1)  4(1) 
C(12) 10(1)  16(1) 13(1)  2(1) 0(1)  4(1) 
C(13) 11(1)  26(1) 26(1)  1(1) -1(1)  -6(1) 
C(14) 10(1)  16(1) 16(1)  0(1) 2(1)  3(1) 
C(15) 21(1)  15(1) 29(1)  4(1) 4(1)  6(1) 
C(16) 22(1)  33(1) 15(1)  -8(1) 4(1)  1(1) 
C(17) 22(1)  14(1) 26(1)  -3(1) 0(1)  6(1) 




Table A10.5 Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 10 3) 
for 203 
_____________________________________________________________________  
 x  y  z  U(eq) 
_____________________________________________________________________  
H(4A) 730(20) 5810(50) 5270(40) 110(14) 
H(8A) 504(8) 5090(30) 7183(13) 18(3) 
H(8B) -34(10) 6580(30) 6933(16) 24(4) 
H(9A) 199(10) 6480(30) 9068(15) 23(4) 
H(9B) 1018(11) 6250(30) 8880(17) 27(5) 
H(10A) 863(11) 9080(30) 9475(18) 33(5) 
H(10B) 216(9) 9320(20) 8589(16) 24(4) 
H(12A) 213(9) 9400(20) 6506(16) 21(4) 
H(12B) 947(8) 9770(20) 5920(13) 12(3) 
H(13A) 4561(12) 8430(30) 9001(19) 37(5) 
H(13B) 4005(10) 9790(30) 8697(17) 34(5) 
H(13C) 4233(10) 8410(20) 7769(16) 23(4) 
H(15A) 3716(14) 2520(40) 7310(20) 53(7) 
H(15B) 2962(11) 2800(30) 7559(18) 34(5) 
H(15C) 3523(11) 3430(30) 8598(19) 35(5) 
H(16A) 2770(12) 5560(30) 4724(17) 36(6) 
H(16B) 1930(11) 6120(30) 4436(18) 31(5) 
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H(16C) 2168(13) 4320(30) 4360(20) 43(6) 
H(17A) 1378(10) 11860(30) 8703(18) 29(5) 
H(17B) 737(13) 11970(30) 7840(20) 42(6) 
H(17C) 1619(10) 12150(30) 7333(18) 32(5) 
H(5A) 4075(17) 7470(50) 5340(30) 76(10) 
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Table A10.7 Hydrogen bonds for 203 [Å and °] 
_____________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
_____________________________________________________________________  
 O(4)-H(4A)...O(5)#1 0.70(4) 2.11(4) 2.7707(15) 158(5) 
 C(12)-H(12A)...O(2)#2 0.993(18) 2.577(18) 3.5655(12) 173.5(14) 
 C(13)-H(13B)...Br(1) 0.98(2) 2.963(19) 3.4746(12) 113.5(13) 
 C(16)-H(16B)...O(4) 0.97(2) 2.54(2) 3.1572(13) 121.7(15) 
 O(5)-H(5A)...O(2) 0.83(4) 2.18(4) 2.8176(15) 133(3) 
 O(5)-H(5B)...O(5)#3 0.93(8) 1.80(7) 2.678(3) 155(8) 
_____________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1/2,y-1/2,-z+1    #2 x-1/2,y+1/2,z    #3 -x+1,y,-z+1       
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Asymmetric Synthesis of All-Carbon Quaternary Spirocycles 
via an Enantioselective Allylic Alkylation Strategy† 
 
 
A11.1   INTRODUCTION AND BACKGROUND 
The widespread prevalence of spirocycles in biologically active molecules has 
inspired the development of many methods for the synthesis1 and, more recently, the 
enantioselective synthesis2 of this motif. During the course of our ongoing efforts in 
natural product synthesis, the preparation of an enantioenriched spirocyclic 
cyclohexenone derivative bearing both an all-carbon quaternary stereogenic spirocenter 
as well as a 1,4-dicarbonyl moiety spanning the spirocenter was required. This goal was 
challenging not only due to the difficulties in constructing 1,4-dicarbonyls,3 but also due 
to the inherent challenges of enantioselectively synthesizing an all-carbon quaternary 
stereocenter.4 As the enantioselective synthesis of all-carbon quaternary stereocenters via 	†	 This work was performed in collaboration with Dr. J. Caleb Hethcox. Portions of this chapter have been 
reproduced with permission from Shockley, S. E.;‡ Hethcox, J. C.;‡ Stoltz, B. M. Tetrahedron Lett. 2017, 
58, 3341–3343 © 2017 Elsevier Ltd. 
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palladium-catalyzed allylic alkylation has been developed extensively by our group,5 we 
envisioned that rapid entry to the spirocyclic cyclohexenone framework could be 
achieved if the olefin was disconnected via a ring-closing metathesis reaction (RCM) and 
the resultant α-quaternary carbonyl derivative could be synthesized asymmetrically via 
our allylic alkylation methodology (Figure A11.1a). In addition to the application to our 
own synthetic endeavor, we imagined that this strategy would be amenable to the 
synthesis of a wide array of all-carbon quaternary spirocyclic compounds, such as 
acorenone, laurencenone B, and α-chamigrene (Figure A11.1b). 6  However, this plan 
hinged on the challenging use of bromomethyl vinyl ketone as an alkylating reagent. 
Nucleophilic addition to bromomethyl vinyl ketone can be problematic due to the 
three electrophilic positions on the molecule, which include positions for Michael 
addition, 1,2-addition, and SN2 displacement (Figure A11.1c, left). As a solution to this 
issue, Funk has developed the use of 6-(bromomethyl)-4H-1,3-dioxin as a bromomethyl 
vinyl ketone surrogate (Figure A11.1c, left). 7  Following alkylation, the dioxin 
functionality of this reagent can be unmasked under thermal conditions to release 
formaldehyde and reveal the latent enone. Therefore, we envisioned that we could 
obviate the challenges of using bromomethyl vinyl ketone by utilizing Funk’s dioxin 
reagent in our planned strategy (Figure A11.1c, right). However, the use of a substrate 
bearing such a bulky substituent with Lewis basic oxygens had not yet been explored in 





Appendix 11 – Asymmetric Synthesis of All-Carbon Quaternary Spirocycles via an  
Enantioselective Allylic Alkylation Strategy             
  





A11.2   REACTION DEVELOPMENT 
We fortuitously discovered that the standard conditions developed by our group 
for palladium-catalyzed allylic alkylation reactions were adaptable to this new substrate 
class (Table A11.1). The use of a catalyst prepared from Pd2(pmdba)3 and (S)-(CF3)3-t-
Bu-PHOX (L15) provided access to a variety of dioxin-substituted allylic alkylation 
products in consistently high yields and enantioselectivities. Cyclohexanone 219a was 
obtained in 91% yield and 83% ee. Moreover, tetralone 219b was afforded in similarly 
O
Br
a) Planned strategy for spirocycle synthesis
c) Bromomethyl vinyl ketone surrogate
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high yield and selectivity, and we were pleased to find that lactam 219c could be 
accessed in an excellent 95% yield and 99% ee. Based on these results in combination 
with the previously established trends in our palladium-catalyzed allylic alkylation 
methodology,5 we infer that the masked methyl vinyl ketone substituent should be 
broadly applicable to all of the ring systems tolerated in this chemistry. 
 
Table A11.1 Enantioselective palladium-catalyzed allylic alkylations with substrates bearing a 
masked methyl vinyl ketonea 
 
[a] Reactions performed on 0.2 mmol scale. [b] Performed using THF at 23 °C. [c] Performed using toluene at 40 °C. [d] 
Isolated yield. [e] Determined by chiral HPLC or SFC. 
 
 
With the feasibility of utilizing substrates bearing a masked methyl vinyl ketone 
functionality in our allylic alkylation chemistry established, we moved to demonstrate the 
ease with which this strategy can provide access to the desired spirocyclic compounds. 
Though the masked methyl vinyl ketone synthon has been shown to provide access to 
bridged and fused bicyclic systems,7 to the best of our knowledge, the utility of this 






































L15 (12.5 mol %)
Pd2(pmdba)3 (5 mol %)
solvent (0.1 M), 18 h
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find that the planned thermal unmasking/RCM sequence proceeded smoothly in a single 
reaction vessel (Table A11.2). In this procedure, dioxin 219 is unmasked via heating in 
toluene at 180 °C for one hour, whereupon the reaction is cooled to 60 °C and a solution 
of Hoveyda-Grubbs second-generation catalyst is introduced to complete the annulation. 
Using this newly developed protocol, spirocyclic cyclohexenones 220a, 220b, and 220c 
were obtained in good to excellent yields, thus demonstrating the viability of this strategy 
for the synthesis of enantioenriched spirocycles.  
 
Table A11.2 One-pot synthesis of spirocyclic compoundsa 
 
 
[a] Reactions performed on 0.1 mmol scale. [b] Isolated yield. 
 
 
A11.3   CONCLUSIONS 
In summary, we have demonstrated that substrates bearing a bulky, highly 
oxygenated methyl vinyl ketone surrogate can be utilized in an enantioselective 
palladium-catalyzed allylic alkylation reaction. The resulting allylic alkylation products 
are obtained in high yields and selectivities with neither the increased sterics nor the 




i. toluene, 180 °C, 1 h
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developed a one-pot unmasking/RCM procedure showcasing that these allylic alkylation 
products can be easily advanced to enantioenriched spirocycles bearing both an all-
carbon quaternary stereogenic spirocenter as well as a 1,4-dicarbonyl functionality 
spanning the spirocenter. This simple two-step strategy is amenable to the synthesis of a 
range of enantioenriched spirocyclic natural products. 
 
A11.4  EXPERIMENTAL SECTION 
A11.4.1 MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried 
by passage through an activated alumina column under argon. Commercially obtained 
reagents were used as received. Chemicals were purchased from Sigma 
Aldrich/Strem/Alfa Aesar/Oakwood Chemicals and used as received.  Reaction 
temperatures were controlled by an IKAmag temperature modulator. Glove box 
manipulations were performed under a nitrogen atmosphere. Thin-layer chromatography 
(TLC) and preparatory TLC was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized by UV fluorescence quenching, KMnO4, or p-
anisaldehyde staining. SiliaFlash P60 Academic Silica gel (particle size 0.040–0.063 
mm) was used for flash chromatography. Analytical chiral HPLC was performed with an 
Agilent 1100 Series HPLC utilizing a Chiralpak IC column (4.6 mm x 25 cm) or 
Chiralpak AD-H column (4.6 mm x 25 cm), both obtained from Daicel Chemical 
Industries, Ltd. with visualization at 210 nm. Analytical SFC was performed with a 
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Mettler SFC supercritical CO2 analytical chromatography system utilizing a Chiralpak 
OJ-H column (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd. with 
visualization at 210 nm. 1H NMR spectra were recorded on a Bruker Avance HD 400 
MHz spectrometer and are reported relative to residual CHCl3 (δ 7.26 ppm). 13C NMR 
spectra were recorded on a Bruker Avance HD 400 MHz spectrometer and are reported 
relative to residual CDCl3 (δ 77.16 ppm). Data for 1H NMR are reported as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br 
s = broad singlet. Data for 13C NMR are reported in terms of chemical shifts (δ ppm). 
Some reported spectra include minor solvent impurities of benzene (δ 7.36 ppm), water 
(δ 1.56 ppm), ethyl acetate (δ 4.12, 2.05, 1.26 ppm), methylene chloride (δ 5.30 ppm), 
grease (δ 1.26, 0.86 ppm), and/or silicon grease (δ 0.07 ppm), which do not impact 
product assignments. IR spectra were obtained using a Perkin Elmer Paragon 1000 
spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm-1). High resolution mass spectra (HRMS) were obtained from the Caltech 
Mass Spectral Facility using a JEOL JMS-600H High Resolution Mass Spectrometer in 
fast atom bombardment (FAB+) or electron ionization (EI+) mode, or an Agilent 6200 
Series TOF with an Agilent G1978A Multimode source in electrospray ionization (ESI+), 
atmospheric pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-
APCI+). Optical rotations were measured with a Jasco P-2000 polarimeter operating on 
the sodium D-line (589 nm), using a 100 mm pathlength cell, and are reported as: [α]DT 
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A11.4.1.1 Preparation of Known Compounds 
Previously reported methods were used to prepare ligand (S)-L15 8  and 6-
(bromomethyl)-4H-1,3-dioxin7. 
 
A11.4.2 EXPERIMENTAL PROCEDURES AND SPECTROSCOPIC DATA 
A11.4.2.1 Experimental Procedures and Spectroscopic Data for the Synthesis 
of Allylic Alkylation Substrates 
	
Allyl 1-((4H-1,3-dioxin-6-yl)methyl)-2-oxocyclohexane-1-carboxylate (218a). Allyl 2-
oxocyclohexane-1-carboxylate9 (0.20 g, 1.1 mmol, 1 equiv), K2CO3 (0.76 g, 5.5 mmol, 5 
equiv), and  6-(bromomethyl)-4H-1,3-dioxin7 (0.30 g, 1.7 mmol, 1.5 equiv) were 
dissolved in acetone (5 mL). The resulting reaction mixture was heated under reflux for 
18 h, whereupon the reaction was cooled to ambient temperature, filtered through celite 
with acetone (10 mL), and concentrated under reduced pressure. The crude product was 
purified by silica gel flash column chromatography (15% EtOAc/hexanes) to give ester 
218a as a colorless oil (0.26 g, 84% yield): 1H NMR (400 MHz, CDCl3) δ 5.83 (ddt, J = 
17.2, 10.4, 5.9 Hz, 1H), 5.31 – 5.12 (m, 2H), 4.89 – 4.80 (m, 2H), 4.66 (t, J = 2.6 Hz, 
1H), 4.57 – 4.48 (m, 2H), 4.14 – 4.09 (m, 2H), 2.76 (dt, J = 15.0, 1.6 Hz, 1H), 2.56 (dt, J 
= 13.9, 3.2 Hz, 1H), 2.43 – 2.25 (m, 2H), 2.24 – 2.16 (m, 1H), 2.01 – 1.89 (m, 1H), 1.82 
– 1.63 (m, 2H), 1.56 (dddd, J = 17.0, 12.4, 8.4, 4.4 Hz, 1H), 1.36 (ddd, J = 13.9, 12.2, 4.7 
Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 206.4, 170.4, 150.3, 131.6, 118.8, 100.8, 90.3, 
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2796, 1715, 1682. 1648, 1451, 1372, 1314, 1175, 1092, 990, 927, 847, 761 cm-1; HRMS 




carboxylate (218b). Allyl 1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate9 (0.60 g, 
2.8 mmol, 1 equiv), Cs2CO3 (1.6 g, 5.0 mmol, 1.8 equiv), and  6-(bromomethyl)-4H-1,3-
dioxin7 (0.55 g, 3.1 mmol, 1.1 equiv) were dissolved in DMF (19 mL). The resulting 
reaction mixture was heated to 70 °C for 18 h, whereupon the reaction was cooled to 
ambient temperature, poured into H2O (40 mL), and the aqueous layer was extracted with 
EtOAc (3 x 25 mL). The combined organics were washed with brine (25 mL), dried over 
Na2SO4, and concentrated under reduced pressure. The crude product was purified by 
silica gel flash column chromatography (10% EtOAc/hexanes) to give ester 218b as a 
pale yellow oil (0.65 g, 71% yield): 1H NMR (400 MHz, CDCl3) δ 8.04 (dd, J = 7.9, 1.4 
Hz, 1H), 7.47 (td, J = 7.5, 1.5 Hz, 1H), 7.34 – 7.27 (m, 1H), 7.21 (dd, J = 7.6, 1.2 Hz, 
1H), 5.80 (ddt, J = 17.2, 10.5, 5.5 Hz, 1H), 5.27 – 5.06 (m, 2H), 4.93 (s, 2H), 4.83 (t, J = 
2.6 Hz, 1H), 4.56 (dq, J = 5.6, 1.6 Hz, 2H), 4.20 (dt, J = 2.6, 1.3 Hz, 2H), 3.22 – 3.07 (m, 
1H), 3.01 – 2.73 (m, 3H), 2.64 (dt, J = 13.9, 4.6 Hz, 1H), 2.23 – 2.11 (m, 1H); 13C NMR 
(101 MHz, CDCl3) δ 194.2, 170.8, 150.5, 143.3, 133.6, 132.0, 131.6, 128.9, 128.3, 126.8, 
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1730, 1688, 1600, 1453, 1371, 1313, 1294, 1232, 1172, 1093, 987, 950, 846, 744 cm-1; 
HRMS (FAB+) m/z calc’d for C19H19O5 [M+H]–H2: 327.1232, found 3267.1223. 
 
 
Allyl 3-((4H-1,3-dioxin-6-yl)methyl)-1-benzoyl-2-oxopiperidine-3-carboxylate (218c). 
Allyl 1-benzoyl-2-oxopiperidine-3-carboxylate5e (0.20 g, 0.70 mmol, 1 equiv), Cs2CO3 
(0.41 g, 1.3 mmol, 1.8 equiv), and  6-(bromomethyl)-4H-1,3-dioxin7 (0.14 g, 0.77 mmol, 
1.1 equiv) were dissolved in DMF (5 mL). The resulting reaction mixture was heated to 
70 °C for 18 h, whereupon the reaction was cooled to ambient temperature, poured into 
H2O (40 mL), and the aqueous layer was extracted with EtOAc (3 x 10 mL). The 
combined organics were washed with brine (10 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
column chromatography (25% EtOAc/hexanes) to give ester 218c as a pale yellow oil 
(0.13 g, 49% yield): 1H NMR (400 MHz, CDCl3) δ 7.73 – 7.66 (m, 2H), 7.53 – 7.42 (m, 
1H), 7.42 – 7.33 (m, 2H), 5.99 (ddt, J = 17.2, 10.4, 6.0 Hz, 1H), 5.49 – 5.28 (m, 2H), 5.05 
– 4.93 (m, 2H), 4.78 (dt, J = 3.0, 1.5 Hz, 1H), 4.72 (ddt, J = 6.0, 1.7, 0.8 Hz, 2H), 4.20 
(dq, J = 2.7, 1.2 Hz, 2H), 3.94 – 3.66 (m, 2H), 2.98 – 2.87 (m, 1H), 2.74 – 2.62 (m, 1H), 
2.50 – 2.33 (m, 1H), 2.14 – 1.92 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 175.1, 171.4, 
171.3, 150.0, 135.9, 131.9, 131.5, 128.3, 128.1, 119.8, 101.7, 90.7, 66.9, 64.0, 55.3, 46.5, 
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1170, 1145, 1090, 985, 939, 845, 721, 694, 647 cm-1; HRMS (FAB+) m/z calc’d for 
C21H24O6N [M+H]+: 386.1604, found 386.1619. 
 
A11.4.2.2 General Procedure for the Asymmetric Palladium-Catalyzed Allylic 
Alkylation 
 
(S)-2-((4H-1,3-Dioxin-6-yl)methyl)-2-allylcyclohexan-1-one (219a). In a nitrogen-filled 
glove box, to a 1 dram vial equipped with a stir bar was added Pd2(pmdba)3 (11 mg, 0.01 
mmol, 5 mol %), ligand (S)-L1 (13 mg, 0.025 mmol, 12.5 mol %), and THF (2 mL). The 
resulting mixture was stirred at 25 °C for 30 min, whereupon substrate 218a (56 mg, 0.20 
mmol, 1 equiv) was added. The vial was sealed, removed from the glove box, and stirred 
at 25 °C. After 18 h, the reaction mixture was concentrated under reduced pressure and 
the crude product was purified by preparatory TLC (10% EtOAc/hexanes) to give allyl 
219a as a colorless oil (43 mg, 91% yield): 83% ee; [α]D25 –13.1 (c 1.9, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 5.66 (ddt, J = 16.5, 10.6, 7.3 Hz, 1H), 5.09 – 4.99 (m, 2H), 4.95 (d, 
J = 5.4 Hz, 1H), 4.88 (d, J = 5.4 Hz, 1H), 4.68 (t, J = 2.6 Hz, 1H), 4.26 – 4.11 (m, 2H), 
2.58 – 2.45 (m, 2H), 2.39 – 2.28 (m, 3H), 2.18 (d, J = 14.5 Hz, 1H), 1.84 (tdd, J = 6.7, 
3.4, 1.6 Hz, 1H), 1.79 – 1.69 (m, 5H); 13C NMR (101 MHz, CDCl3) δ 213.9, 151.5, 
134.0, 118.4, 100.7, 90.4, 63.9, 51.0, 39.5, 39.4, 39.0, 36.8, 27.3, 21.0; IR (Neat Film, 
NaCl) 3391, 3074, 2924, 2854, 2795, 1705, 1681, 1638, 1445, 1372, 1311, 1196, 1172, 
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[M+H]–H2: 235.1334, found 235.1341; HPLC conditions: 3% IPA, 1.0 mL/min, 
Chiralpak AD–H column, λ = 210 nm, tR (min): major = 7.066, minor = 7.722. 
 
A11.4.2.3 Spectroscopic Data for the Asymmetric Palladium-Catalyzed Allylic 
Alkylation Products  
Please note that the absolute configurations of 219a–c were determined by 




Product 219b was prepared according to the general procedure to give a colorless oil (52 
mg, 91% yield): 82% ee; [α]D25 +0.254 (c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
8.05 (dd, J = 7.8, 1.4 Hz, 1H), 7.47 (td, J = 7.5, 1.5 Hz, 1H), 7.35 – 7.29 (m, 1H), 7.27 – 
7.19 (m, 1H), 5.79 (dddd, J = 17.0, 10.3, 7.8, 7.0 Hz, 1H), 5.17 – 5.00 (m, 2H), 5.00 – 
4.88 (m, 2H), 4.74 (t, J = 2.6 Hz, 1H), 4.21 (dt, J = 2.5, 1.2 Hz, 2H), 3.02 (dd, J = 7.2, 5.5 
Hz, 2H), 2.69 (dq, J = 14.3, 1.3 Hz, 1H), 2.55 (ddt, J = 14.1, 7.0, 1.3 Hz, 1H), 2.34 – 2.27 
(m, 1H), 2.27 – 2.21 (m, 1H), 2.11 (ddt, J = 6.0, 4.8, 3.2 Hz, 2H); 13C NMR (101 MHz, 
CDCl3) δ 200.5, 151.5, 143.2, 133.9, 133.2, 132.0, 128.8, 128.2, 126.7, 118.7, 100.8, 
90.4, 64.0, 47.8, 39.6, 38.8, 30.4, 25.3; IR (Neat Film, NaCl) 3072, 3004, 2929, 2859, 
2794, 1677, 1600, 1454, 1432, 1371, 1289, 1225, 1193, 1172, 1093, 1023, 989, 918, 847, 
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283.1338; HPLC conditions: 4% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm, tR 
(min): major = 29.702, minor = 23.387. 
 
 
(S)-3-((4H-1,3-Dioxin-6-yl)methyl)-3-allyl-1-benzoylpiperidin-2-one (219c). Product 
219c was prepared according to the general procedure (toluene used in place of THF, 
reaction mixture heated to 40 °C) to give a pale yellow oil (66 mg, 95% yield): 99% ee; 
[α]D25 +11.4 (c 3.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.31 (m, 5H), 5.76 
(dddd, J = 17.1, 10.3, 7.7, 6.9 Hz, 1H), 5.21 – 5.09 (m, 2H), 5.06 – 4.98 (m, 2H), 4.74 
(td, J = 2.7, 0.8 Hz, 1H), 4.23 (ddd, J = 2.6, 1.7, 0.8 Hz, 2H), 3.91 – 3.67 (m, 2H), 2.76 
(dtd, J = 14.3, 1.7, 0.9 Hz, 1H), 2.59 (ddt, J = 13.8, 6.9, 1.3 Hz, 1H), 2.31 (ddt, J = 13.8, 
7.7, 1.1 Hz, 1H), 2.15 – 2.09 (m, 1H), 2.04 – 1.95 (m, 3H), 1.93 – 1.83 (m, 1H); 13C 
NMR (101 MHz, CDCl3) δ 177.1, 175.6, 151.2, 136.7, 133.3, 131.5, 128.2, 127.8, 119.6, 
101.2, 90.6, 64.1, 47.0 (2C), 43.5, 41.7, 30.0, 20.0; IR (Neat Film, NaCl) 3346, 3072, 
2945, 2868, 2795, 1678, 1600, 1477, 1449, 1386, 1372, 1286, 1150, 1172, 1092, 1023, 
990, 919, 846, 792, 725, 696 cm-1; HRMS (FAB+) m/z calc’d for C20H24NO4 [M+H]+: 
342.1705, found 342.1714; SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak OJ-H 
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A11.4.2.4 General Procedure for Spirocyclic Formation 
 
(S)-Spiro[5.5]undec-9-ene-1,8-dione (220a). To a sealed Biotage microwave vial, allyl 
219a (24 mg, 0.10 mmol, 1 equiv) and toluene (0.7 mL) were added. The reaction 
mixture was heated to 180 °C for 1 h, whereupon the reaction was cooled to 60 °C and a 
solution of Hoveyda-Grubbs 2nd generation catalyst (6.3 mg, 0.010 mmol, 0.10 equiv) in 
toluene (0.3 mL) was added. The reaction mixture was then stirred an additional 18 h at 
60 °C, cooled to ambient temperature, and directly purified by preparatory TLC (15% 
EtOAc/hexanes) to give spirocycle 220a as a colorless oil (17 mg, 93% yield): [α]D25 –1.4 
(c 1.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.81 (dt, J = 10.1, 4.1 Hz, 1H), 5.99 (dt, J 
= 10.0, 2.1 Hz, 1H), 2.84 (ddt, J = 18.8, 4.4, 1.4 Hz, 1H), 2.80 – 2.71 (m, 1H), 2.47 – 
2.32 (m, 4H), 1.95 – 1.73 (m, 6H); 13C NMR (101 MHz, CDCl3) δ 212.3, 197.4, 146.0, 
129.5, 51.5, 45.7, 38.2, 38.1, 33.7, 27.7, 20.8; IR (Neat Film, NaCl) 3037, 2936, 2865, 
1705, 1678, 1446, 1424, 1387, 1252, 1135, 736 cm-1; HRMS (FAB+) m/z calc’d for 
C11H15O2 [M+H]+: 179.1072, found 179.1078. 
 
A11.4.2.5 Spectroscopic Data for Spirocyclic Compounds 
 
(S)-3',4'-dihydro-1'H-spiro[cyclohexane-1,2'-naphthalen]-3-ene-1',5-dione (220b). 
Product 220b was prepared according to the general procedure to give a colorless oil (18 
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1H NMR (400 MHz, CDCl3) δ 8.01 (dd, J = 7.8, 1.4 Hz, 1H), 7.50 (td, J = 7.5, 1.5 Hz, 
1H), 7.40 – 7.30 (m, 1H), 7.26 – 7.20 (m, 1H), 6.91 – 6.77 (m, 1H), 6.10 (dt, J = 10.3, 2.1 
Hz, 1H), 3.09 – 2.89 (m, 3H), 2.82 (d, J = 16.2 Hz, 1H), 2.50 – 2.38 (m, 2H), 2.27 – 2.02 
(m, 2H); 13C NMR (101 MHz, CDCl3) δ 199.2, 197.4, 145.6, 142.7, 133.9, 130.8, 129.5, 
128.9, 128.5, 127.2, 47.7, 44.6, 32.5, 32.3, 25.0; IR (Neat Film, NaCl) 3034, 2926, 2858, 
1683, 1601, 1455, 1388, 1250, 1224, 1157, 946, 750 cm-1; HRMS (FAB+) m/z calc’d for 
C15H15O2 [M+H]+: 227.1072, found 227.1074. 
 
 
(S)-2-benzoyl-2-azaspiro[5.5]undec-9-ene-1,8-dione (220c). Product 220c was prepared 
according to the general procedure to give a colorless oil (15 mg, 53% yield) after 
preparatory TLC (40% EtOAc/hexanes): [α]D25 +29.7 (c 0.9, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.54 – 7.32 (m, 5H), 6.87 (ddd, J = 10.2, 5.0, 3.3 Hz, 1H), 6.06 (dt, J = 
10.1, 2.1 Hz, 1H), 3.91 – 3.74 (m, 2H), 3.09 (dt, J = 18.9, 3.0 Hz, 1H), 2.96 (d, J = 16.1 
Hz, 1H), 2.59 (dd, J = 16.2, 1.3 Hz, 1H), 2.49 (ddt, J = 18.9, 5.0, 1.6 Hz, 1H), 2.09 – 1.95 
(m, 4H); 13C NMR (101 MHz, CDCl3) δ 196.4, 177.0, 175.1, 145.8, 135.8, 131.9, 129.2, 
128.5, 127.6, 47.1, 47.0, 46.4, 34.8, 32.5, 19.3; IR (Neat Film, NaCl) 2949, 1679, 1449, 
1388, 1281, 1151, 919, 729, 694, 665 cm-1; HRMS (FAB+) m/z calc’d for C17H18O3N 
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A11.4.2.6 Determination of Enantiomeric Excess 
Please note racemic products were synthesized using Pd(PPh3)4 in place of 
Pd2(pmdba)3 and (S)-L15. 
 
Table A11.3 Determination of enantiomeric excess 
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 Figure A12.3 13C NMR (101 MHz, CDCl3) of compound 218a 
 
Figure A12.2 Infrared spectrum (Thin Film, NaCl) of compound 218a 
 
605







































































































































 Figure A12.6 13C NMR (101 MHz, CDCl3) of compound 218b 
 
Figure A12.5 Infrared spectrum (Thin Film, NaCl) of compound 218b 
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 Figure A12.9 13C NMR (101 MHz, CDCl3) of compound 218c 
 
Figure A12.8 Infrared spectrum (Thin Film, NaCl) of compound 218c 
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 Figure A12.12 13C NMR (101 MHz, CDCl3) of compound 219a 
 
Figure A12.11 Infrared spectrum (Thin Film, NaCl) of compound 219a 
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 Figure A12.15 13C NMR (101 MHz, CDCl3) of compound 219b 
 
Figure A12.14 Infrared spectrum (Thin Film, NaCl) of compound 219b 
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 Figure A12.18 13C NMR (101 MHz, CDCl3) of compound 219c 
 
Figure A12.17 Infrared spectrum (Thin Film, NaCl) of compound 219c 
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 Figure A12.21 13C NMR (101 MHz, CDCl3) of compound 220a 
 
Figure A12.20 Infrared spectrum (Thin Film, NaCl) of compound 220a 
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 Figure A12.24 13C NMR (101 MHz, CDCl3) of compound 220b 
 
Figure A12.23 Infrared spectrum (Thin Film, NaCl) of compound 220b 
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 Figure A12.27 13C NMR (101 MHz, CDCl3) of compound 220c 
 
Figure A12.26 Infrared spectrum (Thin Film, NaCl) of compound 220c 
 
621







Progress Toward the Synthesis of (+)-Isopalhinine A† 
 
 
A13.1   INTRODUCTION AND BACKGROUND 
The Lycopodium alkaloids are family of complex, polycyclic, bioactive molecules 
that have been the subject of intense synthetic efforts over the past fifty years.1 In 2013, a 
novel Lycopodium alkaloid, (+)-isopalhinine A (221, Scheme A13.1), was isolated 
containing an unprecedented (5/6/6/6/7) pentacyclic scaffold comprised of a densely 
functionalized isotwistane core containing vicinal all-carbon quaternary stereocenters 
appended to a 1-azabicyclo[4.3.1]decane moiety. 2  The complex architecture of (+)-
isopalhinine A (221) has piqued the interest of the synthetic community, however, despite 
one report toward the isotwistane core,3 the natural product has yet to succumb to total 
synthesis. Herein, we detail our progress toward (+)-isopalhinine A (221) via a series of 
evolving strategies unified by the late-stage synthesis of the isotwistane core and the 
early construction of the functionalized nitrogen-containing heterocycle.  
 	†	Portions of this work were performed in collaboration with Dr. J. Caleb Hethcox. 
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A13.2   IRIDIUM-CATALYZED ALLYLIC ALKYLATION ROUTE 
Our initial retrosynthetic analysis of (+)-isopalhinine A (221) began with 
disconnection of the caging architecture by C–N bond cleavage of the bridging propyl 
chain, followed by rupture of the central isotwistane core, which would be formed via an 
intramolecular Diels–Alder cycloaddition, to provide spirocycle 222 (Scheme A13.1). 
Spirocycle 222 would in turn be prepared by enolate formation and subsequent 
hemiaminal formation via the addition of an acyl anion equivalent into spirocyclic lactam 
223. Intramolecular aldol condensation and redox manipulation would then lead back to 
functionalized β-ketolactam 224. Enantioenriched 224 would be generated from β-
ketolactam 225 and allylic electrophile 226, which would require the development of 
novel stereoselective iridium-catalyzed allylic alkylation technology as both the use of 
alkyl-substituted allylic electrophile 226 and endocyclic 1,3-dicarbonyl nucleophile 225 
in iridium-catalyzed allylic alkylation chemistry is unprecedented in the literature. This 
synthetic strategy would enable rapid access to (+)-isopalhinine A (221) in as few as 
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Scheme A13.1 Initial retrosynthetic analysis of (+)-isopalhinine A (221) via iridium-catalyzed allylic 




We began our explorations into this initial synthetic plan with the synthesis of 
proposed iridium-catalyzed allylic alkylation substrates 225 and 226. The preparation of 
allylic electrophile 226 proceeded via known allylic alcohol 230, which was synthesized 
in three steps and 40% overall yield from commercially available 4-pentyn-1-ol (227, 
Scheme A13.2).4,5 Subsequent acylation with methyl chloroformate afforded requisite 
alkyl-substituted allylic electrophile 226 in 89% yield.6  
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Synthesis of proposed endocyclic 1,3-dicarbonyl nucleophile 225 proved more 
challenging. While we were able to rapidly access allylated β-ketolactam 233 from Boc-
β-alanine (231, Scheme A13.3a),7 we were unable to prepare desired alkyl-substituted 
nucleophile 225 (Scheme A13.3b). In our attempt to synthesize desired 225 we explored 
a variety of approaches including C-alkylation and Knoevenagel condensation/reduction 
sequences of β-ketolactam 232, cyclization of β-ketoester 234, as well as 
ozonolysis/reduction of allylated β-ketolactam 233, but all routes were met with failure.  
 




 Unable to synthesize desired alkyl-substituted nucleophile 225, we decided to 
instead explore the proposed iridium-catalyzed allylic alkylation reaction of alkyl-
substituted electrophile 226 with allyl-substituted nucleophile 233, postulating that we 
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order to intercept our original synthetic plan (Table A13.1). Our prior work on iridium-
catalyzed allylic alkylation reactions with crotyl chloride primed us for the challenges  
involved in the use of alkyl-substituted electrophiles like 226. 8  Specifically, we 
anticipated poor regioselectivity in the allylic alkylation reaction as a result of the 
minimal stabilization of the allyl carbocation afforded by the alkyl substituent of 226, in 
addition to poor reactivity due to the steric bulk of the alkyl group. Therefore, we 
hypothesized that we would need to explore novel ligand and additive combinations in 
the iridium-catalyzed allylic alkylation reaction in order to achieve both a selective and 
high yielding transformation.  
We began our studies employing our previously explored conditions for the 
iridium-catalyzed allylic alkylation of cinnamyl-derived electrophiles.9 Unsurprisingly, 
we observed that the reaction proceeded with poor branched selectivity, instead favoring 
the synthesis of the undesired linear product (Table A13.1, entry 1). Though base 
additives have been shown to play an important role in the selectivity of iridium-
catalyzed allylic alkylations,8,9,10 an extensive investigation of bases proved unsuccessful 
in promoting branched selectivity in the reaction (entries 2–5). Turning our attention to 
the ligand, we found that the use of Alexakis ligand L16, instead of Me-THQphos (L2), 
in combination with LiBr or DABCO as additives, reversed the regioselectivity of the 
transformation to favor the synthesis of desired branched product 235 (entries 6 and 9). 
However, poor conversions (15% combined yield of branched and linear products, entry 
9) and our inability to separate the branched and linear isomers by column 
chromatography led us to terminate our studies on endocyclic 1,3-dicarbonyl 
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nucleophiles in order to identify a more suitable nucleophile for the iridium-catalyzed 
allylic alkylation reaction.  
 




[a] Reactions performed on 0.2 mmol scale with 2:1 nucleophile/electrophile. [b] Determined by TOF LCMS analysis of the 
crude reaction mixture. [c] TBD = 1,3,5-triazabicyclo[4.4.0]dec-5-ene. 
 
 
 In a revised retrosynthetic analysis of (+)-isopalhinine A (221), we envisioned 
that we could employ lactone nucleophile 238, in place of β-ketolactam 225, in the 
proposed iridium-catalyzed allylic alkylation reaction of alkyl-substituted electrophile 
226 (Scheme A13.4). Preserving our endgame strategy, allylic alkylation product 237 
would then undergo lactamization to intercept key intermediate 236 from our original 
retrosynthesis (Scheme A13.1). We hypothesized that the similarity between lactone 238 
and our group’s previously explored β-ketoester nucleophiles9,11 would allow for a more 












9 L16 DABCO 63:37
10 L16 DMAP 25:75
11 L16 29:71
2 L2 27:73
3 L2 DABCO 39:61










[Ir(cod)Cl]2 (2 mol %)
TBD (10 mol %)
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Scheme A13.4 Revised retrosynthetic analysis of (+)-isopalhinine A (221) via iridium-catalyzed 
allylic alkylation of lactone nucleophile 238  
 
  
To explore this idea, we synthesized lactone nucleophile 238 (Scheme A13.5). A 
Masamune-Claisen reaction of Boc-β-alanine (231) afforded β-ketoester 239 in 99% 
yield. Subsequent alkylation gave silyl ether 234, which was then exposed to TBAF to 
effect deprotection and cyclization in order to provide lactone 238 in 91% yield.  
 
Scheme A13.5 Synthesis of lactone nucleophile 238  
 
 
With lactone nucleophile 238 in hand, we turned to explore its reactivity in the 
proposed iridium-catalyzed allylic alkylation reaction (Table A13.2). Due to early 
difficulties in isolating branched allylic alkylation product 237 in high purity, we were 
prompted to discover that γ-butyrolactone allylic alkylation product 237 could be 
elaborated to α-quaternary lactam derivative 241 in a one-pot fashion upon treatment 
with trifluoracetic acid. Unlike lactone 237, branched lactam 241 is separable from its 
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With respect to the optimization of the allylic alkylation reaction, our group’s previously 
reported conditions for the iridium-catalyzed allylic alkylation of crotyl chloride8 (Table 
A13.2, entry 1), poorly reactive allylic electrophiles 12  (entry 2), and β-ketoester 
nucleophiles9 (entry 3), all afforded poor selectivities when applied to our desired 
transformation. After extensive exploration of ligands and base additives, we found that 
the bulkier Feringa ligand L17 in combination with DABCO gave desired lactam 241 in 
excellent yield, regio- and enantioselectivity, though poor diastereoselectivity (entry 5). 
We believe that the diastereoselectivity of this transformation can potentially be further 
improved by exploring dual catalytic systems.13 Of note, linear β-ketoester 234 (Scheme 
A13.5) was also explored in the iridium-catalyzed allylic alkylation reaction with 
electrophile 240; however, the best results were observed using the same optimized 
conditions for lactam substrate 238 (Table A13.2, entry 5) and while the regioselectivity 
and yields were high (91:9 b:l, 94% yield), the diastereoselectivity was poor (1.2:1 dr) 
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Table A13.2 Optimization of the iridium-catalyzed allylic alkylation of lactone 238a 
 
 
[a] Reactions performed on 0.1 mmol scale with 2:1 nucleophile/electrophile. [b] 1H NMR yield based on internal standard. 
[c] Determined by 1H NMR analysis of the crude reaction mixture. [d] Determined via chiral HPLC. [e] TBD = 1,3,5-
triazabicyclo[4.4.0]dec-5-ene. 
 
We next turned our attention to the advancement of bicyclic hemiacetal 241 to 
spirocyclic enone 223 (Scheme A13.6), which would set the stage for the pivotal acyl 
anion addition. Toward this end, we performed a Wacker oxidation of pendant olefin 241 
(Scheme A13.6, top). However, despite a variety of conditions, we observed cyclization 
of the hemiacetal moiety into the nascent ketone of 242 forming new unstable hemiacetal 
243, which readily dehydrated to dihydrofuran 244. In an effort to circumvent this 
undesired reactivity, we instead oxidized hemiacetal 241 to aldehyde 245 using Dess–
Martin periodinane prior to the Wacker oxidation (Scheme A13.6, middle). 
Unfortunately, Wacker product 246 suffered an undesirable intramolecular aldol reaction 









(S,S,Sa)-L17R = H: (S,Sa)-L2
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we could perform a directed reduction of hemiacetal 241 using the hydroxyethyl group of 
the opened hemiacetal to access diol 248 (Scheme A13.6, bottom). Subsequent selective 
oxidation of the primary alcohol afforded aldehyde 249. To our disappointment, attempts 
to perform a Wacker oxidation on aldehyde 250 proved unsuccessful. It is likely that 
protection of the primary alcohol and/or amide is required for the Wacker oxidation to 
proceed.  
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A13.3   PALLADIUM-CATALYZED ALLYLIC ALKYLATION ROUTE USING A 
MASKED STABILIZED LACTAM ENOLATE 
 Concurrent with our efforts to develop an iridium-catalyzed allylic alkylation 
approach to (+)-isopalhinine A (221), an alternate route to the natural product relying on 
a palladium-catalyzed allylic alkylation was explored (Scheme A13.7). Maintaining the 
endgame strategy from the iridium-catalyzed allylic alkylation route (Scheme A13.1), 
this alternate retrosynthetic analysis leads through the same disconnects to spirocyclic 
intermediate 223, which in this approach would be synthesized via an α-alkylation and 
diastereoselective reduction of the corresponding ketone of acetal 251. Cyclic enone 251 
would then arise from the ozonolysis and aldol condensation enantioenriched lactam 252, 
which in turn would result from an enantioselective palladium-catalyzed decarboxylative 
allylic alkylation of substrate 253. The key advantage to this alternate route is the 
elimination of the need to control diastereoselectivity in the allylic alkylation reaction, 
which was the main challenge in the aforementioned iridium-catalyzed allylic alkylation 
route. Moreover, the tertiary stereocenter of the vicinal tertiary and quaternary stereodyad 
set in the iridium-catalyzed allylic alkylation pathway was to be ablated later in the 
synthesis in the formation of cyclohexadiene 222 (Scheme A13.1 and Scheme A13.7), 
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Scheme A13.7 Retrosynthetic analysis of (+)-isopalhinine A (221) via palladium-catalyzed allylic 




At the time we began our studies into this palladium-catalyzed route, the Stoltz 
group had previously examined the palladium-catalyzed decarboxylative alkylation of 
enolate-stabilized enol carbonates for the synthesis of all-carbon quaternary 
stereocenters14 as well as developed the asymmetric palladium-catalyzed decarboxylative 
allylic alkylation of lactams to reach quaternary N-heterocycles, specifically lactams, in 
high enantioselectivies.15 However, enolate-stabilized lactams such as 253 had yet to be 
explored in our palladium-catalyzed allylic alkylation chemistry. As such, we utilized 
easy-to-access model substrate 254 in order to explore the effects of protecting groups on 
yield and selectivity in our desired allylic alkylation reaction (Table A13.3). Through a 
series of optimization studies, we found that the nature of both the nitrogen (Table 
A13.3a) and ketone (Table A13.3b) protecting groups play pivotal roles on the 
enantioselectivity of the palladium-catalyzed decarboxylative alkylation of enolate-
stabilized lactam 253. Ultimately, we determined that protecting the amide nitrogen of 
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functionality as a gem-dimethyl-dioxane moiety allowed us to access corresponding 
product 257 in the highest enantioselectivity (93% ee) and a moderate 46% yield.  
 




[a] Reaction performed in cyclohexane.  
 
 Having completed these optimization efforts, we moved to pursue the preparation 
of synthetically relevant substrate 260 for the proposed palladium-catalyzed allylic 
alkylation reaction (Scheme A13.8). Protected lactam 258 can be accessed in three steps 
from Boc-β-alanine (231). Subsequent acylation and allylation provided desired allylic 
alkylation substrate 260. Of note, iridium-catalyzed allylic alkylation was required for the 
allylation of 259, as we found that all attempts to allylate extremely sterically demanding 
259 using standard methods resulted in returned starting material or deprotection of the 




Pd2(dba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX L15  (12.5 mol %)
hexane/toluene (2:1), 35 °C, 18 h
Entry Conversion (%) ee (%)
1 42 48
2a 7 29
3 4-MeO-Bz 75 62
4 3,4,5-triMeO-Bz 86 61

















a) Optimization of Lactam Protecting Group




Pd2(dba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX L15  (12.5 mol %)
hexane/toluene (2:1), 35 °C, 18 h
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high 84% yield. Unfortunately, attempts to render the allylic alkylation reaction 
enantioselective utilizing our optimization conditions from model system 257 (Table 
A13.3) resulted in only modest enantioselectivities and yields, likely due to the now 
increased steric bulk around the reactive site. Additional studies into alternate palladium-
catalyzed allylic alkylation systems, specifically those utilizing Trost ligands known to 
tolerate more sterically encumbered substrates, 16  also showed poor reactivity. 
Nonetheless, we were pleased to find that we could advance rac-261 through an 
ozonolysis and an acid-catalyzed aldol reaction to provide desired spirocyclic enone 263. 
 
Scheme A13.8 Synthesis of spirocyclic intermediate 263 via palladium-catalyzed allylic alkylationa 
 
 
[a] pMBz = 4-MeO-Bz 
 
We next attempted to alkylate spirocyclic enone 263 in order to obtain α’-
alkylated intermediate 267 (Scheme A13.9). To our dismay, early efforts to directly 













1. LiHMDS, THF, –78 °C
2. methallyl Manders, –60 °C
              (80% yield)
allyl methyl carbonate
[Ir(cod)Cl]2 (2 mol %)
 rac-L2 (4 mol %)
LiBr (200 mol %), TBD (10 mol %)
THF, 23 °C
(90% yield)
i. O3, CH2Cl2, –78 °C
ii. PPh3, –78 °C → 23 °C




Pd(PPh3)4 (5 mol %) or
Pd2(pmdba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX L15  (10.5 mol %)
hexanes/toluene (0.03 M), 35 °C
(84% yield, rac)
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neopentyl nature of the intermediate enolate, as well as the possibility of competitive γ-
functionalization. We also found that forming silyl enol ether 266 was not fruitful, and 
were thus unable to explore alternate alkylation strategies.  
 




A13.4   PIPERIDONE PALLADIUM-CATALYZED ALLYLIC ALKYLATION 
ROUTE 
In light of our inability to achieve a highly enantioselective palladium-catalyzed 
allylic alkylation using enolate-stabilized lactam substrate 253 (Section A13.3), we chose 
to investigate a modified palladium-catalyzed allylic alkylation route that employed a 
class of substrates already known to be successful in our group’s methodology: 
piperidones (Scheme A13.10).17 In this revised retrosynthetic analysis of (+)-isopalhinine 
A (221), the N-alkylation and intramolecular Diels–Alder disconnects of the previous 
routes remain, however [4+2] substrate 222 is now the result of an acyl anion addition 
into imine 268, which would arise from a late-stage oxidation of piperidine 269. Similar 
to the previous palladium-catalyzed allylic alkylation route, enone 269 would be formed 
i. LiHMDS
   THF, –78 °C
ii. 264 or allyl iodide
























i. KOt-Bu or TBAT
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via ozonolysis and aldol condensation of diene 270. We envisioned that ether 270 would 
be prepared by diastereoselective reduction of enantioenriched piperidone 271, which 
would be formed via enantioselective palladium-catalyzed decarboxylative allylic 
alkylation of substrate 272. 
 
Scheme A13.10 Retrosynthetic analysis of (+)-isopalhinine A (221) via palladium-catalyzed allylic 




We first explored the feasibility of this revised plan by investigating the reactivity 
of benzyl-protected piperidone 273 (Scheme A13.11). Acylation and alkylation afforded 
allylic alkylation substrate 274, which we were pleased to find smoothly underwent the 
proposed palladium-catalyzed decarboxylative allylic alkylation to afford corresponding 
product 275 in excellent 93% yield and good 82% ee. Of note, product 275 is the 
incorrect enantiomer to access (+)-isopalhinine A (221), however, the challenges of 
preparing the requisite (R)-L15 led us to explore the early chemistry of this route using 
the easy-to-access 275. Subsequent diastereoselective reduction of ketone 275 using CBS 
catalyst delivered alcohol 276 in a 9:1 dr. We found that while we were able to protect 
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ozonolysis of diene 277. Realizing that the basic nitrogen of 277 was likely problematic 
in the ozonolysis reaction, we directed efforts toward investigating alternative protecting 
groups for piperidone 273, ultimately selecting a Boc group.  
 




Boc-protected piperidone 279 performed similarly to benzyl-protected analogue 
273 in the palladium-catalyzed decarboxylative allylic alkylation reaction, providing 
product 281 in 73% yield and 90% ee (Scheme A13.12). However, the CBS reduction of 
ketone 281 to give hydroxy 282 proceeded in significantly diminished yields and a now 
moderate 4:1 dr. Moreover, despite exploring a variety of conditions, efforts to either 
protect alcohol 282 or perform an ozonolysis were not successful. Given these difficulties 
and our concern with successfully performing the proposed selective late-stage oxidation 













O 1. NaH, diallyl carbonate
    THF, 0 °C → 23 °C
2. methallyl bromide, K2CO3
    TBAI, acetone, 50 °C                 
              (23% yield)273
Pd2(dba)3 (5 mol %)
(S)-t-BuPHOX L18  (10.5 mol %)
THF, 23 °C







(S)-CBS catalyst (20 mol %)
BH3•SMe2 (200 mol %)
CH2Cl2, 0 °C















Appendix 13 – Progress Toward the Synthesis of (+)-Isopalhinine A 
  




A13.5  DIASTEREOSELECTIVE ROUTE 
While working to develop an enantioselective route to key spirocyclic 
intermediate 223, we wondered whether we could carry out a rapid, diastereoselective 
synthesis of 223 that would enable the preparation of large quantities of the compound 
for the purposes of exploring the proposed late-stage chemistry (Scheme A13.13). 
Toward this end, we envisioned that spirocyclic intermediate 223 could arise from an 
alkylation and ring closing metathesis of unmasked dioxin 285,18 which would now be 













O 1. NaH, diallyl carbonate
    THF, 0 °C → 23 °C
2. methallyl bromide, K2CO3
    TBAI, acetone, 50 °C                 
              (17% yield)279
Pd2(dba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX L15  (10.5 mol %)
THF (0.05 M), 23 °C







(S)-CBS catalyst (20 mol %)
BH3•SMe2 (200 mol %)
CH2Cl2, 0 °C
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In the forward direction, we began our studies with known β-ketolactam 232 
(Scheme A13.14). Reduction of the ketone functionality with sodium borohydride 
followed by protection of the resultant hydroxyl group gave silyl ether 287 in 70% yield. 
Disappointingly, attempts to allylate or alkylate lactam 287 returned only deprotected 
starting material.  
 













































1. NaBH4, CH2Cl2/AcOH (9:1)
    0 °C → 23 °C
2. TBDPSCl, imidazole
    CH2Cl2, 23 °C





i. LiHMDS, THF, –78 °C
ii. allyl bromide





i. LiHMDS, THF, –78 °C
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Realizing that we would need to replace the Boc group of lactam 287 with a base-
stable protecting group in order to promote functionalization, we considered alkylating 
lactam 291 with the requisite hydroxypropyl tether required for the proposed late-stage 
N-alkylation event (Scheme A13.13). Unfortunately, despite significant efforts to N-
alkylate lactam 291, we observed only elimination of the iodide on the alkylating reagent 
or elimination of the silyl ether of 291 to form an enamide (Scheme A13.15).  
 




To circumvent the issues we were observing with functionalizing lactam 287, we 
explored an alternative route to RCM precursor 298 that did not require the use of strong 
base, but would instead rely on a diastereoselective Tsuji reaction18a (Scheme A13.16). In 
this synthetic sequence, secondary amine 293 is acylated with 294 to give amide 295 in 
76% yield. Subsequent Dieckmann condensation delivered functionalized β-ketolactam 
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We were disappointed to find that attempts to advance β-ketolactam 296 to Tsuji 
substrate 297 were unsuccessful (Scheme A13.17). Specifically, we found that we could 
only reduce ketone 296 in low yields using sodium borohydride (Scheme A13.17, top). 
Efforts to protect the resultant hydroxy group resulted in retro Dieckmann products of 
296 (Scheme A13.17, middle), as did attempts to alkylate 296 with dioxin 28818 (Scheme 
A13.7, bottom). 
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A13.6   FUTURE DIRECTIONS AND PROPOSED LATE-STAGE CHEMISTRY 
TO ACCESS (+)-ISOPALHININE A 
  Should additional efforts enable access to key spirocyclic intermediate 223 via 
any of the aforementioned routes, the proposed late-stage chemistry to synthesize (+)-
isopalhinine A (221) is detailed in Scheme A13.18. Enone 223 will be converted to 
desired cyclohexadiene 302 by enolization and trapping with chloromethyl methyl ether. 
Diastereoselective addition of an acrolein-derived acyl anion equivalent (e.g., 303) to the 
amide functionality of 302 by approach of the anion over the olefinic group (i.e., α-face 
attack) will then provide Diels–Alder substrate 304 upon revealing the carbonyl group by 
desilylation and cyanide extrusion. Such masked acyl-anion additions to lactams have 
ample precedent in the literature,19 and we anticipate that the keto aminal (e.g., 222a) will 
likely be stable to subsequent manipulation, potentially as the free hydroxyl.20 If the need 
arises, we anticipate protecting hemiaminal 222a as a BOM ether (222b), or alternatively, 
reducing to the α-amidocarbonyl system (i.e., 222c).  
From spirocycle 222, an intramolecular diastereoselective [4+2] Diels–Alder 
cycloaddition will furnish the isotwistane core of (+)-isopalhinine A (221) to yield 305.21 
The diastereoselectivity of the IMDA is controlled by the tethering of the dienophile to 
the top face of the spirocycle. Cleavage of the benzyl residues will occur via transfer 
hydrogenolysis (note: BOM cleavage would occur here if 305b is employed) to yield 
aminoalcohol 306. 22  Subsequent N-alkylation via an iridium-catalyzed “borrowing 
hydrogen”-type alkylation will install the final ring.23  Finally, removal of remaining 
MOM group with acid will deliver (+)-isopalhinine A (221). If we are confronted with 
stability issues that require the use of ketone 307b, a late-stage oxidation (e.g., with 
643
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K2Fe(CN)6/NaHCO3/H2O, 24  O2/SiO2/H2O, 25  MnO2, 26  NaOMe/O2/H2O 27 ) will be 
employed to install the aminal group and reach (+)-isopalhinine A (221). 
 
Scheme A13.18 Proposed route to (+)-isopalhinine A (221) from alkylated spirocycle 223  
 
 
   
  Preliminary studies have been undertaken to investigate the proposed acyl anion 
addition chemistry in model systems. While the addition of aryl-functionalized silyl 
cyanohydrins into lactams is known,19 acrolein-derived silyl cyanohydrin, such as 303, 
additions have yet to be explored. Our early studies indicated that γ-addition of acrolein 
equivalent 303 is a competitive pathway. As such, we anticipate that future studies into 
this addition chemistry will involve alternative silyl cyanohydrins, especially those with 



































222a: R = OH1. BOMCl
i-Pr2NEt
2. Et3SiH
TFA 222c: R = H





























    toluene, 110 °C
307a: R = OH
307b: R = H  [O]
305a: R = OH
305c: R = H
305b: R = OBOM
306a: R = OH
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will preclude γ-addition (Scheme A13.19). In the case of masked olefin equivalents, 
following addition, the olefin functionality of 222 can then be exposed by mesylation and 
elimination of the primary alcohol in addition product 313.30  
 
Scheme A13.19 Alternative acyl anion equivalents 
 
 
A13.7   CONCLUSIONS 
In summary, we have detailed our efforts toward the total synthesis of (+)-
isopalhinine A (221) including routes featuring an iridium-catalyzed allylic alkylation of 
an alkyl-substituted electrophile, a palladium-catalyzed allylic alkylation of an enolate-
stabilized lactam, a palladium-catalyzed allylic alkylation of a piperidone, and a 
diastereoselective alkylation/allylation sequence. Each of these routes to (+)-isopalhinine 
A (221) preserve the endgame strategy discussed in Section A13.6, wherein variants of 
key spirocycle 223 is imagined to be advanced to the natural product. Future studies may 
include further optimization of the iridium-catalyzed allylic alkylation reaction of Section 
A13.2 using dual metal catalysis and alternative alkylation methods of palladium-
catalyzed allylic alkylation intermediate 263 of Section A13.3. The successful completion 















    CH2Cl2
2. KOH, TBAB
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A13.8  EXPERIMENTAL SECTION 
A13.8.1 MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried 
by passage through an activated alumina column under argon. Commercially obtained 
reagents were used as received. Chemicals were purchased from Sigma 
Aldrich/Strem/Alfa Aesar/Oakwood Chemicals and used as received.  Reaction 
temperatures were controlled by an IKAmag temperature modulator. Glove box 
manipulations were performed under a nitrogen atmosphere. Thin-layer chromatography 
(TLC) and preparatory TLC was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized by UV fluorescence quenching, KMnO4, or p-
anisaldehyde staining. SiliaFlash P60 Academic Silica gel (particle size 0.040–0.063 
mm) was used for flash chromatography. Analytical chiral HPLC was performed with an 
Agilent 1100 Series HPLC utilizing a Chiralpak AD-H column (4.6 mm x 25 cm), 
Chiralpak AD column (4.6 mm x 25 cm), or a Chiralpak OJ column (4.6 mm x 25 cm), 
all obtained from Daicel Chemical Industries, Ltd. with visualization at 210 nm. 
Analytical SFC was performed with a Mettler SFC supercritical CO2 analytical 
chromatography system utilizing a Chiralpak OJ-H column (4.6 mm x 25 cm) or 
Chiralpak AS-H column (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, 
Ltd. with visualization at 210 nm. 1H NMR spectra were recorded on a Bruker Avance 
HD 400 MHz spectrometer or a Varian Inova 500 MHz spectrometer and are reported 
relative to residual CHCl3 (δ 7.26 ppm). 13C NMR spectra were recorded on a Bruker 
Avance HD 400 MHz spectrometer or a Varian Inova 500 MHz spectrometer and are 
646
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reported relative to residual CDCl3 (δ 77.16 ppm). Data for 1H NMR are reported as 
follows: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = 
multiplet, br s = broad singlet. Data for 13C NMR are reported in terms of chemical shifts 
(δ ppm). Some reported spectra include minor solvent impurities of benzene (δ 7.36 
ppm), water (δ 1.56 ppm), ethyl acetate (δ 4.12, 2.05, 1.26 ppm), methylene chloride (δ 
5.30 ppm), grease (δ 1.26, 0.86 ppm), and/or silicon grease (δ 0.07 ppm), which do not 
impact product assignments. IR spectra were obtained using a Perkin Elmer Paragon 
1000 spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm-1).  
 
A13.8.1.1 Preparation of Known Compounds 
Previously reported methods were used to prepare ligands (R,R,Ra)-L1631 and 
(S,S,Sa)-L17. 32  (S)-L18 was purchased from Sigma Aldrich. For the preparation of 
ligands L2, L5, L11, and L15, see chapter or appendix where initially disclosed. 
Literature procedures were used to prepare known compounds 228–230,4,5 232,7 239,33 
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A13.8.2 EXPERIMENTAL PROCEDURES AND SPECTROSCOPIC DATA 
A13.8.2.1 Experimental Procedures and Spectroscopic Data for the Synthesis 
of Synthetic Intermediates in Section A13.2 
 
 
(E)-6-(Benzyloxy)hex-2-en-1-yl methyl carbonate (226). Pyridine (2.8 mL, 34 mmol, 
3.0 equiv) was added to a solution of alcohol 2304,5 (2.4 g, 11 mmol, 1.0 equiv) in 
CH2Cl2 (100 mL) at 0 °C, followed by addition of methyl chloroformate (1.3 mL, 17 
mmol, 1.5 equiv) dropwise. The resulting solution was allowed to warm to ambient 
temperature and was stirred for 18 h. The reaction was quenched with the addition of 1 M 
HCl (20 mL) and the aqueous layer was extracted with CH2Cl2 (3 x 30 mL). The 
combined organic layers were washed with brine (20 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
column chromatography (10% EtOAc/hexanes) to give carbonate 226 as a colorless oil 
(2.7 g, 89% yield): 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.28 (m, 5H), 5.91 – 5.72 (m, 
1H), 5.60 (dtt, J = 15.5, 6.5, 1.4 Hz, 1H), 4.56 (dq, J = 6.4, 1.0 Hz, 2H), 4.49 (s, 2H), 




Tert-butyl 3-allyl-2,4-dioxopiperidine-1-carboxylate (233). To a solution of β-
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equiv) followed by allyl iodide (1.6 mL, 17 mmol, 0.9 equiv). The resulting solution was 
stirred for 18 h at ambient temperature, whereupon the reaction mixture was directly 
purified by silica gel flash column chromatography (30–50% EtOAc/hexanes) to give 
allyl 233 as a tan oil (1.8 g, 37% yield): 1H NMR (400 MHz, CDCl3) δ 5.90 (ddtd, J = 
17.1, 10.2, 7.0, 1.0 Hz, 1H), 5.23 – 4.96 (m, 2H), 4.62 – 4.39 (m, 1H), 3.88 – 3.68 (m, 
1H), 3.61 – 3.42 (m, 1H), 2.80 – 2.41 (m, 4H), 1.55 (s, 9H); 13C NMR (101 MHz, CDCl3) 




oxopentanoate (234). To a suspension of NaH (2.8 g, 82 mmol, 1.2 equiv, 60% in 
mineral oil) in DME (300 mL) was added a solution of β-ketoester 23933 (17 g, 71 mmol, 
1.0 equiv) in DME (100 mL) followed by a solution of (2-bromoethoxy)(tert-
butyl)dimethylsilane (19 g, 78 mmol, 1.1 equiv) and sodium iodide (5.4 g, 36 mmol, 0.5 
equiv) in DME (50 mL). The resulting solution was heated under reflux for 18 h, then 
cooled to ambient temperature, filtered through a pad of silica, rinsing with EtOAc, and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
column chromatography (20–80% EtOAc/hexanes) to give silyl ether 234 as a pale 
orange oil (20 g, 69% yield): 1H NMR (400 MHz, CDCl3) δ 4.97 (s, 1H), 3.78 – 3.67 (m, 
4H), 3.61 (td, J = 6.0, 1.7 Hz, 2H), 3.37 (q, J = 5.9 Hz, 2H), 2.93 – 2.64 (m, 2H), 2.13 – 
1.99 (m, 2H), 1.42 (s, 9H), 0.87 (s, 9H), 0.02 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 











carboxylate (235). Please note Absolute and relative stereochemistry were not 
determined, and the structure is drawn by analogy to previous work.9 A general 
procedure for the optimization reactions (Table A13.1) is as follows. In a nitrogen-filled 
glove box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 
mg, 0.0040 mmol, 2 mol %), ligand (0.0080 mmol, 4 mol %), TBD (2.8 mg, 0.020 mmol, 
10 mol%), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 min) while another 1 
dram vial (vial B) was charged with additive (0.40 mmol, 200 mol %), nucleophile 233 
(103 mg, 0.40 mmol, 2.0 equiv), and THF (1 mL). The pre-formed catalyst solution (vial 
A) was then transferred to vial B followed by carbonate 226 (53 mg, 0.20 mmol, 1.0 
equiv). The vial was sealed and stirred at 23 °C. After 18, the vial was removed from the 
glove box and filtered through a pad of silica, rinsing with EtOAc, and concentrated 
under reduced pressure. The regioselectivity was determined by TOF LCMS 
(PMM_10min_50-80 ACN-AcOH). The crude mixture was purified by silica gel flash 
column chromatography (5–20% EtOAc/hexanes) to give allylic alkylation product 235 
as a colorless oil and an inseparable mixture of branched and linear isomers: 1H NMR 
(400 MHz, CDCl3) δ 7.45 – 7.05 (m, 5H), 5.74 – 5.41 (m, 2H), 5.36 – 4.91 (m, 4H), 4.46 
(d, J = 4.7 Hz, 2H), 3.93 – 3.62 (m, 2H), 3.49 – 3.33 (m, 2H), 2.70 – 2.44 (m, 6H), 2.03 
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CDCl3) δ 207.9, 207.6, 207.3, 172.0, 152.1, 138.7, 135.5, 132.2, 128.5, 127.7, 123.7, 
119.8, 83.8, 73.0, 69.7, 64.2, 42.0, 41.3, 40.4, 39.3, 29.4, 29.3, 28.1. 
 
 
Tert-butyl (3-oxo-3-(2-oxotetrahydrofuran-3-yl)propyl)carbamate (238). To a 
solution of silyl ether 234 (7.6 g, 19 mmol, 1.0 equiv) in THF (200 mL) was added TBAF 
(25 mL, 25 mmol, 1.3 equiv). The resulting solution was stirred at ambient temperature 
for 7 h, whereupon the reaction mixture was concentrated onto silica gel under reduced 
pressure and purified by silica gel flash column chromatography (50–70% 
EtOAc/hexanes) to give lactone 238 as a pale pink oil (4.4 g, 91% yield): 1H NMR (400 
MHz, CDCl3) δ 4.92 (s, 1H), 4.46 – 4.24 (m, 2H), 3.80 – 3.66 (m, 1H), 3.52 – 3.27 (m, 
2H), 3.27 – 3.09 (m, 1H), 2.95 – 2.69 (m, 2H), 2.32 (dddd, J = 13.3, 9.3, 7.9, 5.7 Hz, 1H), 
1.42 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 201.9, 172.5, 155.8, 79.5, 67.5, 52.2, 42.7, 
35.1, 28.4, 23.8. 
 
 
(E)-(((6-Chlorohex-4-en-1-yl)oxy)methyl)benzene (240, LG = Cl). To a solution of N-
chlorosuccinimide (1.9 g, 14 mmol, 1.5 equiv) in CH2Cl2 (40 mL) at 0 °C was added 
dimethyl sulfide (1.3 mL, 17 mmol, 1.9 equiv) dropwise over 5 min. A solution of 
alcohol 2304,5 (1.9 g, 9.3 mmol, 1.0 equiv) in CH2Cl2 (10 mL) was then added and the 
resulting solution was stirred at 0 °C for 2 h, whereupon the mixture was allowed to 
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the addition of H2O (20 mL), and the aqueous layer was extracted with Et2O (3 x 20 mL). 
The combined organic layers were washed with brine (20 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude residue was purified by silica gel flash 
column chromatography (5% EtOAc/hexanes) to provide chloride 240 as a pale yellow 
oil (1.7 g, 83% yield): 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.26 (m, 5H), 5.82 – 5.72 
(m, 1H), 5.66 – 5.58 (m, 1H), 4.50 (s, 2H), 4.02 (dd, J = 7.1, 1.0 Hz, 2H), 3.48 (t, J = 6.4 
Hz, 2H), 2.25 – 2.07 (m, 2H), 1.81 – 1.61 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 138.6, 




c]pyridin-4(2H)-one (241). Please note Absolute and relative stereochemistry were not 
determined, and the structure is drawn by analogy to previous work.9 A general procedure 
for the optimization reactions (Table A13.2) is as follows. In a nitrogen-filled glove box, 
to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (1.3 mg, 0.0020 
mmol, 2 mol %), ligand (0.0040 mmol, 4 mol %), TBD (1.4 mg, 0.010 mmol, 10 mol %), 
and THF (0.5 mL). Vial A was stirred at 25 °C (ca. 10 min) while another 1 dram vial 
(vial B) was charged with additive (0.20 or 0.40 mmol, 200 or 400 mol %), lactone 
nucleophile 238 (52 mg, 0.20 mmol, 2.0 equiv), and THF (0.5 mL). The pre-formed 
catalyst solution (vial A) was then transferred to vial B followed by electrophile 240 
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removed from the glove box and concentrated under reduced pressure to give lactone 
allylic alkylation product 237. 
To crude 237 was added TFA/CH2Cl2 (1:1, 1 mL) and the resulting solution was 
stirred for 3 h, whereupon NEt3/CH2Cl2 (1:1, 1 mL) was added. The resulting solution 
was stirred for 18 h, whereupon brine (1 mL) was added. The aqueous layer was 
extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were dried over Na2SO4, 
concentrated under reduced pressure and 1,2,4,5-tetrachloro-3-nitrobenzene (0.10 mmol 
in 0.5 mL CDCl3) was added. The NMR yield (measured in reference to 1,2,4,5-
tetrachloro-3-nitrobenzene δ 7.74 ppm (s, 1H)) was determined by 1H NMR analysis of 
the crude mixture. The residue was purified by preparatory TLC (50% acetone/hexanes) 
to afford hemiacetal 241 as an inseparable mixture of diastereomers. The major 
diastereomer was isolated by preparatory HPLC (reverse phase, MeCN/H2O, C18 
column): 96% ee; 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.27 (m, 5H), 5.75 – 5.49 (m, 
2H), 5.21 – 4.91 (m, 2H), 4.48 (s, 2H), 4.04 – 3.94 (m, 1H), 3.70 (dddd, J = 16.7, 9.9, 
8.3, 7.1 Hz, 1H), 3.53 – 3.28 (m, 3H), 3.22 – 3.07 (m, 1H), 2.69 – 2.41 (m, 3H), 2.39 – 
2.11 (m, 3H), 1.89 (dd, J = 13.6, 4.9 Hz, 1H), 1.67 (tdd, J = 10.6, 7.1, 4.2 Hz, 2H), 1.51 – 
1.38 (m, 1H), 1.24 (ddt, J = 17.0, 8.8, 4.4 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 174.4, 
173.9, 140.2, 139.4, 138.8, 138.7, 128.5, 128.5, 127.9, 127.8, 127.7, 127.6, 118.3, 116.4, 
103.4, 103.3, 73.1, 72.9, 70.4, 69.8, 65.6, 65.1, 59.4, 58.9, 48.2, 47.2, 38.3, 38.3, 35.7, 
33.9, 32.0, 30.6, 28.4, 27.6, 27.6, 26.5; HPLC conditions: 8% IPA, 1.0 mL/min, 
Chiralpak AD–H column, λ = 210 nm, tR (min): major = 21.087, minor = 21.876. 
653




(epoxyethano)furo[3,2-c]pyridin-4(5H)-one (243). To a solution of hemiacetal 241 (13 
mg, 0.036 mmol, 1.0 equiv) in dioxane/H2O (7:1, 0.5 mL) was added PdCl2 (1.0 mg, 
0.0056 mmol, 0.16 equiv) and copper(I) chloride (3.6 mg, 0.036 mmol, 1.0 equiv). The 
resulting solution was sparged with oxygen (balloon) and stirred under an oxygen 
atmosphere for 4 h, whereupon the reaction mixture was filtered through a pad of silica, 
rinsing with EtOAc, and concentrated under reduced pressure. The crude residue was 
purified by silica gel flash column chromatography (30% acetone/hexanes) to provide 
243 as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.28 (m, 5H), 6.03 (s, 1H), 
4.49 (d, J = 2.4 Hz, 2H), 4.25 (td, J = 8.6, 6.8 Hz, 1H), 3.86 (td, J = 8.3, 3.8 Hz, 1H), 3.57 
– 3.40 (m, 2H), 3.21 (dp, J = 6.8, 2.9 Hz, 2H), 2.95 (s, 1H), 2.45 (ddd, J = 13.5, 6.7, 3.9 
Hz, 1H), 2.23 (dt, J = 13.4, 8.5 Hz, 1H), 2.17 (s, 1H), 2.16 – 2.07 (m, 2H), 1.96 (ddd, J = 
13.5, 8.2, 5.4 Hz, 2H), 1.78 (dq, J = 8.6, 3.4, 2.1 Hz, 5H), 1.53 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 176.4, 138.7, 128.5, 127.9, 127.6, 115.1, 104.8, 73.1, 70.6, 67.2, 54.9, 















(epoxyethano)furo[3,2-c]pyridin-4(5H)-one (244). Olefin 244 was isolated as a 
byproduct in the synthesis and/or purification of 243. The amount of olefin 244 was 
found to increase when the crude reaction mixture of 243 was subjected to reduced 
pressure: 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.27 (m, 5H), 6.06 (d, J = 5.4 Hz, 1H), 
4.47 (s, 2H), 4.01 (ddd, J = 8.4, 5.3, 2.9 Hz, 1H), 3.78 – 3.67 (m, 1H), 3.42 (t, J = 6.4 Hz, 
2H), 3.31 – 3.12 (m, 2H), 2.34 (dt, J = 13.5, 2.9 Hz, 1H), 2.26 – 2.19 (m, 3H), 1.83 (s, 
3H), 1.71 (td, J = 8.4, 4.5 Hz, 4H), 0.99 – 0.69 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 
207.2, 173.8, 152.8, 138.6, 128.5, 127.8, 114.7, 106.2, 73.0, 69.8, 66.9, 64.5, 37.9, 34.46, 




To a solution of hemiacetal 241 (56 mg, 0.16 mmol, 1.0 equiv) in CH2Cl2 (5 mL) was 
added Dess–Martin periodinane (83 g, 0.20 mmol, 1.2 equiv). The resulting solution was 
heated in a sealed vial to 50 °C for 2.5 h, whereupon the reaction mixture was cooled to 
ambient temperature, diluted with Et2O, sequentially washed with 10% aqueous 
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Na2SO4, and concentrated under reduced pressure. The crude residue was purified by 
silica gel flash column chromatography (50% EtOAc/hexanes then 50% acetone/hexanes) 
to provide 245 as a colorless oil (26 mg, 46% yield): 1H NMR (400 MHz, CDCl3) δ 9.52 
(s, 1H), 7.36 – 7.27 (m, 5H), 6.45 (d, J = 14.5 Hz, 1H), 5.49 (ddt, J = 43.8, 16.9, 10.0 Hz, 
1H), 5.19 (td, J = 10.3, 1.7 Hz, 1H), 5.10 – 5.02 (m, 1H), 4.46 (s, 3H), 3.74 (dtd, J = 12.0, 
5.5, 2.6 Hz, 1H), 3.63 (dtd, J = 14.2, 6.4, 3.6 Hz, 1H), 3.57 – 3.47 (m, 1H), 3.42 (dddd, J 
= 8.7, 7.3, 3.5, 2.2 Hz, 3H), 3.37 – 3.15 (m, 2H), 3.01 – 2.81 (m, 1H), 2.74 – 2.59 (m, 
1H), 2.46 (ddd, J = 12.2, 10.0, 2.3 Hz, 1H), 1.75 – 1.60 (m, 3H), 1.45 – 1.16 (m, 3H); 13C 
NMR (126 MHz, CDCl3) δ 207.6, 207.2, 199.9, 173.8, 173.1, 138.5, 136.6, 136.4, 128.5, 
127.8, 127.7, 119.9, 119.2, 89.5, 73.0, 72.9, 69.7, 59.9, 59.3, 50.6, 50.4, 49.2, 38.9, 37.9, 




(epoxyethano)cyclopenta[c]pyridine-1,6(2H,7H)-dione (247). To a solution of 
aldehyde 245 (39 mg, 0.11 mmol, 1.0 equiv) in dioxane/H2O (7:1, 1.5 mL) was added 
PdCl2 (2.0 mg, 0.011 mmol, 0.1 equiv) and copper(I) chloride (11 mg, 0.11 mmol, 1.0 
equiv). The resulting solution was sparged with oxygen (balloon) and stirred under an 
oxygen atmosphere for 18 h, whereupon the reaction mixture was filtered through a pad 
of silica, rinsing with EtOAc, and concentrated under reduced pressure. The crude 
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to provide 247 as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 7.33 (d, J = 0.9 Hz, 5H), 
5.55 (d, J = 6.1 Hz, 1H), 4.53 – 4.45 (m, 4H), 3.55 – 3.40 (m, 4H), 3.20 (dt, J = 7.7, 4.0 
Hz, 3H), 2.88 – 2.75 (m, 1H), 2.66 – 2.41 (m, 3H), 2.33 (t, J = 6.7 Hz, 1H), 2.22 – 2.07 
(m, 2H), 1.92 (ddd, J = 13.8, 8.8, 5.4 Hz, 1H), 1.88 – 1.70 (m, 6H); 13C NMR (101 MHz, 
CDCl3) δ 175.8, 138.5, 128.4, 127.8, 127.6, 116.1, 107.0, 99.8, 72.9, 70.4, 55.0, 38.2, 




2-one (248). Please note Relative stereochemistry was not confirmed. To a solution of 
hemiacetal 241 (25 mg, 0.072 mmol, 1.0 equiv) in MeOH (1 mL) was added NaBH4 (8.0 
mg, 0.22 mmol, 3.0 equiv). The resulting solution was stirred for 18 h, whereupon the 
reaction was quenched with a saturated aqueous solution of sodium citrate (1 mL) and 
extracted with EtOAc (3 x 5 mL), washed with brine (5 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude residue was purified by preparatory TLC 
(33% acetone/hexanes) to provide hydroxy 248 as a colorless oil (11 mg, 44% yield): 1H 
NMR (400 MHz, CDCl3) δ 7.39 – 7.26 (m, 5H), 5.99 (ddd, J = 17.3, 8.6, 2.6 Hz, 1H), 
5.85 – 5.67 (m, 1H), 5.27 – 5.04 (m, 2H), 4.48 (d, J = 3.0 Hz, 2H), 4.03 (ddd, J = 23.5, 
7.0, 4.3 Hz, 1H), 3.94 – 3.64 (m, 2H), 3.58 – 3.39 (m, 3H), 3.26 (dddd, J = 14.5, 11.7, 
6.9, 4.0 Hz, 1H), 2.70 (dtd, J = 9.4, 6.0, 2.6 Hz, 1H), 2.16 – 1.98 (m, 3H), 1.94 – 1.82 (m, 
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CDCl3) δ 176.4, 176.3, 140.5, 138.7, 138.7, 138.6, 128.5, 128.5, 128.4, 127.9, 127.8, 
127.7, 127.6, 118.3, 117.6, 73.0, 72.9, 71.4, 70.9, 70.4, 70.3, 59.5, 59.4, 52.5, 52.1, 47.7, 




yl)acetaldehyde (249). To solution of alcohol 248 (10 mg, 0.029 mmol, 1.0 equiv) in 
MeCN (1 mL) was added IBX (25 mg, 0.089 mmol, 3.0 equiv). The resulting solution 
was stirred for 18 h, whereupon the reaction mixture was filtered through celite, rinsing 
with EtOAc, and concentrated under reduced pressure. The crude residue was purified by 
preparatory TLC (44% acetone/hexanes) to provide aldehyde 249 as a colorless oil (4.0 
mg, 40% yield): 1H NMR (400 MHz, CDCl3) δ 9.52 (s, 1H), 7.36 – 7.28 (m, 5H), 5.45 
(dt, J = 16.9, 10.1 Hz, 1H), 5.20 (ddd, J = 11.4, 10.1, 1.8 Hz, 1H), 5.07 (dddd, J = 17.0, 
12.4, 1.8, 0.6 Hz, 1H), 4.47 (s, 3H), 3.83 – 3.72 (m, 1H), 3.66 (ddd, J = 6.2, 4.6, 2.5 Hz, 
1H), 3.61 – 3.48 (m, 1H), 3.48 – 3.37 (m, 3H), 3.33 (dd, J = 18.9, 5.4 Hz, 1H), 3.02 – 
2.83 (m, 1H), 2.75 – 2.61 (m, 1H), 2.51 – 2.40 (m, 1H), 1.75 – 1.63 (m, 2H), 1.54 – 1.14 
(m, 3H); 13C NMR (101 MHz, CDCl3) δ 207.5, 206.9, 199.9, 199.8, 173.7, 172.9, 138.6, 
136.6, 136.4, 128.5, 127.9, 127.8, 127.72, 127.71, 119.9, 119.2, 73.0, 72.9, 69.8, 69.7, 
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A13.8.2.2 Experimental Procedures and Spectroscopic Data for the Synthesis 




azaspiro[5.5]undecane-7-carboxylate (256). To a solution of LiHMDS (0.89 g, 5.4 
mmol, 1.1 equiv) in THF (20 mL) at –78 °C was added a solution of protected lactam 295 
(1.6 g, 4.9 mmol, 1.0 equiv) in THF (20 mL). The resulting mixture was stirred for 2 h at 
–78 °C, whereupon allyl chloroformate (0.59 g, 5.4 mmol, 1.1 equiv) was added 
dropwise. The reaction mixture was stirred for 3 h at –78 °C followed by an additional 18 
h at –50 °C. The reaction was quenched with the addition of brine (20 mL) and the 
aqueous layer was extracted with CH2Cl2 (3 x 20 mL), washed with brine (5 mL), dried 
over Na2SO4, and concentrated under reduced pressure. The crude residue was purified 
by silica gel flash column chromatography (35% EtOAc/hexanes) to provide acylated-
295 as a colorless oil (0.70 g, 34% yield).  
 To a solution of acylated-295 (0.20 g, 0.48 mmol, 1.0 equiv) in acetone (5 mL) 
was added potassium carbonate (0.33 g, 2.4 mmol, 5.0 equiv) and ethyl iodide (0.39 mL, 
4.8 mmol, 10.0 equiv). The resulting solution was stirred for 18 h at ambient temperature, 
whereupon the mixture was filtered through a pad of silica, rinsing with EtOAc, and 
concentrated under reduced pressure. The crude residue was purified by preparatory TLC 
(50% EtOAc/hexanes) to provide ethyl 256 as a colorless oil (36 mg, 17% yield): 1H 
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1H), 5.51 – 5.19 (m, 2H), 4.86 – 4.60 (m, 2H), 3.82 (s, 4H), 3.79 – 3.40 (m, 6H), 2.74 (dt, 





azaspiro[5.5]undecan-8-one (257). In a nitrogen-filled glove box, to a 1 dram vial 
equipped with a stir bar was added Pd2(dba)3 (3.7 mg, 0.0040 mmol, 5 mol %), (S)-L15 
(5.2 mg, 0.010 mmol, 12.5 mol %), and hexanes/toluene (2:1, 2.7 mL). The resulting 
solution was stirred at 25 °C for 10 min, whereupon substrate 256 (36 mg, 0.081 mmol, 
1.0 equiv) was added. The vial was sealed and stirred at 35 °C for 18 h, whereupon the 
vial was removed from the glove box and filtered through a pad of silica, rinsing with 
EtOAc, and concentrated under reduced pressure. The crude residue was purified by 
preparatory TLC (30% EtOAc/hexanes) to provide allylic alkylation product 257 as a 
colorless solid (7.4 mg, 46% yield): 93% ee; 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 
8.9 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 6.23 – 6.00 (m, 1H), 5.18 – 4.93 (m, 2H), 3.83 (s, 
3H), 3.77 – 3.56 (m, 4H), 3.43 (ddd, J = 11.7, 5.2, 2.6 Hz, 2H), 2.91 – 2.59 (m, 3H), 2.30 
(ddd, J = 14.5, 8.5, 7.3 Hz, 1H), 2.15 – 1.98 (m, 1H), 1.93 (dt, J = 14.4, 7.4 Hz, 1H), 1.20 
(s, 3H), 0.99 (t, J = 7.5 Hz, 3H), 0.77 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 176.8, 
175.3, 162.4, 136.5, 130.1, 128.9, 116.5, 113.6, 100.3, 70.4, 56.8, 55.5, 41.5, 33.2, 29.9, 
25.2, 23.7, 22.5, 20.1, 9.1; SFC conditions: 3% MeOH, 3.0 mL/min, Chiralpak OJ–H 












To a solution of 2327 (45 g, 210 mmol, 1.0 equiv) in toluene (300 mL) was added para-
toluenesulfonic acid (2.0 g, 11 mmol, 0.05 equiv) and 2,2-dimethyl-1,3-propanediol (33 
g, 320 mmol, 1.5 equiv). The resulting solution was heated under reflux for 18 h with 
azeotropic removal of water via Dean–Stark trap, whereupon the mixture was cooled to 
ambient temperature and concentrated under reduced pressure. The crude residue was 
purified by recrystallization from boiling EtOAc to give the protected ketone-232 (23 g, 
54% yield).  
To a solution of protected ketone-232 (1.5 g, 7.5 mmol, 1.0 equiv) in THF (25 
mL) was added NEt3 (1.6 mL, 11.3 mmol, 1.5 equiv), 4-dimethylaminopyridine (0.91 g, 
0.75 mmol, 0.1 equiv), and para-anisoyl chloride (1.3 mL, 9.8 mmol, 1.3 equiv). The 
resulting solution was stirred at ambient temperature for 18 h, whereupon the mixture 
was filtered through celite, rinsing CH2Cl2, and concentrated under reduced pressure. The 
crude reside was purified by silica gel flash column chromatography (20% 
acetone/hexanes) to afford protected lactam 258 as a white solid (1.3 g, 54% yield): 1H 
NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.9 Hz, 2H), 6.88 (d, J = 8.9 Hz, 2H), 3.84 (s, 
3H), 3.82 – 3.75 (m, 2H), 3.55 (s, 4H), 2.92 (t, J = 1.0 Hz, 2H), 2.35 – 2.21 (m, 2H), 1.00 
(d, J = 6.4 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 173.6, 170.6, 162.9, 130.9, 127.6, 














azaspiro[5.5]undecane-7-carboxylate (259). To a solution of LiHMDS (1.1 g, 6.6 
mmol, 1.1 equiv) in THF (40 mL) at –78 °C was added a solution of protected lactam 258 
(2.0 g, 6.0 mmol, 1.0 equiv) in THF (40 mL). The resulting mixture was stirred for 2 h at 
–78 °C, whereupon methallyl chloroformate (0.83 g, 6.6 mmol, 1.1 equiv) was added 
dropwise. The reaction mixture was stirred for 2 h at –78 °C followed by an additional 18 
h at –60 °C. The reaction was quenched with the addition of brine (20 mL) and the 
aqueous layer was extracted with CH2Cl2 (3 x 40 mL), washed with brine (5 mL), dried 
over Na2SO4, and concentrated under reduced pressure. The crude residue was purified 
by silica gel flash column chromatography (20–40% EtOAc/hexanes) to provide acylated 
259 as a colorless foam (2.1 g, 80% yield): 1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.9 
Hz, 2H), 6.85 (d, J = 8.9 Hz, 2H), 5.12 – 4.92 (m, 2H), 4.77 – 4.55 (m, 2H), 4.27 (d, J = 
2.2 Hz, 1H), 4.12 (q, J = 7.2 Hz, 1H), 3.83 (s, 4H), 3.81 – 3.67 (m, 2H), 3.63 – 3.43 (m, 
3H), 2.55 (ddd, J = 13.8, 12.5, 5.9 Hz, 1H), 2.28 (ddt, J = 13.8, 4.5, 2.4 Hz, 1H), 1.79 (d, 

















azaspiro[5.5]undecane-7-carboxylate (260). In a nitrogen-filled glove box, to a 2 dram 
vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (31 mg, 0.046 mmol, 2 mol 
%), rac-L2 (42 mg, 0.093 mmol, 4 mol %), TBD (32 mg, 0.23mmol, 10 mol %), and 
THF (5 mL). Vial A was stirred at 25 °C (ca. 10 min) while another a 100 mL round 
bottom flask was charged with β-ketoamide 259 (1.0 g, 2.3 mmol, 1.0 equiv), LiBr (0.40 
g, 4.6 mmol, 2.0 equiv), and THF (15 mL). The pre-formed catalyst solution (vial A) was 
then transferred to the round bottom flask followed by allyl methyl carbonate (0.40 g, 3.5 
mmol, 1.5 equiv). The flask was removed from the glove box, placed under an argon 
atmosphere, and stirred at ambient temperature for 3.5 h, whereupon the reaction mixture 
was filtered through a pad of silica, rinsing with EtOAc, and concentrated under reduced 
pressure. The crude residue was purified by silica gel flash column chromatography (10% 
EtOAc/hexanes) to afford allylated 260 (0.98 g, 90% yield): 1H NMR (400 MHz, CDCl3) 
δ 7.81 – 7.71 (m, 2H), 6.89 – 6.78 (m, 2H), 6.00 (dddd, J = 16.8, 10.1, 7.7, 6.5 Hz, 1H), 
5.14 – 5.02 (m, 2H), 4.97 (td, J = 4.3, 3.6, 2.2 Hz, 2H), 4.69 – 4.50 (m, 2H), 3.80 (s, 3H), 
3.79 – 3.68 (m, 2H), 3.68 – 3.56 (m, 2H), 3.48 (ddd, J = 21.8, 11.4, 2.6 Hz, 2H), 3.06 – 
2.90 (m, 2H), 2.78 (dt, J = 14.6, 4.9 Hz, 1H), 2.24 (ddd, J = 14.6, 10.3, 5.8 Hz, 1H), 1.76 
















9-azaspiro[5.5]undecan-8-one (rac-261). In a nitrogen-filled glove box, to a 100 mL 
round bottom flask equipped with a stir bar was added Pd(PPh3)4 (46 mg, 0.040 mmol, 
0.05 equiv), substrate 260 (0.37 g, 0.79 mmol, 1.0 equiv), and toluene (20 mL). The flask 
was removed from the glove box, placed under an argon atmosphere, and stirred at 35 °C 
for 18 h, whereupon the reaction mixture was filtered through a pad of silica, rinsing with 
EtOAc, and concentrated under reduced pressure. The crude residue was purified by 
silica gel flash column chromatography (10% EtOAc/hexanes) to afford allylic alkylation 
product rac-261 (0.29 g, 84% yield): 24% ee; 1H NMR (400 MHz, CDCl3) δ 7.66 – 7.52 
(m, 2H), 6.90 – 6.78 (m, 2H), 6.12 (ddt, J = 17.1, 10.1, 7.0 Hz, 1H), 5.11 – 4.94 (m, 2H), 
4.83 (ddd, J = 10.4, 2.4, 1.3 Hz, 2H), 3.83 (s, 4H), 3.70 (dd, J = 18.9, 11.6 Hz, 2H), 3.55 
(ddd, J = 12.6, 10.3, 6.0 Hz, 1H), 3.46 (ddd, J = 11.7, 3.9, 2.5 Hz, 2H), 2.92 – 2.69 (m, 
3H), 2.69 – 2.49 (m, 2H), 2.21 (ddd, J = 14.6, 10.2, 6.5 Hz, 1H), 1.72 (d, J = 0.6 Hz, 3H), 
1.23 (s, 3H), 0.78 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 175.9, 174.7, 162.5, 143.1, 
136.8, 130.7, 128.4, 116.6, 115.9, 113.5, 99.6, 70.4, 56.9, 55.5, 41.4, 41.0, 36.8, 29.9, 
24.7, 23.9, 22.6, 20.2; SFC conditions: 3% MeOH, 3.0 mL/min, Chiralpak AS–H 















azaspiro[5.5]undecan-7-yl)acetaldehyde (262). A solution of olefin 261 (20 mg, 0.047 
mmol, 1.0 equiv) in CH2Cl2 (5 mL) was cooled to –78 °C. Ozone was bubbled through 
the reaction mixture for 0.5 h, whereupon the reaction mixture was sparged with N2 and 
triphenylphosphine (25 mg, 0.094 mmol, 2.0 equiv) was added. The cooling bath was 
then removed and the reaction was stirred for 1.5 h at ambient temperature. The reaction 
mixture was concentrated under reduced pressure and the crude residue was purified by 
silica gel flash column chromatography (40% EtOAc/hexanes) to afford aldehyde 262 as 
a colorless oil (17 mg, 82% yield): 1H NMR (400 MHz, CDCl3) δ 9.59 (s, 1H), 7.67 (d, J 
= 8.9 Hz, 2H), 6.88 (d, J = 8.9 Hz, 3H), 3.83 (s, 4H), 3.78 – 3.61 (m, 5H), 3.42 (ddd, J = 
11.9, 7.3, 2.6 Hz, 2H), 3.20 (d, J = 15.8 Hz, 1H), 3.11 (dd, J = 16.0, 2.6 Hz, 1H), 2.96 (d, 
J = 15.9 Hz, 1H), 2.81 (dd, J = 16.1, 2.1 Hz, 1H), 2.48 (qdd, J = 14.6, 6.9, 5.6 Hz, 2H), 
2.21 (s, 3H), 1.16 (s, 3H), 0.77 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 206.4, 199.1, 


















ene-9,13-dione (263). To a solution of bis-carbonyl 262 (20 mg, 0.046 mmol, 1.0 equiv) 
in toluene (2 mL) was added para-toluenesulfonic acid monohydrate (1 mg, 0.0046 
mmol, 0.1 equiv) and MgSO4 (20 mg, 100 wt %). The resulting slurry was heated to 100 
°C for 0.5 h, whereupon the mixture was cooled to ambient temperature, filtered through 
a pad of silica, rinsing with EtOAc, and concentrated under reduced pressure. The crude 
reside was purified by preparatory TLC (40% acetone/hexanes) to afford enone 263 as a 
colorless oil (10 mg, 53% yield): 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.36 (m, 2H), 
6.89 (ddd, J = 10.2, 5.8, 2.5 Hz, 1H), 6.84 – 6.76 (m, 2H), 6.08 – 5.98 (m, 1H), 3.81 (s, 
3H), 3.77 – 3.54 (m, 4H), 3.45 (ddd, J = 11.7, 4.1, 2.5 Hz, 2H), 3.12 – 2.76 (m, 4H), 2.58 
(dt, J = 14.7, 5.9 Hz, 1H), 2.35 (ddd, J = 14.6, 8.3, 6.1 Hz, 1H), 1.18 (s, 3H), 0.78 (s, 3H); 
13C NMR (101 MHz, CDCl3) δ 197.0, 175.9, 174.2, 162.8, 145.5, 130.3, 129.1, 127.4, 
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A13.8.2.3 Experimental Procedures and Spectroscopic Data for the Synthesis 
of Synthetic Intermediates in Section A13.4 
 
 
Allyl 1-benzyl-3-(2-methylallyl)-4-oxopiperidine-3-carboxylate (274). To a solution of 
NaH (2.2 g, 66 mmol, 2.5 equiv, 60% in mineral oil) in THF (24 mL) at 0 °C was added a 
solution of 1-benzyl-4-piperidone (5 g, 26 mmol, 1.9 equiv) in THF (10 mL) over 15 
min. The resulting mixture was warmed to ambient temperature, diallyl carbonate (5.7 
mL, 40 mmol, 1.5 equiv) was added, and the solution was stirred for an additional 18 h. 
The reaction was quenched with a saturated aqueous solution of NH4Cl (10 mL) and 
acidified (pH = 4) with 1 M HCl. The aqueous layer was extracted with EtOAc (3 x 40 
mL), washed with brine (40 mL), dried over Na2SO4, and concentrated under reduced 
pressure. The crude residue was purified by silica gel flash column chromatography (20% 
EtOAc/hexanes) to provide acylated-274 as a colorless oil (2.5 g, 35% yield). 
 To a solution of acylated-274 (0.10 g, 0.37 mmol, 1.0 equiv) in acetone (5 mL) 
was added potassium carbonate (0.10 g, 0.73 mmol, 2.0 equiv), tetrabutylammonium 
iodide (14 mg, 0.037 mmol, 0.1 equiv), and methallyl bromide (0.074 mL, 0.73 mmol, 
2.0 equiv). The resulting solution was heated to 50 °C for 18 h, whereupon the reaction 
mixture was cooled to ambient temperature, filtered through a pad of silica, rinsing with 
EtOAc, and concentrated under reduced pressure. The crude residue was purified by 
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piperidone 274 as a colorless oil (78 mg, 65% yield): 1H NMR (400 MHz, CDCl3) δ 7.41 
– 7.18 (m, 6H), 5.89 (ddt, J = 17.3, 10.4, 5.8 Hz, 1H), 5.44 – 5.16 (m, 2H), 4.80 (s, 1H), 
4.71 – 4.56 (m, 3H), 3.72 – 3.54 (m, 2H), 3.49 (dd, J = 11.6, 2.7 Hz, 1H), 3.09 – 2.91 (m, 
1H), 2.84 (ddd, J = 15.3, 11.8, 6.6 Hz, 1H), 2.64 (dd, J = 13.9, 0.9 Hz, 1H), 2.46 – 2.34 
(m, 3H), 2.29 (d, J = 11.6 Hz, 1H), 1.66 (t, J = 1.1 Hz, 3H). 
 
 
(S)-3-Allyl-1-benzyl-3-(2-methylallyl)piperidin-4-one (275). In a nitrogen-filled glove 
box, to a 250 mL round bottom flask equipped with a stir bar was added Pd2(dba)3 (81 
mg, 0.088 mmol, 2.5 mol %), (S)-L18 (85 mg, 0.22 mmol, 6.25 mol %), and THF (110 
mL). The resulting solution was stirred at 25 °C for 10 min, whereupon substrate 274 (1.2 
g, 3.5 mmol, 1.0 equiv) was added. The flask was sealed and stirred at ambient 
temperature. After 18, the flask was removed from the glove box and filtered through a 
pad of silica, rinsing with EtOAc, and concentrated under reduced pressure. The crude 
residue was purified by silica gel flash column chromatography (8% EtOAc/hexanes) to 
provide allylic alkylation product 275 as a colorless oil (7.4 mg, 46% yield): 82% ee; 1H 
NMR (400 MHz, CDCl3) δ 7.46 – 7.21 (m, 5H), 5.75 – 5.58 (m, 1H), 5.12 – 4.95 (m, 
2H), 4.84 (dq, J = 2.9, 1.5 Hz, 1H), 4.68 (dq, J = 2.0, 0.9 Hz, 1H), 3.68 – 3.47 (m, 2H), 
2.78 (dddd, J = 8.4, 6.4, 3.1, 1.5 Hz, 1H), 2.69 – 2.56 (m, 4H), 2.53 – 2.45 (m, 2H), 2.46 
– 2.36 (m, 2H), 1.68 (t, J = 1.0 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 212.3, 142.1, 
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24.6; HPLC conditions: 1% EtOH, 1.0 mL/min, Chiralpak OJ column, λ = 210 nm, tR 
(min): major = 10.113, minor = 8.486. 
 
 
(3S,4R)-3-Allyl-1-benzyl-3-(2-methylallyl)piperidin-4-ol (276). Please note Relative 
stereochemistry was not confirmed. To a solution of ketone 275 (0.50 g, 1.8 mmol, 1.0 
equiv) in CH2Cl2 (20 mL) at 0 °C was added (S)-CBS (1 M, 0.35 mL, 0.35 mmol, 0.2 
equiv) followed by BH3•DMS (2 M, 1.8 mL, 3.5 mmol, 2.0 equiv). The resulting solution 
was stirred for 1.5 h, whereupon the reaction was quenched with MeOH (5 mL) and a 
saturated aqueous sodium citrate solution (10 mL) then warmed to ambient temperature 
and stirred for an additional 15 min. The aqueous layer was extracted with Et2O (3 x 30 
mL), dried over Mg2SO4, and concentrated under reduced pressure. The crude residue 
was purified by silica gel flash column chromatography (20% EtOAc/hexanes) to afford 
alcohol 276 as an inseparable mixture (9:1) of diastereomers and a colorless oil (0.50 g, 
59% yield): 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.31 (m, 5H), 5.98 (ddt, J = 17.4, 9.8, 
7.5 Hz, 1H), 5.19 – 5.07 (m, 2H), 4.90 (dd, J = 2.6, 1.4 Hz, 1H), 4.80 (dd, J = 2.6, 1.1 Hz, 
1H), 3.62 (t, J = 6.9 Hz, 1H), 3.53 (d, J = 13.0 Hz, 1H), 3.34 (d, J = 13.1 Hz, 1H), 2.63 – 
2.42 (m, 2H), 2.42 – 2.32 (m, 1H), 2.29 (d, J = 13.3 Hz, 1H), 2.21 – 2.00 (m, 2H), 1.82 (t, 
J = 1.1 Hz, 3H), 1.80 – 1.69 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 144.1, 139.1, 135.6, 
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(3S,4R)-3-Allyl-1-benzyl-4-(methoxymethoxy)-3-(2-methylallyl)piperidine (277). To 
a solution of alcohol 276 (70 mg, 0.25 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at 0°C was 
added DIPEA (0.065 mL, 0.38 mmol, 1.5 equiv) and bromomethyl methyl ether (0.040 
mL, 0.49 mmol, 2.0 equiv). The resulting mixture was stirred for 3 h, whereupon the 
reaction was quenched with a saturated aqueous NaHCO3 solution (5 mL) and the 
aqueous layer was extracted with EtOAc (3 x 10 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude residue was purified by silica gel flash 
column chromatography (10% EtOAc/hexanes) to afford ether 277 as a colorless oil (61 
mg, 74% yield): 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.13 (m, 5H), 5.88 (dddt, J = 27.1, 
17.3, 10.1, 7.4 Hz, 1H), 5.15 – 4.99 (m, 2H), 4.97 – 4.84 (m, 1H), 4.78 – 4.68 (m, 2H), 
4.65 (dd, J = 7.7, 6.9 Hz, 1H), 3.59 – 3.41 (m, 2H), 3.39 (d, J = 1.1 Hz, 4H), 2.75 – 2.30 
(m, 4H), 2.30 – 1.89 (m, 5H). 
 
  
3-Allyl 1-(tert-butyl) 3-(2-methylallyl)-4-oxopiperidine-1,3-dicarboxylate (280). To a 
solution of NaH (4.2 g, 130 mmol, 2.5 equiv, 60% in mineral oil) in THF (45 mL) at 0 °C 
was added a solution of 1-Boc-4-piperidone (10.0 g, 50.2 mmol, 1.0 equiv) in THF (20 
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carbonate (11 mL, 75 mmol, 1.5 equiv) was added, and the solution was stirred for an 
additional 18 h. The reaction was quenched with a saturated aqueous solution of NH4Cl 
(30 mL) and acidified (pH = 4) with 1 M HCl. The aqueous layer was extracted with 
EtOAc (3 x 60 mL), washed with brine (60 mL), dried over Na2SO4, and concentrated 
under reduced pressure.  
 To a solution of the crude residue in acetone (60 mL) was added potassium 
carbonate (14 g, 104 mmol, 2.0 equiv), tetrabutylammonium iodide (0.96 g, 2.6 mmol, 
0.1 equiv), and methallyl chloride (10.0 mL, 104 mmol, 2.0 equiv). The resulting solution 
was heated to 45 °C for 18 h, whereupon the reaction mixture was cooled to ambient 
temperature, filtered through a pad of silica, rinsing with acetone, and concentrated under 
reduced pressure. The crude residue was purified by silica gel flash column 
chromatography (10–20% EtOAc/hexanes) to afford functionalized piperidone 280 as a 
colorless oil (2.9 g, 17% yield over 2 steps): 1H NMR (400 MHz, CDCl3) δ 5.90 (ddt, J = 
17.2, 10.3, 5.9 Hz, 1H), 5.39 – 5.20 (m, 2H), 4.88 (t, J = 1.7 Hz, 1H), 4.74 (dp, J = 2.9, 
1.0 Hz, 1H), 4.68 – 4.57 (m, 3H), 4.32 – 4.06 (m, 1H), 3.34 – 3.18 (m, 1H), 3.09 (d, J = 
13.7 Hz, 1H), 2.78 – 2.67 (m, 2H), 2.55 – 2.41 (m, 2H), 1.75 (t, J = 1.1 Hz, 1H), 1.71 (t, J 
= 1.1 Hz, 3H), 1.51 (d, J = 2.1 Hz, 9H); 13C NMR (101 MHz, CDCl3) δ 208.8, 203.8, 
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Tert-butyl (S)-3-allyl-3-(2-methylallyl)-4-oxopiperidine-1-carboxylate (281). In a 
nitrogen-filled glove box, to 1 dram vial equipped with a stir bar was added Pd2(dba)3 (12 
mg, 0.013 mmol, 2.5 mol %), (S)-L15 (17 mg, 0.033 mmol, 6.25 mol %), and THF (10 
mL). The resulting solution was stirred at 25 °C for 10 min, whereupon substrate 280 
(0.18 g, 0.52 mmol, 1.0 equiv) was added. The flask was sealed and stirred at ambient 
temperature for 18 h, whereupon the flask was removed from the glove box and 
concentrated under reduced pressure. The crude residue was purified by silica gel flash 
column chromatography (8% EtOAc/hexanes) to provide allylic alkylation product 81 as 
a colorless oil (0.11 g, 73% yield): 90% ee; 1H NMR (400 MHz, CDCl3) δ 5.68 (dddd, J 
= 17.0, 10.3, 7.9, 6.8 Hz, 1H), 5.19 – 4.95 (m, 2H), 4.86 (s, 1H), 4.70 (d, J = 1.0 Hz, 1H), 
3.95 – 3.35 (m, 4H), 2.71 – 2.19 (m, 6H), 1.66 (d, J = 0.7 Hz, 3H), 1.49 (s, 9H); 13C 
NMR (101 MHz, CDCl3) δ 154.9, 141.2, 132.9, 119.1, 115.8, 80.5, 52.9, 41.3, 39.1, 38.3, 
31.7, 28.5, 24.5, 22.8, 14.3; HPLC conditions: 0.9% EtOH, 1.0 mL/min, Chiralpak AD & 




(282). Please note Relative stereochemistry was not confirmed. To a solution of ketone 
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0.057 mL, 0.057 mmol, 0.2 equiv) followed by BH3•DMS (2 M, 0.35 mL, 0.70 mmol, 
2.0 equiv). The resulting solution was stirred for 7 h, whereupon a second aliquot of 
BH3•DMS (2 M, 0.10 mL, 0.20 mmol, 0.7 equiv) was added.  The reaction was stirred for 
an additional 3.5 h, quenched with MeOH (5 mL) and a saturated aqueous sodium citrate 
solution (10 mL), then warmed to ambient temperature and stirred for an additional 15 
min. The aqueous layer was extracted with Et2O (3 x 10 mL), dried over Mg2SO4, and 
concentrated under reduced pressure. The crude residue was purified by silica gel flash 
column chromatography (30% EtOAc/hexanes) to afford alcohol 282 as an inseparable 
mixture (4:1) of diastereomers and a colorless oil (83 mg, 33% yield): 1H NMR (400 
MHz, CDCl3) δ 6.20 – 5.85 (m, 1H), 5.23 – 5.06 (m, 2H), 5.03 – 4.94 (m, 1H), 4.86 (s, 
1H), 4.04 – 3.13 (m, 2H), 3.01 – 2.84 (m, 2H), 2.43 – 2.19 (m, 3H), 2.01 (d, J = 13.7 Hz, 
1H), 1.89 – 1.79 (m, 3H), 1.56 (q, J = 2.3, 1.8 Hz, 11H); 13C NMR (101 MHz, CDCl3) δ 
155.2, 143.4, 134.3, 118.4, 118.2, 115.8, 115.6, 42.4, 41.9, 37.5, 29.7, 28.8, 28.4, 25.4, 
25.4. 
 
A13.8.2.4 Experimental Procedures and Spectroscopic Data for the Synthesis 
of Synthetic Intermediates in Section A13.5 
 
 
4-((Tert-butyldiphenylsilyl)oxy)piperidin-2-one (291). To a solution of 3 M 
HCl/EtOAc (0.5 mL) at 0 °C was added 28735 (0.10 g, 0.22 mmol, 1.0 equiv). The 
resulting mixture was stirred for 1 h, whereupon the reaction was concentrated under 
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100% acetone/hexanes) to afford deprotected lactam 291 as a colorless solid (51 mg, 66% 
yield): 1H NMR (400 MHz, CDCl3) δ 7.78 – 7.32 (m, 10H), 7.17 (s, 1H), 4.15 (p, J = 4.9 
Hz, 1H), 3.69 – 3.42 (m, 1H), 3.27 – 2.99 (m, 1H), 2.41 (dd, J = 4.8, 1.6 Hz, 2H), 1.74 (q, 
J = 5.7 Hz, 2H), 1.07 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 171.9, 135.7, 135.7, 133.7, 
133.4, 129.9, 129.9, 127.8, 127.8, 65.8, 40.5, 37.8, 29.9, 26.9, 19.1. 
 
 
3-(Allyloxy)-3-oxopropanoic acid (294). A solution of Meldrum’s acid (20.0 g, 0.14 
mmol, 1.0 equiv) in allyl alcohol (40 mL) was heated under reflux for 18 h, whereupon 
the reaction was cooled to ambient temperature and concentrated under reduced pressure. 
The crude residue was dissolved in MeOH (60 mL), aqueous ammonia (50%, 7 mL) was 
added, the resulting solution was stirred for 15 min, and then concentrated under reduced 
pressure. The crude residue was washed with hexanes/Et2O (1:1, 2 x 15 mL), dissolved in 
H2O (20 mL) and acidified with 1 M HCl. The aqueous layer was extracted with Et2O (3 
x 30 mL), washed with brine, dried over Na2SO4, and concentrated under reduced 
pressure to give acid 294 as a colorless solid (13.0 g, 65% yield).  
 
 
Allyl 3-((3-hydroxypropyl)(3-methoxy-3-oxopropyl)amino)-3-oxopropanoate (295). 
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dimethylaminopyridine (0.15 g, 1.2 mmol, 0.1 equiv), NEt3 (4.5 mL, 32 mmol, 2.6 equiv) 
in CH2Cl2 (24 mL) at 0 °C was added acid 294 (2.3 g, 16 mmol, 1.3 equiv) followed by 
EDCI•HCl (3.1 g, 16 mmol, 1.3 equiv) portionwise. The resulting solution was stirred for 
18 h, whereupon the reaction was quenched with 1 M HCl (pH < 7), extracted with 
CH2Cl2 (3 x 20 mL), washed with brine, dried over Na2SO4, and concentrated under 
reduced pressure to afford β-ketoamide 295 as a colorless oil (2.7 g, 76% yield): 1H 
NMR (400 MHz, CDCl3) δ 6.02 – 5.76 (m, 1H), 5.47 – 5.13 (m, 2H), 4.63 (ddtt, J = 4.8, 
3.8, 2.5, 1.2 Hz, 2H), 3.89 – 3.18 (m, 7H), 2.64 (td, J = 7.1, 4.4 Hz, 1H), 2.06 – 1.44 (m, 
1H); 13C NMR (101 MHz, CDCl3) δ 172.6, 171.3, 167.7, 131.5, 119.2, 118.9, 66.3, 66.2, 
66.1, 58.2, 52.3, 45.8, 43.9, 42.1, 41.4, 40.9, 33.2, 32.3, 31.1, 30.2. 
 
 
Allyl 1-(3-hydroxypropyl)-2,4-dioxopiperidine-3-carboxylate (296). To allyl alcohol 
(35 mL) was added Na metal (0.67 g, 29 mmol, 2.1 equiv) followed by β-ketoamide 295 
(4.0 g, 14 mmol, 1.0 equiv). The resulting solution was heated under reflux for 18 h, 
whereupon the reaction was cooled to ambient temperature and concentrated under 
reduced pressure. The crude residue was dissolved in H2O (30 mL) and the aqueous layer 
was extracted with EtOAc (3 x 30 mL). The aqueous layer was then acidified with 6 M 
HCl and extracted with 10% isopropanol/CH2Cl2 (3 x 30 mL). The combined organics 
were dried over Na2SO4 and concentrated under reduced pressure. The crude residue was 
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yellow oil (1.9 g, 52% yield): 1H NMR (400 MHz, CDCl3) δ 5.99 (ddt, J = 17.2, 10.5, 5.5 
Hz, 1H), 5.50 – 5.41 (m, 1H), 5.28 (dt, J = 10.5, 1.4 Hz, 1H), 4.81 (dt, J = 5.5, 1.5 Hz, 
2H), 4.03 (p, J = 6.1 Hz, 3H), 3.57 (q, J = 6.0, 5.6 Hz, 4H), 3.46 – 3.37 (m, 2H), 2.67 (t, J 




















Appendix 13 – Progress Toward the Synthesis of (+)-Isopalhinine A 
  
A13.8.2.5 Determination of Enantiomeric Excess 
Please note racemic products for palladium-catalyzed allylic alkylations were 
synthesized using Pd(PPh3)4. Racemic products for iridium-catalyzed allylic alkylations 
were synthesized using racemic L2.  
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Spectra Relevant to Appendix 13: 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Notebook Cross-Reference for New Compounds 
 
 
The following notebook cross-reference provides the file name for all original 
spectroscopic data obtained for new compounds presented within this thesis. The 
information is organized by chapter or appendix and sequentially by compound 
number. All 1H NMR, 13C NMR, as well as 19F NMR and any two-dimensional NMR 
data, if applicable, are electronically stored on the Caltech NMR laboratory server 
(mangia.caltech.edu, most typically under the usernames ‘sshockle’, ‘chethcox’, or 
‘jholder’) and on the Stoltz group server. Electronic copies of all IR spectra can also 
be found on the Stoltz group server. All laboratory notebooks are stored in the Stoltz 














Appendix 15 – Notebook Cross-Reference for New Compounds 	
Table A15.1 Notebook cross-reference for compounds in Chapter 1 
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Appendix 15 – Notebook Cross-Reference for New Compounds 	
Table A15.2 Notebook cross-reference for compounds in Chapter 2 
 
 


































































































































Appendix 15 – Notebook Cross-Reference for New Compounds 	
Table A15.3 Notebook cross-reference for compounds in Chapter 3 
 
 





















































Appendix 15 – Notebook Cross-Reference for New Compounds 	
 

















































































































Appendix 15 – Notebook Cross-Reference for New Compounds 	
 
 






















































































Appendix 15 – Notebook Cross-Reference for New Compounds 	
















































































Appendix 15 – Notebook Cross-Reference for New Compounds 	
 
 











































































































































































Appendix 15 – Notebook Cross-Reference for New Compounds 	
Table A15.5 Notebook cross-reference for compounds in Appendix 8 
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Appendix 15 – Notebook Cross-Reference for New Compounds 	
Table A15.6 Notebook cross-reference for compounds in Appendix 11 
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